DEFM14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the
Registrant þ
Filed by a Party other than the
Registrant o
Check the appropriate box:
o Preliminary
Proxy Statement
o Confidential,
for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
þ Definitive
Proxy Statement
o Definitive
Additional Materials
o Soliciting
Material Under
Rule 14a-12
DARWIN PROFESSIONAL UNDERWRITERS, INC.
(Name of Registrant as Specified in
Its Charter)
(Name of Person(s) Filing Proxy
Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
o No
fee required.
|
|
o |
Fee computed on table below per Exchange Act
Rules 14a-6(i)(1)
and 0-11.
|
|
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act
Rule 0-11
(set forth the amount on which the filing fee is calculated and
state how it was determined):
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
(5) Total fee paid:
þ Fee
paid previously with preliminary materials.
|
|
o |
Check box if any part of the fee is offset as provided by
Exchange Act
Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
|
|
|
(1)
|
Amount previously paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
(4) Date Filed:
DARWIN
PROFESSIONAL UNDERWRITERS, INC.
9
Farm Springs Road
Farmington, CT 06032
September 16, 2008
Dear Stockholder:
On behalf of the board of directors of Darwin Professional
Underwriters, Inc. (Darwin), I cordially invite you
to a special meeting of stockholders of Darwin, to be held on
October 15, 2008, at 10:00 a.m. local time, located at
Darwins principal corporate offices at 9 Farm Springs
Road in Farmington, Connecticut.
At the special meeting, you will be asked to consider and vote
on (i) a proposal to adopt the Agreement and Plan of
Merger, dated as of June 27, 2008, by and among Darwin,
Allied World Assurance Company Holdings, Ltd (Allied
World), and Allied World Merger Company, an indirect
wholly owned subsidiary of Allied World, and (ii) a
proposal to approve the adjournment of the special meeting, if
Darwin deems such adjournment to be necessary or appropriate, to
solicit additional proxies if there are insufficient votes at
the time of the special meeting to adopt the merger agreement.
If the merger is consummated, Darwin, as the surviving
corporation, will become an indirect wholly owned subsidiary of
Allied World and you will be entitled to receive the merger
consideration of $32.00 per share in cash, without interest and
less any applicable withholding taxes, for each share of our
common stock that you own at the consummation of the merger, as
more fully described in the enclosed proxy statement. The
consideration you will receive is subject to a potential
downward price adjustment in the event that certain
representations by Darwin in the merger agreement with respect
to its capitalization prove to be inaccurate and, as a result of
such inaccuracy, the aggregate consideration payable by Allied
World in the merger would otherwise be increased by more than
$1,000,000.
After careful consideration, our board of directors, acting upon
the unanimous recommendation of a special committee of the board
of directors consisting of four independent directors, approved
the merger agreement and determined that the merger and the
other transactions contemplated by the merger agreement are in
the best interests of Darwin and its stockholders. Our board
of directors recommends that you vote FOR the
adoption of the merger agreement and FOR the
adjournment of the special meeting, if Darwin deems such
adjournment to be necessary or appropriate, to solicit
additional proxies if there are insufficient votes at the time
of the special meeting to adopt the merger agreement.
The accompanying proxy statement provides you with information
about the special meeting, the merger agreement, the merger and
the other transactions contemplated by the merger agreement. A
copy of the merger agreement is attached as Annex A to the
proxy statement. We encourage you to read the entire proxy
statement and the merger agreement carefully. You may also
obtain more information about Darwin from documents we have
filed with the Securities and Exchange Commission.
Your vote is very important. We cannot
complete the merger unless the majority of the outstanding
shares of common stock entitled to be cast at the special
meeting are voted FOR the adoption of the merger
agreement. The failure of any stockholder to vote on the
proposal to adopt the merger agreement will have the same effect
as a vote against the adoption of the merger agreement. As more
fully described in Voting Agreement beginning on
page 56, Alleghany Insurance Holdings LLC, a wholly owned
subsidiary of Alleghany Corporation, which owns approximately
55% of Darwins outstanding common stock, has agreed to,
among other things, vote a number of shares equal to 40% of
Darwins outstanding voting stock in favor of adoption of
the merger agreement, subject to certain limitations and the
occurrence of certain events, pursuant to the terms of a voting
agreement entered into with Allied World.
Whether or not you plan to attend the special meeting, please
complete, date, sign and return, as promptly as possible, the
enclosed proxy in the accompanying reply envelope, or submit
your proxy by telephone or the Internet, using the telephone
number or Internet voting instructions printed on your proxy
card prior to the special meeting to ensure that your shares
will be represented at the special meeting if you are unable to
attend. If you have Internet access, we encourage you to record
your vote via the Internet. If you return your signed proxy
card, but do not mark the boxes showing how you wish to vote,
all of your shares of
i
common stock will be voted FOR the proposal to adopt
the merger agreement and FOR the proposal to adjourn
the special meeting, if Darwin deems such adjournment to be
necessary or appropriate, to solicit additional proxies in the
event there are insufficient votes at the time of the special
meeting to adopt the merger agreement. If you attend the special
meeting and vote in person, your vote by ballot will revoke any
proxy previously submitted.
Thank you in advance for your cooperation and continued support.
Sincerely,
Mark I. Rosen
Executive Vice President, General Counsel
and Secretary
Neither the Securities and Exchange Commission nor any state
securities regulatory agency has approved or disapproved the
merger, passed upon the merits or fairness of the merger or
passed upon the adequacy or accuracy of the disclosure in this
document. Any representation to the contrary is a criminal
offense.
The proxy statement is dated September 16, 2008, and is
first being mailed to stockholders on or about
September 16, 2008.
ii
DARWIN
PROFESSIONAL UNDERWRITERS, INC.
9 Farm Springs Road
Farmington, CT 06032
NOTICE OF SPECIAL MEETING OF
STOCKHOLDERS
To Be Held On October 15, 2008
Dear Stockholder:
A special meeting of stockholders of Darwin Professional
Underwriters, Inc., a Delaware corporation (Darwin),
will be held on October 15, 2008, at 10:00 a.m. local
time, located at Darwins principal corporate offices at
9 Farm Springs Road in Farmington, Connecticut, for the
following purposes:
1. To consider and vote on a proposal to adopt the
Agreement and Plan of Merger, dated as of June 27, 2008
(the Merger Agreement), by and among Darwin, Allied
World Assurance Company Holdings, Ltd, a Bermuda company
(Allied World), and Allied World Merger Company, a
Delaware corporation and an indirect wholly owned subsidiary of
Allied World (MergerCo). A copy of the Merger
Agreement is attached as Annex A to the accompanying proxy
statement. Pursuant to the terms of the Merger Agreement,
MergerCo will merge with and into Darwin (the
Merger), with Darwin as the surviving corporation.
If the Merger is consummated, Darwin will become an indirect
wholly owned subsidiary of Allied World and you will be entitled
to receive the merger consideration of $32.00 per share in cash,
without interest and less any applicable withholding taxes, for
each share of our common stock that you own at the consummation
of the Merger (unless you properly exercise appraisal rights
under Delaware law), as more fully described in the enclosed
proxy statement. The consideration you will receive is subject
to a potential downward price adjustment in the event that
certain representations by Darwin in the Merger Agreement with
respect to its capitalization prove to be inaccurate and, as a
result of such inaccuracy, the aggregate consideration payable
by Allied World in the Merger would otherwise be increased by
more than $1,000,000.
2. To consider and vote on the adjournment of the special
meeting, if Darwin deems such adjournment to be necessary or
appropriate, to solicit additional proxies if there are
insufficient votes at the time of the meeting to adopt the
Merger Agreement.
3. To consider and vote on any other business that may
properly come before the special meeting.
Our board of directors has specified September 15, 2008, as
the record date for the purpose of determining the stockholders
who are entitled to receive notice of, and to vote at (in person
or by proxy), the special meeting. Only stockholders of record
at the close of business on the record date are entitled to
notice of, and to vote at (in person or by proxy), the special
meeting and at any adjournment or postponement thereof. Each
stockholder is entitled to one vote for each share of our common
stock held on the record date.
The adoption of the Merger Agreement requires that a majority of
the outstanding shares of our common stock entitled to be cast
at the special meeting be voted FOR the adoption of
the Merger Agreement. Even if you plan to attend the special
meeting in person, we request that you complete, sign, date and
return the enclosed proxy in the accompanying reply envelope or
submit your proxy by telephone or the Internet, using the
telephone number or Internet voting instructions printed on your
proxy card, prior to the special meeting to ensure that your
shares will be represented at the special meeting if you are
unable to attend. If you have Internet access, we encourage
you to record your vote via the Internet. If you return your
signed proxy card, but do not mark the boxes showing how you
wish to vote, all of your shares of common stock will be voted
FOR the proposal to adopt the Merger Agreement and
FOR the proposal to adjourn the special meeting, if
Darwin deems such adjournment to be necessary or appropriate, to
solicit additional proxies in the event there are insufficient
votes at the time of the special meeting to adopt the Merger
Agreement. If you fail to return your proxy card or fail to
submit your proxy by phone or the Internet, your shares will not
be counted for purposes of determining whether a quorum is
present at the meeting and will have the same effect as a vote
against the adoption of the Merger Agreement, but will not
affect the outcome of the vote regarding the adjournment
proposal. If you are a stockholder of record, voting in person
at the
iii
meeting will revoke any proxy previously submitted. If you hold
your shares through a bank, broker or other custodian, you must
obtain a legal proxy from such custodian in order to vote in
person at the meeting.
After careful consideration, our board of directors, acting upon
the unanimous recommendation of a special committee of the board
of directors consisting of four independent directors, approved
the Merger Agreement and determined that the Merger and the
other transactions contemplated by the Merger Agreement are
advisable and fair to, and in the best interests of, Darwin and
its stockholders. Our board of directors recommends that you
vote FOR the adoption of the Merger Agreement and
FOR the adjournment of the special meeting, if
Darwin deems such adjournment to be necessary or appropriate, to
solicit additional proxies if there are insufficient votes at
the time of the special meeting to adopt the Merger
Agreement.
Please note that space limitations make it necessary to limit
attendance at the special meeting to stockholders as of the
record date (or their authorized representatives) holding
admission tickets or other evidence of ownership. The admission
ticket is detachable from your proxy card. If your shares are
held by a bank or broker, please bring to the special meeting a
statement evidencing your beneficial ownership of our common
stock and photo identification.
Stockholders of Darwin who do not vote in favor of the adoption
of the Merger Agreement will have the right to seek appraisal of
the fair value of their shares of common stock if they deliver a
demand for appraisal before the vote is taken on the Merger
Agreement and comply with all requirements of Delaware law,
which are summarized in the accompanying proxy statement.
For more information about the Merger and the other
transactions contemplated by the Merger Agreement, please review
the accompanying proxy statement and the Merger Agreement
attached to it as Annex A. The proposal to adjourn the
special meeting, if Darwin deems such adjournment to be
necessary or appropriate, to solicit additional proxies in the
event that there are insufficient votes at the time of the
special meeting to adopt the Merger Agreement is also described
in the accompanying proxy statement.
Please do not send your stock certificates at this time. If
the Merger is completed, you will be sent instructions regarding
the surrender of your stock certificates.
By Order of the Board of Directors,
Mark I. Rosen
Executive Vice President, General Counsel and Secretary
Farmington, Connecticut
September 16, 2008
iv
TABLE OF
CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
1
|
|
|
|
|
10
|
|
|
|
|
14
|
|
|
|
|
15
|
|
|
|
|
16
|
|
|
|
|
16
|
|
|
|
|
16
|
|
|
|
|
16
|
|
|
|
|
17
|
|
|
|
|
18
|
|
|
|
|
18
|
|
|
|
|
18
|
|
|
|
|
18
|
|
|
|
|
18
|
|
|
|
|
19
|
|
|
|
|
19
|
|
|
|
|
25
|
|
|
|
|
27
|
|
|
|
|
32
|
|
|
|
|
33
|
|
|
|
|
33
|
|
|
|
|
39
|
|
|
|
|
40
|
|
|
|
|
41
|
|
|
|
|
41
|
|
|
|
|
42
|
|
|
|
|
42
|
|
|
|
|
42
|
|
|
|
|
43
|
|
|
|
|
43
|
|
|
|
|
43
|
|
|
|
|
44
|
|
|
|
|
46
|
|
|
|
|
48
|
|
|
|
|
48
|
|
|
|
|
49
|
|
|
|
|
50
|
|
|
|
|
51
|
|
|
|
|
52
|
|
|
|
|
52
|
|
|
|
|
52
|
|
|
|
|
53
|
|
|
|
|
53
|
|
v
|
|
|
|
|
|
|
Page
|
|
|
|
|
54
|
|
|
|
|
55
|
|
|
|
|
56
|
|
|
|
|
56
|
|
|
|
|
58
|
|
|
|
|
61
|
|
|
|
|
61
|
|
|
|
|
61
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
vi
SUMMARY
The following summary highlights selected information in this
proxy statement and may not contain all the information that may
be important to you. Accordingly, we encourage you to read
carefully this entire proxy statement, its annexes and the
documents referred to or incorporated by reference in this proxy
statement. Each item in this summary includes a page reference
directing you to a more complete description of that topic. See
Where You Can Find More Information beginning on
page 61. References to Darwin, the
Company, Surviving Corporation,
we, our or us in this proxy
statement refer to Darwin Professional Underwriters, Inc. and
its subsidiaries unless otherwise indicated by the context. We
refer to Allied World Assurance Company Holdings, Ltd as
Allied World or Parent, and Allied World
Merger Company as MergerCo.
The
Parties to the Merger (Page 15)
Darwin
Professional Underwriters, Inc.
Darwin was initially formed in March 2003 and became a publicly
traded company on May 19, 2006. We are a holding company,
the subsidiaries of which are engaged in insurance underwriting
and distribution across a spectrum of the specialty commercial
property-casualty insurance market. Darwin is focused on the
professional liability insurance market and underwrites
directors and officers liability for public and private
companies, errors and omissions liability insurance, medical
malpractice liability insurance, and other specialty coverages.
Darwin member companies include Darwin Professional
Underwriters, Inc., Darwin National Assurance Company and Darwin
Select Insurance Company. Darwins majority stockholder,
Alleghany Corporation (Alleghany), through its
wholly owned subsidiary, Alleghany Insurance Holdings LLC
(AIHL), owns approximately 55% of Darwins
issued and outstanding common stock.
Allied
World Assurance Company Holdings, Ltd
Allied World Assurance Company Holdings, Ltd is a Bermuda-based
specialty insurance and reinsurance holding company and its
subsidiaries underwrite a global, diversified portfolio of
property and casualty insurance and reinsurance lines of
business. Allied World was initially formed in November 2001 and
became a publicly traded company on the New York Stock Exchange
on July 11, 2006 under the symbol AWH. Allied
World writes direct property and casualty insurance as well as
reinsurance through its operations in Bermuda, the United
States, Ireland and the United Kingdom. Allied World has three
business segments: property insurance, casualty insurance and
reinsurance. The property segment provides direct coverage of
physical property and business interruption coverage for
commercial property and energy-related risks. The casualty
segment specializes in insurance products providing coverage for
general and product liability, professional liability and
healthcare liability risks. The reinsurance segment includes the
reinsurance of property, general casualty, professional
liability, specialty lines and property catastrophe coverages
written by other insurance companies. For more information about
Allied World, please visit its website at www.awac.com. Allied
Worlds website address is provided as an inactive textual
reference only. The information provided on this website is not
part of this proxy statement, and therefore is not incorporated
by reference.
Allied
World Merger Company
Allied World Merger Company, which we refer to as MergerCo, is a
Delaware corporation that was formed solely for the purpose of
completing the proposed Merger (as defined below). MergerCo is
an indirect wholly owned subsidiary of Allied World and has not
engaged in any business except for activities incidental to its
formation and as contemplated by the Agreement and Plan of
Merger (the Merger Agreement). Upon consummation of
the proposed Merger, MergerCo will cease to exist and Darwin
will continue as the surviving corporation, as an indirect
wholly owned subsidiary of Allied World.
1
The
Merger (Page 19)
The Merger Agreement provides as follows:
|
|
|
|
|
MergerCo will merge with and into Darwin (the
Merger); and
|
|
|
|
Darwin will be the surviving corporation in the Merger (the
Surviving Corporation) and will continue to do
business as Darwin Professional Underwriters, Inc.
following the Merger.
|
Each outstanding share of Darwin capital stock consisting of
common stock, par value $0.01 per share (the Common
Stock) (other than shares of Common Stock owned by Darwin,
its subsidiaries, Allied World, MergerCo or any of their wholly
owned subsidiaries or any stockholders who properly exercise
appraisal rights under Delaware law, as described in this proxy
statement), will be converted into the right to receive $32.00
in cash, without interest and less any applicable withholding
tax, and subject to the potential downward price adjustment
described below, which we refer to in this proxy statement as
the merger consideration.
Effects
of the Merger (Page 42)
If the Merger is completed, you will be entitled to receive the
merger consideration of $32.00 per share in cash, without
interest and less any applicable withholding taxes, for each
share of Common Stock owned by you, unless you have exercised
your statutory appraisal rights with respect to the Merger. Such
cash payment is subject to a potential downward price adjustment
in the event that certain representations by Darwin in the
Merger Agreement with respect to its capitalization prove to be
inaccurate and, as a result of such inaccuracy, the aggregate
consideration payable by Allied World in the Merger would
otherwise be increased by more than $1,000,000 (see The
Merger Agreement Potential Downward Purchase Price
Adjustment beginning on page 43). As a result of the
Merger, Darwin will cease to be an independent, publicly traded
company and our Common Stock will cease to be listed on any
stock exchange or quotation system. You will not own any shares
of or other interest in the Surviving Corporation.
The
Special Meeting (Page 16)
Time,
Place and Date (Page 16)
The special meeting will be held on October 15, 2008,
starting at 10:00 a.m. local time, and located at the
Companys principal corporate offices at 9 Farm
Springs Road in Farmington, Connecticut.
Purpose
(Page 16)
You will be asked to consider and vote on (i) the adoption
of the Merger Agreement, pursuant to which MergerCo will merge
with and into Darwin, (ii) the adjournment of the special
meeting, if Darwin deems such adjournment to be necessary or
appropriate, to solicit additional proxies if there are not
sufficient votes at the time of the special meeting to adopt the
Merger Agreement and (iii) any other business that may
properly come before the special meeting.
Record
Date and Quorum (Page 16)
You are entitled to vote at the special meeting if you owned
shares of Common Stock at the close of business on
September 15, 2008, the record date for the special
meeting. You will have one vote for each share of Common Stock
that you owned on the record date. As of the record date, there
were 17,017,866 shares of Common Stock outstanding and
entitled to vote. The presence in person or by proxy of
stockholders entitled to cast a majority of all the votes
entitled to be cast at the special meeting constitutes a quorum
for the purpose of considering the proposals.
Vote
Required (Page 16)
The adoption of the Merger Agreement requires that a majority of
the outstanding shares of Common Stock entitled to be cast at
the special meeting be voted FOR the adoption of the
Merger Agreement. Approval of the proposal to adjourn the
special meeting, if Darwin deems such adjournment to be
necessary or appropriate, to solicit additional proxies if there
are insufficient votes at the time of the special meeting to
adopt the Merger Agreement,
2
requires the affirmative vote of a majority of the votes present
and entitled to be cast at the special meeting, whether or not a
quorum is present.
As more fully described in Voting Agreement
beginning on page 56, AIHL, which owns approximately 55% of
Darwins outstanding Common Stock, has agreed to, among
other things, vote a number of shares of Common Stock equal to
40% of Darwins outstanding voting stock in favor of the
adoption of the Merger Agreement, subject to certain limitations
and the occurrence of certain events, pursuant to the terms of a
voting agreement entered into with Allied World and MergerCo
(the Voting Agreement). The Voting Agreement is
attached hereto as Annex D.
As of the record date, the directors and executive officers of
Darwin held in the aggregate approximately 8% of the shares of
Common Stock entitled to vote at the special meeting. In the
aggregate, these shares of Common Stock represent approximately
16% of the votes necessary to adopt the Merger Agreement at the
special meeting. All of our directors and executive officers
have advised us that they plan to vote all of their shares of
Common Stock in favor of the adoption of the Merger Agreement.
Voting
and Proxies (Page 16)
Any stockholder of record entitled to vote at the special
meeting may submit a proxy by telephone, the Internet, by
returning the enclosed proxy card by mail, or may vote in person
at the special meeting. If you intend to submit your proxy by
telephone or the Internet you must do so no later than
12:00 a.m., on October 15, 2008. If you do not return
your proxy card, submit your proxy by phone or the Internet or
attend the special meeting, your shares of Common Stock will not
be voted, which will have the same effect as a vote
AGAINST the adoption of the Merger Agreement. Even
if you plan to attend the special meeting, if you hold your
shares of Common Stock in your own name as the stockholder of
record, please vote your shares of Common Stock by completing,
signing, dating and returning the enclosed proxy card or by
using the telephone number printed on your proxy card or by
using the Internet voting instructions printed on your proxy
card.
If you return your signed proxy card, but do not mark the boxes
showing how you wish to vote, all of your shares of Common Stock
will be voted FOR the proposal to adopt the Merger
Agreement and FOR the proposal to adjourn the
special meeting, if Darwin deems such adjournment to be
necessary or appropriate, to solicit additional proxies if there
are insufficient votes at the time of the special meeting to
adopt the Merger Agreement.
If your shares of Common Stock are held in street
name by your broker, bank or nominee, you should instruct
your broker, bank or nominee on how to vote your shares of
Common Stock using the instructions provided by your broker,
bank or nominee. In the absence of specific instructions by you
on how to vote, your broker, bank or nominee will not be
entitled to vote your shares of Common Stock. Because the
adoption of the Merger Agreement requires that a majority of the
outstanding shares of Common Stock entitled to be cast at the
special meeting be voted FOR the adoption of the
Merger Agreement, the failure to provide your broker, bank or
nominee with voting instructions will have the same effect as a
vote AGAINST the proposal to adopt the Merger
Agreement. Because the proposal to adjourn the special meeting,
if Darwin deems such adjournment to be necessary or appropriate,
to solicit additional proxies if there are insufficient votes at
the time of the special meeting to adopt the Merger Agreement
requires the affirmative vote of a majority of the votes present
and entitled to be cast at the special meeting, whether or not a
quorum is present, and because your broker, bank or nominee does
not have discretionary authority to vote on that proposal, the
failure to provide your broker, bank or nominee with voting
instructions on how to vote your shares of Common Stock will
have no effect on the approval of that proposal.
Revocability
of Proxy (Page 17)
Any stockholder of record who executes and returns a proxy card
(or submits a proxy via telephone or the Internet) may revoke
the proxy at any time before the polls close at the special
meeting in any one of the following ways:
|
|
|
|
|
by notifying us in a signed written revocation, bearing a date
later than the date of the proxy, addressed and delivered to our
Executive Vice President, General Counsel and Secretary, Mark I.
Rosen, 9 Farm Springs Road, Farmington, CT 06032;
|
3
|
|
|
|
|
by attending the special meeting and voting in person (your
attendance at the meeting will not, by itself, revoke your
proxy; you must vote in person at the meeting); or
|
|
|
|
by submitting a later-dated proxy (including by telephone or the
Internet) relating to the same shares of Common Stock.
|
If you have instructed a broker, bank or other nominee to vote
your shares of Common Stock, you must follow the directions
received from your broker, bank or other nominee to change those
instructions.
Treatment
of Options and Other Awards (Page 43)
Stock Options. Immediately prior to the
effective time of the Merger, all outstanding options to acquire
shares of Common Stock under Darwins equity incentive
plans (Stock Options) will become fully vested. All
such Stock Options not exercised prior to the Merger will be
cancelled upon the consummation of the Merger and converted into
the right to receive a cash payment equal to the number of
shares of Common Stock underlying the Stock Options multiplied
by the amount (if any) by which the merger consideration of
$32.00 per share in cash exceeds the exercise price, without
interest and less any applicable withholding taxes. Such cash
payment is subject to a potential downward price adjustment in
the event that certain representations by Darwin in the Merger
Agreement with respect to its capitalization prove to be
inaccurate and, as a result of such inaccuracy, the aggregate
consideration payable by Allied World in the Merger would
otherwise be increased by more than $1,000,000.
Restricted Shares. Immediately prior to
the effective time of the Merger, all outstanding restricted
shares of Common Stock shall vest and become free of all
restrictions and, upon the consummation of the Merger, shall be
cancelled, retired and shall cease to exist and shall be
converted into the right to receive a cash payment equal to the
number of restricted shares of Common Stock multiplied by the
merger consideration of $32.00 per share in cash, without
interest and less any applicable withholding taxes. Such cash
payment is subject to a potential downward price adjustment in
the event that certain representations by Darwin in the Merger
Agreement with respect to its capitalization prove to be
inaccurate and, as a result of such inaccuracy, the aggregate
consideration payable by Allied World in the Merger would
otherwise be increased by more than $1,000,000.
Director Share Units. Upon the
consummation of the Merger, each director share unit that is
outstanding immediately prior to the Merger will be converted
into the right to receive an amount in cash equal to the merger
consideration of $32.00 per share unit in cash. Such cash
payment is subject to a potential downward price adjustment in
the event that certain representations by Darwin in the Merger
Agreement with respect to its capitalization prove to be
inaccurate and, as a result of such inaccuracy, the aggregate
consideration payable by Allied World in the Merger would
otherwise be increased by more than $1,000,000.
Recommendation
of the Special Committee and Our Board of Directors
(Page 25)
Special Committee. Our board of
directors (the Board) formed a committee of four
independent directors on February 28, 2008 (the
Special Committee) for the purpose of, among other
things, evaluating potential strategic alternatives for Darwin.
The Special Committee unanimously (i) determined that the
Merger Agreement and the transactions contemplated thereby,
including the Merger, are advisable and fair to, and in the best
interests of, Darwin and its stockholders and (ii) resolved
to recommend to the Board that it approve and declare advisable
the Merger Agreement and the transactions contemplated thereby,
including the Merger.
Board of Directors. The Board, acting
upon the unanimous recommendation of the Special Committee, has
(i) determined that the Merger Agreement and the
transactions contemplated thereby, including the Merger, are
advisable and fair to, and in the best interests of, Darwin and
its stockholders, (ii) approved and declared advisable the
Merger Agreement and the transactions contemplated thereby,
including the Merger, (iii) resolved to recommend that
Darwins stockholders adopt the Merger Agreement and
(iv) directed that the Merger Agreement be submitted to
Darwins stockholders for their adoption.
The
Voting Agreement (Page 56)
Concurrently with the execution of the Merger Agreement, AIHL,
which owns shares of Common Stock representing approximately 55%
of Darwins outstanding Common Stock, entered into the
Voting Agreement.
4
Under the terms of the Voting Agreement, AIHL agreed to, among
other things, and subject to certain limitations and the
occurrence of certain events, (i) vote a number of shares
of Common Stock equal to 40% of Darwins outstanding voting
stock in favor of the adoption of the Merger Agreement and
(ii) vote all of the shares of Common Stock it holds
against any other proposal or action that may hinder the
consummation of the Merger. In addition, AIHL agreed not to
transfer or encumber any of its shares of Common Stock.
AIHLs obligations under the Voting Agreement will
terminate upon the first to occur of (i) the effective time
of the Merger, (ii) the date upon which the Merger
Agreement is terminated in accordance with its terms,
(iii) the date upon which the Board withdraws (or amends or
modifies in a manner adverse to Allied World) or publicly
proposes to withdraw (or amend or modify in a manner adverse to
Allied World) its approval, recommendation or declaration of
advisability of the Merger Agreement, the Merger or the other
transactions contemplated by the Merger Agreement, or
recommends, adopts or approves, or proposes publicly to
recommend, adopt or approve, any company acquisition
proposal (as defined under The Merger
Agreement Restrictions on Solicitations of Other
Offers beginning on page 49) and
(iv) unless consented to by AIHL, the date of any amendment
to the Merger Agreement that is materially adverse to Darwin,
its stockholders or AIHL (including, without limitation, any
decrease in or change in the form of the consideration to be
paid to Darwins stockholders or the addition of any
material obligation or liability on the part of Darwin or its
stockholders).
Interests
of Darwins Directors and Executive Officers in the Merger
(Page 33)
In considering the recommendation of the Board that you vote to
adopt the Merger Agreement, you should be aware that our
directors and executive officers may have interests in the
Merger that are different from, or in addition to, your
interests as a stockholder, and that may present actual or
potential conflicts of interest. For example:
|
|
|
|
|
certain of our executive officers hold Stock Options which,
whether vested or unvested, will be cancelled and entitle such
holders (and all other holders of Stock Options) to receive in
cash the excess, if any, of the merger consideration of $32.00
per share over the option exercise price for each share of
Common Stock subject to the Stock Option, less any applicable
withholding taxes, without interest and subject to the potential
downward price adjustment;
|
|
|
|
|
|
certain of our executive officers hold restricted shares of
Common Stock which will vest and become free of all restrictions
and which will be cancelled and converted into the right to
receive a cash payment equal to the number of restricted shares
of Common Stock multiplied by the merger consideration of $32.00
per share in cash, plus any declared and unpaid dividends, less
any applicable withholding taxes, without interest and subject
to the potential downward price adjustment;
|
|
|
|
|
|
the non-employee members of our Board hold director share units
(issued under Darwins Stock and Unit Plan for Non-Employee
Directors, approved by Darwins stockholders, pursuant to
which a minimum of 50% of the fees for such directors
board and committee service are payable in director share units)
which will be converted into the right to receive an amount in
cash equal to the merger consideration of $32.00 per unit in
cash, and subject to the potential downward price adjustment;
|
|
|
|
|
|
certain of our executive officers have interests in
Darwins Long Term Incentive Plan (the LTIP)
and each such participants vested percentage in his
respective portion of the LTIP profit pools for fiscal years
2003 through 2008 shall be 100% upon the consummation of the
Merger, subject to forfeiture for termination for Cause (as
defined in the LTIP);
|
|
|
|
our current and former directors and officers will continue to
be indemnified after the completion of the Merger and will have
the benefit of liability insurance for six years after
completion of the Merger;
|
|
|
|
certain of our executive officers may be entitled to severance
benefits if, following the Merger, Darwin terminates such
executives employment for any reason other than for cause
or such executive terminates his employment for good reason;
|
5
|
|
|
|
|
certain members of our management team entered into employment
agreements with Darwin in connection with the Merger, which
provide for their continued employment effective as of the
closing of the Merger, subject to the terms and conditions set
forth in each employment agreement; and
|
|
|
|
our chief executive officer entered into an amendment to his
employment agreement, pursuant to which he will retire upon the
closing of the Merger, be entitled to certain payments and
benefits, and be subject to certain restrictive covenants for
two years following the closing of the Merger.
|
The Special Committee and the Board were aware of these
potential conflicts of interest and considered them, among other
matters, in reaching their decisions to approve the Merger
Agreement and the Merger and the recommendations that our
stockholders vote in favor of adopting the Merger Agreement.
Opinion
of UBS Securities LLC (Page 27)
In connection with the Merger, UBS Securities LLC
(UBS) delivered to each of the Special Committee and
the Board a written opinion dated June 27, 2008, addressed
to each of the Special Committee and the Board, to the effect
that, as of that date and based upon and subject to various
assumptions, matters considered and limitations described in its
opinion, the merger consideration of $32.00 per share in cash to
be received in the Merger by the holders of shares of Common
Stock (other than Alleghany, AIHL or any of their respective
affiliates) was fair, from a financial point of view, to such
holders.
The full text of UBS written opinion, dated June 27,
2008, is attached to this proxy statement as Annex B.
UBS opinion was provided for the benefit of the Special
Committee and the Board in connection with, and for the purpose
of, their evaluation of the merger consideration of $32.00 per
share in cash from a financial point of view and does not
address any other aspect of the Merger. The opinion does not
address the relative merits of the Merger as compared to other
business strategies or transactions that might be available with
respect to Darwin or Darwins underlying business decision
to effect the Merger. The opinion does not constitute a
recommendation to any stockholder as to how to vote or act with
respect to the Merger. Holders of shares of Common Stock are
encouraged to read UBS opinion carefully in its entirety
for a description of the assumptions made, procedures followed,
matters considered and limitations on the review undertaken by
UBS.
Financing
(Page 33)
The Merger is not conditioned upon Allied World or MergerCo
obtaining financing. Allied World and MergerCo estimate that the
total amount of cash funds necessary to consummate the Merger
and related transactions will be approximately
$550 million. Allied World has informed us that it expects
that its cash on hand will be sufficient to complete the
acquisition.
Regulatory
Approvals (Page 40)
Under the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the HSR
Act), and the rules promulgated thereunder by the Federal
Trade Commission (FTC), the Merger may not be
completed until notification and report forms have been filed
with the FTC and the Antitrust Division of the Department of
Justice (DOJ), and the applicable waiting period has
expired or been terminated. Darwin and Allied World filed
notification and report forms under the HSR Act with the FTC and
the Antitrust Division of the DOJ on July 14, 2008. Darwin
and Allied World received notice that the waiting period under
the HSR Act was terminated as of July 21, 2008. The Merger
is also subject to review by the governmental authorities of
various states under the antitrust laws of those states.
State insurance laws generally require that, prior to the
acquisition of control of an insurance company, the acquiring
party must obtain approval from the insurance commissioner of
the insurance companys state of domicile and any state in
which the insurance company is commercially domiciled.
Accordingly, Allied World has made the necessary applications
with the insurance commissioners of Delaware and Arkansas, which
are the states of domicile of Darwins insurance company
subsidiaries. As of the date of this proxy statement, Allied
World has not yet obtained the approvals under the applicable
state insurance laws that may be required to complete the
Merger. There can be no assurance that the insurance
commissioners will provide the approvals under the applicable
state
6
insurance laws. Subject to the terms and conditions provided in
the Merger Agreement, as promptly as practicable, each of Allied
World and Darwin has agreed to use reasonable best efforts to
take, or cause to be taken, all actions and do, or cause to be
done, all things necessary or appropriate to consummate the
Merger as soon as practicable, including obtaining the
termination of any waiting period under the HSR Act and seeking
the receipt of governmental consents (including the consents of
insurance regulators).
In addition, the insurance laws and regulations of certain
states in the United States require that, prior to an
acquisition of control of an insurance company doing business in
that state or licensed by that state (or the acquisition of its
holding company), a notice filing disclosing certain market
share data in the applicable jurisdiction must be made and an
applicable waiting period must expire or be terminated. These
notice filings have been made in the applicable jurisdictions.
Material
U.S. Federal Income Tax Consequences (Page 39)
Generally, the exchange of shares of Common Stock for cash
merger consideration will be a taxable transaction for
U.S. federal income tax purposes, and it may also be a
taxable transaction under applicable state, local, foreign or
other tax laws.
Tax matters can be complicated, and the tax consequences of
the Merger to you will depend on the facts of your own
situation. You should consult your tax advisor about the
particular tax consequences of the Merger to you.
Conditions
to the Merger (Page 48)
Completion of the Merger depends on a number of conditions being
satisfied or waived, including the following:
Conditions to Each Partys
Obligations. Each partys obligation to
complete the Merger is subject to the satisfaction or waiver of
the following conditions:
|
|
|
|
|
the majority of the outstanding shares of Common Stock entitled
to be cast at the special meeting shall have been voted
FOR the adoption of the Merger Agreement;
|
|
|
|
any applicable waiting period under the HSR Act shall have
expired or been terminated;
|
|
|
|
no order, injunction, decree or ruling (whether temporary,
preliminary or permanent) by any governmental authority of
competent jurisdiction that renders illegal or prohibits
consummation of the Merger shall be in effect; and
|
|
|
|
certain specified approvals or filings under all applicable
state laws regulating the business of insurance shall have been
obtained or filed.
|
Conditions to Allied Worlds and MergerCos
Obligations. The obligation of Allied World and
MergerCo to complete the Merger is subject to the satisfaction
or waiver of the following additional conditions:
|
|
|
|
|
our representations and warranties that (i) are not made as
of a specific date must be true and correct as of the date of
the Merger Agreement and as of the closing of the Merger and
(ii) are made as of a specific date must be true and
correct as of such date, in each case, except where the failure
of such representations or warranties to be true and correct
(without giving effect to any qualification as to materiality or
material adverse effect set forth in such representations and
warranties) has not had and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse
Effect (as defined under The Merger Agreement
Representations and Warranties beginning on page 44);
provided, however, that our representations and warranties with
respect to corporate status, corporate authority and the absence
of certain events since March 31, 2008 that have had or
would reasonably be expected to have a Material Adverse Effect
must be true and correct in all respects, in each case, as of
the date of the Merger Agreement and as of the closing of the
Merger;
|
|
|
|
we must have performed, in all material respects, our
obligations and complied with, in all material respects, our
agreements and covenants under the Merger Agreement; and
|
7
|
|
|
|
|
we must have delivered to Allied World and MergerCo a
certificate signed by an executive officer of Darwin with
respect to the satisfaction of the conditions relating to our
representations, warranties, obligations, covenants and
agreements.
|
Conditions to Darwins Obligations. Our
obligation to complete the Merger is subject to the satisfaction
or waiver of the following further conditions:
|
|
|
|
|
Allied Worlds and MergerCos representations and
warranties that (i) are not made as of a specific date must
be true and correct as of the date of the Merger Agreement and
as of the closing of the Merger and (ii) are made as of a
specific date must be true and correct as of such date, in each
case, except where the failure of such representations or
warranties to be true and correct (without giving effect to any
qualification as to materiality or parent material adverse
effect set forth in such representations and warranties) has not
had and would not reasonably be expected to have, individually
or in the aggregate, an effect, event, development or change
that would reasonably be expected to prevent or materially
hinder or delay Allied World or MergerCo from consummating the
Merger;
|
|
|
|
Allied World and MergerCo must have, in all material respects,
performed all of their obligations and complied with, in all
material respects, their agreements and covenants under the
Merger Agreement; and
|
|
|
|
Allied World must deliver to Darwin an officers
certificate with respect to the satisfaction of the conditions
relating to its representations, warranties, obligations,
covenants and agreements.
|
Termination
of the Merger Agreement and Termination Fees and Expenses (Pages
51 and 52)
The Merger Agreement may be terminated by mutual written consent
of Darwin and Allied World or by either Darwin or Allied World
under certain specified circumstances as more fully described in
The Merger Agreement Termination of the Merger
Agreement beginning on page 51. Upon termination of
the Merger Agreement under certain circumstances, Darwin may be
required to pay to Allied World a termination fee of
$16.5 million as more fully described in The Merger
Agreement Termination Fees and Expenses
beginning on page 52.
Restrictions
on Solicitations and Other Offers (Page 49)
During the term of the Merger Agreement, we have agreed not to:
|
|
|
|
|
initiate, solicit, knowingly encourage or knowingly facilitate
any inquiries or the making of any proposal or other action that
constitutes, or may reasonably be expected to lead to, any
company acquisition proposal;
|
|
|
|
enter into discussions or negotiate with any person in
furtherance of such inquiries or to obtain a company acquisition
proposal; or
|
|
|
|
enter into an agreement with respect to a company acquisition
proposal.
|
Notwithstanding the foregoing restrictions, at any time prior to
obtaining the approval of the Merger Agreement by our
stockholders, if we receive a company acquisition proposal that
was not received in breach of the foregoing restrictions, we may
contact the potential acquiror to determine whether the company
acquisition proposal is, or is reasonably likely to lead to, a
company superior proposal. If our Board or the Special Committee
determines in good faith after consultation with its legal and
financial advisors that such company acquisition proposal is, or
is reasonably likely to lead to, a company superior proposal,
then we are permitted to furnish information to or engage in
discussions or negotiations with the potential acquiror if we
provide Allied World with notice within 36 hours of any
such furnishing of information and the same information has been
previously or is currently provided to Allied World.
We must promptly advise Allied World in writing of any company
acquisition proposal (and in no event less than 36 hours
following our initial receipt of any company acquisition
proposal), the material terms and conditions of any such company
acquisition proposal (including any changes thereto) and the
identity of the party making any such company acquisition
proposal. We must also keep Allied World reasonably informed of
the status (including any change to the material terms and
conditions thereof) of any such company acquisition proposal.
8
Appraisal
Rights (Page 58)
Under Delaware law, holders of shares of Common Stock who do not
vote in favor of adopting the Merger Agreement will have the
right to seek appraisal of the fair value of their shares of
Common Stock as determined by the Delaware Court of Chancery if
the Merger is completed, but only if they comply with all
requirements of Section 262 of the Delaware General
Corporation Law, which are summarized in this proxy statement.
The text of Section 262 of the Delaware General Corporation
Law is attached as Annex C to this proxy statement. No
representation is made as to the outcome of the appraisal of
fair value as determined by the Delaware Court of Chancery, and
you should be aware that the fair value of your shares of Common
Stock as determined under Section 262 could be more than,
the same as, or less than the value that you are entitled to
receive under the terms of the Merger Agreement. Any holder of
shares of Common Stock intending to exercise such holders
appraisal rights, among other things, must submit a written
demand for an appraisal to us prior to the vote on the adoption
of the Merger Agreement and must not vote in favor of adoption
of the Merger Agreement in person or by proxy. Your failure to
follow exactly the procedures specified under Delaware law will
result in the loss of your appraisal rights. We encourage you to
read these provisions carefully in their entirety.
Market
Price of Common Stock (Page 55)
The merger consideration of $32.00 per share in cash to be paid
for each share of Common Stock in the Merger (which is subject
to a potential downward price adjustment in the event that
certain representations by Darwin in the Merger Agreement with
respect to its capitalization prove to be inaccurate and, as a
result of such inaccuracy, the aggregate consideration payable
by Allied World in the Merger would otherwise be increased by
more than $1,000,000) represents a premium of approximately
30.4% over the
90-day
average trading price of Darwins Common Stock on the New
York Stock Exchange (the NYSE) prior the
announcement of the Merger on June 30, 2008.
Certain
Litigation Related to the Merger (Page 41)
As of the date of this proxy statement, a purported class action
complaint has been served on Darwin, in connection with the
Merger, naming as defendants Darwin, the members of its board of
directors, and Allied World. Although Darwin, the members of its
board of directors and Allied World believe that the claims
asserted are without merit, on September 16, 2008, the
parties reached an agreement in principle to settle this
litigation, while specifically denying any wrongdoing by any of
the defendants. Pursuant to the proposed settlement, we have
agreed to make certain additional disclosures in Darwins
proxy statement, which are contained herein. The proposed
settlement is subject to the satisfaction of a number of
conditions, including the execution of a definitive settlement
agreement, final court approval of the settlement and notice to
our stockholders (see The Merger Certain
Litigation Related to the Merger beginning on
page 41).
9
QUESTIONS
AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER
The following questions and answers are intended to address
briefly some commonly asked questions regarding the Merger, the
Merger Agreement and the special meeting. These questions and
answers may not address all questions that may be important to
you as a Darwin stockholder. Please refer to the
Summary and the more detailed information contained
elsewhere in this proxy statement, the annexes to this proxy
statement and the documents referred to or incorporated by
reference in this proxy statement, which you should read
carefully. See Where You Can Find More Information
beginning on page 61.
Q. What matters will be voted on at the special
meeting?
A. You will vote on the following proposals: (1) to
adopt the Merger Agreement and (2) to approve the
adjournment of the special meeting to a later date, if we deem
such adjournment to be necessary or appropriate, to solicit
additional proxies if there are insufficient votes at the time
of the special meeting to adopt the Merger Agreement.
On June 27, 2008, we entered into a Merger Agreement with
Allied World and MergerCo. Under the Merger Agreement, Darwin,
as the surviving corporation, will become an indirect wholly
owned subsidiary of Allied World and holders of shares of Common
Stock will be entitled to receive the merger consideration of
$32.00 per share in cash (subject to a potential downward price
adjustment in the event that certain representations by Darwin
in the Merger Agreement with respect to its capitalization prove
to be inaccurate and, as a result of such inaccuracy, the
aggregate consideration payable by Allied World in the Merger
would otherwise be increased by more than $1,000,000), without
interest and less any applicable withholding tax. This proxy
statement contains important information about the Merger and
the special meeting, and you should read it carefully. The
enclosed voting materials allow you to vote your shares of
Common Stock without attending the special meeting.
Q. What will I receive in the Merger?
A. Upon completion of the Merger, you will be entitled to
receive the merger consideration of $32.00 per share in cash
(subject to a potential downward price adjustment in the event
that certain representations by Darwin in the Merger Agreement
with respect to its capitalization prove to be inaccurate and,
as a result of such inaccuracy, the aggregate consideration
payable by Allied World in the Merger would otherwise be
increased by more than $1,000,000), without interest and less
any applicable withholding tax, for each share of Common Stock
that you own, unless you have exercised your appraisal rights
with respect to the Merger. For example, if you own
100 shares of Common Stock, you will receive $3,200.00 in
cash in exchange for your 100 shares of Common Stock, less
any applicable withholding tax and subject to the potential
downward price adjustment. You will not own any shares or other
interest in the Surviving Corporation.
Q. When and where is the special meeting?
A. The special meeting of stockholders of Darwin will be
held on October 15, 2008, at 10:00 a.m. local time,
and located at the Companys principal corporate offices at
9 Farm Springs Road in Farmington, Connecticut.
Q. What vote is required for Darwins stockholders
to adopt the Merger Agreement?
A. The adoption of the Merger Agreement requires that a
majority of the outstanding shares of Common Stock entitled to
be cast at the special meeting be voted FOR the
adoption of the Merger Agreement. As more fully described in
Voting Agreement beginning on page 56, AIHL,
which owns approximately 55% of Darwins outstanding Common
Stock, has entered into a voting agreement under which it has
agreed, among other things, to vote a number of shares of Common
Stock equal to 40% of Darwins outstanding voting stock in
favor of the adoption of the Merger Agreement, subject to
certain limitations and the occurrence of certain events.
Q: What vote of our stockholders is required to approve
the proposal to adjourn the special meeting, if Darwin deems
such adjournment to be necessary or appropriate, to solicit
additional proxies if there are insufficient votes at the time
of the special meeting to adopt the Merger Agreement?
A. The proposal to adjourn the special meeting, if Darwin
deems such adjournment to be necessary or appropriate, to
solicit additional proxies if there are insufficient votes at
the time of the special meeting to adopt the Merger
10
Agreement requires the affirmative vote of a majority of the
votes present and entitled to be cast at the special meeting,
whether or not a quorum is present.
Q. How does the Board recommend that I vote?
A. The Board, acting upon the unanimous recommendation of
the Special Committee, recommends that you vote FOR
the proposal to adopt the Merger Agreement and FOR
the proposal to adjourn the special meeting, if Darwin deems
such adjournment to be necessary or appropriate, to solicit
additional proxies if there are not sufficient votes at the time
of the special meeting to adopt the Merger Agreement. You should
read The Merger Reasons for the Merger;
Recommendation of the Special Committee and Our Board
beginning on page 25 for a discussion of the factors that
the Special Committee and the Board considered in deciding to
recommend the adoption of the Merger Agreement.
Q. What
effects will the proposed Merger have on Darwin?
A. As a result of the proposed Merger, Darwin will cease to
be a stand-alone publicly-traded company and will be indirectly
wholly owned by Allied World. You will no longer have any
interest in Darwins future earnings or growth. Following
the consummation of the Merger, the registration of our Common
Stock and our reporting obligations with respect to our Common
Stock under the Securities Exchange Act of 1934, as amended (the
Exchange Act), will be terminated upon application
to the Securities and Exchange Commission (the SEC).
In addition, upon completion of the proposed Merger, our Common
Stock will no longer be listed on any stock exchange or
quotation system, including the NYSE.
Q. What
happens if the Merger is not consummated?
A. If the Merger Agreement is not adopted by our
stockholders or if the Merger is not completed for any other
reason, you will not receive any payment for your shares of
Common Stock in connection with the Merger. Instead, Darwin will
remain an independent public company and our Common Stock will
continue to be listed and traded on the NYSE. If the Merger
Agreement is terminated under specified circumstances, Darwin
may be required to pay to Allied World a termination fee of
$16.5 million as described under the caption The
Merger Agreement Termination Fees and Expenses
beginning on page 52.
Q. What
do I need to do now?
A. Even if you plan to attend the special meeting, after
carefully reading and considering the information contained in
this proxy statement, if you hold your shares of Common Stock in
your own name as the stockholder of record, please vote your
shares of Common Stock by (i) completing, signing, dating
and returning the enclosed proxy card, (ii) using the
telephone number printed on your proxy card or (iii) using
the Internet voting instructions printed on your proxy card. If
you have Internet access, we encourage you to record your vote
via the Internet. You can also attend the special meeting and
vote. Please DO NOT return your stock certificate(s) with
your proxy.
If your shares of Common Stock are held in street
name by your broker, after carefully reading and
considering the information contained in this proxy statement,
you should instruct your broker on how to vote your shares of
Common Stock using the instructions provided by your broker.
Q. How
do I vote?
A: You may vote by:
|
|
|
|
|
attending the special meeting and voting in person;
|
|
|
|
completing, signing and dating each proxy card you receive and
returning it in the enclosed prepaid envelope;
|
|
|
|
using the telephone number printed on your proxy card;
|
|
|
|
using the Internet voting instructions printed on your proxy
card; or
|
11
|
|
|
|
|
if you hold your shares of Common Stock in street
name, following the procedures provided by your broker,
bank or other nominee.
|
If you return your signed proxy card, but do not mark the boxes
showing how you wish to vote, all of your shares of Common Stock
will be voted FOR the proposal to adopt the Merger
Agreement and FOR the proposal to adjourn the
special meeting, if Darwin deems such adjournment to be
necessary or appropriate, to solicit additional proxies if there
are insufficient votes at the time of the meeting to adopt the
Merger Agreement.
Q. How
can I change or revoke my vote?
A. Any Darwin stockholder of record who executes and
returns a proxy card (or submits a proxy via telephone or the
Internet) may revoke the proxy at any time before the polls
close at the special meeting in any one of the following ways:
|
|
|
|
|
by notifying us in a signed written revocation, bearing a date
later than the date of the proxy, addressed and delivered to our
Executive Vice President, General Counsel and Secretary, Mark I.
Rosen, 9 Farm Springs Road, Farmington, CT 06032;
|
|
|
|
by attending the special meeting and voting in person (your
attendance at the meeting will not, by itself, revoke your
proxy; you must vote in person at the meeting); or
|
|
|
|
by submitting a later-dated proxy (including by telephone or the
Internet) relating to the same shares of Common Stock.
|
If you have instructed a broker, bank or other nominee to vote
your shares of Common Stock, you must follow the directions
received from your broker, bank or other nominee to change those
instructions.
Q. If my shares of Common Stock are held in street
name by my broker, bank or other nominee, will my broker,
bank or other nominee vote my shares for me?
A. Your broker, bank or other nominee will only be
permitted to vote your shares of Common Stock if you instruct
your broker, bank or other nominee how to vote. You should
follow the procedures provided by your broker, bank or other
nominee regarding the voting of your shares of Common Stock. If
you do not instruct your broker, bank or other nominee to vote
your shares of Common Stock, your shares of Common Stock will
not be voted and the effect will be the same as a vote
AGAINST the adoption of the Merger Agreement, but
will not have an effect on the proposal to adjourn the special
meeting.
Q. What do I do if I receive more than one proxy or set
of voting instructions?
A. You may receive more than one set of voting materials,
including multiple copies of this proxy statement and multiple
proxy cards or voting instruction cards. For example, if you
hold your shares of Common Stock in more than one brokerage
account, you will receive a separate voting instruction card for
each brokerage account in which you hold shares of Common Stock.
If you are a holder of record and your shares of Common Stock
are registered in more than one name, you will receive more than
one proxy card. Please complete, sign, date and return each
proxy card and voting instruction card that you receive to
ensure that all of your shares of Common Stock are voted.
Q. What happens if I sell my shares of Common Stock
before the special meeting?
A. The record date of the special meeting is earlier than
the date of the special meeting and the date that the Merger is
expected to be completed. If you transfer your shares of Common
Stock after the record date but before the special meeting, you
will retain your right to vote at the special meeting, but will
have transferred the right to receive the merger consideration
of $32.00 per share in cash to be received by our stockholders
in the Merger. In order to receive the merger consideration of
$32.00 per share in cash, you must hold your shares through
completion of the Merger.
12
Q. Am I entitled to exercise appraisal rights instead of
receiving the merger consideration for my shares of Common
Stock?
A. Yes. As a holder of shares of Common Stock, you are
entitled to appraisal rights under Delaware law in connection
with the Merger if you meet certain conditions. See
Dissenters Rights of Appraisal beginning on
page 58.
Q. When is the Merger expected to be completed?
A. We are working toward completing the Merger as quickly
as possible, and we anticipate that it will be completed in the
fourth calendar quarter of 2008. However, the exact timing of
the completion of the Merger cannot be predicted. In order to
complete the Merger, we must obtain stockholder approval and the
other closing conditions under the Merger Agreement must be
satisfied or waived.
Q. Is the Merger contingent upon Allied World obtaining
financing?
A. No. The Merger is not conditioned upon Allied World
or MergerCo obtaining financing. Allied World and MergerCo
estimate that the total amount of cash funds necessary to
consummate the Merger and related transactions will be
approximately $550 million. Allied World has informed us
that it expects that its cash on hand will be sufficient to
complete the acquisition.
Q. Will a proxy solicitor be used?
A. Yes. Darwin has engaged Georgeson Inc. to assist in the
solicitation of proxies for the special meeting and Darwin
estimates it will pay Georgeson Inc. a fee of approximately
$8,500. Darwin has also agreed to reimburse Georgeson Inc. for
reasonable administrative and out-of-pocket expenses incurred in
connection with the proxy solicitation and indemnify Georgeson
Inc., absent Georgeson Inc.s gross negligence or willful
misconduct, against certain losses, costs and expenses.
Q. Should I send in my stock certificates now?
A. No. After the Merger is completed, you will be sent
a letter of transmittal with detailed written instructions for
exchanging your Common Stock certificates for the merger
consideration. If your shares of Common Stock are held in
street name by your broker, bank or other nominee,
you will receive instructions from your broker, bank or other
nominee as to how to effect the surrender of your street
name shares in exchange for the merger consideration.
Please do NOT send your stock certificates in now.
Q. Who can help answer my other questions?
A. If you have additional questions about the Merger, need
assistance in submitting your proxy or voting your shares of
Common Stock, or need additional copies of the proxy statement
or the enclosed proxy card, please call Georgeson Inc. toll free
at 1-888-679-2903.
13
CAUTIONARY
STATEMENT CONCERNING FORWARD-LOOKING INFORMATION
This proxy statement, and the documents to which we refer you in
this proxy statement, include forward-looking statements,
including information relating to the Merger, based on estimates
and assumptions. There are forward-looking statements throughout
this proxy statement, including, without limitation, under the
headings Summary, Questions and Answers about
the Special Meeting and the Merger, The
Merger, and Opinion of Financial Advisor, and
in statements containing words such as believes,
estimates, anticipates,
continues, contemplates,
expects, may, will,
could, should, or would or
other similar words or phrases. These statements, which are
based on information currently available to us, are not
guarantees of future performance and may involve risks and
uncertainties that could cause our actual growth, results of
operations, performance and business prospects, and
opportunities to materially differ from those expressed in, or
implied by, these statements. These forward-looking statements
speak only as of the date on which the statements were made and
we expressly disclaim any obligation to release publicly any
updates or revisions to any forward-looking statement included
in this proxy statement or elsewhere. In addition to other
factors and matters contained or incorporated in this document,
these statements are subject to risks, uncertainties, and other
factors that could cause actual results to differ materially
from those in the forward-looking statements, including, among
others:
|
|
|
|
|
the occurrence of any event, change or other circumstances that
could give rise to the termination of the Merger Agreement;
|
|
|
|
the outcome of any legal proceedings that have been or may be
instituted against Darwin and others relating to the Merger
Agreement;
|
|
|
|
the inability to complete the Merger due to the failure to
obtain stockholder approval or the failure to satisfy other
conditions to consummation of the Merger;
|
|
|
|
the failure of the Merger to close for any other reason;
|
|
|
|
risks that the proposed transaction disrupts current plans and
operations and the potential difficulties in employee retention
as a result of the Merger;
|
|
|
|
the accuracy of assumptions underlying Darwins outlook;
|
|
|
|
the effect of the announcement of the Merger on our customer
relationships, operating results and business generally;
|
|
|
|
the amount of the costs, fees, expenses and charges related to
the Merger and the actual terms of certain financings that will
be obtained for the Merger; and
|
|
|
|
other risks described in our current filings with the SEC,
including our most recent filings on our Annual Report on
Form 10-K
for the year ended December 31, 2007 and our
Form 10-Qs
for the first and second quarters of 2008, which should be read
in conjunction with this proxy statement. See Where You
Can Find More Information beginning on page 61.
|
Many of the factors that will determine our future results are
beyond our ability to control or predict. In light of the
significant uncertainties inherent in the forward-looking
statements contained herein, readers should not place undue
reliance on forward-looking statements, which reflect
managements views only as of the date hereof. We cannot
guarantee any future results, levels of activity, performance or
achievements. The statements made in this proxy statement
represent our views as of the date of this proxy statement, and
it should not be assumed that the statements made herein remain
accurate as of any future date. Moreover, we assume no
obligation to update forward-looking statements or update the
reasons that actual results could differ materially from those
anticipated in forward-looking statements, except as required by
law.
14
THE
PARTIES TO THE MERGER
Darwin
Darwin Professional Underwriters, Inc.
9 Farm Springs Road
Farmington, CT 06032
860-284-1300
Darwin was initially formed in March 2003 and became a publicly
traded company on May 19, 2006. We are a holding company,
the subsidiaries of which are engaged in insurance underwriting
and distribution across a spectrum of the specialty commercial
property-casualty insurance market. Darwin is focused on the
professional liability insurance market and underwrites
directors and officers liability for public and private
companies, errors and omissions liability insurance, medical
malpractice liability insurance, and other specialty coverages.
Darwin member companies include Darwin Professional
Underwriters, Inc., Darwin National Assurance Company and Darwin
Select Insurance Company.
Our majority stockholder, Alleghany, through its wholly owned
subsidiary AIHL, indirectly owns approximately 55% of
Darwins outstanding Common Stock. Our Common Stock is
publicly traded on the NYSE under the symbol DR. For
more information about Darwin, please visit our website at
www.darwinpro.com. Our website address is provided as an
inactive textual reference only. The information provided on our
website is not part of this proxy statement, and therefore is
not incorporated by reference. See also Where You Can Find
More Information beginning on page 61.
Allied
World
Allied World Assurance Company Holdings, Ltd
27 Richmond Road
Pembroke HM 08, Bermuda
441-278-5400
Allied World Assurance Company Holdings, Ltd is a Bermuda-based
specialty insurance and reinsurance holding company and its
subsidiaries underwrite a global, diversified portfolio of
property and casualty insurance and reinsurance lines of
business. Allied World was initially formed in November 2001 and
became a publicly traded company on the NYSE on July 11,
2006 under the symbol AWH. Allied World writes
direct property and casualty insurance as well as reinsurance
through its operations in Bermuda, the United States, Ireland
and the United Kingdom. Allied World has three business
segments: property insurance, casualty insurance and
reinsurance. The property segment provides direct coverage of
physical property and business interruption coverage for
commercial property and energy-related risks. The casualty
segment specializes in insurance products providing coverage for
general and product liability, professional liability and
healthcare liability risks. The reinsurance segment includes the
reinsurance of property, general casualty, professional
liability, specialty lines and property catastrophe coverages
written by other insurance companies. For more information about
Allied World, please visit its website at www.awac.com. Allied
Worlds website address is provided as an inactive textual
reference only. The information provided on this website is not
part of this proxy statement, and therefore is not incorporated
by reference.
MergerCo
Allied World Merger Company
c/o Allied
World Assurance Company Holdings, Ltd
27 Richmond Road
Pembroke HM 08, Bermuda
441-278-5400
MergerCo is a Delaware corporation that was formed solely for
the purpose of completing the proposed Merger. MergerCo is an
indirect wholly owned subsidiary of Allied World and has not
engaged in any business except for activities incidental to its
formation and as contemplated by the Merger Agreement. Upon
consummation of the proposed Merger, MergerCo will cease to
exist and Darwin will continue as the Surviving Corporation.
15
THE
SPECIAL MEETING
Time,
Place and Purpose of the Special Meeting
This proxy statement is being furnished to our stockholders as
part of the solicitation of proxies by our Board for use at the
special meeting to be held on October 15, 2008, starting at
10:00 a.m. local time, located at the Companys
principal corporate offices at 9 Farm Springs Road in
Farmington, Connecticut, or at any postponement or adjournment
thereof. The purpose of the special meeting is for our
stockholders to consider and vote on (i) a proposal to
adopt the Merger Agreement, and (ii) a proposal to approve
the adjournment of the special meeting, if Darwin deems such
adjournment to be necessary or appropriate, to solicit
additional proxies if there are insufficient votes at the time
of the special meeting to adopt the Merger Agreement. Our
stockholders must adopt the Merger Agreement in order for the
Merger to occur. If our stockholders fail to adopt the Merger
Agreement, the Merger will not occur. A copy of the Merger
Agreement is attached to this proxy statement as Annex A.
You are urged to read the Merger Agreement in its entirety. This
proxy statement and the enclosed form of proxy are first being
mailed to our stockholders on September 16, 2008.
Record
Date and Quorum
We have fixed the close of business on September 15, 2008
as the record date for the special meeting, and only holders of
record of shares of Common Stock on the record date are entitled
to vote at the special meeting. On the record date, there were
17,017,866 shares of Common Stock outstanding and entitled
to vote. Each share of Common Stock entitles its holder to one
vote on all matters properly coming before the special meeting.
The presence in person or by proxy of stockholders entitled to
cast a majority of all the votes entitled to be cast at the
special meeting constitutes a quorum for the purpose of
considering the proposals. Shares of Common Stock represented at
the special meeting but not voted, including shares of Common
Stock for which proxies have been received but for which
stockholders have abstained, will be treated as present at the
special meeting for purposes of determining the presence or
absence of a quorum for the transaction of all business. In the
event that a quorum is not present at the special meeting, it is
expected that the meeting will be adjourned or postponed to
solicit additional proxies.
Vote
Required for Approval
The adoption of the Merger Agreement requires that a majority of
the outstanding shares of Common Stock entitled to be cast at
the special meeting be voted FOR the adoption of the
Merger Agreement. For the proposal to adopt the Merger
Agreement, you may vote FOR, AGAINST or
ABSTAIN. Abstentions will count for the purpose of
determining whether a quorum is present. If you abstain or
fail to vote, it will have the same effect as a vote
AGAINST the adoption of the Merger Agreement. If
you return your signed proxy card, but do not mark the boxes
showing how you wish to vote, all of your shares of Common Stock
will be voted FOR the proposal to adopt the merger
agreement and FOR the proposal to adjourn the
special meeting, if Darwin deems such adjournment to be
necessary or appropriate, to solicit additional proxies in the
event there are insufficient votes at the time of the special
meeting to adopt the merger agreement.
The adoption of the proposal to adjourn the special meeting, if
Darwin deems such adjournment to be necessary or appropriate, to
solicit additional proxies if there are insufficient votes at
the time of the special meeting to adopt the Merger Agreement
requires the affirmative vote of a majority of the votes present
and entitled to be cast at the special meeting, whether or not a
quorum is present. Therefore, if your shares of Common Stock are
present and entitled to be cast but you abstain, it will have
the same effect as a vote AGAINST the adoption of
the proposal to adjourn the special meeting. If your shares of
Common Stock are not present or are present but not entitled to
be cast, it will have no effect on the outcome of the proposal.
If your shares of Common Stock are held in street
name by your broker, bank or nominee, you should instruct
your broker, bank or nominee on how to vote your shares of
Common Stock using the instructions provided by your broker,
bank or nominee. In the absence of specific instructions, your
broker, bank or nominee will not be entitled to vote your shares
of Common Stock. Because the adoption of the Merger Agreement
requires that a majority of the outstanding shares of Common
Stock entitled to be cast at the special meeting be voted
FOR the adoption of the
16
Merger Agreement, the failure to provide your broker, bank or
nominee with voting instructions will have the same effect as a
vote AGAINST the proposal to adopt the Merger
Agreement. Because the proposal to adjourn the special meeting,
if Darwin deems such adjournment to be necessary or appropriate,
to solicit additional proxies if there are insufficient votes at
the time of the special meeting to adopt the Merger Agreement
requires the affirmative vote of a majority of the votes present
and entitled to be cast at the special meeting, whether or not a
quorum is present, and because your broker, bank or nominee does
not have discretionary authority to vote on that proposal, the
failure to provide your broker, bank or nominee with voting
instructions on how to vote your shares of Common Stock will
have no effect on the approval of that proposal.
As more fully described in Voting Agreement
beginning on page 56, pursuant to the terms of the Voting
Agreement, AIHL, which owns approximately 55% of Darwins
outstanding Common Stock, has agreed to, among other things,
vote a number of shares of Common Stock equal to 40% of
Darwins outstanding voting stock in favor of adoption of
the Merger Agreement, subject to certain limitations and the
occurrence of certain events.
As of September 15, 2008, the record date, the directors
and executive officers of Darwin held and are entitled to vote,
in the aggregate, 1,365,125 shares of Common Stock
representing approximately 8% of the outstanding shares of
Common Stock. The directors and executive officers have informed
Darwin that they currently intend to vote all of their shares of
Common Stock FOR the adoption of the Merger
Agreement.
Proxies
and Revocation
If you submit a proxy by telephone or the Internet or by
returning a signed proxy card by mail, your shares of Common
Stock will be voted at the special meeting as you indicate on
your proxy card or by such other method. If you return your
signed proxy card, but do not mark the boxes showing how you
wish to vote, all of your shares of Common Stock will be voted
FOR the proposal to adopt the Merger Agreement and
FOR the proposal to adjourn the special meeting, if
Darwin deems such adjournment to be necessary or appropriate, to
solicit additional proxies if there are insufficient votes at
the time of the special meeting to adopt the Merger Agreement,
and in accordance with the recommendations of our Board on any
other matters properly brought before the special meeting for a
vote.
If your shares of Common Stock are held in street name, you will
receive instructions from your broker, bank or other nominee
that you must follow in order to have your shares of Common
Stock voted.
Proxies received at any time before the special meeting, and not
revoked or superseded before being voted, will be voted at the
special meeting.
Any stockholder of record who executes and returns a proxy card
(or submits a proxy via telephone or the Internet) may revoke
the proxy at any time before the polls close at the special
meeting in any one of the following ways:
|
|
|
|
|
by notifying us in a signed written revocation, bearing a date
later than the date of the proxy, addressed and delivered to our
Executive Vice President, General Counsel and Secretary, Mark I.
Rosen, 9 Farm Springs Road, Farmington, CT 06032;
|
|
|
|
by attending the special meeting and voting in person (your
attendance at the meeting will not, by itself, revoke your
proxy; you must vote in person at the meeting); or
|
|
|
|
by submitting a later-dated proxy (including by telephone or the
Internet) relating to the same shares of Common Stock.
|
If you have instructed a broker, bank or other nominee to vote
your shares of Common Stock, you must follow the directions
received from your broker, bank or other nominee to change those
instructions.
Please do not send in your stock certificates with your proxy
card. When the Merger is completed, a separate letter of
transmittal will be mailed to you that will enable you to
receive the merger consideration in exchange for your stock
certificates.
17
Adjournments
and Postponements
Although it is not currently expected, the special meeting may
be adjourned, if Darwin deems such adjournment to be necessary
or appropriate, to solicit additional proxies if there are
insufficient votes at the time of the special meeting to adopt
the Merger Agreement. Any adjournment may be made without notice
(if the adjournment is not for more than 30 days and a new
record date is not set for the adjourned meeting) by an
announcement made at the special meeting of the time, date and
place of the adjourned meeting. Approval of the proposal to
adjourn the special meeting requires the affirmative vote of a
majority of the votes present and entitled to be cast at the
special meeting, whether or not a quorum is present. Any signed
proxies received by Darwin in which no voting instructions are
provided on such matter will be voted FOR an
adjournment of the special meeting, if Darwin deems such
adjournment to be necessary or appropriate, to solicit
additional proxies if there are insufficient votes at the time
of the special meeting to adopt the Merger Agreement. Any
adjournment or postponement of the special meeting to solicit
additional proxies will allow Darwins stockholders who
have already sent in their proxies to revoke them at any time
prior to their use at the special meeting as adjourned or
postponed.
Rights of
Stockholders Who Object to the Merger
Under Delaware law, holders of shares of Common Stock who do not
vote in favor of adopting the Merger Agreement will have the
right to seek appraisal of the fair value of their shares of
Common Stock as determined by the Delaware Court of Chancery if
the Merger is completed, but only if they comply with all
requirements of Section 262 of the Delaware General
Corporation Law, which are summarized in this proxy statement.
The text of Section 262 of the Delaware General Corporation
Law is attached as Annex C to this proxy statement. No
representation is made as to the outcome of the appraisal of
fair value as determined by the Delaware Court of Chancery, and
you should be aware that the fair value of your shares of Common
Stock as determined under Section 262 could be more than,
the same as, or less than the value that you are entitled to
receive under the terms of the Merger Agreement. Any holder of
shares of Common Stock intending to exercise such holders
appraisal rights, among other things, must submit a written
demand for an appraisal to us prior to the vote on the adoption
of the Merger Agreement and must not vote in favor of adoption
of the Merger Agreement in person or by proxy. Your failure to
follow exactly the procedures specified under Delaware law will
result in the loss of your appraisal rights. We encourage you to
read these provisions carefully in their entirety. See
Dissenters Rights of Appraisal beginning on
page 58 and the text of the Delaware appraisal rights
statute reproduced in its entirety as Annex C.
Solicitation
of Proxies
This proxy solicitation is being made and paid for by Darwin on
behalf of its Board. In addition, we have retained Georgeson
Inc. to assist in the solicitation. We will pay Georgeson Inc.
approximately $8,500 plus reasonable out-of-pocket expenses for
their assistance. Our directors, officers and employees may also
solicit proxies by personal interview, mail,
e-mail,
telephone, facsimile or other means of communication. These
directors, officers and employees will not be paid additional
remuneration for their efforts. We will also request brokers and
other fiduciaries to forward proxy solicitation material to the
beneficial owners of shares of Common Stock that the brokers and
fiduciaries hold of record. Upon request, we will reimburse the
brokers and other fiduciaries for their reasonable out-of-pocket
expenses. In addition, we will indemnify Georgeson Inc., absent
Georgeson Inc.s gross negligence or willful misconduct,
against any losses arising out of that firms proxy
soliciting services on our behalf.
Questions
and Additional Information
If you have more questions about the Merger or how to submit
your proxy, or if you need additional copies of this proxy
statement or the enclosed proxy card or voting instructions,
please call Georgeson Inc. at
1-888-679-2903.
Availability
of Documents
The reports, opinions or appraisals referenced in this proxy
statement will be made available for inspection and copying at
the principal executive offices of Darwin during its regular
business hours by any interested holder of shares of Common
Stock.
18
THE
MERGER
This discussion of the Merger is qualified in its entirety by
reference to the Merger Agreement, which is attached to this
proxy statement as Annex A. You should read the entire
Merger Agreement carefully as it is the legal document that
governs the Merger.
Background
of the Merger
Darwin was originally formed in March 2003 by Stephen J. Sills,
the president and chief executive officer of Darwin, and
Alleghany and became a publicly traded company in May 2006. In
August 2007, at the request of Alleghany, Darwin registered all
of the shares of Common Stock owned by Alleghany (which
currently represent approximately 55% of Darwins total
outstanding shares) to allow Alleghany to sell all or a part of
its equity interest in Darwin, if and when Alleghany decided to
sell such interest.
As they had done in the ordinary course of business in the past,
senior management of Alleghany and Darwin, in December 2007 and
January 2008, held discussions with respect to possible
strategic alternatives for Darwin. During that same time period,
in connection with Darwins periodic review of potential
business opportunities, Mr. Sills met separately with
senior management of three insurance companies to discuss the
trends and outlook for the insurance industry generally as well
as possible business opportunities for the companies.
Mr. Sills reported these discussions to the independent
members of the Board and to Mr. Weston M. Hicks, the
president and chief executive officer of Alleghany.
Mr. Sills, representatives of Alleghany, and the members of
the Board discussed whether, and how, a sales process should be
conducted, including the process of selecting an investment
banking firm to assist in the evaluation of potential strategic
alternatives. Following these discussions, it was agreed that
Darwins senior management would interview investment
banking firms to assist Darwin in evaluating potential strategic
alternatives to maximize value for Darwins stockholders,
including the continued pursuit of Darwins business plan.
Mr. Sills expressed his views that, at that time, targeted
discussions with one or more potential identified partners would
yield more benefit to Darwin and its stockholders than a broad,
open-ended auction process. Mr. Sills views were
based upon his concern that a broad, open-ended auction process
would result in rumors that would be detrimental to the business
operations of Darwin.
On February 28, 2008, in light of the foregoing
discussions, the Board held a meeting to discuss, among other
things, the potential strategic alternatives for Darwin. A
representative of Dewey & LeBoeuf LLP
(Dewey & LeBoeuf), legal counsel to
Darwin, participated in the meeting and reviewed with the
members of the Board their fiduciary duties associated with
their evaluation of Darwins strategic alternatives.
Following such presentation and discussion among the members of
the Board, the Board formed the Special Committee of independent
directors consisting of R. Bruce Albro, William C. Popik, George
M. Reider, Jr. and Irving B. Yoskowitz. The Board
authorized the Special Committee to, among other things,
examine, negotiate and evaluate potential strategic alternatives
for Darwin and any related matters.
On March 4, 2008, the Special Committee held a meeting to
elect a chair of the Special Committee and to identify and
retain legal counsel and a financial advisor to the Special
Committee. The Special Committee members elected
Mr. Yoskowitz to act as chair (the Chair) and
retained Cleary Gottlieb Steen & Hamilton LLP
(Cleary Gottlieb) to act as legal counsel to the
Special Committee. After meeting with three potential financial
advisors, the Special Committee decided to retain UBS as
financial advisor to the Special Committee.
From March 7, 2008 through March 18, 2008,
representatives of UBS met with members of Darwins senior
management, reviewed the market environment and reviewed certain
financial information and other data relating to the business
and financial prospects of the Company that were provided to UBS
by Darwins management.
On March 19, 2008, at a telephone meeting of the Special
Committee with representatives of Cleary Gottlieb and UBS,
representatives of UBS presented their preliminary analysis to
the Special Committee. A representative of Cleary Gottlieb
reviewed the fiduciary duties of the directors associated with
their evaluation of Darwins strategic alternatives. The
UBS representatives discussed the state of the mergers and
acquisitions market for insurance companies and various
considerations regarding Darwin and the property and casualty
sector generally, including the cyclical nature of Darwins
business. The UBS representatives also reviewed with the Special
Committee preliminary financial analyses of Darwin based on, in
part, information provided by Darwins management and an
19
indicative timeline for a potential sale process as well as a
preliminary list of parties, including domestic and
international insurance companies and financial buyers, that
might be interested in a business combination transaction with
Darwin. The Special Committee members discussed the analysis,
the timeline and the list of potential acquirors with the
representatives of UBS. After further deliberation, the Special
Committee members unanimously agreed that it was in the best
interests of Darwin and its stockholders to explore a potential
business combination transaction, including a possible sale of
Darwin. The Special Committee requested that, prior to
contacting potential strategic acquirors, UBS review the list of
such potential acquirors with Darwins management to
consider the likelihood that each such potential acquiror would
find a strategic fit with Darwins business.
On March 27, 2008, the Special Committee held a telephone
meeting with representatives of Cleary Gottlieb and UBS to
discuss the parties to be contacted in connection with a
potential business combination with Darwin. A representative of
Cleary Gottlieb reviewed the fiduciary duties of the directors
associated with their evaluation of Darwins strategic
alternatives. Representatives of UBS presented a list of
potential financial and strategic acquirors to the Special
Committee. A representative of UBS indicated that, as requested
by the Special Committee, the list of potential strategic
acquirors had been prepared after consultation with
Darwins senior management. In identifying the potential
acquirors, UBS considered their known or potential interest in a
transaction, their ability to complete a transaction of this
size in a timely manner and, in the case of strategic acquirors,
strategic interests that would be consistent with making a bid
for Darwin. Of the initial 21 potential acquirors presented to
the Special Committee, four were financial buyers, and the
others were insurance companies.
The Special Committee reviewed and discussed the list of
potential acquirors, the process for contacting such parties and
UBS further preliminary financial analyses of Darwin,
which had been prepared in consultation with Darwins
senior management and were based, in part, on information
provided by Darwins management. After such discussions,
the Special Committee instructed UBS to contact each of the
potential acquirors identified by UBS.
Beginning on March 31, 2008 and through the month of April,
UBS contacted representatives of each of the potential bidders.
During this process, two additional parties contacted UBS to
express interest in a potential transaction involving Darwin.
Eleven potential bidders executed confidentiality agreements
with Darwin containing customary confidentiality and standstill
provisions.
During the month of April 2008, each of the parties who executed
a confidentiality agreement received a process letter along with
confidential information regarding Darwins operations,
financial performance and growth strategy. Interested bidders
were asked to submit non-binding indications of interest by
May 7, 2008.
On May 7, 2008, UBS received initial non-binding
indications of interest from three potential acquirors. One of
the indications of interest was from Allied World. The other
bids were from two other insurance companies (referred to in
this Proxy Statement as Bidder A and Bidder B). Allied
Worlds indication of interest valued Darwins capital
stock between $27.00 and $30.00 per share and proposed a mixture
of cash and stock as consideration for 100% of the shares of
capital stock of Darwin. Bidder As indication of
interest valued the outstanding stock of Darwin in the range of
$433.70 million to $484.70 million, or between $25.50
and $28.50 per share, for 100% of Darwins outstanding
capital stock. Bidder Bs indication of interest
valued Darwins capital stock at $32.00 per share for 100%
of the outstanding stock (including shares underlying options or
other convertible securities) of Darwin. Bidder A and
Bidder B both proposed to pay 100% cash consideration. None
of the indications of interest contained a financing contingency.
On May 8, 2008, the Special Committee held a telephone
meeting to discuss the initial indications of interest.
Representatives of Cleary Gottlieb and UBS participated in the
meeting. The members of the Special Committee discussed the
three proposals including the price and key non-financial terms
and conditions. The Special Committee unanimously agreed to
request final offers and comments to a draft merger agreement
from Allied World and Bidder B. The Special Committee
instructed UBS to inform Bidder A that it would need to
raise its offer substantially in order to be permitted to
continue in the process.
UBS also communicated with Bidder A that it would need to
increase its offer substantially in order to be permitted to
continue in the process. Bidder A did not increase its
offer or otherwise continue in the process.
20
Management presentations to Allied World and Bidder B were
given on May 15, 2008 and May 23, 2008, respectively.
At the presentations, management provided information regarding
Darwins operations and business plan, recent financial
performance and prospects.
On May 28, 2008, UBS provided Allied World and
Bidder B with copies of a draft merger agreement and
requested that each submit its definitive bid, including a
mark-up of
the merger agreement, by no later than June 9, 2008.
Prior to June 2, 2008, Darwins management drafted a
proposal concerning compensation payable to Darwins
management and other employees, in the event of a change of
control of Darwin, under the incentive compensation plans of
Darwin in which such persons participate. On June 2, 2008,
prior to entering into negotiations with potential buyers, the
Compensation Committee of the Board and the Special Committee
held a joint telephone meeting to consider the proposal by
Darwins management. Representatives of Darwins
management attended the meeting in order to present their
proposal. Cleary Gottlieb, Dewey & LeBoeuf and
Alleghanys internal counsel participated in the meeting.
The proposal provided for, among other things, immediate vesting
of Darwins LTIP in the event of a change of control (as
provided for pursuant to the existing terms of the LTIP),
continued payouts under the plan for profit pool years 2003
through 2008, continuation of Darwins performance
incentive plan for 2008 with certain changes to the
administration of the plan and cash payments in lieu of
restricted stock and option awards that would be paid in
February 2009 pursuant to Darwins Stock Incentive Plan in
the absence of a change in control. After discussion, the
Compensation Committee and the Special Committee recommended
eliminating the cash payments in lieu of the restricted stock
and option awards and requiring that for an employee to receive
payments under the performance incentive plan, certain other
conditions would need to be satisfied. The joint meeting
adjourned. The Special Committee further discussed the proposal
and then approved a term sheet, as amended, to reflect the
changes discussed in the joint meeting.
On June 9, 2008, UBS received proposals from Allied World
and Bidder B. Allied World proposed to acquire 100% of
Darwins equity interests on a fully diluted basis for
$32.00 per share in cash or approximately $550 million in
the aggregate. The proposal, which included a revised draft of
the merger agreement, indicated it was subject to completion of
due diligence, agreement with certain key employees of Darwin
regarding their continued employment by Darwin following the
transaction and execution of a voting agreement by Alleghany
that would commit Alleghany to vote at least 40% of
Darwins shares of Common Stock in favor of the
acquisition. Allied World indicated that its offer would be
subject to revision if certain assumptions related to
Darwins retention bonus payments, LTIP accruals, deferred
underwriting fees and certain transaction fees were incorrect.
In addition, Allied World proposed in its revised draft of the
merger agreement that if Darwins representations and
warranties relating to its capitalization were not true and
correct in all respects as of the date of the merger agreement
and as of the closing of the merger, Allied World would have the
option not to close the merger (the Capitalization Closing
Condition). Bidder B proposed to acquire 100% of
Darwins outstanding stock (including shares underlying
options or other convertible securities) for $31.00 per share in
cash or approximately $532.2 million in the aggregate. The
proposal, which included a revised draft of the merger
agreement, indicated it was subject to completion of due
diligence, agreement with all key members of senior management
of Darwin regarding their continued employment by Darwin
following the transaction, including that they would invest
their after-tax proceeds from the transaction in the common
stock of Bidder B, and execution of a voting agreement with
Alleghany. Bidder Bs revised draft of the merger
agreement provided that the unavailability of any of specified
key members of management at the closing of the merger to
provide services to Darwin would be deemed an event that would
permit Bidder B to elect not to complete the transaction.
Following receipt of the proposals on June 9, 2008, the
Special Committee held a telephone meeting to review the
proposals. Representatives of Cleary Gottlieb and UBS
participated in the meeting. After discussion of the proposals,
the Special Committee determined that it needed more information
from the potential acquirors, including as to their respective
conditions related to the ongoing employment of Darwins
management. The Special Committee asked UBS to seek such
information from the potential acquirors and determine whether
either bidder was prepared to improve its proposal.
21
On June 11, 2008, representatives from Darwin, Allied World
and Willkie Farr & Gallagher LLP, legal counsel to
Allied World (Willkie), participated in a telephone
conference call to discuss certain due diligence items regarding
Darwin.
On June 12, 2008, UBS arranged (and attended) a meeting
between senior members of management from Allied World and
Darwin to discuss a potential strategic transaction between the
companies and the role of Darwins senior management
following such a transaction. At the meeting, Darwins
chief executive officer informed the Allied World
representatives that he did not expect to continue his
employment with Darwin following a merger with Allied World.
On June 13, 2008, representatives of Bidder B advised
UBS that Bidder B was prepared to increase its proposed
merger price to $32.00 per share in cash. UBS also offered
Bidder B an opportunity to meet with Darwins senior
management so as to permit Bidder B to clarify the
condition to its proposal related to the ongoing employment of
senior management and an opportunity to complete its due
diligence. Bidder B declined these opportunities, noting
that it would require a period of exclusivity before proceeding
further.
On June 13, 2008, the Special Committee held a telephone
meeting to discuss the final offers. Representatives of Cleary
Gottlieb and UBS participated in the meeting. Representatives of
UBS presented the financial terms of the two proposals, which
were now equivalent at $32.00 per share in cash. Allied World
proposed a termination fee of 4% of the aggregate offer price
and Bidder B proposed a termination fee of 3% of the
aggregate offer price. UBS noted that Allied World had completed
substantially all of its due diligence, while Bidder B
required additional diligence to confirm its proposal. UBS also
noted that each of Allied World and Bidder B had requested
a period of exclusivity as a condition to proceeding with
further discussions. UBS and the Special Committee discussed the
likelihood of obtaining an increase in the proposed purchase
price from either bidder. UBS noted that Allied World had on
several occasions in the preceding days, in response to
inquiries from UBS, declined to increase its price.
Representatives of Cleary Gottlieb then reviewed with the
Special Committee the non-financial terms of the two proposals,
including the material adverse effect definitions, voting
agreements, closing conditions, representations and warranties
and termination fees. Cleary Gottlieb concluded that Allied
Worlds draft was more favorable to Darwin in substantially
all non-financial respects (including the representations and
warranties, covenants and conditions) than Bidder Bs
draft. In addition, Bidder B requested agreements and other
terms from Alleghany (including a request that Alleghany make
representations and warranties regarding Darwin directly to
Bidder B and indemnify Bidder B for certain matters)
that the Special Committee was advised would be unacceptable to
Alleghany and that Alleghany had no legal obligation to provide.
After discussion of the two proposals, including discussion of
the number of terms proposed in Bidder Bs draft of
the merger agreement that were unfavorable to Darwin and
Bidder Bs statement that it was not prepared to
proceed further with the transaction unless Darwin agreed to
deal exclusively with Bidder B and a discussion of whether
Darwin could deliver greater value to its shareholders as a
standalone company, the Special Committee unanimously determined
to instruct UBS to request that Allied World improve its
proposal in three respects: (i) increase the price,
(ii) reduce the termination fee and (iii) eliminate
the material adverse effect trigger related to a reduction in
Darwins A.M. Best or credit ratings. If Allied World
improved its proposal in response to items (ii) and
(iii) above, the Special Committee also instructed UBS to
advise Allied World that Darwin would like to work with Allied
World with the goal of negotiating and signing a definitive
merger agreement and agreeing on the related arrangements with
management (which Allied World required as a condition to
entering into a merger agreement). Shortly after completion of
the meeting, UBS advised the Chair that Allied World had
declined to raise its price, but had agreed to reduce the
proposed termination fee from 4% to 3% and to eliminate the
ratings trigger in the material adverse effect definition.
In the afternoon of June 13, 2008, representatives of
Morris, Nichols, Arsht & Tunnell LLP (Morris
Nichols), legal counsel to Alleghany, distributed a voting
agreement that committed Alleghany to voting 40% of the shares
of Common Stock of Darwin in favor of the Allied World
transaction and against any competing transaction.
Representatives of Goldman, Sachs & Co. (Goldman
Sachs), financial advisors to Allied World, requested that
Darwin enter into exclusive negotiations with Allied World.
Cleary Gottlieb advised Willkie that the Special Committee had
not authorized execution of an exclusivity agreement with Allied
World, but that the Special Committee had not authorized
proceeding with any other bidder at that time.
22
From June 14, 2008 through the execution of the definitive
merger agreement, Allied World and its advisors completed their
due diligence review of Darwin, including reviewing drafts of
Darwins disclosure schedules to the draft merger agreement.
On June 14, 2008, the Chair and representatives of Cleary
Gottlieb and UBS had a telephone meeting to discuss the status
of Allied Worlds proposed separation arrangements with
Darwins chief executive officer and employment
arrangements with the other members of Darwins senior
management. The Chair directed UBS to facilitate discussions
among Allied World, Darwins management and their
respective legal representatives.
In the evening of June 14, 2008, Dewey & LeBoeuf
distributed a revised draft of the merger agreement which, among
other things, modified Allied Worlds proposed
Capitalization Closing Condition so that Allied World would be
required to close the merger unless the inaccuracy of the
Capitalization Closing Condition was material.
On June 16, 2008, representatives of Cleary Gottlieb,
Dewey & LeBoeuf and Willkie discussed the draft merger
agreement by telephone.
On June 17, 2008, Willkie circulated a revised draft of the
merger agreement. Later that day, representatives of Cleary
Gottlieb, Dewey & LeBoeuf and Willkie held a telephone
meeting to discuss the outstanding issues in the merger
agreement, including the dollar amount above which the
Capitalization Closing Condition needed to be inaccurate in
order for Allied World not to close the merger.
From June 17, 2008 through June 27, 2008, members of
Darwins senior management and representatives of Allied
World and UBS engaged in discussions regarding the post-merger
employment
and/or
separation arrangements for such members of Darwins senior
management.
On June 18, 2008, representatives of Cleary Gottlieb,
Goldman Sachs, UBS and Willkie held a telephone meeting to
discuss the status of discussions among Allied World and members
of Darwins senior management with respect to proposed
post-merger employment and separation arrangements.
Later on June 18, 2008, the Special Committee held a
telephone meeting to discuss the status of the possible
transaction with Allied World. Representatives of Cleary
Gottlieb and UBS participated in the meeting. The Special
Committee authorized the Chair to seek to facilitate the
discussions among Darwins management and Allied World. On
June 19, 2008, the Chair discussed with the chief executive
officer of Allied World the status of the transaction, including
the negotiations with members of Darwins senior management.
On June 21, 2008, representatives of Goldman Sachs and
Willkie advised representatives of UBS and Cleary Gottlieb that
Allied World wanted to resolve two issues before proceeding with
the transaction: (i) reaching satisfactory post-merger
employment arrangements with nine senior managers of Darwin (not
including Darwins chief executive officer) and
(ii) reaching a satisfactory separation arrangement with
Darwins chief executive officer, including an extension of
his existing post-employment restrictive covenants, contained in
his current employment agreement, from one year to two years and
an expansion of the scope of the restrictive covenants contained
in that agreement. The Allied World representatives also
communicated Allied Worlds position that any incremental
amounts that would need to be paid to the chief executive
officer to induce him to agree to such proposed separation
arrangements, including the expansion and extension of his
post-employment covenants from one year to two years, would
result in a reduction by Allied World of the proposed merger
consideration unless such amounts were borne by a third party
such as Alleghany.
Later on June 21, 2008, representatives of Morris Nichols
circulated a revised draft of the voting agreement to Allied
World and its advisors.
On June 22, 2008, the Special Committee held a telephone
meeting to discuss the status of the possible transaction with
Allied World, including the status of discussions between Allied
World and Darwins senior management. Following a
discussion of the employment and separation issues,
representatives of Cleary Gottlieb reviewed the fiduciary duties
of the directors in connection with their consideration of a
possible transaction with Allied World as well as the basic
terms and principal outstanding issues related to the merger
agreement and the voting agreement. After discussion, the
Special Committee unanimously concluded to continue the
discussions with Allied World.
23
Later that same day, at the direction of the Chair, a
representative of UBS spoke with Alleghanys chief
executive officer to ask that Alleghany consider bearing the
cost of any additional payment to Darwins chief executive
officer in consideration of his agreement to expand and extend
his post-employment restrictive covenants from one year to two
years.
On June 23, 2008, representatives of Cleary Gottlieb,
Dewey & LeBoeuf and Willkie held a conference call to
continue negotiation of the merger agreement. Also, on
June 23, 2008, the Chair held separate discussions with
Darwins chief executive officer and Alleghanys chief
executive officer concerning separation arrangements for
Darwins chief executive officer and Allied Worlds
position that any additional payment to be made to Darwins
chief executive officer in consideration of his agreement to
expand and extend his post-employment restrictive covenants from
one year to two years be paid by a third party such as Alleghany
or else Allied World would reduce the proposed merger
consideration amount.
On June 24, 2008, the Special Committee held a telephone
meeting to discuss the status of the possible transaction with
Allied World. Representatives of Cleary Gottlieb and UBS
attended the meeting. The Special Committee discussed the status
of negotiations regarding the merger agreement and voting
agreement and the status of negotiations with Darwins
senior management. Representatives of Cleary Gottlieb informed
the Special Committee that progress had been made with respect
to employment agreements with certain of Darwins senior
managers but the separation arrangements with Darwins
chief executive officer were still under discussion.
Following additional separate discussions among Alleghanys
chief executive officer, the Chair and Darwins chief
executive officer, on June 24 and 25, Alleghany agreed to pay
$973,413 of the incremental amounts to be paid to Darwins
chief executive officer to induce him to accept Allied
Worlds proposal for expansion and extension of his
post-employment restrictive covenants from one year to two years
(such amount being the estimated amount of his projected base
salary and cash bonus compensation for the additional year).
On June 25, 2008, the Special Committee held a telephone
meeting to review the terms for the proposed transaction as
negotiated to that date. Representatives of Cleary Gottlieb
reviewed the principal terms of the proposed merger agreement
with Allied World and responded to questions from the Special
Committee regarding various terms. Representatives of UBS then
reviewed with the Special Committee UBS financial analysis
of the consideration to be received by Darwins
shareholders in the proposed merger.
Later in the afternoon of June 25, 2008 and during the
course of the day on June 26, 2008, Cleary Gottlieb,
Dewey & LeBoeuf, Morris Nichols and Willkie continued
negotiating the terms of the merger agreement and the voting
agreement. Because the parties were unable to agree on a
threshold amount regarding the Capitalization Closing Condition,
the parties instead agreed that the per share purchase price
would be subject to a potential downward adjustment in the event
that certain of Darwins capitalization representations and
warranties prove to be inaccurate and, as a result of such
inaccuracy, the aggregate consideration payable by Allied World
in the merger would be increased by more than $1,000,000.
On June 27, 2008, Cleary Gottlieb, Dewey &
LeBoeuf, Morris Nichols and Willkie concluded negotiations on
the merger agreement and the voting agreement. Also, the
employment arrangements with Darwins senior management and
the separation arrangements with Darwins chief executive
officer were concluded.
On that same date, the Special Committee held a meeting to
receive a final update on the merger agreement, the voting
agreement and the employment and separation arrangements between
Allied World and Darwins senior management.
Representatives of Cleary Gottlieb reviewed with the Special
Committee the fiduciary duties of the directors in connection
with their consideration of the proposed transaction with Allied
World, reviewed the status of discussions with respect to the
merger and voting agreements and the employment and separation
arrangements and noted that such discussions were very close to
completion. Representatives of UBS confirmed that their
financial analysis had not changed materially since the analysis
presented to the Special Committee on June 25, 2008. UBS
then delivered to the Special Committee an oral opinion,
subsequently confirmed in writing, to the effect that, as of
such date and based on and subject to various assumptions,
matters considered and limitations described in its opinion, the
$32.00 per share cash consideration to be received by the
holders of shares of Common Stock (other than Alleghany, AIHL
and their respective affiliates) in the proposed merger was
fair, from a financial point of view, to such holders.
24
After deliberation and based upon the totality of the
information considered during its evaluation of the merger and
the merger agreement, the Special Committee unanimously
determined that the merger agreement and the transactions
contemplated by the merger agreement, including the merger, are
advisable and fair to, and in the best interests of, Darwin and
its stockholders. In addition, the Special Committee resolved to
recommend that the full board of directors approve and declare
advisable the merger agreement and the transactions contemplated
thereby, including the merger.
In the afternoon of June 27, 2008, the full Board (other
than Mr. Phillip Ben-Zvi) held a meeting to consider the
potential transaction with Allied World. Representatives of
Cleary Gottlieb, Dewey & LeBoeuf, UBS and Morris
Nichols participated in the meeting. Representatives of
Dewey & LeBoeuf reviewed with the members of the Board
their fiduciary duties in connection with their consideration of
the potential transaction with Allied World. Representatives of
Cleary Gottlieb and Dewey & LeBoeuf reviewed the
principal terms of the proposed merger agreement with Allied
World. Representatives of UBS presented UBS analysis of
the consideration to be received by Darwins stockholders
in the proposed merger from a financial point of view and
delivered to the Board an oral opinion, subsequently confirmed
in writing, to the effect that, as of such date and based on and
subject to various assumptions, matters considered and
limitations described in its opinion, the $32.00 per share cash
consideration to be received by the holders of shares of Common
Stock (other than Alleghany, AIHL, and their respective
affiliates) in the proposed merger was fair, from a financial
point of view, to such holders. Darwins chief executive
officer described his arrangement to separate from Darwin and
the expansion of his non-compete covenant. Following a
discussion regarding the recommendation of the Special Committee
and the proposed resolutions, the Board approved the merger
agreement and the transactions contemplated by the merger
agreement, including the merger, and resolved to recommend that
the stockholders of Darwin vote to adopt the merger agreement
and approve the merger.
The merger agreement and voting agreement were entered into on
June 27, 2008 and the transaction was publicly announced on
June 30, 2008.
Reasons
for the Merger; Recommendation of the Special Committee and Our
Board
Special
Committee
The Special Committee unanimously (i) determined that the
Merger Agreement and the transactions contemplated thereby,
including the Merger, are advisable and fair to, and in the best
interests of, Darwin and its stockholders and (ii) resolved
to recommend to the Board that it approve and declare advisable
the Merger Agreement and the transactions contemplated thereby,
including the Merger.
In the course of reaching its determination, the Special
Committee considered the following substantive factors and
potential benefits of the Merger, each of which the Special
Committee believed supported its decisions:
|
|
|
|
|
its belief that the Merger was more favorable to the
stockholders than the potential value that might result from
other alternatives available to Darwin, including remaining an
independent company and pursuing the current business plan,
given the potential rewards, risks and uncertainties associated
with those alternatives. Such risks and uncertainties included
those relating to Darwins ability to achieve its business
plan and projected future financial performance, the
increasingly competitive nature of the specialty
property-casualty insurance industry and Darwins
relatively small size in comparison with a number of its
competitors;
|
|
|
|
the fact that the cash merger consideration of $32.00 per share
of Common Stock allows Darwins stockholders to realize in
the near term a fair value, in cash, for their investment and
provides such stockholders certainty of value for their shares;
|
|
|
|
the current and historical market prices of the Common Stock
relative to those of other industry participants and general
market indices, and the fact that the cash merger consideration
of $32.00 per share of Common Stock represents a premium of
approximately 30.4% over the
90-day
average trading price of the Common Stock on the NYSE prior the
announcement of the Merger;
|
25
|
|
|
|
|
its analysis and understanding of the business, operations,
financial performance, financial condition, earnings and future
prospects for Darwin on a stand-alone basis;
|
|
|
|
the fact that the Special Committee consists solely of directors
who are not officers, employees or controlling stockholders of
Darwin, are not otherwise affiliated with Alleghany or Allied
World and are all independent of Darwin management;
|
|
|
|
the fact that the Special Committee and its independent
financial and legal advisors negotiated on an arms-length
basis with Allied World and its representatives;
|
|
|
|
the financial and other terms and conditions of the Merger
Agreement, including the absence of a financing condition;
|
|
|
|
the fact that the terms of the Merger Agreement allow Darwin,
prior to the adoption of the Merger Agreement by our
stockholders, to respond to unsolicited acquisition proposals
under certain circumstances;
|
|
|
|
the fact that, subject to compliance with the terms and
conditions of the Merger Agreement, Darwin is permitted to
terminate the Merger Agreement in order to approve an
alternative transaction proposal by a third party that is a
company superior proposal as defined in the Merger
Agreement, upon the payment to Allied World of a
$16.5 million termination fee;
|
|
|
|
the availability of appraisal rights to holders of shares of
Common Stock who comply with all of the required procedures
under Delaware law, which allows such holders to seek appraisal
of the fair value of their shares of Common Stock as determined
by the Delaware Court of Chancery;
|
|
|
|
the terms of the voting agreement between Alleghany and Allied
World, including the fact that the voting agreement would
terminate if the Merger Agreement terminates or if the Board
withdraws its approval of the Merger Agreement or the
Merger; and
|
|
|
|
the financial presentations of UBS and its opinion as described
above.
|
The Special Committee also considered a variety of risks and
other potentially negative factors concerning the Merger and the
Merger Agreement including the following:
|
|
|
|
|
the risks and costs to Darwin if the Merger does not close,
including the diversion of management and employee attention,
potential employee attrition and the effect on business and
customer relationships;
|
|
|
|
the potential downward price adjustment of the per share
purchase price to be paid by Allied World in the event that
certain representations by Darwin in the Merger Agreement with
respect to its capitalization prove to be inaccurate and, as a
result of such inaccuracy, the aggregate consideration payable
by Allied World in the Merger would be increased by more than
$1,000,000;
|
|
|
|
the fact that Darwins stockholders whose shares of Common
Stock are acquired for cash in the Merger will not participate
in any future earnings or growth of Darwin and will not benefit
from any appreciation in the value of Darwin;
|
|
|
|
|
|
the fact that certain of Darwins officers and directors
have interests in the Merger, described in the section
Merger Interests of Darwins Directors and
Executive Officers in the Merger beginning on
page 33, that may be different from the interests of
Darwins stockholders;
|
|
|
|
|
|
the amount of time it could take to complete the Merger,
including the fact that consummation of the Merger is subject to
governmental and regulatory approvals and that there can be no
assurance that such approvals will be received prior to the
outside date, or at all;
|
|
|
|
the fact that an all-cash transaction would be taxable to
Darwins stockholders that are U.S. persons for
U.S. federal income tax purposes; and
|
|
|
|
the fact that a termination fee is payable to Allied World under
specified circumstances, including in the event the Board
decides to terminate the Merger Agreement to accept a company
superior proposal.
|
26
This discussion summarizes the material factors considered by
the Special Committee in its consideration of the Merger. After
considering these factors, the Special Committee concluded that
the positive factors relating to the Merger Agreement and the
Merger outweighed the potential negative factors. In view of the
wide variety of factors considered by the Special Committee, and
the complexity of these matters, the Special Committee did not
find it practicable to quantify or otherwise assign relative
weights to the foregoing factors. In addition, individual
members of the Special Committee may have assigned different
weights to various factors. The Special Committee unanimously
resolved that the Merger Agreement and the transactions
contemplated by the Merger Agreement, including the Merger, are
advisable and fair to, and in the best interests of the Company
and its stockholders based upon the totality of the information
presented to and considered by it.
Our
Board
The Board, acting upon the unanimous recommendation of the
Special Committee, has (i) determined that the Merger
Agreement and the transactions contemplated thereby, including
the Merger, are advisable and fair to, and in the best interests
of, Darwin and its stockholders, (ii) approved and declared
advisable the Merger Agreement and the transactions contemplated
thereby, including the Merger, (iii) resolved to recommend
that Darwins stockholders adopt the Merger Agreement and
(iv) directed that the Merger Agreement be submitted to
Darwins stockholders for their adoption.
In reaching these determinations, the Board considered
(i) a variety of business, financial and market factors,
(ii) each of the factors considered by the Special
Committee in its unanimous recommendation, as described above,
(iii) the financial presentation of UBS, including the
opinion of UBS as to the fairness, from a financial point of
view, to the holders of shares of Common Stock (other than
Alleghany, AIHL or any of their respective affiliates) of the
cash merger consideration and (iv) the unanimous
recommendation of the Special Committee.
The foregoing discussion summarizes the material factors
considered by the Board in its consideration of the Merger. In
view of the wide variety of factors considered by the Board, and
the complexity of these matters, the Board did not find it
practicable to quantify or otherwise assign relative weights to
the foregoing factors. In addition, individual members of the
Board may have assigned different weights to various factors.
The Board approved and recommends the Merger Agreement and the
Merger based upon the totality of the information presented to
and considered by it.
Our Board recommends that you vote FOR the
adoption of the Merger Agreement and FOR the
adjournment of the special meeting, if Darwin deems such
adjournment to be necessary or appropriate, to solicit
additional proxies.
Opinion
of Financial Advisor
On June 27, 2008, at meetings of the Special Committee and
the Board held to evaluate the proposed merger, UBS delivered to
each of the Special Committee and the Board an oral opinion,
which opinion was confirmed by delivery of a written opinion
dated June 27, 2008, addressed to each of the Special
Committee and the Board, to the effect that, as of that date and
based upon and subject to various assumptions, matters
considered and limitations described in its opinion, the merger
consideration of $32.00 per share in cash to be received in the
Merger by the holders of Common Stock (other than Alleghany, its
subsidiary AIHL or any of their respective affiliates) was fair,
from a financial point of view, to such holders.
The full text of UBS opinion describes assumptions made,
procedures followed, matters considered and limitations on the
review undertaken by UBS. This opinion is attached as
Annex B and is incorporated into this proxy statement by
reference. UBS opinion was provided for the benefit of
the Special Committee and the Board in connection with, and for
the purpose of, their evaluation of the merger consideration of
$32.00 per share in cash from a financial point of view and does
not address any other aspect of the Merger. The opinion does not
address the relative merits of the Merger as compared to other
business strategies or transactions that might be available with
respect to Darwin or Darwins underlying business decision
to effect the Merger. The opinion does not constitute a
recommendation to any stockholder as to how to vote or act with
respect to the Merger. Holders of shares of Common Stock are
encouraged to read UBS opinion carefully in its
27
entirety. The following summary of UBS opinion is
qualified in its entirety by reference to the full text of
UBS opinion.
In arriving at its opinion, UBS, among other things:
|
|
|
|
|
reviewed certain publicly available business and financial
information relating to Darwin;
|
|
|
|
reviewed certain internal financial information and other data
relating to the business and financial prospects of Darwin that
were provided to UBS by Darwins management and not
publicly available, including financial forecasts and estimates
prepared by Darwins management that the Special Committee
and the Board directed UBS to utilize for purposes of its
analysis;
|
|
|
|
conducted discussions with members of Darwins senior
management concerning the business and financial prospects of
Darwin;
|
|
|
|
reviewed publicly available financial and stock market data with
respect to certain other companies UBS believed to be generally
relevant;
|
|
|
|
compared the financial terms of the Merger with the publicly
available financial terms of certain other transactions UBS
believed to be generally relevant;
|
|
|
|
reviewed current and historical market prices of the Common
Stock;
|
|
|
|
reviewed a draft dated June 26, 2008 of the merger
agreement; and
|
|
|
|
conducted such other financial studies, analyses and
investigations, and considered such other information, as UBS
deemed necessary or appropriate.
|
In connection with its review, with the consent of the Special
Committee and the Board, UBS assumed and relied upon, without
independent verification, the accuracy and completeness in all
material respects of the information provided to or reviewed by
UBS for the purpose of its opinion. In addition, with the
consent of the Special Committee and the Board, UBS did not make
any independent evaluation or appraisal of any of the assets or
liabilities (contingent or otherwise) of Darwin, and was not
furnished with any such evaluation or appraisal. With respect to
the financial forecasts and estimates referred to above, UBS
assumed, at the direction of the Special Committee and the
Board, that such forecasts and estimates had been reasonably
prepared on a basis reflecting the best currently available
estimates and judgments of Darwins management as to the
future financial performance of Darwin. UBS opinion was
necessarily based on economic, monetary, market and other
conditions as in effect on, and the information available to UBS
as of, the date of its opinion.
At the request of the Special Committee and the Board, UBS
contacted third parties to solicit indications of interest in a
possible transaction with Darwin and held discussions with
certain of these parties prior to the date of UBS opinion.
At the direction of the Special Committee and the Board, UBS was
not asked to, nor did it, offer any opinion as to the terms,
other than the merger consideration of $32.00 per share in cash
to the extent expressly specified in UBS opinion, of the
Merger Agreement or any related documents or the form of the
Merger. In addition, UBS expressed no opinion as to the fairness
of the amount or nature of any compensation to be received by
any officers, directors or employees of any parties to the
Merger, or any class of such persons, relative to the merger
consideration of $32.00 per share in cash. In rendering its
opinion, UBS assumed, with the consent of the Special Committee
and the Board, that (i) the final executed form of the
merger agreement would not differ in any material respect from
the draft that UBS reviewed, (ii) Allied World and Darwin
would comply with all material terms of the Merger Agreement and
(iii) the Merger would be consummated in accordance with
the terms of the Merger Agreement without any adverse waiver or
amendment of any material term or condition thereof. Except as
described above, the Special Committee and the Board imposed no
other instructions or limitations on UBS with respect to the
investigations made or the procedures followed by UBS in
rendering its opinion. The issuance of UBS opinion was
approved by an authorized committee of UBS.
In connection with rendering its opinion to the Special
Committee and the Board, UBS performed a variety of financial
and comparative analyses which are summarized below. The
following summary is not a complete description of all analyses
performed and factors considered by UBS in connection with its
opinion. The preparation of a financial opinion is a complex
process involving subjective judgments and is not necessarily
susceptible to
28
partial analysis or summary description. With respect to the
selected public company analysis and selected precedent
transactions analysis summarized below, no company or
transaction used as a comparison was identical to Darwin or the
Merger. These analyses necessarily involved complex
considerations and judgments concerning financial and operating
characteristics and other factors that could affect the public
trading or acquisition values of the companies concerned.
UBS believes that its analysis and the summary below must be
considered as a whole and that selecting portions of its
analysis and factors or focusing on information presented in
tabular format, without considering all analyses and factors or
the full narrative description of the analyses, could create a
misleading or incomplete view of the processes underlying
UBS analyses and opinion. UBS did not draw, in isolation,
conclusions from or with regard to any one factor or method of
analysis for purposes of its opinion, but rather arrived at its
ultimate opinion based on results of all analyses undertaken by
it and assessed as a whole.
The estimates of the future performance of Darwin provided by
Darwins management in or underlying UBS analyses are
not necessarily indicative of future results or values, which
may be significantly more or less favorable than those
estimates. In performing its analyses, UBS considered industry
performance, general business and economic conditions and other
matters, many of which were beyond the control of Darwin.
Estimates of the financial value of companies do not purport to
be appraisals or necessarily reflect the prices at which
companies may actually be sold.
The merger consideration was determined through negotiation
between Darwin and Allied World, and the decisions by the
Special Committee to recommend the Merger and the Merger
Agreement, and by the Board to enter into the Merger Agreement,
were solely that of the Special Committee and the Board,
respectively. UBS opinion and financial analyses were only
one of many factors considered by the Special Committee and the
Board in their evaluation of the Merger and should not be viewed
as determinative of the views of the Special Committee or the
Board with respect to the Merger or the merger consideration.
The following is a brief summary of the material financial
analyses performed by UBS and reviewed with the Special
Committee and the Board on June 27, 2008 in connection with
UBS opinion relating to the proposed merger. The
financial analyses summarized below include information
presented in tabular format. In order to fully understand
UBS financial analyses, the tables must be read together
with the text of each summary. The tables alone do not
constitute a complete description of the financial analyses.
Considering the data below without considering the full
narrative description of the financial analyses, including the
methodologies and assumptions underlying the analyses, could
create a misleading or incomplete view of UBS financial
analyses. Financial data of Darwin were based on
Darwins public filings, Institutional Brokers
Estimate System (IBES) estimates for Darwin and
certain financial forecasts and estimates prepared by
Darwins management that the Special Committee and the
Board directed UBS to utilize for purposes of its analyses.
Selected
Public Company Analysis
UBS compared selected financial information, ratios and public
market data for Darwin to the corresponding data for the
publicly traded companies identified below in the property and
casualty insurance industry that were selected by UBS.
Although none of these companies is directly comparable to
Darwin, these companies were selected, among other reasons,
because their equity is publicly traded in the United States and
they are in the property and casualty insurance industry:
|
|
|
|
|
American Physicians Capital, Inc.
|
|
|
|
FPIC Insurance Group, Inc.
|
|
|
|
First Mercury Financial Corporation
|
|
|
|
ProAssurance Corporation
|
|
|
|
RLI Corp.
|
|
|
|
Tower Group, Inc.
|
29
For each of the companies selected by UBS, UBS reviewed, among
other things:
|
|
|
|
|
closing market price per share of common stock, as of
June 26, 2008, as a multiple of book value of common equity
per share, as of the most recently completed fiscal quarter for
which information was publicly available;
|
|
|
|
closing market price per share of common stock, as of
June 26, 2008, as a multiple of estimated earnings per
share of common stock (EPS) for each of fiscal years
2008 and 2009; and
|
|
|
|
estimated net income as a percentage of estimated average
stockholders common equity for each of fiscal years 2008
and 2009.
|
UBS then compared these multiples and percentages derived for
the selected companies with corresponding multiples and
percentages implied for Darwin based on the closing price of the
Common Stock on June 26, 2008 and the merger consideration
of $32.00 per share in cash in the Merger. Financial data for
the selected companies were based on public filings and
estimated financial data for the selected companies were based
on IBES consensus estimates.
The results of these analyses are summarized in the following
table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
per Share on
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 26, 2008 /
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
|
Book Value of
|
|
|
|
|
|
|
|
|
Net Income as
|
|
|
|
Common Equity
|
|
|
|
|
|
|
|
|
a Percentage
|
|
|
|
per Share as of
|
|
|
Closing Price per Share on
|
|
|
of Estimated
|
|
|
|
Most Recently
|
|
|
June 26, 2008 /
|
|
|
Average Stockholders
|
|
|
|
Completed Fiscal
|
|
|
Estimated EPS
|
|
|
Common Equity
|
|
|
|
Quarter
|
|
|
2008
|
|
|
2009
|
|
|
2008
|
|
|
2009
|
|
|
Selected Companies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
1.85
|
x
|
|
|
12.5
|
x
|
|
|
12.4
|
x
|
|
|
20.3
|
%
|
|
|
19.2
|
%
|
Mean
|
|
|
1.51
|
|
|
|
9.8
|
|
|
|
9.7
|
|
|
|
15.0
|
|
|
|
13.9
|
|
Median
|
|
|
1.43
|
|
|
|
10.2
|
|
|
|
10.3
|
|
|
|
14.6
|
|
|
|
13.0
|
|
Low
|
|
|
1.25
|
|
|
|
7.4
|
|
|
|
6.9
|
|
|
|
11.3
|
|
|
|
10.2
|
|
Darwin at Closing Price per share of Common Stock on
June 26, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IBES Consensus Estimates
|
|
|
1.80
|
|
|
|
11.2
|
|
|
|
12.1
|
|
|
|
13.8
|
|
|
|
12.0
|
|
Management Estimates
|
|
|
1.80
|
|
|
|
12.1
|
|
|
|
11.1
|
|
|
|
14.6
|
|
|
|
13.8
|
|
Darwin at $32.00 per share of Common Stock Merger
Consideration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IBES Consensus Estimates
|
|
|
2.04
|
|
|
|
12.5
|
|
|
|
13.6
|
|
|
|
13.8
|
|
|
|
12.0
|
|
Management Estimates
|
|
|
2.04
|
|
|
|
13.7
|
|
|
|
12.7
|
|
|
|
14.6
|
|
|
|
13.8
|
|
Selected
Precedent Transactions Analysis
UBS reviewed the transaction value, calculated as the purchase
price paid for the target companys common equity, for each
of the nine selected transactions set forth below involving
target entities in the property and casualty insurance industry.
30
|
|
|
|
|
Date Announced
|
|
Acquiror
|
|
Target
|
|
February 20, 2008
|
|
Meadowbrook Insurance Group, Inc.
|
|
ProCentury Corporation
|
January 10, 2008
|
|
Employers Holdings, Inc.
|
|
AmCOMP Incorporated
|
October 15, 2007
|
|
The Doctors Company
|
|
SCPIE Holdings Inc.
|
October 15, 2007
|
|
Munich Re Group
|
|
The Midland Company
|
June 11, 2007
|
|
D.E. Shaw & Company, LLC
|
|
James River Group, Inc.
|
March 2, 2007
|
|
Zurich Financial Services Group
|
|
Bristol West Holdings, Inc.
|
December 13, 2006
|
|
QBE Insurance Group, Ltd.
|
|
Praetorian Financial Group Inc.
|
December 5, 2006
|
|
Elara Holdings Inc.
|
|
Direct General Corp.
|
August 4, 2006
|
|
Delek Group Ltd.
|
|
Republic Companies Group, Inc.
|
For each selected transaction, UBS calculated and compared:
|
|
|
|
|
transaction value as a multiple of estimated earnings for the
four fiscal quarters commencing with the first fiscal quarter
for which results were not yet publicly available as of the
announcement of the transaction (NTM); and
|
|
|
|
transaction value as a multiple of book value of common equity,
as of the most recently completed fiscal quarter for which
information was publicly available.
|
UBS then compared these multiples derived from the selected
transactions to the multiple implied for Darwin based on the
merger consideration of $32.00 per share in cash in the Merger,
Darwins estimated NTM earnings and Darwins book
value of net assets as of March 31, 2008. Financial data
for the selected transactions were based on publicly available
information and various research reports, and estimated
financial data for the selected transactions were based on
various research reports and IBES consensus estimates at the
time of announcement of the relevant transaction.
The following table summarizes the results of these analyses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transaction Value /
|
|
|
|
Transaction Value /
|
|
|
Book Value of
|
|
|
|
NTM Earnings
|
|
|
Common Equity
|
|
|
Selected Precedent Property and Casualty Insurance Industry
Transactions
|
|
|
|
|
|
|
|
|
High
|
|
|
16.7
|
x
|
|
|
2.34
|
x
|
Mean
|
|
|
13.4
|
|
|
|
1.76
|
|
Median
|
|
|
13.5
|
|
|
|
1.74
|
|
Low
|
|
|
10.4
|
|
|
|
1.23
|
|
Darwin at $32.00 per share of Common Stock Merger
Consideration
|
|
|
|
|
|
|
|
|
IBES Consensus Estimates
|
|
|
13.1
|
|
|
|
2.04
|
|
Management Estimates
|
|
|
13.2
|
|
|
|
2.04
|
|
Discounted
Cash Flow Analysis
UBS performed a discounted cash flow analysis of Darwin using
certain financial forecasts and estimates prepared by
Darwins management for fiscal years 2008 through 2012 that
the Special Committee and the Board directed UBS to utilize for
purposes of its analysis. UBS calculated a range of implied
present values as of June 30, 2008 of the stand-alone
distributable cash flows that Darwin was forecasted to generate
from July 1, 2008 through December 31, 2012 using
discount rates ranging from 11.0% to 13.0%. UBS also calculated
estimated terminal values for Darwin as of December 31,
2012, using price-to-book terminal multiples ranging from 1.60
to 1.90 times estimated stockholders common equity as of
December 31, 2012. The estimated terminal values were then
discounted to present value as of June 30, 2008 using
discount rates ranging from 11.0% to 13.0%. The discounted
31
cash flow analysis resulted in an implied equity reference range
per share of Common Stock of approximately $26 to $32.
Miscellaneous
Under the terms of UBS engagement, Darwin has agreed to
pay UBS for its financial advisory services in connection with
the Merger an aggregate fee currently estimated to be
approximately $5.0 million, approximately $1.2 million
of which was payable in connection with UBS opinion and
approximately $3.8 million of which is contingent upon
consummation of the Merger. In addition, Darwin has agreed to
reimburse UBS for its reasonable expenses, including fees,
disbursements and other charges of its counsel, and to indemnify
UBS and related parties against liabilities, including
liabilities under federal securities laws, relating to, or
arising out of, its engagement.
Other than UBS financial advisory services to Darwin in
connection with the Merger, no material relationship existed
during the two years prior to June 27, 2008, or was
contemplated, between UBS, on the one hand, and any of Darwin,
Allied World or Alleghany, on the other hand, in which any
compensation was received or was intended to be received as a
result of such relationship. In the ordinary course of business,
UBS and its affiliates may hold or trade, for their own accounts
and the accounts of their customers, securities of Darwin,
Allied World and Alleghany and, accordingly, may at any time
hold a long or short position in such securities.
Darwin selected UBS as its financial advisor in connection with
the Merger because UBS is an internationally recognized
investment banking firm with substantial experience in similar
transactions and because of UBS familiarity with Darwin
and its businesses. UBS is continually engaged in the valuation
of businesses and their securities in connection with mergers
and acquisitions, leveraged buyouts, negotiated underwritings,
competitive bids, secondary distributions of listed and unlisted
securities and private placements.
Projected
Financial Data
Darwin does not, as a matter of course, publicly disclose
forecasts of future revenues, earnings, financial condition or
other results. However, in connection with the discussions
concerning the proposed merger described in The
Merger Background of the Merger beginning on
page 19, Darwin provided Allied World with financial
forecasts of our operating performance for the fiscal years 2008
through 2012 prepared by Darwins management, which we
refer to as the Projections. The Projections were
also provided to our financial advisor, UBS, and were utilized
by UBS, at the direction of the Special Committee and the Board,
for purposes of its analyses in connection with its opinion.
The Projections were not prepared with a view to public
disclosure and are included in this proxy statement because such
information was made available, in whole or in part, to Allied
World, in connection with its due diligence review of Darwin.
The Projections were not prepared with a view to compliance with
published guidelines of the SEC regarding projections or the
guidelines established by the American Institute of Certified
Public Accountants for preparation and presentation of
prospective financial information. Furthermore, our auditor has
not examined, compiled or otherwise applied procedures to the
Projections and, accordingly, assumes no responsibility for, and
expresses no opinion on them.
The Projections provided are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
|
2010
|
|
|
2011
|
|
|
2012
|
|
|
Net Premiums Written ($000s)
|
|
|
245,728
|
|
|
|
294,873
|
|
|
|
339,104
|
|
|
|
389,970
|
|
|
|
428,967
|
|
Net Income ($000s)
|
|
|
40,015
|
|
|
|
43,486
|
|
|
|
52,278
|
|
|
|
61,403
|
|
|
|
69,163
|
|
The material assumptions made by Darwin in developing these
Projections are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2009
|
|
|
2010
|
|
|
2011
|
|
|
2012
|
|
|
Net Premiums Written Growth(1)
|
|
|
23.0
|
%
|
|
|
20.0
|
%
|
|
|
15.0
|
%
|
|
|
15.0
|
%
|
|
|
10.0
|
%
|
Loss Ratio
|
|
|
54.7
|
%
|
|
|
62.5
|
%
|
|
|
62.5
|
%
|
|
|
62.5
|
%
|
|
|
62.5
|
%
|
Expense Ratio
|
|
|
28.0
|
%
|
|
|
27.1
|
%
|
|
|
28.0
|
%
|
|
|
29.0
|
%
|
|
|
29.5
|
%
|
|
|
|
(1) |
|
Expressed as a percentage change over the prior year. |
32
The development of the Projections entailed numerous
assumptions, including assumptions regarding Darwins
industry, products and services, Darwins ability to
execute on its strategic growth plan and general business,
economic, regulatory, market and financial conditions. Although
the Projections are presented with numerical specificity, the
Projections reflect numerous assumptions and estimates as to
future events made by Darwins management that
Darwins management believed were reasonable at the time
the Projections were prepared. These Projections were initially
created at the end of the third quarter of 2007 and were updated
only to record actual results through the end of the first
quarter of 2008. They do not take into account any circumstances
or events occurring after the date that they were prepared, such
as, among other things, increased pricing competition, changes
in overall business strategy and employee turnover, and,
accordingly, do not give effect to the Merger or any changes to
our operations or strategy that may be implemented after
completion of the Merger. For the foregoing reasons, the
inclusion of the Projections in this proxy statement should not
be regarded as an indication that Darwin, the Board, the Special
Committee, Allied World, MergerCo, UBS or any other recipient of
this information considered, or now considers, the Projections
to be necessarily predictive of actual future events or
conditions, and they should not be relied on as such. You should
review our most recent SEC filings for a description of risk
factors with respect to our business. See Where You Can
Find More Information beginning on page 61.
No representation is made by Darwin or any other person to any
Darwin stockholder regarding any information included in these
Projections. Except to the extent required by applicable federal
securities laws, we do not intend, and expressly disclaim any
responsibility, to update or otherwise revise the Projections to
reflect circumstances existing after the date when prepared or
to reflect the occurrence of future events even in the event
that any of the assumptions underlying the Projections are shown
to be in error.
Financing
of the Merger
The Merger is not conditioned upon Allied World or MergerCo
obtaining financing. Allied World and MergerCo estimate that the
total amount of cash funds necessary to consummate the Merger
and related transactions will be approximately
$550 million. Allied World has informed us that it expects
that its cash on hand will be sufficient to complete the
acquisition.
Interests
of Darwins Directors and Executive Officers in the
Merger
In considering the recommendations of the Board that you vote to
adopt the Merger Agreement, Darwins stockholders should be
aware that certain of Darwins directors and executive
officers have interests in the Merger that are different from,
or in addition to, the interests of Darwins stockholders
generally. These interests may present such directors and
executive officers with actual or potential conflicts of
interest, and these interests, to the extent material, are
described below. The Special Committee and the Board were aware
of these potential conflicts of interest and considered them,
among other matters, in reaching their decisions to approve the
Merger Agreement and the Merger and the recommendations that our
stockholders vote in favor of adopting the Merger Agreement.
Treatment
of Stock Options
Immediately prior to the effective time of the Merger, each
Stock Option that is then outstanding, whether vested or
unvested, will become fully vested and exercisable. At the
effective time of the Merger, each unexercised Stock Option will
be cancelled and converted into the right to receive a cash
payment equal to the excess of the merger consideration of
$32.00 per share in cash over the exercise price of such Stock
Option, without interest and less any applicable withholding
taxes, multiplied by the number of shares of Common Stock
underlying the Stock Option, subject to the potential downward
purchase price adjustment.
The following table identifies, for each of our directors and
executive officers, the aggregate number of shares of Common
Stock subject to his outstanding vested and unvested Stock
Options as of September 15, 2008, the aggregate number of
shares of Common Stock subject to his outstanding unvested Stock
Options that will become fully vested in connection with the
Merger, the weighted average exercise price and the value of
such unvested Stock Options, and the weighted average exercise
price and value of his collective vested and unvested Stock
Options. The information in the table assumes that all Stock
Options included therein remain outstanding on the closing date
of the Merger.
33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Weighted
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
Aggregate
|
|
|
Shares of
|
|
|
Average
|
|
|
|
|
|
Exercise
|
|
|
|
|
|
|
Shares of
|
|
|
Common Stock
|
|
|
Exercise
|
|
|
|
|
|
Price of
|
|
|
Value of
|
|
|
|
Common Stock
|
|
|
Underlying
|
|
|
Price of
|
|
|
Value of
|
|
|
Vested and
|
|
|
Vested and
|
|
|
|
Subject to
|
|
|
Unvested
|
|
|
Unvested
|
|
|
Unvested
|
|
|
Unvested
|
|
|
Unvested
|
|
Name
|
|
Stock Options
|
|
|
Stock Options
|
|
|
Stock Options
|
|
|
Stock Options(1)
|
|
|
Stock Options
|
|
|
Stock Options(2)
|
|
|
Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R. Bruce Albro
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Phillip N. Ben-Zvi
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher K. Dalrymple
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weston M. Hicks
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William C. Popik, M.D.
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
George M. Reider, Jr.
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John L. Sennott, Jr.(3)
|
|
|
31,381
|
|
|
|
22,528
|
|
|
$
|
21.02
|
|
|
$
|
247,464
|
|
|
$
|
20.07
|
|
|
$
|
374,471
|
|
Stephen J. Sills(4)
|
|
|
95,487
|
|
|
|
63,003
|
|
|
$
|
20.02
|
|
|
$
|
754,763
|
|
|
$
|
19.00
|
|
|
$
|
1,241,120
|
|
James P. Slattery(5)
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Irving B. Yoskowitz
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert Asensio
|
|
|
20,665
|
|
|
|
19,601
|
|
|
$
|
24.33
|
|
|
$
|
150,355
|
|
|
$
|
24.38
|
|
|
$
|
157,415
|
|
Paul Martin
|
|
|
21,343
|
|
|
|
16,408
|
|
|
$
|
21.78
|
|
|
$
|
167,736
|
|
|
$
|
21.02
|
|
|
$
|
234,413
|
|
David J. Newman
|
|
|
26,508
|
|
|
|
19,624
|
|
|
$
|
21.36
|
|
|
$
|
208,724
|
|
|
$
|
20.49
|
|
|
$
|
305,219
|
|
Paul F. Romano(6)
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark I. Rosen
|
|
|
50,336
|
|
|
|
35,665
|
|
|
$
|
21.45
|
|
|
$
|
376,315
|
|
|
$
|
20.57
|
|
|
$
|
575,438
|
|
|
|
|
(1) |
|
Illustrates the economic value of all unvested Stock Options
that will become fully vested and cashed out in connection with
the Merger. Calculated for each individual by multiplying the
number of shares of Common Stock underlying unvested Stock
Options by the difference, if any, between the merger
consideration of $32.00 per share in cash (subject to the
potential downward purchase price adjustment) and the weighted
average exercise price of the unvested Stock Options. |
|
(2) |
|
Illustrates the economic value of all Stock Options to be
cancelled and cashed out in connection with the Merger.
Calculated for each individual by multiplying the aggregate
number of shares of Common Stock subject to Stock Options by the
difference between the merger consideration of $32.00 per share
in cash (subject to the potential downward purchase price
adjustment) and the weighted average exercise price of all such
Stock Options. |
|
(3) |
|
Mr. Sennott is Executive Vice President and Chief Financial
Officer of Darwin. |
|
(4) |
|
Mr. Sills is President and Chief Executive Officer of
Darwin. |
|
(5) |
|
Mr. Slattery was not nominated for election to the Board in
2008. |
|
(6) |
|
Mr. Romano resigned from Darwin effective March 27,
2008. |
Treatment
of Restricted Shares
Immediately prior to the effective time of the Merger, each
restricted share of Common Stock that is then outstanding,
whether vested or unvested, will become fully vested and
payable. At the effective time of the Merger, each restricted
share of Common Stock will be cancelled and converted into the
right to receive an amount in cash
34
equal to the merger consideration of $32.00 per share in cash,
plus any declared and unpaid dividends, subject to the potential
downward purchase price adjustment.
The following table identifies, for each of our directors and
executive officers, the number of restricted shares of Common
Stock owned as of September 15, 2008 and the value of such
restricted shares of Common Stock that will become fully vested
in connection with the Merger. The information in the table
assumes that all such restricted shares of Common Stock included
therein remain outstanding on the closing date of the Merger.
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
|
Restricted Shares of
|
|
|
Restricted Shares of
|
|
Name
|
|
Common Stock
|
|
|
Common Stock(1)
|
|
|
Directors
|
|
|
|
|
|
|
|
|
R. Bruce Albro
|
|
|
0
|
|
|
|
|
|
Phillip N. Ben-Zvi
|
|
|
0
|
|
|
|
|
|
Christopher K. Dalrymple
|
|
|
0
|
|
|
|
|
|
Weston M. Hicks
|
|
|
0
|
|
|
|
|
|
William C. Popik, M.D.
|
|
|
0
|
|
|
|
|
|
George M. Reider, Jr.
|
|
|
0
|
|
|
|
|
|
John L. Sennott, Jr.(2)
|
|
|
6,071
|
|
|
$
|
194,272
|
|
Stephen J. Sills(3)
|
|
|
13,623
|
|
|
$
|
435,936
|
|
James P. Slattery(4)
|
|
|
0
|
|
|
|
|
|
Irving B. Yoskowitz
|
|
|
0
|
|
|
|
|
|
Executive Officers
|
|
|
|
|
|
|
|
|
Robert Asensio
|
|
|
7,290
|
|
|
$
|
233,280
|
|
Paul Martin
|
|
|
5,094
|
|
|
$
|
163,008
|
|
David J. Newman
|
|
|
5,657
|
|
|
$
|
181,024
|
|
Paul F. Romano(5)
|
|
|
0
|
|
|
|
|
|
Mark I. Rosen
|
|
|
9,850
|
|
|
$
|
315,200
|
|
|
|
|
(1) |
|
Illustrates the economic value of all restricted shares of
Common Stock that will become fully vested and cashed out in
connection with the Merger. Calculated for each individual by
multiplying the aggregate number of restricted shares of Common
Stock by the merger consideration of $32.00 per share in cash,
subject to the potential downward purchase price adjustment. |
|
(2) |
|
Mr. Sennott is Executive Vice President and Chief Financial
Officer of Darwin. |
|
(3) |
|
Mr. Sills is President and Chief Executive Officer of
Darwin. |
|
(4) |
|
Mr. Slattery was not nominated for election to the Board in
2008. |
|
(5) |
|
Mr. Romano resigned from Darwin effective March 27,
2008. |
Treatment
of Director Share Units
At the effective time of the Merger, each director share unit
that is outstanding immediately prior to the Merger will be
cancelled and converted into the right to receive an amount in
cash equal to the merger consideration of $32.00 per share,
subject to the potential downward purchase price adjustment.
The following table identifies, for each of our non-employee
directors (defined as a director who is neither our employee nor
an employee of any of our affiliates including Alleghany), the
number of director share units as of September 15, 2008 and
the value of such director share units that will become payable
in connection with the Merger. Such director share units were
issued under Darwins Stock and Unit Plan for Non-Employee
Directors, approved by Darwins stockholders, pursuant to
which a minimum of 50% of the fees for such directors
board and
35
committee service are payable in director share units. The
information in the table assumes that all such director share
units included therein remain outstanding on the closing date of
the Merger.
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
Name
|
|
Share Units
|
|
|
Share Units(1)
|
|
|
R. Bruce Albro
|
|
|
6,647
|
|
|
$
|
212,704
|
|
Phillip N. Ben-Zvi
|
|
|
8,097
|
|
|
$
|
259,104
|
|
William C. Popik, M.D.
|
|
|
9,097
|
|
|
$
|
291,104
|
|
George M. Reider, Jr.
|
|
|
4,547
|
|
|
$
|
145,504
|
|
Irving B. Yoskowitz
|
|
|
7,467
|
|
|
$
|
238,944
|
|
|
|
|
(1) |
|
Illustrates the economic value of all director share units that
will be cashed out in connection with the Merger. Calculated for
each individual by multiplying the aggregate number of director
share units by the merger consideration of $32.00 per share in
cash, subject to the potential downward purchase price
adjustment. |
Treatment
of Long Term Incentive Plan
At the effective time of the Merger, each participants
vested percentage in his respective portion of the LTIP profit
pools for the fiscal years 2003 through 2008 in the LTIP shall
be 100%. Payments of the LTIP profit pools for the fiscal years
2003 through 2008 shall continue under the current terms of the
LTIP.
The following table identifies, for each of our executive
officers with interests in the LTIP profit pools for the fiscal
years 2003 through 2008, the aggregate vested amount of such
interests prior to the Merger, the aggregate vested amount of
such interests subsequent to the Merger and the increase in such
vested amount due to the Merger. An employees vested
amount in the LTIP is subject to forfeiture if such employee is
terminated for Cause (as defined in the LTIP).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
Aggregate Vested
|
|
|
Aggregate
|
|
|
|
Aggregate Vested
|
|
|
LTIP Interest
|
|
|
Vested LTIP
|
|
|
|
LTIP Interest
|
|
|
Subsequent
|
|
|
Interest
|
|
Name
|
|
Prior to Merger
|
|
|
to Merger
|
|
|
Due to Merger(1)
|
|
|
Stephen J. Sills
|
|
$
|
2,854,483
|
|
|
$
|
5,777,051
|
|
|
$
|
2,922,568
|
|
Robert Asensio
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
Paul Martin
|
|
$
|
356,810
|
|
|
$
|
722,131
|
|
|
$
|
365,321
|
|
David J. Newman
|
|
$
|
535,216
|
|
|
$
|
1,083,197
|
|
|
$
|
547,981
|
|
Paul F. Romano(2)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
Mark I. Rosen
|
|
$
|
1,070,431
|
|
|
$
|
2,166,394
|
|
|
$
|
1,095,963
|
|
John L. Sennott, Jr.
|
|
$
|
713,621
|
|
|
$
|
1,444,262
|
|
|
$
|
730,641
|
|
|
|
|
(1) |
|
Due to a change of control, which will occur upon the closing of
the Merger, LTIP payments will continue through 2014 unless the
employee is terminated for Cause. These amounts are only
estimates based on data as of the date of this proxy statement
relating to the losses and loss adjustment expenses for each
profit pool year. As loss experience matures for each profit
pool year, the profitability estimate and associated benefits
for each profit pool year is subject to change. |
|
(2) |
|
Mr. Romano resigned from Darwin effective March 27,
2008. |
Employment
Arrangements
Robert Asensio, Employment Agreement
On June 27, 2008, Darwin entered into an employment
agreement with Robert Asensio, to be effective upon the closing
of the Merger. Mr. Asensio shall be employed and serve as
the Executive Vice President and Chief Information Officer of
Darwin. Pursuant to the agreement, Mr. Asensio is entitled
to receive an annual base salary of not less than $230,000 and
is eligible for an annual incentive bonus award determined by
Darwin in respect of each fiscal year. In addition,
Mr. Asensio will be eligible to participate in the equity
incentive plans maintained by Allied World.
Mr. Asensios term of employment commences on the
effective time of the Merger and terminates upon the
36
earliest to occur of (i) his death, (ii) a termination
by reason of a Disability (as defined in the agreement),
(iii) a termination by Darwin with or without Cause (as
defined in the agreement) and (iv) a termination by
Mr. Asensio with or without Good Reason (as defined in the
agreement). In the event that Mr. Asensios employment
is terminated by Darwin without Cause or if he terminates his
employment for Good Reason, the agreement provides for a payment
to him of his then current base salary and annual bonus prorated
in equal payments for the 12 months following the
termination, continued participation in health and other
insurance plans for 12 months following termination and
vesting of equity awards that would have vested in the
12 months following termination. The agreement includes
confidentiality, non-competition, non-interference and
indemnification provisions.
Paul Martin, Employment Agreement
On June 27, 2008, Darwin entered into an employment
agreement with Paul Martin, to be effective upon the closing of
the Merger. Mr. Martin shall be employed and serve as
Senior Vice President and Chief Actuary of Darwin. Pursuant to
the agreement, Mr. Martin is entitled to receive an annual
base salary of not less than $229,100 and is eligible for an
annual incentive bonus award determined by Darwin in respect of
each fiscal year. In addition, Mr. Martin will be eligible
to participate in the equity incentive plans maintained by
Allied World. Mr. Martins term of employment
commences on the effective time of the Merger and terminates
upon the earliest to occur of (i) his death, (ii) a
termination by reason of a Disability (as defined in the
agreement), (iii) a termination by Darwin with or without
Cause (as defined in the agreement) and (iv) a termination
by Mr. Martin with or without Good Reason (as defined in
the agreement). In the event that Mr. Martins
employment is terminated by Darwin without Cause or if he
terminates his employment for Good Reason, the agreement
provides for a payment to him of his then current base salary
and annual bonus prorated in equal payments for the
12 months following the termination, continued
participation in health and other insurance plans for
12 months following termination and vesting of equity
awards that would have vested in the 12 months following
termination. The agreement includes confidentiality,
non-competition, non-interference and indemnification provisions.
David Newman, Employment Agreement
On June 27, 2008, Darwin entered into an employment
agreement with David Newman, to be effective upon the closing of
the Merger. Mr. Newman shall be employed and serve as
Senior Vice President and Chief Underwriting Officer of Darwin.
Pursuant to the agreement, Mr. Newman is entitled to
receive an annual base salary of not less than $273,181 and is
eligible for an annual incentive bonus award determined by
Darwin in respect of each fiscal year. In addition,
Mr. Newman will be eligible to participate in the equity
incentive plans maintained by Allied World. Upon the occurrence
of a Change in Control as defined in the agreement, all such
equity-based awards will fully vest immediately prior to such
Change in Control. Mr. Newmans term of employment
commences on the effective time of the Merger and terminates
upon the earliest to occur of (i) his death, (ii) a
termination by reason of a Disability (as defined in the
agreement), (iii) a termination by Darwin with or without
Cause (as defined in the agreement) and (iv) a termination
by Mr. Newman with or without Good Reason (as defined in
the agreement). In the event that Mr. Newmans
employment is terminated by Darwin without Cause or if he
terminates his employment for Good Reason, the agreement
provides for a payment to him of his then current base salary
and annual bonus prorated in equal payments for the
12 months following the termination, continued
participation in health and other insurance plans for
12 months following termination and vesting of equity
awards that would have vested in the 12 months following
termination. The agreement includes confidentiality,
non-competition, non-interference and indemnification provisions.
Mark I. Rosen, Employment Agreement
On June 27, 2008, Darwin entered into an employment
agreement with Mark I. Rosen, to be effective upon the closing
of the Merger, and which supersedes (unless stated otherwise)
the terms of his prior employment agreement. Mr. Rosen
shall be employed and serve as Executive Vice President, General
Counsel and Chief Claims Officer of Darwin. Pursuant to the
agreement, Mr. Rosen is entitled to receive an annual base
salary of not less than $346,094 and is eligible for an annual
incentive bonus award determined by Darwin in respect of each
fiscal year. In addition, Mr. Rosen will be eligible to
participate in the equity incentive plans maintained by Allied
World. Under the agreement, any awards under Darwins LTIP
immediately vest upon the Merger, with payments of his interest
in Profit Pools to be made at times, in amounts, and
in the manner provided in the LTIP as if the Merger had not
occurred. With respect to any parachute payments
paid in connection with the Merger, the excise tax
gross-up
37
provision of Mr. Rosens prior employment agreement
will remain in full force. Mr. Rosens term of
employment commences on the effective time of the Merger and
terminates upon the earliest to occur of (i) his death,
(ii) a termination by reason of a Disability (as defined in
the agreement), (iii) a termination by Darwin with or
without Cause (as defined in the agreement) and (iv) a
termination by Mr. Rosen with or without Good Reason (as
defined in the agreement). In the event that
Mr. Rosens employment is terminated by Darwin without
Cause or if he terminates his employment for Good Reason, the
agreement provides for a payment to him of his then current base
salary and annual bonus prorated in equal payments for the
12 months following the termination, continued
participation in health and other insurance plans for
12 months following termination and vesting of equity
awards that would have vested in the 12 months following
termination. The agreement includes confidentiality,
non-competition, non-interference and indemnification provisions.
John L. Sennott, Jr., Employment Agreement
On June 27, 2008, Darwin entered into an employment
agreement with John L. Sennott, Jr., to be effective upon
the closing of the Merger. Mr. Sennott shall be employed
and serve as Chief Operating Officer of Darwin. In the event the
position of Chief Operating Officer of Allied Worlds
U.S. operations becomes available, Mr. Sennott will be
offered such position. If Mr. Sennott is not offered such
position within 12 months of the closing of the Merger,
Mr. Sennott will have the right to terminate his employment
for Good Reason (as defined in the agreement). Pursuant to the
agreement, Mr. Sennott is entitled to receive an annual
base salary of not less than $273,181 and is eligible for an
annual incentive bonus award determined by Darwin in respect of
each fiscal year. In addition, Mr. Sennott will be eligible
to participate in the equity incentive plans maintained by
Allied World. Upon the occurrence of a Change in Control as
defined in the agreement, all such equity-based awards will
fully vest immediately prior to such Change in Control.
Mr. Sennotts term of employment commences on the
effective time of the Merger and terminates upon the earliest to
occur of (i) his death, (ii) a termination by reason
of a Disability (as defined in the agreement), (iii) a
termination by Darwin with or without Cause (as defined in the
agreement) and (iv) a termination by Mr. Sennott with
or without Good Reason (as defined in the agreement). In the
event that Mr. Sennotts employment is terminated by
Darwin without Cause or if he terminates his employment for Good
Reason, the agreement provides for a payment to him of his then
current base salary and annual bonus prorated in equal payments
for the 12 months following the termination, continued
participation in health and other insurance plans for
12 months following termination and vesting of equity
awards that would have vested in the 12 months following
termination. The agreement includes confidentiality,
non-competition, non-interference and indemnification provisions.
Stephen J. Sills, Employment Agreement
On June 27, 2008, Darwin amended the amended and restated
employment agreement between Darwin and Stephen J. Sills,
effective as of the closing of the Merger. Under the terms of
the amended agreement, Mr. Sills employment will
terminate effective immediately upon the closing of the Merger,
and such termination will be treated as being without Cause, as
defined in the agreement. Under the amended employment
agreement, Mr. Sills will be entitled to (i) continued
payment of base salary and a medical coverage subsidy (as
described in the employment agreement) for 12 months,
(ii) a payment of $259,577 (on or about March 15,
2009) in satisfaction of the annual bonus component of the
severance obligation under the amended and restated employment
agreement, and (iii) an additional lump-sum payment,
payable on the date of the closing of the Merger, equal to
$973,413. A letter agreement between Darwin and AIHL provides
that AIHL will pay to Darwin an amount equal to the $973,413
described in the previous sentence, reduced by the amount of the
reduction in Darwins federal, state and local income taxes
that is expected to be realized because of such payment (such
expected realization assumed based on a combined effective
federal, state and local tax rate of 25%). Such payment shall
not occur if the Merger is not consummated. Under the amended
employment agreement, if any amounts payable to Mr. Sills
trigger an excise tax under Section 4999 of the Internal
Revenue Code on account of being deemed parachute
payments within the meaning of Section 280G of the
Internal Revenue Code, then Mr. Sills will be entitled to
receive a gross-up payment based on such excise tax
amount, and any interest and penalties incurred in connection
therewith. In substantial part in consideration for the payments
described above, the amendment to Mr. Sills
employment agreement also includes enhanced non-competition and
non-interference provisions. Specifically, Mr. Sills will
be subject to non-competition and non-interference restrictions
for 24 months following the termination of his employment.
38
Indemnification
and Insurance
Allied World and the Surviving Corporation have agreed to
indemnify and hold harmless the current and former directors and
officers of Darwin to the fullest extent permitted by applicable
law for all claims pertaining to matters that relate to such
indemnified partys duties or services as a director or
officer. Allied World and the Surviving Corporation will
advance, to the fullest extent authorized or permitted by
applicable law, any expenses incurred in defending or
participating in such claims.
The Merger Agreement requires that we purchase, immediately
prior to the closing of the Merger, a single payment, run-off
policy of directors and officers liability insurance
which shall become effective at the closing and remain in effect
for 6 years after the closing covering current and former
officers and directors of Darwin and Darwins subsidiaries,
with limits of $20,000,000 for each claim and in the aggregate.
The premium for such run-off policy or policies will not exceed
$400,000. Immediately prior to the closing of the Merger, Allied
World will provide for the current officers and directors of
Darwin and Darwins subsidiaries who continue in such
capacity after the closing to be covered under Allied
Worlds directors and officers liability
program with the same terms as those applicable to the officers
and directors of Allied World and its subsidiaries.
Continued
Benefits
Allied World will honor, in accordance with their terms, all
existing employment plans and agreements (other than
equity-based incentive plans) in effect immediately before the
effective time of the Merger. For a period of one year after the
Merger, Allied World will provide (i) compensation
(including incentive compensation) no less favorable in the
aggregate than the compensation (including incentive
compensation) provided to employees of Darwin immediately before
the effective time of the Merger and (ii) employee benefits
no less favorable than provided to similarly situated employees
of Allied World.
Material
U.S. Federal Income Tax Consequences
The following discussion summarizes the material
U.S. federal income tax consequences to beneficial holders
of shares of Common Stock whose shares are converted into the
right to receive cash pursuant to the Merger, and is based upon
present law (which may change, possibly with retroactive
effect). The tax consequences set forth below are not intended
to constitute a complete description of all tax consequences
relating to the Merger.
Due to the individual nature of tax consequences, you should
consult your tax advisors as to the specific tax consequences of
the Merger to you, including the effects of applicable federal,
state, local, foreign and other tax laws.
The following discussion applies only if you hold your shares of
Common Stock as a capital asset and does not apply if you
(i) acquired your shares of Common Stock, or receive
payment pursuant to the Merger, in connection with the exercise
of Stock Options or other compensation arrangements with Darwin,
(ii) hold your shares of Common Stock as part of a hedge,
straddle or conversion transaction or (iii) are a person
otherwise subject to special tax treatment under the Internal
Revenue Code of 1986, as amended. In addition, this discussion
does not address the U.S. federal income tax consequences
to a beneficial holder of shares of Common Stock who, for
U.S. federal income tax purposes, is a non-resident alien
individual, a foreign corporation, a foreign partnership or a
foreign estate or trust, nor does it consider the effect of any
state, local or foreign tax laws. If a partnership (including an
entity treated as a partnership for U.S. federal income tax
purposes) holds shares of Common Stock, the tax treatment of a
partner generally will depend on the status of the partners and
activities of the partnership. A partner of a partnership
holding shares of Common Stock should consult its tax advisor.
The receipt of cash pursuant to the Merger will be a taxable
transaction for U.S. federal income tax purposes, and it
may also be a taxable transaction under applicable state, local,
foreign and other tax laws. In general, if you receive cash
pursuant to the Merger, you will recognize gain or loss equal to
the difference, if any, between the amount of cash received
(determined before the deduction of any withholding tax) and
your adjusted tax basis in the shares of Common Stock converted
into cash pursuant to the Merger. Gain or loss will be
determined separately for each block of shares of Common Stock
(i.e., shares of Common Stock acquired for the same cost in a
single transaction) converted into cash pursuant to the Merger.
Such gain or loss generally will be capital gain or loss and
39
generally will be long-term capital gain or loss if your holding
period for the shares is more than one year at the time of
consummation of the Merger. Long-term capital gains of
individuals are subject to U.S. federal income tax at a
maximum rate of 15%. The deduction of capital losses is subject
to limitations.
Cash payments received by beneficial holders of shares of Common
Stock pursuant to the Merger are subject to information
reporting, and may be subject to backup withholding at the
applicable rate (currently 28%) if the beneficial holder or
other payee fails to provide a valid taxpayer identification
number and comply with certain certification procedures or
otherwise establish an exemption from backup withholding. Backup
withholding is not an additional U.S. federal income tax.
Rather, the U.S. federal income tax liability of the person
subject to backup withholding will be reduced by the amount of
tax withheld. If backup withholding results in an overpayment of
taxes, a refund may be obtained provided that the required
information is timely furnished to the Internal Revenue Service.
The receipt of cash pursuant to the exercise of statutory
appraisal rights will be a taxable transaction for
U.S. federal income tax purposes and may also be a taxable
transaction under applicable state, local, foreign and other tax
laws. Any beneficial holder of shares of Common Stock
considering exercising statutory appraisal rights should consult
its own tax advisor with respect to its particular circumstances.
Regulatory
Approvals
Antitrust
Under the HSR Act, we cannot consummate the Merger until we and
Allied World have notified the DOJ and the FTC of the Merger,
furnished them with certain information and materials relating
to the Merger and the applicable waiting periods have terminated
or expired. The termination of the waiting period means the
parties have satisfied the regulatory requirements under the HSR
Act. We and Allied World filed notification and report forms
under the HSR Act with the Antitrust Division of the DOJ and the
FTC on July 14, 2008. Darwin and Allied World received
notice that the waiting period under the HSR Act was terminated
as of July 21, 2008.
At any time before or after consummation of the Merger,
notwithstanding the early termination of the waiting period
under the HSR Act, the Antitrust Division of the DOJ or the FTC
could take such action under the antitrust laws as it deems
necessary or desirable in the public interest, including seeking
to enjoin the consummation of the Merger or seeking divestiture
of substantial assets of Darwin. At any time before or after the
consummation of the Merger, and notwithstanding the early
termination of the waiting period under the HSR Act, any state
could take such action under the antitrust laws as it deems
necessary or desirable in the public interest. Such action could
include seeking to enjoin the consummation of the Merger or
seeking divestiture of substantial assets of Darwin. Private
parties may also seek to take legal action under the antitrust
laws under certain circumstances.
Insurance
Regulations
The insurance laws and regulations of all 50 U.S. states,
the District of Columbia, Puerto Rico and the U.S. Virgin
Islands generally require that, prior to the acquisition of
control of an insurance company, either through the acquisition
of or merger with the insurance company or a holding company of
that insurance company, the acquiring party must obtain approval
from the insurance commissioner of the insurance companys
state of domicile and any state in which an insurance company is
commercially domiciled.
In connection with this state approval and notification process,
Allied World has made formal filing applications, called Form
A filings, for approval of the Merger with the
insurance commissioners of Delaware and Arkansas, the states in
which the insurance company subsidiaries of Darwin are
domiciled. As of the date of this proxy statement, Allied World
has not yet obtained the approvals under the applicable state
insurance laws that may be required to complete the Merger.
There can be no assurance that the insurance commissioners will
provide the approvals under the applicable state insurance laws.
Subject to the terms and conditions provided in the Merger
Agreement, as promptly as practicable, each of Allied World and
Darwin has agreed to use reasonable best efforts to take, or
cause to be taken, all actions and do, or cause to be done, all
things necessary or appropriate to consummate the Merger as soon
as practicable, including obtaining the termination of any
waiting period under the HSR Act and seeking the receipt of
governmental consents (including the consents of insurance
regulators).
40
In addition, Allied World has made notice filings in certain
other jurisdictions regarding the potential competitive impact
of the Merger on market share in particular insurance lines in
those jurisdictions. Approval of the Merger is generally not
required in these states, but state insurance departments could
determine to take action to prevent or impose conditions on the
Merger or on any related change of control affecting
Darwins existing insurance licenses and authorizations.
Although Darwin and Allied World do not expect these regulatory
authorities to raise any significant concerns in connection with
their review of the Merger, there is no assurance that Allied
World will obtain all required regulatory approvals.
Other than the filings described above, neither Darwin nor
Allied World is aware of any regulatory approvals required to be
obtained, or waiting periods to expire, to complete the Merger.
If the parties discover that other approvals or waiting periods
are necessary, they will seek to obtain or comply with them.
Delisting
and Deregistration of Common Stock
Following consummation of the Merger, the registration of shares
of Common Stock and Darwins reporting obligations with
respect to the Common Stock under the Exchange Act will be
terminated upon application to the SEC and we will no longer
file periodic reports with the SEC on account of Darwin or the
Common Stock. In addition, upon completion of the Merger, shares
of the Common Stock will be delisted from the NYSE and will no
longer be listed on any stock exchange or quotation system,
including the NYSE.
Certain
Litigation Related to the Merger
On August 28, 2008, a purported class action complaint,
Broadbased Equities v. R. Bruce Albro, et al.
(Superior Court, Judicial District of Hartford), was served
on Darwin, naming as defendants Darwin, the members of its board
of directors and Allied World, allegedly on behalf of
Darwins stockholders, in the Superior Court for the
Judicial District of Hartford. The complaint alleges, among
other things, that (i) the directors of Darwin breached
their fiduciary duties in connection with the proposed
transaction by approving a transaction that purportedly protects
and advances the interests of Darwins directors and Allied
World at the expense of Darwins public stockholders and
(ii) that Darwins preliminary proxy statement filed
with the SEC in connection with the Merger concealed material
information from Darwins public stockholders. The
complaint seeks declaratory and injunctive relief, monetary
and/or
rescissory damages and other relief, together with an award of
attorneys fees and litigation costs and interest.
Although Darwin, the members of its board of directors and
Allied World believe that the claims asserted are without merit,
on September 16, 2008, the parties reached an agreement in
principle to settle this litigation, while specifically denying
any wrongdoing by any of the defendants. Pursuant to the
proposed settlement, we have agreed to make certain additional
disclosures in Darwins proxy statement, which are
contained herein. The proposed settlement is subject to the
satisfaction of a number of conditions, including the execution
of a definitive settlement agreement, final court approval of
the settlement and notice to our stockholders.
41
THE
MERGER AGREEMENT
This section of the proxy statement describes the material
provisions of the Merger Agreement but does not purport to
describe all of the terms of the Merger Agreement. The following
summary is qualified in its entirety by reference to the
complete text of the Merger Agreement, which is attached as
Annex A to this proxy statement and incorporated into this
proxy statement by reference. We urge you to read the full text
of the Merger Agreement because it is the legal document that
governs the Merger. It is not intended to provide you with any
other factual information about us. In particular, the
assertions embodied in the representations and warranties
contained in the Merger Agreement (and summarized below) are
qualified by information in confidential disclosure schedules
provided by Darwin and Parent to each other in connection with
the signing of the Merger Agreement. These disclosure schedules
contain information that modifies, qualifies and creates
exceptions to the representations and warranties set forth in
the Merger Agreement. Moreover, certain representations and
warranties in the Merger Agreement were used for the purpose of
allocating risk between Darwin and Parent rather than
establishing matters as facts and may be subject to a
contractual standard of materiality or material adverse effect
different from that generally applicable to public disclosures
to stockholders. Accordingly, you should not rely on the
representations and warranties in the Merger Agreement (or the
summaries contained herein) as characterizations of the actual
state of facts about Darwin or Parent. The representations and
warranties in the Merger Agreement and the description of them
in this document should not be read alone but instead should be
read in conjunction with the other information contained in the
reports, statements and filings we publicly file with the SEC.
Such information can be found elsewhere in this proxy statement
and in the public filings we make with the SEC, as described in
the section entitled Where You Can Find More
Information beginning on page 61.
The
Merger and Effective Time
The Merger Agreement provides for the merger of MergerCo with
and into Darwin upon the terms, and subject to the conditions,
of the Merger Agreement. As the Surviving Corporation, Darwin
will continue to exist as an indirect wholly owned subsidiary of
Parent following the Merger. Upon consummation of the Merger,
the directors of MergerCo immediately prior to the effective
time of the Merger will be the initial directors of the
Surviving Corporation and the officers of Darwin immediately
prior to the effective time of the Merger will be the initial
officers of the Surviving Corporation. All of Surviving
Corporations directors and officers will hold their
positions until their successors are duly elected or appointed
and qualified or until the earlier of their death, resignation
or removal.
We, Parent or MergerCo may terminate the Merger Agreement prior
to the consummation of the Merger in some circumstances, whether
before or after the adoption by our stockholders of the Merger
Agreement. Additional details on termination of the Merger
Agreement are described in Termination of the
Merger Agreement beginning on page 51.
The Merger will be effective at the time the certificate of
merger is filed with the Secretary of State of the State of
Delaware (or at a later time, if agreed upon by the parties and
specified in the certificate of merger).
The parties are required to close the Merger no later than the
third business day after the satisfaction or waiver of the
conditions described under Conditions to the
Merger beginning on page 48, or such other time
agreed to by the parties.
Merger
Consideration
Each share of Common Stock issued and outstanding immediately
prior to the effective time of the Merger will be converted into
the right to receive the merger consideration of $32.00 per
share in cash, without interest and less any applicable
withholding taxes, and subject to a potential downward price
adjustment in the event that certain representations by the
Company in the Merger Agreement with respect to its
capitalization prove to be inaccurate and, as a result of such
inaccuracy, the aggregate consideration payable by Parent in the
Merger would otherwise be increased by more than $1,000,000 (see
Potential Downward Purchase Price
Adjustment beginning on
42
page 43). These provisions related to the merger
consideration will not apply to the following shares of Common
Stock:
|
|
|
|
|
shares of Common Stock held by holders who have properly
demanded and perfected their appraisal rights. See
Dissenters Rights of Appraisal beginning on
page 58; and
|
|
|
|
shares of Common Stock held in treasury by the Company or held
by any Company subsidiary or owned by Parent or MergerCo (or any
wholly owned subsidiary of Parent or MergerCo).
|
After the Merger is effective, each holder of a certificate
representing any shares of Common Stock (other than the excluded
shares listed above) will no longer have any rights with respect
to the shares of Common Stock, except for the right to receive
the merger consideration.
Potential
Downward Purchase Price Adjustment
In the event that certain representations and warranties of the
Company in the Merger Agreement with respect to its
capitalization prove to be inaccurate and, as a result of such
inaccuracy, the aggregate consideration to be paid by Parent
pursuant to the Merger would otherwise be increased by more than
$1,000,000, then the merger consideration will be ratably and
equitably reduced so that the aggregate consideration to be paid
by Parent at the closing of the Merger is reduced by an amount
equal to the amount of such increase above $1,000,000.
Treatment
of Options and Other Awards
Stock Options. Immediately prior to the
effective time of the Merger, all outstanding Stock Options
under the Companys equity incentive plans will become
fully vested and exercisable. All such Stock Options not
exercised prior to the Merger will be cancelled and converted
into the right to receive a cash payment equal to the number of
shares of Common Stock underlying the Stock Options multiplied
by the amount (if any) by which the merger consideration of
$32.00 per share in cash exceeds the exercise price of the Stock
Option, subject to the potential downward purchase price
adjustment, without interest and less any applicable withholding
taxes.
Restricted Shares. Immediately prior to
the effective time of the Merger, all restricted shares of
Common Stock will vest and will be cancelled and converted into
the right to receive a cash payment equal to the number of
restricted shares multiplied by the merger consideration of
$32.00 per share in cash, plus any declared and unpaid
dividends, without interest and less any applicable withholding
taxes, subject to the potential downward purchase price
adjustment.
Director Share Units. Upon the
consummation of the Merger, each director share unit that is
outstanding immediately prior to the Merger will be converted
into the right to receive an amount in cash equal to $32.00 per
share unit in cash, subject to the potential downward purchase
price adjustment, without interest and less any applicable
withholding taxes, plus any declared and unpaid dividends.
Payment
for the Shares of Common Stock
We will designate a paying agent reasonably satisfactory to
Parent to make payment of the merger consideration as described
above. At or prior to the effective time of the Merger, Parent
will, or will cause the Surviving Corporation to, deposit in
trust with the paying agent the funds appropriate to pay the
merger consideration to the stockholders and holders of Stock
Options, restricted shares of Common Stock and director share
units.
Following the effective time of the Merger, we will close our
stock transfer books. After that time, there will be no further
transfers of shares of Common Stock.
As promptly as practicable after the effective time of the
Merger, but no later than three business days following the
effective time of the Merger, Parent and the Surviving
Corporation will cause the paying agent to send you a letter of
transmittal and instructions advising you how to surrender your
certificates or Stock Options or transfer your shares of Common
Stock (as applicable) in exchange for the merger consideration.
The paying agent will pay you your merger consideration after
you have surrendered your certificates and provided your signed
letter of transmittal to the paying agent, along with any other
items specified by the letter of transmittal, or complied with
procedures specified by the paying agent for shares not
represented by certificates. Interest will not be paid or
43
accrue in respect of the merger consideration. The Surviving
Corporation will deduct and withhold any applicable withholding
taxes from the amount of any merger consideration paid to you.
You should not forward your stock certificates to the paying
agent without a letter of transmittal and you should not return
your stock certificates with the enclosed proxy.
If any cash deposited with the paying agent is not distributed
within 1 year following the effective time of the Merger,
such cash will be returned to the Surviving Corporation upon
demand and you will be entitled to look only to the Surviving
Corporation for the payment of your merger consideration.
If the paying agent is to pay some or all of your merger
consideration to a person other than you, as the registered
owner of a stock certificate, you must have your certificates
properly endorsed or otherwise in proper form for transfer, and
you must pay any transfer or other taxes payable by reason of
the transfer or establish to the paying agents reasonable
satisfaction that the taxes have been paid or are not required
to be paid.
The transmittal instructions will tell you what to do if you
have lost your certificate, or if it has been stolen or
destroyed. You will have to provide an affidavit to that fact
and, if required by the Surviving Corporation, post a bond in a
reasonable amount that the Surviving Corporation may direct as
indemnity against any claim that may be made against the
Surviving Corporation in respect of the lost, stolen or
destroyed certificate.
Representations
and Warranties
The Merger Agreement contains representations and warranties
made by us to Parent and MergerCo and representations and
warranties made by Parent and MergerCo to us. The assertions
embodied in those representations and warranties were made
solely for purposes of the Merger Agreement and may be subject
to important qualifications and limitations agreed by the
parties in connection with negotiating its terms. In particular,
the assertions embodied in the representations and warranties
contained in the Merger Agreement (and summarized below) are
qualified by information in confidential disclosure schedules
provided by Darwin and Parent to each other in connection with
the signing of the Merger Agreement. These disclosure schedules
contain information that modifies, qualifies and creates
exceptions to the representations and warranties set forth in
the Merger Agreement. Moreover, certain representations and
warranties in the Merger Agreement were used for the purpose of
allocating risk between Darwin and Parent rather than
establishing matters as facts and may be subject to a
contractual standard of materiality or material adverse effect
different from that generally applicable to public disclosures
to stockholders. Accordingly, you should not rely on the
representations and warranties in the Merger Agreement (or the
summaries contained herein) as characterizations of the actual
state of facts about Darwin or Parent. The representations and
warranties in the Merger Agreement and the description of them
in this document should not be read alone but instead should be
read in conjunction with the other information contained in the
reports, statements and filings we publicly file with the SEC.
In the Merger Agreement, Darwin, Parent and MergerCo each made
representations and warranties relating to, among other things:
|
|
|
|
|
corporate organization, qualification and authority;
|
|
|
|
corporate power and authority to enter into and perform its
obligations under, and enforceability of, the Merger Agreement;
|
|
|
|
the absence of conflicts with or defaults under organizational
documents, other contracts and applicable laws;
|
|
|
|
required regulatory filings and consents and approvals of
governmental entities;
|
|
|
|
information supplied for inclusion in this proxy statement;
|
|
|
|
the absence of litigation; and
|
|
|
|
brokers fees.
|
In the Merger Agreement, Parent and MergerCo also each made
representations and warranties relating to:
|
|
|
|
|
the ownership of MergerCo by Parent;
|
44
|
|
|
|
|
the availability of the funds necessary to perform their
obligations under the Merger Agreement;
|
|
|
|
their lack of ownership of any shares of Common Stock;
|
|
|
|
the absence of other agreements or understandings with officers,
directors or stockholders of Darwin beneficially owning 5% or
more of Darwins outstanding capital stock that relates to
the voting or disposition of shares of Common Stock in respect
of the Merger; and
|
|
|
|
the absence of any significant interest in Darwins
competitors.
|
Darwin also made representations and warranties relating to:
|
|
|
|
|
subsidiaries;
|
|
|
|
capital structure;
|
|
|
|
compliance with applicable laws and permits and insurance
matters;
|
|
|
|
documents filed with the SEC and financial statements;
|
|
|
|
the absence of certain changes or events since March 31,
2008;
|
|
|
|
the absence of undisclosed liabilities;
|
|
|
|
employee benefit matters;
|
|
|
|
intellectual property matters;
|
|
|
|
tax matters;
|
|
|
|
environmental matters;
|
|
|
|
material contracts;
|
|
|
|
transactions with interested parties;
|
|
|
|
insurance; and
|
|
|
|
|
|
the receipt by the Board and the Special Committee of an opinion
from UBS.
|
Many of Darwins representations and warranties are
qualified by a material adverse effect standard. For purposes of
the Merger Agreement, Material Adverse Effect is
defined to mean, with respect to the Company, an effect, event,
development or change that is materially adverse to the
business, assets, results of operations or financial condition
of the Company and the Company subsidiaries, taken as a whole,
other than any of the following, or any effect, event,
development or change arising out of or resulting from any of
the following:
|
|
|
|
|
changes in the market price of shares of Common Stock (except
that the underlying cause of any such change shall not be
excluded from the determination of whether there has been a
Material Adverse Effect);
|
|
|
|
changes in conditions in the U.S. or global economy or
capital or financial markets generally, including changes in
interest or exchange rates (except to the extent that the
Company and the Company subsidiaries taken as a whole are
materially disproportionately adversely affected relative to
other participants in the industries in which the Company or the
Company subsidiaries participate);
|
|
|
|
changes in general legal, tax, regulatory, political or business
conditions in the geographic regions in which the Company and
the Company subsidiaries do business (except to the extent that
the Company and the Company subsidiaries taken as a whole are
materially disproportionately adversely affected relative to
other participants in the industries in which the Company or the
Company subsidiaries participate);
|
|
|
|
general market or economic conditions in the specialty property
and casualty insurance industry (except to the extent that the
Company and the Company subsidiaries taken as a whole are
materially disproportionately adversely affected relative to
other participants in the industries in which the Company or the
Company subsidiaries participate);
|
|
|
|
changes in law following the date of the Merger Agreement;
|
45
|
|
|
|
|
changes in generally accepted accounting principles as applied
in the United States or statutory accounting practices
prescribed or permitted by the applicable insurance regulatory
authority following the date of the Merger Agreement;
|
|
|
|
the negotiation, execution, announcement, pendency or
performance of the Merger Agreement or the transactions
contemplated thereby or the consummation of the transactions
contemplated by the Merger Agreement, including the impact
thereof on relationships, contractual or otherwise, with
insureds, customers, insurance brokers, reinsurance
intermediaries, suppliers, vendors, lenders, venture partners or
employees;
|
|
|
|
acts of war, armed hostilities, sabotage or terrorism, or any
escalation or worsening of any such acts of war, armed
hostilities, sabotage or terrorism threatened or underway as of
the date of the Merger Agreement (except to the extent that the
insurance business of the Company and the Company subsidiaries
taken as a whole are materially disproportionately adversely
affected as a result of payments required to be made under
insurance policies written by the Company relative to other
participants in the insurance industry);
|
|
|
|
earthquakes, hurricanes, floods, or other natural disasters
(except to the extent that the insurance business of the Company
and the Company subsidiaries taken as a whole are materially
disproportionately adversely affected as a result of payments
required to be made under insurance policies written by the
Company relative to other participants in the insurance
industry);
|
|
|
|
any change or announcement of a potential change in the credit
rating or A.M. Best rating of the Company or any of the
Company subsidiaries or any of their securities (except that the
underlying cause of any such change or announcement shall not be
excluded from the determination of whether there has been a
Material Adverse Effect);
|
|
|
|
any failure by the Company to meet any internal or external
projections, forecasts or estimates of revenues or earnings for
any period (except that the underlying cause of any such failure
shall not be excluded from the determination of whether there
has been a Material Adverse Effect);
|
|
|
|
any action by Parent or any of its affiliates or the omission of
an action that is expressly required to be taken by Parent or
any of its affiliates pursuant to the Merger Agreement; or
|
|
|
|
any action taken by the Company at the written request or with
the written consent of Parent or MergerCo.
|
Conduct
of Business Prior to Closing
We have agreed in the Merger Agreement that, until the
consummation of the Merger, except as consented to in writing by
Parent, we will:
|
|
|
|
|
conduct, and cause our subsidiaries to conduct, our business in
the ordinary course consistent with past practices; and
|
|
|
|
use, and cause each of our subsidiaries to use, our commercially
reasonable efforts to preserve substantially intact our
business, assets and organization and to preserve our current
beneficial relationships with any person with which the Company
or any Company subsidiary has material business relations
(including customers, suppliers, directors, officers and key
employees).
|
We have also agreed that, until the consummation of the Merger,
except as expressly required or contemplated by the Merger
Agreement, as may be required by applicable law, or with the
prior written consent of Parent, we and our subsidiaries will
not:
|
|
|
|
|
amend our organizational documents;
|
|
|
|
authorize for issuance, issue, sell, pledge, dispose of, grant
or transfer or agree or commit to issue, sell, dispose of, grant
or transfer any shares of capital stock, or any other ownership
interest, of the Company or any Company subsidiary, other than
the issuance of Common Stock issuable pursuant to Company stock
awards outstanding on the date of the Merger Agreement;
|
46
|
|
|
|
|
repurchase, redeem or otherwise acquire any securities or equity
equivalents except in connection with the exercise of Company
Stock Options or the vesting of Company stock awards;
|
|
|
|
declare or pay any dividends on, or make any other distributions
in respect of, any shares of the Companys capital stock or
the shares of stock or other equity interests in any Company
subsidiary that is not wholly owned by the Company, other than
(i) dividends by any wholly owned Company subsidiary to the
Company or any other Company subsidiary and (ii) dividend
equivalents already accrued as of the date of the Merger
Agreement and paid with respect to outstanding Company stock
awards outstanding on the date of the Merger Agreement;
|
|
|
|
split, combine or reclassify any shares, stock or other equity
interests of the Company or any Company subsidiary or issue or
authorize the issuance of any securities in respect of such
shares, stock or other equity interests;
|
|
|
|
merge with any other entity, adopt a plan of complete or partial
liquidation, dissolution or other reorganization of the Company
or any Company subsidiary, except for acquisitions for a
purchase price less than $5,000,000 individually or $10,000,000
in the aggregate;
|
|
|
|
sell, lease, dispose of or encumber any assets other than in the
ordinary course of business, except for (i) sales of
investment assets by the Company or any of the Company
subsidiaries in the ordinary course of business consistent with
past practice, (ii) transfers and pledges of assets in
connection with the conduct of the insurance business in the
ordinary course of business consistent with past practice,
(iii) sales or transfers of assets between wholly owned
Company subsidiaries, (iv) pursuant to certain existing
written contracts or commitments or (v) amounts no greater
than $5,000,000 in the aggregate;
|
|
|
|
incur or guarantee any indebtedness or issue any debt
securities, other than for borrowed money in the ordinary course
of business and pursuant to any credit agreement to which the
Company or any Company subsidiary is a party as of the date of
the Merger Agreement;
|
|
|
|
increase the compensation or benefits payable to its directors,
officers or employees (other than increases for employees or
officers below the level of senior vice president made in the
ordinary course of business consistent with past practice);
|
|
|
|
amend, waive or terminate any rights under certain employment
agreements;
|
|
|
|
establish, adopt or amend to materially increase benefits under
any collective bargaining, bonus, compensation, retirement,
severance or other similar plan or arrangement with any
director, officer or employee (other than with respect to new
hires of non-executive officers in the ordinary course of
business consistent with past practice that do not provide for
change of control benefits and each award under the
Companys performance incentive plan and long term
incentive plan);
|
|
|
|
pre-pay any long-term debt in an amount exceeding $5,000,000 in
the aggregate except in the ordinary course of business
consistent with past practice;
|
|
|
|
materially change any of its accounting policies (whether for
financial accounting or tax purposes);
|
|
|
|
authorize or commit to any new material capital expenditures in
an amount in excess of $2,000,000 in the aggregate;
|
|
|
|
settle any material litigation, claims or obligations other than
in the ordinary course of business consistent with past practice
(which includes policyholder claims) where the amounts paid or
to be paid, except in the case of policyholder claims, are
covered by insurance or are in an amount less than $5,000,000 in
the aggregate;
|
|
|
|
cause any of the Companys representations or warranties in
the Merger Agreement to become inaccurate in any material
respect or any of the Companys covenants to be breached in
any material respect or result in the failure to be satisfied of
any of the conditions to the obligations of Parent and MergerCo
set forth in the Merger Agreement;
|
|
|
|
create or have any subsidiary other than the Company
subsidiaries as of the date of the Merger Agreement;
|
47
|
|
|
|
|
enter into any new material contract (as defined in
Item 601(b)(10) of
Regulation S-K)
or amend, terminate or release, in any material respect, any
rights under any material contract;
|
|
|
|
settle any material tax audit, make or change any material tax
election, file any material amendment to a material tax return
or surrender any right to claim a material tax refund;
|
|
|
|
enter into any agreement that would be required to be reported
by the SEC as a transaction with a related person, promoter or
control person;
|
|
|
|
enter into any agreement with Alleghany or its
affiliates; or
|
|
|
|
enter into any agreement to do any of the foregoing.
|
Agreement
to Take Further Action and to Use Reasonable Best
Efforts
Subject to the terms and conditions provided in the Merger
Agreement, as promptly as practicable, each party to the Merger
Agreement has agreed to use reasonable best efforts to take, or
cause to be taken, all actions and do, or cause to be done, all
things necessary or appropriate to consummate the Merger as soon
as practicable, including obtaining the termination of any
waiting period under the HSR Act and seeking the receipt of
governmental consents (including the consents of insurance
regulators). The agreement to use reasonable best efforts
includes the obligation of Parent or Darwin, as applicable, to
(i) execute settlements and undertakings, (ii) sell,
hold separate or divest any of Parents particular assets
or businesses, (iii) agree to sell, hold separate or divest
Darwins particular assets or businesses contemporaneously
with or subsequent to the consummation of the Merger,
(iv) permit Darwin to sell, hold separate or divest
particular assets prior to the closing of the Merger and
(v) take actions that, after the consummation of the
Merger, would limit the freedom of action of Parent or Darwin
with respect to one or more of their businesses, product lines
or assets, in each case, as may be required in order to avoid a
regulatory order or proceeding that would prevent or materially
delay the consummation of the Merger.
Conditions
to the Merger
Conditions to Each Partys
Obligations. Each partys obligation to
complete the Merger is subject to the satisfaction or waiver of
the following conditions:
|
|
|
|
|
the majority of the outstanding shares of Common Stock entitled
to be cast at the special meeting shall have been voted
FOR the adoption of the Merger Agreement;
|
|
|
|
any applicable waiting period under the HSR Act shall have
expired or been terminated;
|
|
|
|
no governmental authority shall have enacted or issued any
injunction or order which is then in effect and has the effect
of making consummation of the Merger illegal or prohibiting
consummation of the Merger; and
|
|
|
|
the required filings with, and approval of, the applicable
insurance regulatory authorities shall have been obtained and
the applicable waiting periods shall have terminated or expired.
|
Conditions to Parents and MergerCos
Obligations. The obligations of Parent and
MergerCo to complete the Merger are subject to the satisfaction
or waiver of the following additional conditions:
|
|
|
|
|
our representations and warranties that (i) are not made as
of a specific date must be true and correct as of the date of
the Merger Agreement and as of the closing and (ii) are
made as of a specific date must be true and correct as of such
date, in each case, except where the failure of such
representations or warranties to be true and correct (without
giving effect to any qualification as to materiality or material
adverse effect set forth in such representations and warranties)
has not had and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect;
provided, however, that our representations and warranties with
respect to corporate status, corporate authority and the absence
of certain events since March 31, 2008 that have had or
would reasonably be expected to have a Material Adverse Effect
must be true and correct in all respects, in each case, as of
the date of the Merger Agreement and as of the closing of the
Merger;
|
48
|
|
|
|
|
we must have performed, in all material respects, all
obligations and complied with, in all material respects, our
agreements and covenants under the Merger Agreement on or prior
to the effective time of the Merger; and
|
|
|
|
we must have delivered to Parent a certificate of one of our
executive officers with respect to the satisfaction of the
conditions to the obligations of Parent and MergerCo to complete
the Merger.
|
Conditions to Darwins Obligations. Our
obligation to complete the Merger is subject to the satisfaction
or waiver of the following further conditions:
|
|
|
|
|
the representations and warranties of Parent and MergerCo that
(i) are not made as of a specific date must be true and
correct as of the date of the Merger Agreement and as of the
closing of the Merger and (ii) are made as of a specific
date must be true and correct as of such date, in each case,
except where the failure of such representations or warranties
to be true and correct (without giving effect to any
qualification as to materiality or parent material adverse
effect set forth in such representations and warranties) has not
had and would not reasonably be expected to have, individually
or in the aggregate, an effect, event, development or change
that would reasonably be expected to prevent or materially
hinder or delay Parent or MergerCo from consummating the Merger;
|
|
|
|
each of Parent and MergerCo must have, in all material respects,
performed all obligations, and complied with, in all material
respects, their agreements and covenants on or prior to the
effective time of the Merger; and
|
|
|
|
Parent shall have delivered to us a certificate of one of its
officers with respect to the satisfaction of the conditions to
the obligations of the Company to complete the Merger.
|
Restrictions
on Solicitations of Other Offers
During the term of the Merger Agreement, we have agreed not to:
|
|
|
|
|
initiate, solicit, knowingly encourage or knowingly facilitate
any inquiries or the making of any proposal or other action that
constitutes, or may reasonably be expected to lead to, any
company acquisition proposal;
|
|
|
|
enter into discussions or negotiate with any person in
furtherance of such inquiries or to obtain a company acquisition
proposal; or
|
|
|
|
enter into an agreement with respect to a company acquisition
proposal.
|
Notwithstanding the foregoing restrictions, at any time prior to
obtaining the approval of the Merger Agreement by our
stockholders, if we receive a company acquisition proposal that
was not received in breach of the foregoing restrictions, we may
contact the potential acquiror to determine whether the company
acquisition proposal is, or is reasonably likely to lead to, a
company superior proposal. If our Board or the Special Committee
determines in good faith after consultation with its legal and
financial advisors that such company acquisition proposal is, or
is reasonably likely to lead to, a company superior proposal,
then we are permitted to furnish information to or engage in
discussions or negotiations with the potential acquiror if we
provide Parent with notice within 36 hours of any such
furnishing of information and the same information has been
previously or is concurrently provided to Parent.
We must promptly advise Parent in writing of any company
acquisition proposal (and in no event less than 36 hours
following our initial receipt of any company acquisition
proposal), the material terms and conditions of any such company
acquisition proposal (including any changes thereto) and the
identity of the party making any such company acquisition
proposal. We must also keep Parent reasonably informed of the
status (including any change to the material terms and
conditions thereof) of any such company acquisition proposal.
49
A company acquisition proposal means any proposal or
offer for, whether in one transaction or a series of related
transactions, any:
|
|
|
|
|
merger, consolidation or similar transaction involving the
Company or any Company subsidiary that would constitute a
significant subsidiary (as defined in
Rule 1-02
of
Regulation S-X,
but substituting 25% for references to 10% therein);
|
|
|
|
sale or other disposition, directly or indirectly, by merger,
consolidation, share exchange or any similar transaction, of any
assets of the Company or the Company subsidiaries representing
25% or more of the consolidated assets of the Company and the
Company subsidiaries;
|
|
|
|
issuance, sale or other disposition by the Company or any
Company subsidiary of (including by way of merger,
consolidation, share exchange or any similar transaction)
securities (or options, rights or warrants to purchase, or
securities convertible into, such securities) representing 25%
or more of the outstanding voting interests in the Company or
any Company subsidiary;
|
|
|
|
tender offer or exchange offer in which any person or
group (as such term is defined under the Exchange
Act) offers to acquire beneficial ownership, or the right to
acquire beneficial ownership, of 25% or more of the outstanding
shares of Common Stock; or
|
|
|
|
transaction which is similar in form, substance or purpose to
any of the foregoing transactions.
|
Notwithstanding the foregoing definition, the term company
acquisition proposal shall not include:
|
|
|
|
|
the Merger or any of the other transactions contemplated by the
Merger Agreement; or
|
|
|
|
any merger, consolidation, business combination, share exchange,
reorganization, recapitalization or similar transaction solely
among the Company and one or more Company subsidiaries or among
Company subsidiaries.
|
A company superior proposal means a company
acquisition proposal (on its most recently amended and modified
terms, if amended and modified) made by a third party (and not
obtained in breach of the non-solicitation provisions of the
Merger Agreement or in material breach of any other provision of
the Merger Agreement) which our Board, on the recommendation of
the Special Committee, determines in good faith (after
consultation with its financial and legal advisors) to be more
favorable to our stockholders than the Merger. For purposes of
this definition of company superior proposal, the
references to 25% in the definition of company
acquisition proposal shall be deemed to be references to
50%.
Recommendation
Withdrawal
The Merger Agreement requires us to promptly and duly call, give
notice of, convene and hold a meeting of our stockholders to
adopt the Merger Agreement as soon as reasonably practicable
after the SEC clears the proxy statement. Our Board will
(i) except as otherwise provided in the non-solicitation
provisions of the Merger Agreement, recommend adoption of the
Merger Agreement and include in this proxy statement such
recommendation and (ii) use its commercially reasonable
efforts to solicit such adoption. In this regard, our Board has
resolved to recommend that our stockholders adopt the Merger
Agreement.
Generally, our Board may not (i) withdraw (or amend or
modify in a manner adverse to Parent) or publicly propose to
withdraw (or amend or modify in a manner adverse to Parent), its
approval, recommendation or declaration of advisability of the
Merger Agreement, the Merger or the other transactions
contemplated by the Merger Agreement, (ii) recommend or
approve, or propose publicly to recommend or approve, any
company acquisition proposal or (iii) allow Darwin to enter
into an agreement or arrangement constituting or that could
reasonably be expected to lead to a company acquisition proposal
or requiring Darwin to abandon, terminate or fail to consummate
the Merger. However, our Board may, at any time prior to the
adoption of the Merger Agreement by our stockholders, withdraw
(or amend or modify in a manner adverse to Parent) or publicly
propose to withdraw (or amend or modify in a manner adverse to
Parent), its approval, recommendation or declaration of
advisability of the Merger Agreement, the Merger or the other
transactions contemplated by the Merger Agreement, or recommend,
adopt or approve, or propose publicly to recommend, adopt or
approve, any company acquisition proposal, if our
50
Board determines in good faith after consultation with its legal
and financial advisors that failure to take such action would be
inconsistent with its fiduciary duties to the stockholders of
the Company under applicable law. Additionally, our Board may
allow Darwin to enter into an agreement or arrangement requiring
Darwin to abandon, terminate or fail to consummate the Merger in
the event of a Superior Proposal Termination (as defined
below).
Termination
of the Merger Agreement
The Merger Agreement may be terminated at any time prior to the
consummation of the Merger, whether before or after stockholder
approval has been obtained:
|
|
|
|
|
by mutual written consent of Darwin and Parent;
|
|
|
|
by either Darwin or Parent if:
|
|
|
|
|
|
the Merger is not consummated on or before March 27, 2009
(as such date may be extended for up to 3 months in the
event that conditions related to termination of the HSR waiting
period and insurance regulatory approvals have not been
satisfied), but only to the extent the party seeking to
terminate for this reason shall not have failed to fulfill any
obligation under the Merger Agreement that materially
contributed to the failure of the Merger to be consummated on or
before such date;
|
|
|
|
any final and nonappealable order, decree or ruling by a
governmental authority which has the effect of making
consummation of the Merger illegal or otherwise preventing or
prohibiting consummation of the Merger, but only to the extent
the party seeking to terminate for this reason shall have used
its reasonable best efforts to oppose any such governmental
order or to have such governmental order vacated or made
inapplicable to the Merger; and
|
|
|
|
our stockholders, at the special meeting or at any adjournment
or postponement thereof at which the Merger Agreement was voted
on, fail to adopt the Merger Agreement, provided that Darwin may
not terminate the Merger Agreement if the failure to adopt the
Merger Agreement was caused by Darwins material breach of
the Merger Agreement.
|
|
|
|
|
|
our Board (i) withdraws (or amends or modifies in a manner
adverse to Parent) or publicly proposes to withdraw (or amend or
modify in a manner adverse to Parent) its approval,
recommendation or declaration of advisability of the Merger
Agreement, the Merger or the other transactions contemplated by
the Merger Agreement or (ii) recommends, adopts or
approves, or proposes publicly to recommend, adopt or approve,
any company acquisition proposal but only if Parent exercises
its right to terminate for this reason within 10 business days
of obtaining actual knowledge of such occurrence.
|
|
|
|
|
|
by Darwin if prior to obtaining stockholder approval:
|
|
|
|
|
|
the Board or the Special Committee receives a company superior
proposal;
|
|
|
|
the Company is in compliance in all material respects with the
non-solicitation provisions of the Merger Agreement;
|
|
|
|
|
|
the Company gives written notice to Parent at least 3 business
days prior written notice of its intent to terminate the Merger
Agreement and to enter into an agreement with respect to such
company superior proposal;
|
|
|
|
|
|
the Company negotiates, or offers to negotiate, with Parent
during the 3 business day period immediately following the
delivery of such notice to make such adjustments to the terms
and conditions of the Merger Agreement as would enable the
Company, Parent and MergerCo to proceed with the Merger on such
adjusted terms;
|
|
|
|
after taking into account any such adjustments, the Board
determines in good faith that the company superior proposal
continues to be a company superior proposal;
|
51
|
|
|
|
|
concurrently with such termination, the Company pays to Allied
World the $16.5 million termination fee as described in
further detail in Termination Fees and
Expenses beginning on page 52; and
|
|
|
|
the Board concurrently approves and the Company concurrently
enters into a definitive agreement with respect to such company
superior proposal (a Superior Proposal Termination).
|
Termination
Fees and Expenses
We must pay a $16.5 million termination fee if:
|
|
|
|
|
we terminate the Merger Agreement prior to the special meeting
in order to enter into a definitive agreement in connection with
a company superior proposal;
|
|
|
|
Parent or Darwin terminates because of failure to obtain
stockholder approval, but only if AIHL voted its shares of
Common Stock subject to the Voting Agreement in favor of the
Merger in compliance with the Voting Agreement; or
|
|
|
|
|
|
Parent terminates because our Board (i) withdraws (or
amends or modifies in a manner adverse to Parent) or publicly
proposes to withdraw (or amend or modify in a manner adverse to
Parent) its approval, recommendation or declaration of
advisability of the Merger Agreement, the Merger or the other
transactions contemplated by the Merger Agreement or
(ii) recommends, adopts or approves, or proposes publicly
to recommend, adopt or approve, any company acquisition proposal
but only if Parent exercises its right to terminate for this
reason within 10 business days of obtaining actual knowledge of
such occurrence.
|
Indemnification
and Insurance
From and after the Merger Effective Time, Parent and the
Surviving Corporation will (i) indemnify and hold harmless
each person who was, at the date of the Merger Agreement, or
becomes, during the period from the date of the Merger Agreement
through the closing of the Merger, a director or officer of the
Company or the Company subsidiaries or a director, officer or
trustee of another entity (but only to the extent that such
person is or was serving in such capacity at the request of the
Company) and (ii) promptly pay on behalf of or, within
30 days after any request for advancement, advance to each
of the indemnified parties, to the fullest extent authorized or
permitted by applicable laws, any expenses incurred in
defending, serving as a witness with respect to or otherwise
participating in any claim in advance of the final disposition
of such claim.
Immediately prior to the closing of the Merger, the Company will
purchase a single payment, run-off policy of directors and
officers liability insurance, which will become effective
at the closing and remain in effect for 6 years. The policy
will cover current and former officers and directors of the
Company and the Company subsidiaries, with limits of $20,000,000
for each claim and in the aggregate. The premium for such
run-off policy or policies will not exceed $400,000. In
addition, immediately prior to the closing of the Merger, Parent
will provide for the current officers and directors of the
Company and the Company subsidiaries who continue in such
capacity after the closing to be covered under Parents
directors and officers liability program with the
same terms as those applicable to the officers and directors of
Parent and its subsidiaries.
Employee
Benefits
From and after the effective time of the Merger, Parent will
honor, in accordance with their terms, and will cause the
Surviving Corporation to honor all employee benefit plans,
compensation arrangements and employment, severance and
termination plans and agreements of the Company in effect
immediately before the effective time of the Merger (other than
equity-based incentive plans). For a period of one year
following the effective time of the Merger, Parent will provide,
or will cause to be provided, to each Company employee
(i) compensation no less favorable in the aggregate than
the compensation provided to such Company employee immediately
before the effective time of the Merger and (ii) employee
benefits that are no less favorable, in the aggregate, than the
benefits provided to similarly situated employees of Parent.
For all purposes under the employee benefit plans of Parent and
its subsidiaries providing benefits to any Company employees
after the effective time of the Merger, each Company employee
will be credited with his or her
52
years of service with the Company and the Company subsidiaries
and their respective predecessors before the effective time of
the Merger, to the same extent as such Company employee was
entitled, before the effective time of the Merger, to credit for
such service under any similar Company employee benefits plan in
which such Company employee participated or was eligible to
participate immediately prior to the effective time of the
Merger, except to the extent that such service credit would
result in a duplication of benefits.
Each Company employee will be immediately eligible to
participate, without any waiting time, in any and all employee
benefit plans of Parent and its subsidiaries to the extent
coverage under such new plans is comparable to coverage under
any plan in which such Company employee participated immediately
before the consummation of the Merger. For purposes of each
employee benefit plan of Parent and its subsidiaries providing
medical, dental, pharmaceutical or vision benefits to any
Company employee, Parent will cause all pre-existing condition
exclusions and actively-at-work requirements of such new plan to
be waived for such Company employee and his or her covered
dependents, unless such conditions would not have been waived
under an old Company employee benefits plan in which such
Company employee participated immediately prior to the effective
time of the Merger.
Amendment,
Extension and Waiver
The Merger Agreement may be amended by action taken by the
respective boards of directors of each of the parties at any
time prior to the effective time of the Merger. However, after
approval of the Merger by our stockholders, no amendment may be
made without further stockholder approval which, by law or in
accordance with the rules of the NYSE, requires further approval
by our stockholders. The Merger Agreement may not be amended
except by an instrument in writing signed by each of the parties.
At any time prior to the consummation of the Merger, the
Company, on the one hand, and Parent and MergerCo, on the other
hand, may, by written instrument:
|
|
|
|
|
extend the time for the performance of any obligation or other
act of the other party;
|
|
|
|
waive any inaccuracy in the representations and warranties of
the other party contained therein or in any document delivered
pursuant thereto; and
|
|
|
|
waive compliance with any agreement of the other party or any
condition to its own obligations contained therein.
|
The failure of any party to assert any of its rights under the
Merger Agreement or otherwise shall not constitute a waiver of
those rights.
Specific
Performance
Each of the parties will be entitled to specific performance of
the terms of the Merger Agreement, in addition to any other
remedy at law or equity. Notwithstanding the foregoing, each of
Darwin and Parent acknowledges and agrees that in the event that
Parent is entitled to receive and actually receives the
termination fee pursuant to the Merger Agreement, Parents
receipt of the termination fee will constitute each of Parent
and MergerCos sole and exclusive remedy for, and such
amount shall constitute liquidated damages in respect of any
termination of the Merger Agreement regardless of the
circumstances giving rise to such termination.
53
ADJOURNMENT
OF THE SPECIAL MEETING
If at the special meeting the number of shares of Common Stock
present or represented and voting in favor of the adoption of
the Merger Agreement is insufficient to adopt the Merger
Agreement under Delaware law and under our certificate of
incorporation, the officer of Darwin presiding over the special
meeting or our Board may move to adjourn the special meeting in
order to enable our Board to continue to solicit additional
proxies in favor of the adoption of the Merger Agreement. In
that event, we will ask you to vote only upon the adjournment
proposal and not the Merger proposal.
In this proposal, we are asking you to authorize the holder of
any proxy solicited by the Board to vote in favor of adjourning
the special meeting and any later adjournments. If the Darwin
stockholders approve the adjournment proposal, we could use the
additional time to solicit additional proxies in favor of the
proposal to adopt the Merger Agreement, including the
solicitation of proxies from Darwin stockholders that have
previously voted against the Merger proposal. Among other
things, approval of the adjournment proposal could mean that,
even if we had received proxies representing a sufficient number
of votes against the proposal to adopt the Merger Agreement, we
could adjourn the special meeting without a vote on the proposal
to adopt the Merger Agreement and seek to convince the holders
of those shares of Common Stock to change their vote to vote in
favor of the adoption of the Merger Agreement.
Approval of the proposal to adjourn the special meeting requires
the affirmative vote of a majority of the votes present and
entitled to be cast at the special meeting, whether or not a
quorum is present. Accordingly, broker non-votes will have no
effect on the outcome of this proposal. However, abstentions
will have the same effect as a vote AGAINST the
adjournment proposal. No proxy that is specifically marked
AGAINST the proposal to approve the Merger Agreement
will be voted in favor of the adjournment proposal, unless it is
specifically marked FOR the discretionary authority
to adjourn the special meeting to a later date.
The Board believes that if the number of shares of Common Stock
present or represented at the special meeting and voting in
favor of the proposal to adopt the Merger Agreement is
insufficient to adopt the Merger Agreement, it is in the best
interests of the Darwin stockholders to enable the Board, for a
limited period of time, to continue to seek to obtain a
sufficient number of additional votes to adopt the Merger
Agreement.
The Board recommends that you vote FOR the
proposal to authorize the adjournment of the special meeting.
54
MARKET
PRICE OF COMMON STOCK
Our Common Stock is traded on the NYSE under the symbol
DR. The table below sets forth by quarter, beginning
with Darwins initial public offering on May 19, 2006,
the high and low sales prices, and the closing prices as of each
quarters end, of our Common Stock on the NYSE. Darwin has
not paid any dividends during that period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market Price
|
|
|
|
High
|
|
|
Low
|
|
|
Close
|
|
|
Fiscal year ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
May 19, 2006 to June 30, 2006
|
|
$
|
20.12
|
|
|
$
|
16.00
|
|
|
$
|
17.66
|
|
Third Quarter
|
|
$
|
23.50
|
|
|
$
|
17.75
|
|
|
$
|
22.21
|
|
Fourth Quarter
|
|
$
|
25.29
|
|
|
$
|
20.61
|
|
|
$
|
23.45
|
|
Fiscal year ended December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
27.16
|
|
|
$
|
22.25
|
|
|
$
|
25.15
|
|
Second Quarter
|
|
$
|
27.50
|
|
|
$
|
22.75
|
|
|
$
|
25.17
|
|
Third Quarter
|
|
$
|
26.84
|
|
|
$
|
19.06
|
|
|
$
|
21.60
|
|
Fourth Quarter
|
|
$
|
26.50
|
|
|
$
|
21.33
|
|
|
$
|
24.17
|
|
Fiscal year ended December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
24.83
|
|
|
$
|
19.51
|
|
|
$
|
22.49
|
|
Second Quarter
|
|
$
|
32.20
|
|
|
$
|
21.82
|
|
|
$
|
30.80
|
|
Third Quarter through September 15, 2008
|
|
$
|
32.00
|
|
|
$
|
30.00
|
|
|
$
|
31.40
|
|
On June 27, 2008, the last full trading day prior to the
public announcement of the Merger Agreement, the closing sale
price of our Common Stock as reported on the NYSE was $30.20. On
September 15, 2008, the last full trading day prior to the
date of this proxy statement, the closing price of the Common
Stock as reported on the NYSE was $31.40.
You are encouraged to obtain current market quotations for our
Common Stock in connection with voting your shares of Common
Stock.
Following the Merger there will be no further market for our
Common Stock.
55
VOTING
AGREEMENT
The following is a brief summary of the Voting Agreement. This
description does not provide a complete description of all of
the terms and conditions of the Voting Agreement. It is
qualified in its entirety by the annexes hereto, including the
text of the Voting Agreement, which is attached as Annex D
to this proxy statement. The Voting Agreement is incorporated
herein by reference. You are urged to read the annexes in their
entirety.
In connection with the execution of the Merger Agreement, AIHL
entered into a voting agreement with Allied World and MergerCo
on June 27, 2008. As of September 15, 2008, the record
date for the special meeting, AIHL held approximately
9,371,096 shares of the Common Stock representing
approximately 55% percent of Darwins outstanding Common
Stock.
Pursuant to the Voting Agreement, subject to certain limitations
and the occurrence of certain events, AIHL agreed, among other
things, (i) to vote a number of shares of Common Stock
equal to 40% of Darwins outstanding voting stock in favor
of the adoption of the Merger Agreement, (ii) to vote all
of its shares of Common Stock against (A) any company
acquisition proposal or (B) any other action or proposal
that could reasonably be expected to impede, interfere with,
delay or postpone the Merger or change in any manner the voting
rights of any class of shares of Darwin, (iii) to grant to
the proxyholders named in Darwins proxy card, three
business days prior to the date of the special meeting, a
revocable proxy to vote such shares in favor of the adoption of
the Merger Agreement and, subject to certain conditions, not to
revoke such proxy and (iv) not to sell, transfer, pledge,
assign or otherwise dispose of any of its shares of the Common
Stock or interest therein or grant any proxy or enter into any
voting trust or other voting agreement or arrangement with
respect to its shares of the Common Stock.
The Voting Agreement, and all the rights and obligations of the
parties thereto, will terminate upon the first to occur of
(i) the effective time of the Merger, (ii) the date on
which the Merger Agreement is terminated in accordance with its
terms, (iii) the date upon which the Board withdraws (or
amends or modifies in a manner adverse to Allied World) or
publicly proposes to withdraw (or amend or modify in a manner
adverse to Allied World), its approval, recommendation or
declaration of advisability of the Merger Agreement, the Merger
or the other transactions contemplated by the Merger Agreement,
or recommends, adopts or approves, or proposes publicly to
recommend, adopt or approve, any company acquisition proposal
and (iv) unless consented to by AIHL, the date of any
amendment to the Merger Agreement that is materially adverse to
Darwin, its stockholders or AIHL (including, without limitation,
any decrease in or change in the form of the consideration paid
to Darwins stockholders or the addition of any material
obligation or liability on the part of Darwin or its
stockholders).
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following tables set forth information with respect to the
beneficial ownership of shares of Common Stock, which is
Darwins only class of voting stock, as of
September 15, 2008, for:
|
|
|
|
|
each person known by Darwin to own beneficially more than 5% of
the shares of Common Stock;
|
|
|
|
each of Darwins directors;
|
|
|
|
Darwins named executive officers; and
|
|
|
|
all of Darwins directors and executive officers as a group.
|
As of September 15, 2008, the number of outstanding shares
of Common Stock was 17,017,866 (which includes 125,554
restricted shares of Common Stock). The amounts and percentages
of the shares of Common Stock beneficially owned are reported on
the basis of regulations of the SEC governing the determination
of beneficial ownership of securities. Under the rules of the
SEC, a person is deemed to be a beneficial owner of a security
if that person has or shares voting power, which includes the
power to vote or to direct the voting of the security, or
investment power, which includes the power to dispose of or to
direct the disposition of the security. Unless otherwise
indicated below, each beneficial owner named in the table below
has sole voting and sole investment power with respect to all
shares of Common Stock beneficially owned, subject to community
property laws where applicable.
56
Persons
Known to Own More than 5% of the Shares of Common Stock
Outstanding
|
|
|
|
|
|
|
|
|
|
|
Amount and Nature Of
|
|
|
Percentage
|
|
Name and Address of Beneficial Owner
|
|
Beneficial Ownership
|
|
|
Beneficially Owned
|
|
|
Alleghany Corporation
7 Times Square Tower
New York, NY 10036
|
|
|
9,371,096
|
*
|
|
|
55
|
%
|
|
|
|
* |
|
The shares of Common Stock are beneficially owned directly by
AIHL. Alleghany owns 100% of the equity interest in AIHL. |
Director
and Executive Officer Common Stock Ownership
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shared Voting Power
|
|
|
|
|
|
|
|
|
|
Sole Voting and
|
|
|
and/or Shared
|
|
|
|
|
|
|
|
|
|
Investment Power
|
|
|
Investment Power
|
|
|
Total
|
|
|
Percent of Class
|
|
|
R. Bruce Albro
|
|
|
9,147
|
(l)
|
|
|
500
|
(2)
|
|
|
9,647
|
|
|
|
|
*
|
Phillip N. Ben-Zvi
|
|
|
13,297
|
(3)
|
|
|
|
|
|
|
13,297
|
|
|
|
|
*
|
Christopher K. Dalrymple
|
|
|
0
|
(4)
|
|
|
|
|
|
|
0
|
|
|
|
|
*
|
Weston M. Hicks
|
|
|
0
|
(4)
|
|
|
|
|
|
|
0
|
|
|
|
|
*
|
William C. Popik, M.D.
|
|
|
17,447
|
(5)
|
|
|
|
|
|
|
17,447
|
|
|
|
|
*
|
George M. Reider, Jr.
|
|
|
7,497
|
(6)
|
|
|
|
|
|
|
7,497
|
|
|
|
|
*
|
John L. Sennott, Jr.
|
|
|
188,674
|
(7)
|
|
|
|
|
|
|
188,674
|
|
|
|
1.11
|
|
Stephen J. Sills
|
|
|
327,889
|
(8)
|
|
|
427,506
|
(9)
|
|
|
755,395
|
|
|
|
4.43
|
|
Irving B. Yoskowitz
|
|
|
8,467
|
(10)
|
|
|
|
|
|
|
8,467
|
|
|
|
|
*
|
David J. Newman
|
|
|
137,541
|
(11)
|
|
|
5,100
|
(12)
|
|
|
142,641
|
|
|
|
|
*
|
Paul F. Romano(13)
|
|
|
126,750
|
|
|
|
|
|
|
|
126,750
|
|
|
|
|
*
|
Mark I. Rosen
|
|
|
135,827
|
(14)
|
|
|
600
|
(15)
|
|
|
136,427
|
|
|
|
|
*
|
Directors and Executive Officers as a Class (14 people)
|
|
|
1,161,883
|
|
|
|
433,706
|
|
|
|
1,595,589
|
|
|
|
9.32
|
|
|
|
|
* |
|
denotes less than one percent |
|
(1) |
|
Includes 6,647 share units credited under Darwins
stock and unit plan for non-employee directors (the
Directors Plan). |
|
(2) |
|
Owned by Mr. Albros spouse, as to which shares
Mr. Albro disclaims beneficial interest. |
|
(3) |
|
Includes 8,097 share units credited under the Directors
Plan. |
|
(4) |
|
Messrs. Dalrymple and Hicks are officers of Alleghany, the
parent company of AIHL, which beneficially owns approximately
55% of the Common Stock. |
|
(5) |
|
Includes 9,097 share units credited under the Directors
Plan. |
|
(6) |
|
Includes 4,547 share units credited under the Directors
Plan. |
|
(7) |
|
Includes 8,853 shares of Common Stock issuable upon
exercise of outstanding Stock Options within 60 days. |
|
(8) |
|
Includes 32,485 shares of Common Stock issuable upon
exercise of outstanding Stock Options within 60 days. |
|
(9) |
|
Includes 420,000 shares of Common Stock held in
grantor retained annuity trusts of which
Mr. Sills is sole trustee and sole beneficiary. Also
includes 7,506 shares of Common Stock held in an account
for Mr. Sills children (under the Uniform Transfers
To Minors Act), the custodian of which is Mr. Sills. |
|
(10) |
|
Includes 7,467 share units credited under the Directors
Plan. |
|
(11) |
|
Includes 6,884 shares of Common Stock issuable upon
exercise of outstanding Stock Options within 60 days. |
|
(12) |
|
Includes 5,100 shares of Common Stock owned by
Mr. Newmans spouse and child, as to which shares
Mr. Newman disclaims beneficial ownership. |
|
(13) |
|
Mr. Romano resigned from Darwin effective March 27,
2008. |
|
(14) |
|
Includes 14,671 shares of Common Stock issuable upon
exercise of outstanding Stock Options within 60 days. |
|
(15) |
|
Owned by Mr. Rosens son, as to which shares
Mr. Rosen disclaims beneficial interest. |
57
DISSENTERS
RIGHTS OF APPRAISAL
Under the General Corporation Law of the State of Delaware (the
DGCL), you have the right to dissent from the Merger
and to receive payment in cash for the fair value of your shares
of Common Stock as determined by the Delaware Court of Chancery,
together with a fair rate of interest, if any, as determined by
the court, in lieu of the consideration you would otherwise be
entitled to pursuant to the Merger Agreement. These rights are
known as appraisal rights. Darwins stockholders electing
to exercise appraisal rights must comply with the provisions of
Section 262 of the DGCL (Section 262) in
order to perfect their rights. Darwin will require strict
compliance with the statutory procedures.
The following is intended as a brief summary of the material
provisions of the Delaware statutory procedures required to be
followed by a stockholder in order to dissent from the Merger
and perfect appraisal rights.
This summary, however, is not a complete statement of all
applicable requirements and is qualified in its entirety by
reference to Section 262, the full text of which appears in
Annex C to this proxy statement. Failure to precisely
follow any of the statutory procedures set forth in
Section 262 may result in a termination or waiver of your
appraisal rights. All references in this summary to a
stockholder are to the record holder of shares of
our Common Stock unless otherwise indicated.
Section 262 requires that stockholders be notified that
appraisal rights will be available not less than 20 days
before the stockholders meeting to vote on the Merger. A
copy of Section 262 must be included with such notice. This
proxy statement constitutes Darwins notice to its
stockholders of the availability of appraisal rights in
connection with the Merger in compliance with the requirements
of Section 262. If you wish to consider exercising your
appraisal rights, you should carefully review the text of
Section 262 contained in Annex C since failure to
timely and properly comply with the requirements of
Section 262 will result in the loss of your appraisal
rights under the DGCL.
If you elect to demand appraisal of your shares of Common Stock,
you must satisfy each of the following conditions:
|
|
|
|
|
You must deliver to Darwin a written demand for appraisal of
your shares of Common Stock before the vote with respect to the
Merger is taken. This written demand for appraisal must be in
addition to and separate from any proxy or vote abstaining from
or voting against the adoption of the Merger Agreement. Voting
against or failing to vote for the adoption of the Merger
Agreement by itself does not constitute a demand for appraisal
within the meaning of Section 262.
|
|
|
|
You must not vote in favor of the adoption of the Merger
Agreement. A vote in favor of the adoption of the Merger
Agreement, by proxy, over the Internet, by telephone or in
person, will constitute a waiver of your appraisal rights in
respect of the shares of Common Stock so voted and will nullify
any previously filed written demands for appraisal.
|
|
|
|
You must continue to hold your shares of Common Stock through
the effective date of the Merger. Therefore, a stockholder who
is the record holder of shares of Common Stock on the date the
written demand for appraisal is made but who thereafter
transfers the shares of Common Stock prior to the effective date
of the Merger will lose any right to appraisal with respect to
such shares of Common Stock.
|
If you fail to comply with these conditions and the Merger is
completed, you will be entitled to receive the cash payment for
your shares of Common Stock as provided for in the Merger
Agreement, but you will have no appraisal rights with respect to
your shares of Common Stock. A proxy card which is signed and
does not contain voting instructions will, unless revoked, be
voted FOR the adoption of the Merger Agreement and
will constitute a waiver of your right of appraisal and will
nullify any previous written demand for appraisal.
All demands for appraisal should be addressed to Darwin
Professional Underwriters, Inc., 9 Farm Springs Road,
Farmington, CT 06032 Attention: Executive Vice President,
General Counsel and Secretary, and must be delivered before the
vote on the Merger Agreement is taken at the special meeting,
and should be executed by, or on behalf of, the record holder of
the shares of Common Stock. The demand must reasonably inform
Darwin of the identity of the stockholder and the intention of
the stockholder to demand appraisal of his, her or its shares of
Common Stock.
58
To be effective, a demand for appraisal by a holder of shares of
Common Stock must be made by, or in the name of, such registered
stockholder, fully and correctly, as such stockholders
name appears on his or her stock certificate(s). Beneficial
owners who do not also hold the shares of Common Stock of record
may not directly make appraisal demands to Darwin. The
beneficial holder must, in such cases, have the registered
owner, such as a broker or other nominee, submit the required
demand in respect of those shares of Common Stock. If shares of
Common Stock are owned of record in a fiduciary capacity, such
as by a trustee, guardian or custodian, execution of a demand
for appraisal should be made by or for the fiduciary; and if the
shares of Common Stock are owned of record by more than one
person, as in a joint tenancy or tenancy in common, the demand
should be executed by or for all joint owners. An authorized
agent, including an authorized agent for two or more joint
owners, may execute the demand for appraisal for a stockholder
of record; however, the agent must identify the record owner or
owners and expressly disclose the fact that, in executing the
demand, he or she is acting as agent for the record owner. A
record owner, such as a broker, who holds shares of Common Stock
as a nominee for others, may exercise his or her right of
appraisal with respect to the shares of Common Stock held for
one or more beneficial owners, while not exercising this right
for other beneficial owners. In that case, the written demand
should state the number of shares of Common Stock as to which
appraisal is sought. Where no number of shares of Common Stock
is expressly mentioned, the demand will be presumed to cover all
shares of Common Stock held in the name of the record owner.
If you hold your shares of Common Stock in a brokerage
account or in other nominee form and you wish to exercise
appraisal rights, you should consult with your broker or the
other nominee to determine the appropriate procedures for the
making of a demand for appraisal by the nominee.
Within 10 days after the effective time of the Merger, the
Surviving Corporation must give written notice that the Merger
has become effective to each Darwin stockholder who has properly
filed a written demand for appraisal and who did not vote in
favor of the Merger Agreement. At any time within 60 days
after the effective time, any stockholder who has demanded an
appraisal and who has not commenced an appraisal proceeding or
joined that proceeding as a named party has the right to
withdraw the demand and to accept the cash payment specified by
the Merger Agreement for his or her shares of Common Stock.
Within 120 days after the effective date of the Merger, any
stockholder who has complied with Section 262 shall, upon
written request to the Surviving Corporation, be entitled to
receive a written statement setting forth the aggregate number
of shares of Common Stock not voted in favor of the Merger
Agreement and with respect to which demands for appraisal rights
have been received and the aggregate number of holders of such
shares. Such written statement will be mailed to the requesting
stockholder within 10 days after such written request is
received by the Surviving Corporation or within 10 days
after expiration of the period for delivery of demands for
appraisal, whichever is later. Within 120 days after the
effective time, either the Surviving Corporation or any
stockholder who has complied with the requirements of
Section 262 may file a petition in the Delaware Court of
Chancery demanding a determination of the fair value of the
shares of Common Stock held by all stockholders entitled to
appraisal. Upon the filing of the petition by a stockholder,
service of a copy of such petition shall be made upon the
Surviving Corporation. The Surviving Corporation has no
obligation to file such a petition in the event there are
dissenting stockholders and there is no present intent to file
an appraisal petition and stockholders seeking to exercise
appraisal rights should not assume that the Surviving
Corporation will file such a petition or that the Surviving
Corporation will initiate any negotiations with respect to the
fair value of such shares of Common Stock. Accordingly, holders
of Common Stock who desire to have their shares appraised should
initiate any petitions necessary for the perfection of their
appraisal rights within the time periods and in the manner
prescribed in Section 262. A person who is the beneficial
owner of shares of Common Stock held in a voting trust or by a
nominee on behalf of such person may, in such persons own
name, file a petition or request from the Surviving Corporation
the statement described in this paragraph.
If a petition for appraisal is duly filed by a stockholder and a
copy of the petition is delivered to the Surviving Corporation,
the Surviving Corporation will then be obligated, within
20 days after receiving service of a copy of the petition,
to provide the Chancery Court with a duly verified list
containing the names and addresses of all stockholders who have
demanded an appraisal of their shares of Common Stock and with
whom agreements as to the value of their shares have not been
reached by the Surviving Corporation. After notice to dissenting
stockholders who demanded appraisal of their shares of Common
Stock, the Chancery Court is empowered to conduct a hearing upon
the petition, and to determine those stockholders who have
complied with Section 262 and who have become entitled to
the appraisal rights provided thereby. The Chancery Court may
require the stockholders who have
59
demanded payment for their shares of Common Stock to submit
their stock certificates to the Register in Chancery for
notation thereon of the pendency of the appraisal proceedings;
and if any stockholder fails to comply with that direction, the
Chancery Court may dismiss the proceedings as to that
stockholder.
After determination of the stockholders entitled to appraisal of
their shares of the Common Stock, the Chancery Court will
appraise the shares, determining their fair value exclusive of
any element of value arising from the accomplishment or
expectation of the Merger, together with a fair rate of
interest, if any. Unless the Delaware Court of Chancery
determines otherwise for good cause shown, interest from the
effective time of the Merger through the date of payment of the
judgment shall accrue at 5% over the Federal Reserve discount
rate, established from time to time during such period,
compounded quarterly. When the value is determined, the Chancery
Court will direct the payment of such value, with interest
thereon accrued during the pendency of the proceeding, if the
Chancery Court so determines, to the stockholders entitled to
receive the same, upon surrender by such holders of the
certificates representing those shares of Common Stock.
In determining fair value, the Chancery Court is required to
take into account all relevant factors. In Weinberger v.
UOP, Inc., the Supreme Court of Delaware discussed the
factors that could be considered in determining fair value in an
appraisal proceeding, stating that proof of value by any
techniques or methods that are generally considered acceptable
in the financial community and otherwise admissible in
court should be considered, and that fair price
obviously requires consideration of all relevant factors
involving the value of a company. The Delaware Supreme
Court stated that, in making this determination of fair value,
the court must consider market value, asset value, dividends,
earnings prospects, the nature of the enterprise and any other
facts that could be ascertained as of the date of the merger
that throw any light on future prospects of the merged
corporation. Section 262 provides that fair value is to be
exclusive of any element of value arising from the
accomplishment or expectation of the merger. In
Cede & Co. v. Technicolor, Inc., the
Delaware Supreme Court stated that such exclusion is a
narrow exclusion that does not encompass known elements of
value, but which rather applies only to the speculative
elements of value arising from such accomplishment or
expectation. In Weinberger, the Supreme Court of Delaware
also stated that elements of future value, including the
nature of the enterprise, which are known or susceptible of
proof as of the date of the merger and not the product of
speculation, may be considered. No representation is
made as to the outcome of the appraisal of fair value as
determined by the Delaware Court of Chancery, and you should be
aware that the fair value of your shares of Common Stock as
determined under Section 262 could be more than, the same
as, or less than the value that you are entitled to receive
under the terms of the Merger Agreement.
Costs of the appraisal proceeding may be imposed upon the
Surviving Corporation and the stockholders participating in the
appraisal proceeding by the Chancery Court as the Chancery Court
deems equitable in the circumstances. Upon the application of a
stockholder, the Chancery Court may order all or a portion of
the expenses incurred by any stockholder in connection with the
appraisal proceeding, including, without limitation, reasonable
attorneys fees and the fees and expenses of experts, to be
charged pro rata against the value of all shares of Common Stock
entitled to appraisal. Any stockholder who had demanded
appraisal rights will not, after the effective time of the
Merger, be entitled to vote shares of Common Stock subject to
that demand for any purpose or to receive payments of dividends
or any other distribution with respect to those shares, other
than with respect to payment as of a record date prior to the
effective time of the Merger; however, if no petition for
appraisal is filed within 120 days after the effective time
of the Merger, or if the stockholder delivers a written
withdrawal of his or her demand for appraisal and an acceptance
of the terms of the Merger within 60 days after the
effective time of the Merger, then the right of that stockholder
to appraisal will cease and that stockholder will be entitled to
receive the cash payment for shares of his, her or its Common
Stock pursuant to the Merger Agreement. Any withdrawal of a
demand for appraisal made more than 60 days after the
effective time of the Merger may only be made with the written
approval of the Surviving Corporation and must, to be effective,
be made within 120 days after the effective time.
In view of the complexity of Section 262, Darwins
stockholders who may wish to dissent from the Merger and pursue
appraisal rights should consult their legal advisors.
60
STOCKHOLDER
PROPOSALS
If the Merger is consummated, we will not have public
stockholders and there will be no public participation in any
future meeting of stockholders. However, if the Merger is not
completed, Darwins by-laws require that Darwin be
furnished with timely written notice with respect to the
submission of a proposal, other than a proposal submitted by or
at the direction of the Board, at a meeting of stockholders. In
order for any submission to be proper, the notice must contain
certain information concerning the proposing stockholder and the
proposal and must be furnished to Darwin generally not less than
90 days prior to the anniversary of the preceding
years annual meeting. A copy of the applicable by-law
provisions may be obtained, without charge, upon written request
to the Secretary of Darwin at Darwins principal executive
offices.
In accordance with
Rule 14a-8
of the Securities and Exchange Commission, any proposal of a
stockholder intended to be presented at Darwins 2009
Annual Meeting of Stockholders must be received by the Secretary
of Darwin by December 6, 2008 in order for the proposal to
be considered for inclusion in Darwins notice of meeting,
proxy statement and proxy relating to the 2009 Annual Meeting,
scheduled for Friday, May 1, 2009.
MULTIPLE
STOCKHOLDERS SHARING ONE ADDRESS
Some banks, brokers, and other nominee record holders may be
participating in the practice of householding proxy
statements. This means that only one copy of this notice and
proxy statement may have been sent to multiple stockholders in
your household. If you would prefer to receive separate copies
of the proxy statement, please contact Georgeson Inc. either by
calling Georgeson Inc. toll free at
1-888-679-2903,
or by writing to Georgeson Inc., 199 Water Street,
26th Floor, New York, New York 10038.
Upon written or oral request to Georgeson Inc., they will
provide separate copies of the proxy statement. In addition,
security holders sharing an address can request delivery of a
single copy of the proxy statements if you are receiving
multiple copies upon written or oral request to Georgeson Inc.
at the address and telephone number stated above.
WHERE YOU
CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements
and other information with the SEC. You may read and copy any
document we file at the SECs public reference room located
at 100 F Street, N.E., Room 1580,
Washington, D.C. 20549. Please call the SEC at
1-800-SEC-0330
for further information on the public reference room. Our SEC
filings are also available to the public at the SECs
website at
http://www.sec.gov.
You also may obtain free copies of the documents Darwin files
with the SEC by going to the Investors Relations
section of our website at
http://www.darwinpro.com.
The SEC allows Darwin to incorporate by reference
information into this proxy statement. This means that we can
disclose important information to you by referring you to
another document filed separately with the SEC. The information
incorporated by reference is considered to be a part of this
proxy statement, except for any information that is superseded
by information that is included directly in this proxy statement
or incorporated by reference subsequent to the date of this
proxy statement. Our website address is provided as an inactive
textual reference only. The information provided on our website
is not part of this proxy statement, and therefore is not
incorporated by reference.
61
This proxy statement incorporates by reference the documents
listed below that we have previously filed with the SEC.
|
|
|
Company SEC Filings
|
|
|
(File
No. 001-32883)
|
|
Period and Date Filed
|
|
Annual Report on
Form 10-K
|
|
Fiscal year ended December 31, 2007, filed on February 29, 2008
|
|
|
|
|
|
|
Amendment No. 1 to Annual Report on
Form 10-K
|
|
Fiscal year ended December 31, 2007, filed on
August 28, 2008
|
|
|
|
|
|
|
Quarterly Reports on
Form 10-Q
|
|
Quarterly period ended March 31, 2008, filed on May 6, 2008;
quarterly period ended June 30, 2008, filed on
August 8, 2008
|
|
|
|
|
|
|
Current Reports on
Form 8-K
|
|
Filed on June 30, 2008 and September 2, 2008
|
In addition, Darwin incorporates by reference additional
documents that it may file with the SEC pursuant to
Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act
between the date of this proxy statement and the date of the
special meeting. These documents include periodic reports, such
as quarterly reports on
Form 10-Q
and current reports on
Form 8-K.
We undertake to provide without charge to each person to whom a
copy of this proxy statement has been delivered, upon request,
by first class mail or other equally prompt means, within one
business day of receipt of the request, a copy of any or all of
the documents incorporated by reference into this proxy
statement, other than the exhibits to these documents, unless
the exhibits are specifically incorporated by reference into the
information that this proxy statement incorporates.
Requests for copies of our filings should be directed to:
Executive
Vice President, General Counsel and Secretary, Mark I. Rosen
Darwin Professional Underwriters, Inc.
9 Farm Springs Road, Farmington, CT 06032
Tel:
(860) 284-1300
The request should be made by October 8, 2008 in order to
receive them before the special meeting.
Reports, proxy statements or other information concerning us may
also be inspected at the offices of the NYSE at
20 Broad Street, New York, NY 10005.
Any person, including any beneficial owner, to whom this proxy
statement is delivered may request additional copies of the
proxy statement, without charge on Darwins website at
http://www.darwinpro.com
or from the SEC through the SECs website at
http://www.sec.gov.
This proxy does not constitute the solicitation of a proxy in
any jurisdiction to or from any person to whom or from whom it
is unlawful to make such proxy solicitation in that
jurisdiction. You should rely only on the information contained
or incorporated by reference in this proxy statement to vote
your shares of Common Stock at the special meeting. We have not
authorized anyone to provide you with information that is
different from what is contained in this proxy statement. This
proxy statement is dated September 16, 2008. You should not
assume that the information contained in this proxy statement is
accurate as of any date other than that date, and the mailing of
this proxy statement to stockholders does not create any
implication to the contrary.
62
AGREEMENT
AND PLAN OF MERGER
by and among
DARWIN PROFESSIONAL UNDERWRITERS, INC.,
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, LTD
and
ALLIED WORLD MERGER COMPANY
Dated as of June 27, 2008
EXHIBITS
|
|
|
Exhibit A
|
|
Knowledge of the Company
|
Exhibit B
|
|
Certificate of Incorporation of the Surviving Corporation
|
A-iv
AGREEMENT
AND PLAN OF MERGER
THIS AGREEMENT AND PLAN OF MERGER (this
Agreement) is made and entered into as of
June 27, 2008, by and among Darwin Professional
Underwriters, Inc., a Delaware corporation (the
Company), Allied World Assurance Company
Holdings, Ltd, a Bermuda company (Parent),
and Allied World Merger Company, a Delaware corporation and a
wholly owned subsidiary of Parent (MergerCo
and, together with Parent, the Buyer Parties).
RECITALS
WHEREAS, the parties intend that MergerCo will be merged with
and into the Company (the Merger), with
the Company surviving the Merger as a wholly owned subsidiary of
Parent in accordance with the General Corporation Law of the
State of Delaware (the DGCL) on the terms and
conditions set forth herein;
WHEREAS, a special committee of independent directors (the
Special Committee) of the Board of Directors
of the Company (the Company Board) has
(i) determined that this Agreement and the transactions
contemplated hereby, including the Merger, are advisable and
fair to, and in the best interests of, the Company and its
stockholders and (ii) resolved to recommend to the Company
Board that it approve and declare advisable this Agreement and
the transactions contemplated hereby, including the Merger;
WHEREAS, the Company Board (upon the recommendation of the
Special Committee) has (i) determined that this Agreement
and the transactions contemplated hereby, including the Merger,
are advisable and fair to, and in the best interests of, the
Company and its stockholders, (ii) approved and declared
advisable this Agreement and the transactions contemplated
hereby, including the Merger, (iii) resolved to recommend
that the Companys stockholders adopt this Agreement and
(iv) directed that this Agreement be submitted to the
Companys stockholders for their adoption;
WHEREAS, the respective boards of directors of MergerCo and
Parent have approved and declared advisable this Agreement and
the transactions contemplated hereby, including the Merger;
WHEREAS, concurrently with the execution of this Agreement, the
Company has entered into employment agreements, to be effective
as of the Closing, with each of the Persons set forth on
Section 1.01(a)(i) of the Company Disclosure
Schedule (the Employment Agreements);
WHEREAS, concurrently with the execution of this Agreement,
Parent, MergerCo and Alleghany Insurance Holdings, LLC have
entered into a voting agreement (the Voting
Agreement); and
WHEREAS, the Company, Parent and MergerCo desire to make certain
representations, warranties, covenants and agreements in
connection with the Merger and also to prescribe certain
conditions to the Merger, as set forth herein.
NOW, THEREFORE, in consideration of the foregoing premises and
the representations, warranties, covenants and agreements set
forth herein, as well as other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged,
and intending to be legally bound hereby, Parent, MergerCo and
the Company hereby agree as follows:
ARTICLE I
DEFINITIONS
Section 1.01 Definitions.
(a) For purposes of this Agreement:
Action means any claim, action, suit,
proceeding, arbitration, mediation or investigation as to which
written notice has been provided to the applicable party.
Affiliate or
affiliate of a specified person means a
person who, directly or indirectly, through one or more
intermediaries, controls, is controlled by, or is under common
control with, such specified person.
A-1
beneficial owner or beneficial
ownership, with respect to any Company Common Shares,
has the meaning ascribed to such term under
Rule 13d-3(a)
promulgated under the Exchange Act.
Business Day means any day on which the
principal offices of the SEC in Washington, D.C. are open
to accept filings and on which banks are not required or
authorized to close in New York, New York.
Claim means any threatened, asserted, pending
or completed Action, whether instituted by any party hereto, any
Governmental Authority or any other person, that any Indemnified
Party in good faith believes might lead to the institution of
any such Action, whether civil, criminal, administrative,
investigative or other, arising out of or pertaining to matters
that relate to such Indemnified Partys duties or service
as a director, officer, trustee, employee, agent, or fiduciary
of the Company, any of the Company Subsidiaries, or any employee
benefit plan (within the meaning of Section 3(3) of ERISA)
maintained by any of the foregoing or any other person at or
prior to the Merger Effective Time at the request of the Company
or any of the Company Subsidiaries.
Code means the Internal Revenue Code of 1986.
Company Acquisition Proposal means any
proposal or offer for, whether in one transaction or a series of
related transactions, any (a) merger, consolidation or
similar transaction involving the Company or any Company
Subsidiary that would constitute a significant
subsidiary (as defined in
Rule 1-02
of
Regulation S-X,
but substituting 25% for references to 10% therein),
(b) sale or other disposition, directly or indirectly, by
merger, consolidation, share exchange or any similar
transaction, of any assets of the Company or the Company
Subsidiaries representing 25% or more of the consolidated assets
of the Company and the Company Subsidiaries, (c) issuance,
sale or other disposition by the Company or any Company
Subsidiary of (including by way of merger, consolidation, share
exchange or any similar transaction) securities (or options,
rights or warrants to purchase, or securities convertible into,
such securities) representing 25% or more of the outstanding
voting interests in the Company or any Company Subsidiary,
(d) tender offer or exchange offer in which any Person or
group (as such term is defined under the Exchange
Act) offers to acquire beneficial ownership, or the right to
acquire beneficial ownership, of 25% or more of the outstanding
Company Common Shares or (e) transaction which is similar
in form, substance or purpose to any of the foregoing
transactions; provided, however, that the term
Company Acquisition Proposal shall not include
(i) the Merger or any of the other transactions
contemplated by this Agreement or (ii) any merger,
consolidation, business combination, share exchange,
reorganization, recapitalization or similar transaction solely
among the Company and one or more Company Subsidiaries or among
Company Subsidiaries.
Company Bylaws means the Amended and Restated
Bylaws of the Company.
Company Charter means the Restated
Certificate of Incorporation of the Company.
Company Common Shares means the shares of
common stock, par value $0.01 per share, of the Company.
Company Disclosure Schedule means the
disclosure schedule delivered by the Company to Parent
concurrently with the execution of this Agreement for which the
disclosure of any fact or item in any Section of such disclosure
schedule shall, should the existence of such fact or item be
relevant to any other Section, be deemed to be disclosed with
respect to that other Section so long as the relevance of such
disclosure to such other Section is reasonably apparent from the
nature of such disclosure. Nothing in the Company Disclosure
Schedule is intended to broaden the scope of any representation
or warranty of the Company made herein.
Company Superior Proposal means a Company
Acquisition Proposal (on its most recently amended and modified
terms, if amended and modified) made by a third party (and not
obtained in breach of Section 7.03 or in material
breach of any other provision of this Agreement) which the
Company Board, on the recommendation of the Special Committee,
determines in good faith (after consultation with its financial
and legal advisors) to be more favorable to the stockholders of
the Company than the Merger; provided, however,
for purposes of this definition of Company Superior
Proposal, the term Company Acquisition Proposal shall have
the meaning assigned to such term herein, except that the
references to 25% in such definition shall be deemed
to be references to 50%.
control (including the terms
controlled by and under common
control with) means the possession, directly or
indirectly, of the power to direct or cause the direction of the
management and policies of a person, whether through the
ownership of voting securities, as trustee or executor, by
contract or credit arrangement or otherwise.
A-2
Disclosure Schedules means, collectively, the
Company Disclosure Schedule and the Parent Disclosure Schedule.
Environmental Law means any Law relating to
the environment, natural resources, or safety or health of human
beings or other living organisms, including the manufacture,
distribution in commerce and use or Release of Hazardous
Substances.
Expenses means attorneys fees and all
other costs, expenses and obligations (including experts
fees, travel expenses, court costs, retainers, transcript fees,
duplicating, printing and binding costs, as well as
telecommunications, postage and courier charges) paid or
incurred in connection with investigating, defending, being a
witness in or participating in (including on appeal), or
preparing to investigate, defend, be a witness in or participate
in, any Claim for which indemnification is authorized pursuant
to Section 7.06(a), including any Action relating to
a claim for indemnification or advancement brought by an
Indemnified Party.
GAAP means generally accepted accounting
principles as applied in the United States.
Governmental Authority means any foreign or
domestic national, state, provincial, municipal or local
government, governmental, regulatory or administrative
authority, agency, instrumentality or commission or any court,
tribunal, or judicial or arbitral body.
Hazardous Substances means any pollutant,
contaminant, hazardous substance, hazardous waste, medical
waste, special waste, toxic substance, petroleum or
petroleum-derived substance, waste or additive, radioactive
material, or other compound, element, material or substance in
any form whatsoever (including products) regulated, restricted
or addressed by or under any applicable Environmental Law.
Intellectual Property means (a) patents,
patent applications and invention registrations of any type,
(b) trademarks, service marks, trade dress, logos, trade
names, corporate names and other source identifiers, and
registrations and applications for registration thereof,
(c) copyrightable works, copyrights, and registrations and
applications for registration thereof, and (d) confidential
and proprietary information, including trade secrets and
know-how.
knowledge of the Company or
knowledge when used in reference to the
Company means the actual knowledge of those individuals listed
on Exhibit A.
Law means any national, state, provincial,
municipal or local statute, law, ordinance, regulation, rule,
code, executive order, injunction, judgment, decree or other
order.
Liens means, with respect to any asset
(including any security), any mortgage, claim, lien, pledge,
charge, security interest or encumbrance of any kind in respect
of such asset.
Material Adverse Effect means, with respect
to the Company, an effect, event, development or change that is
materially adverse to the business, assets, results of
operations or financial condition of the Company and the Company
Subsidiaries, taken as a whole, other than any of the following,
or any effect, event, development or change arising out of or
resulting therefrom (a) changes in the market price of
Company Common Shares, (b) changes in conditions in the
U.S. or global economy or capital or financial markets
generally, including changes in interest or exchange rates,
(c) changes in general legal, tax, regulatory, political or
business conditions in the geographic regions in which the
Company and the Company Subsidiaries do business,
(d) general market or economic conditions in the specialty
property and casualty insurance industry, (e) changes in
Law following the date hereof, (f) changes in GAAP or SAP
following the date hereof, (g) the negotiation, execution,
announcement, pendency or performance of this Agreement or the
transactions contemplated hereby or the consummation of the
transactions contemplated by this Agreement, including the
impact thereof on relationships, contractual or otherwise, with
insureds, customers, insurance brokers, reinsurance
intermediaries, suppliers, vendors, lenders, venture partners or
employees, (h) acts of war, armed hostilities, sabotage or
terrorism, or any escalation or worsening of any such acts of
war, armed hostilities, sabotage or terrorism threatened or
underway as of the date of this Agreement, (i) earthquakes,
hurricanes, floods, or other natural disasters, (j) any
change or announcement of a potential change in the credit
rating or A.M. Best rating of the Company or any of the
Company Subsidiaries or any of their securities, (k) any
failure by the Company to meet any internal or external
projections, forecasts or estimates of revenues or earnings for
any period, (l) (i) any action by Parent or any of its
Affiliates or (ii) the omission of an
A-3
action that is expressly required to be taken by Parent or any
of its Affiliates pursuant to this Agreement or (m) any
action taken by the Company at the written request or with the
written consent of any of the Buyer Parties; provided,
however, with respect to (a), (j) and
(k) above, the underlying cause of any such change or
failure shall not be excluded from the determination of whether
there has been a Material Adverse Effect; provided,
further, with respect to (b), (c) and (d), except to
the extent that the Company and the Company Subsidiaries taken
as a whole are materially disproportionately adversely affected
relative to other participants in the industries in which the
Company or the Company Subsidiaries participate;
provided, further, with respect to (h) and
(i), except to the extent that the insurance business of the
Company and the Company Subsidiaries taken as a whole are
materially disproportionately adversely affected as a result of
payments required to be made under insurance policies written by
the Company relative to other participants in the insurance
industry.
NYSE means the New York Stock Exchange.
Other Filings means any document, other
than the Proxy Statement, to be filed with the SEC in connection
with this Agreement.
Parent Disclosure Schedule means the
disclosure schedule delivered by Parent and MergerCo to the
Company concurrently with the execution of this Agreement for
which the disclosure of any fact or item in any Section of such
disclosure schedule shall, should the existence of such fact or
item be relevant to any other Section, be deemed to be disclosed
with respect to that other Section so long as the relevance of
such disclosure to such other Section is reasonably apparent
from the nature of such disclosure. Nothing in the Parent
Disclosure Schedule is intended to broaden the scope of any
representation or warranty of Parent made herein.
Parent Material Adverse Effect means any
effect, event, development or change that would reasonably be
expected to prevent, or materially hinder or delay Parent or
MergerCo from consummating the Merger or any of the other
transactions contemplated by this Agreement.
Permits means registrations, applications,
licenses, requests for exemptions, permits, certifications,
approvals, consents, and other regulatory authorizations issued
or granted by a Governmental Authority.
Permitted Liens means (a) Liens for
Taxes and other governmental charges and assessments not yet due
and payable and Liens for Taxes and other governmental charges
and assessments being contested in good faith and for which
there are adequate reserves on the financial statements of the
Company (if such reserves are required pursuant to GAAP),
(b) inchoate mechanics and materialmens Liens
for construction in progress, (c) inchoate workmens,
repairmens, warehousemens and carriers Liens
securing payments not due and payable or payments that are being
contested in good faith that are incurred in the ordinary course
of business consistent with past practice of the Company or any
Company Subsidiary, (d) zoning restrictions, survey
exceptions, utility easements, rights of way and similar Liens
that are imposed by any Governmental Authority having
jurisdiction thereon or otherwise are typical for the applicable
property type and locality and that do not detract from the
value, use or operation of the underlying property,
(e) interests of any lessor or lessee to any leased
property, (f) matters that would be disclosed on current
title reports or surveys that arise or have arisen in the
ordinary course of business consistent with past practice and
that do not detract in any material respect from the value, use
or operation of the underlying property, (g) licenses of
Intellectual Property, (h) transfer restrictions imposed by
applicable securities Laws, (i) deposits of investment
securities with or on behalf of state insurance departments in
connection with the operations of the Company Insurance
Subsidiaries and (j) Liens set forth in
Section 1.01(a)(ii) of the Company Disclosure
Schedule.
Person or person means an
individual, corporation, partnership, limited partnership,
limited liability company, syndicate, person (including a
person as defined in Section 13(d)(3) of the
Exchange Act), trust, association, entity or joint venture or
Governmental Authority, but shall exclude Company Subsidiaries.
Release means any release, pumping, pouring,
emptying, injecting, escaping, leaching, migrating, dumping,
seepage, spill, leak, flow, discharge or emission.
SAP means statutory accounting practices
prescribed or permitted by the applicable insurance regulatory
authority.
subsidiary or subsidiaries
of any Person means another Person in which such Person (or any
other subsidiary of such Person): (a) is a general partner
(in the case of a partnership) or managing member (in the case
of
A-4
a limited liability company), (b) is entitled to elect at
least a majority of the board of directors, board of managers or
similar governing body or (c) owns, directly or indirectly,
more than fifty percent (50%) of the outstanding voting
securities, equity securities, profits interest or capital
interest.
Tax or Taxes means any
federal, state, local or foreign income, gross receipts,
license, payroll, employment, excise, severance, stamp,
occupation, premium, windfall profits, environmental, customs
duties, capital stock, franchise, profits, withholding, social
security, unemployment, disability, real property, personal
property, sales, use, transfer, registration, value added,
alternative or add-on minimum, estimated or other tax of any
kind whatsoever, including any interest, penalty, or addition
thereto, whether disputed or not.
Tax Return means any return, declaration,
report, claim for refund, or information return or statement
relating to Taxes, including any schedule or attachment thereto,
and including any amendment thereof.
Voting Debt means bonds, debentures, notes or
other indebtedness having the right to vote (or convertible
into, or exchangeable for, securities having the right to vote)
on any matters on which holders of equity interests in the
Company or any Company Subsidiary may vote.
(b) The following terms have the meaning set forth in the
Sections set forth below:
|
|
|
Defined Term
|
|
Location of Definition
|
|
Actuarial Analyses
|
|
Section 4.06(e)
|
Adverse Recommendation Change
|
|
Section 7.03(b)
|
Agreement
|
|
Preamble
|
Buyer Parties
|
|
Preamble
|
Capital Expenditures
|
|
Section 6.01(i)
|
Certificate of Merger
|
|
Section 2.03
|
Closing
|
|
Section 2.04
|
Closing Date
|
|
Section 2.04
|
Company
|
|
Preamble
|
Company 401(k) Plan
|
|
Section 7.04(d)
|
Company Board
|
|
Recitals
|
Company Common Share Certificates
|
|
Section 3.03(c)
|
Company Dissenting Shares
|
|
Section 3.04
|
Company Employees
|
|
Section 7.04(a)
|
Company Insurance Approvals
|
|
Section 4.05(b)
|
Company Insurance Intermediary
|
|
Section 4.02(b)
|
Company Insurance Subsidiaries
|
|
Section 4.02(b)
|
Company Intellectual Property
|
|
Section 4.13(a)
|
Company Material Contract
|
|
Section 4.16(a)
|
Company Paying Agent
|
|
Section 3.03(a)
|
Company Preferred Shares
|
|
Section 4.03(a)
|
Company Reinsurance Agreements
|
|
Section 4.06(f)
|
Company Restricted Shares
|
|
Section 3.01(d)
|
Company SAP Statements
|
|
Section 4.07(c)
|
Company SEC Reports
|
|
Section 4.07(a)
|
Company Stock Awards
|
|
Section 4.03(b)
|
Company Stock Options
|
|
Section 3.01(c)
|
Company Stockholder Approval
|
|
Section 4.04(a)
|
Company Stockholders Meeting
|
|
Section 7.01(d)
|
Company Subsidiaries
|
|
Section 4.02(a)
|
A-5
|
|
|
Defined Term
|
|
Location of Definition
|
|
Confidentiality Agreement
|
|
Section 7.02(b)
|
Delaware Courts
|
|
Section 10.09(b)
|
DGCL
|
|
Recitals
|
Employment Agreements
|
|
Recitals
|
ERISA
|
|
Section 4.11(a)
|
ERISA Affiliate
|
|
Section 4.11(f)
|
Excess Amount
|
|
Section 3.06
|
Exchange Act
|
|
Section 4.05(b)
|
Governmental Order
|
|
Section 9.01(c)
|
HSR Act
|
|
Section 4.05(b)
|
Incentive Plans
|
|
Section 3.01(c)
|
Indemnified Parties
|
|
Section 7.06(a)
|
Insurance Contracts
|
|
Section 4.06(b)
|
IRS
|
|
Section 4.11(a)
|
Merger
|
|
Recitals
|
MergerCo
|
|
Preamble
|
Merger Consideration
|
|
Section 3.01(b)
|
Merger Effective Time
|
|
Section 2.03
|
Merger Shares
|
|
Section 3.01(b)
|
New Plans
|
|
Section 7.04(b)
|
Old Plans
|
|
Section 7.04(b)
|
Option Consideration
|
|
Section 3.01(c)
|
Outside Date
|
|
Section 9.01(b)
|
Parent
|
|
Preamble
|
Parent Insurance Approvals
|
|
Section 5.04(b)
|
Plans
|
|
Section 4.11(a)
|
Producers
|
|
Section 4.06(g)
|
Proxy Statement
|
|
Section 4.12
|
SEC
|
|
Section 4.07(a)
|
Section 16
|
|
Section 7.05
|
Section 262
|
|
Section 3.04
|
Securities Act
|
|
Section 4.03(c)
|
Special Committee
|
|
Recitals
|
Superior Proposal Notice
|
|
Section 9.01(f)
|
Surviving Corporation
|
|
Section 2.01
|
Surviving Corporation Fund
|
|
Section 3.03(a)
|
Termination Date
|
|
Section 9.01
|
Termination Fee
|
|
Section 9.03(d)
|
Transaction Insurance Approvals
|
|
Section 5.04(b)
|
Uncertificated Shares
|
|
Section 3.03(c)
|
Voting Agreement
|
|
Recitals
|
(c) In this Agreement, except to the extent otherwise
provided or that the context otherwise requires:
(i) when a reference is made in this Agreement to an
Article, Section, Exhibit or Schedule, such reference is to an
Article or Section of, or an Exhibit or Schedule to, this
Agreement unless otherwise indicated;
A-6
(ii) the table of contents and headings for this Agreement
are for reference purposes only and do not affect in any way the
meaning or interpretation of this Agreement;
(iii) whenever the words include,
includes or including are used in this
Agreement, they are deemed to be followed by the words
without limitation;
(iv) the words hereof, herein and
hereunder and words of similar import, when used in
this Agreement, refer to this Agreement as a whole and not to
any particular provision of this Agreement;
(v) references to any statute, rule or regulation are to
the statute, rule or regulation as amended, modified,
supplemented or replaced from time to time (and, in the case of
statutes, include any rules and regulations promulgated under
said statutes) and to any section of any statute, rule or
regulation including any successor to said section;
(vi) all terms defined in this Agreement have the defined
meanings when used in any certificate or other document made or
delivered pursuant hereto, unless otherwise defined therein;
(vii) the definitions contained in this Agreement are
applicable to the singular as well as the plural forms of such
terms;
(viii) references to a person are also to its successors
and permitted assigns;
(ix) references to monetary amounts are to the lawful
currency of the United States;
(x) words importing the singular include the plural and
vice versa and words importing gender include all genders;
(xi) time is of the essence in the performance of the
parties respective obligations; and
(xii) time periods within or following which any payment is
to be made or act is to be done shall be calculated by excluding
the day on which the period commences and including the day on
which the period ends and by extending the period to the next
Business Day following if the last day of the period is not a
Business Day.
ARTICLE II
THE MERGER
Section 2.01 Merger. Upon the terms
and subject to the conditions set forth in this Agreement, at
the Merger Effective Time (as defined in
Section 2.03), MergerCo shall be merged with and
into the Company and the separate corporate existence of
MergerCo shall thereupon cease. The Company shall be the
surviving corporation in the Merger (sometimes hereinafter
referred to as the Surviving Corporation),
and the separate corporate existence of the Company with all its
property, rights, privileges, immunities, powers and franchises
shall continue unaffected by the Merger. At the Merger Effective
Time, the effect of the Merger shall be as provided in this
Agreement, the Certificate of Merger and the applicable
provisions of the DGCL. Without limiting the generality of the
foregoing, and subject thereto, at the Merger Effective Time,
all of the property, rights, privileges, immunities, powers and
franchises of the Company and MergerCo shall vest in the
Surviving Corporation, and all debts, liabilities and duties of
the Company and MergerCo shall become the debts, liabilities and
duties of the Surviving Corporation.
Section 2.02 Charter and Bylaws.
(a) At the Merger Effective Time, the Company Charter shall
be amended to read as set forth on
Exhibit B. As so amended, such
Certificate of Incorporation shall be the Certificate of
Incorporation of the Surviving Corporation until thereafter
further amended as provided therein or by applicable Law.
(b) At the Merger Effective Time, the Bylaws of MergerCo in
effect immediately prior to the Merger Effective Time shall be
the Bylaws of the Surviving Corporation until thereafter amended
as provided therein or by applicable Law.
A-7
(c) The Company Charter and Company Bylaws, as amended
pursuant to clauses (a) and (b) above, respectively,
shall include any provisions required by
Section 7.06.
Section 2.03 Effective Time of the
Merger. Subject to the provisions of this
Agreement, as soon as practicable on the Closing Date, the
parties shall file a certificate of merger as contemplated by
the DGCL (the Certificate of Merger),
together with any required related certificates, filings or
recordings with the Secretary of State of the State of Delaware,
in such form as required by, and executed in accordance with,
the relevant provisions of the DGCL. The Merger shall become
effective upon the filing of the Certificate of Merger with the
Secretary of State of the State of Delaware or at such later
date and time as the Company and Parent may agree upon and as is
set forth in such Certificate of Merger (such time, the
Merger Effective Time).
Section 2.04 Closing. Unless this
Agreement shall have been terminated in accordance with
Section 9.01, the closing of the Merger (the
Closing) shall occur as promptly as
practicable (but in no event later than the third (3rd) Business
Day) after all of the conditions set forth in
Article VIII (other than conditions which by their
terms are required to be satisfied or waived at the Closing, but
subject to the satisfaction or waiver of such conditions) shall
have been satisfied or waived by the party entitled to the
benefit of the same, or at such other time and on a date as
agreed to by the parties (the Closing Date).
The Closing shall take place at the offices of Willkie
Farr & Gallagher LLP, 787 Seventh Avenue, New York,
New York or at such other place as agreed to by the parties
hereto.
Section 2.05 Directors and Officers of the Surviving
Corporation. From and after the Merger
Effective Time, the directors of MergerCo immediately prior to
the Merger Effective Time shall be the directors of the
Surviving Corporation and the officers of the Company
immediately prior to the Merger Effective Time shall be the
officers of the Surviving Corporation, in each case, until their
respective successors are duly elected or appointed and
qualified, or until the earlier of their death, resignation or
removal.
ARTICLE III
EFFECTS OF
THE MERGER
Section 3.01 Effects of the Merger on Company
Securities. At the Merger Effective Time, by
virtue of the Merger and without any action on the part of the
Company or the holders of any capital stock of the Company
(other than the requisite approval of the Merger by the
stockholders of the Company in accordance with the DGCL):
(a) Each Company Common Share held in treasury by the
Company or any Company Subsidiary and each Company Common Share
that is owned by Parent or MergerCo (or by any wholly owned
subsidiary of Parent or MergerCo) immediately prior to the
Merger Effective Time shall be cancelled and retired and shall
cease to exist, without any conversion thereof and no payment or
distribution shall be made with respect thereto.
(b) Each Company Common Share issued and outstanding
immediately prior to the Merger Effective Time (other than
Company Dissenting Shares and Company Common Shares to be
cancelled in accordance with Section 3.01(a)), shall
be converted and exchanged automatically into the right to
receive an amount in cash equal to $32.00 per Company Common
Share (the Merger Consideration), payable to
the holder thereof in accordance with
Section 3.03. At the Merger Effective
Time, all such Company Common Shares which have been converted
into the right to receive the Merger Consideration shall no
longer be outstanding and shall automatically be cancelled and
retired and shall cease to exist, and each holder of any such
Company Common Share immediately prior to the Merger Effective
Time shall cease to have any rights with respect thereto, except
the right to receive the Merger Consideration, without interest.
The Company Common Shares and the Company Restricted Shares that
are to be so converted into the right to receive the Merger
Consideration are referred to herein as the Merger
Shares.
(c) Immediately prior to the Merger Effective Time, each
outstanding qualified or nonqualified option to purchase Company
Common Shares (Company Stock Options) under
any employee or director share option or compensation plan or
arrangement of the Company (collectively,
Incentive Plans) shall become fully
vested and exercisable (whether or not then vested or subject to
any performance condition that has not been satisfied, and
regardless of the exercise price thereof). At the Merger
Effective Time, each Company Stock Option not theretofore
exercised shall be cancelled in exchange for the right to
receive an amount in cash (without interest and less any
applicable Taxes required to be withheld in accordance with
Section 3.05 with respect to such payment)
determined
A-8
by multiplying (x) the excess of the Merger Consideration
over the applicable exercise price per share of such Company
Stock Option by (y) the number of Company Common Shares
subject to such Company Stock Option (the Option
Consideration). Payment of the Option Consideration
shall be made in accordance with Section 3.03, and each
holder of any Company Stock Options immediately prior to the
Merger Effective Time shall cease to have any rights with
respect thereto, except the right to receive the Option
Consideration.
(d) Immediately prior to the Merger Effective Time, each
outstanding share of restricted stock granted under the
Incentive Plans, whether vested or unvested (the
Company Restricted Shares), shall become
fully vested and payable (whether or not then vested or subject
to any performance condition that has not been satisfied). At
the Merger Effective Time, each Company Restricted Share shall
be cancelled in exchange for the right to receive an amount in
cash equal to the Merger Consideration, plus any declared and
unpaid dividends, without interest and less any applicable Taxes
required to be withheld in accordance with
Section 3.05 with respect to such payment. Payment
of the Merger Consideration to the holders of Company Restricted
Shares shall be made in accordance with
Section 3.03. At the Merger Effective
Time, all Company Restricted Shares which have been converted
into the right to receive the Merger Consideration shall no
longer be outstanding and shall automatically be cancelled and
retired and shall cease to exist, and each holder of any such
Company Restricted Shares immediately prior to the Merger
Effective Time shall cease to have any rights with respect
thereto, except the right to receive the Merger Consideration.
Section 3.02 Effects of the Merger on MergerCo
Securities. At the Merger Effective Time, by
virtue of the Merger and without any action by MergerCo or
Parent, as the holder of all outstanding capital stock of Merger
Co (other than the requisite approval by the sole stockholder of
MergerCo in accordance with the DGCL, which approval will be
obtained immediately following the execution hereof), each
outstanding common share, par value $0.01 per share, of MergerCo
issued and outstanding immediately prior to the Merger Effective
Time shall be converted into and become one fully paid and
nonassessable common share, par value $0.01 per share, of the
Surviving Corporation.
Section 3.03 Payment of Merger Consideration; Stock
Transfer Books.
(a) Prior to the Merger Effective Time, the Company shall
appoint as paying agent a bank or trust company reasonably
satisfactory to Parent (the Company Paying
Agent). At or prior to the Merger Effective Time,
Parent shall deposit or cause the Surviving Corporation to
deposit with the Company Paying Agent, for the benefit of the
holders of Merger Shares and Company Stock Options, cash in an
amount sufficient to pay the aggregate Merger Consideration
required to be paid plus cash in an amount sufficient to pay
holders of Company Stock Options and Company Restricted Shares,
in accordance with this Agreement (such cash being hereinafter
referred to as the Surviving Corporation
Fund). The Surviving Corporation Fund shall not be
used for any other purpose.
(b) The Surviving Corporation Fund shall be invested by the
Company Paying Agent in (i) direct obligations of the
United States of America, (ii) obligations for which the
full faith and credit of the United States of America is pledged
to provide for payment of all principal and interest or
(iii) commercial paper obligations receiving the highest
rating from either Moodys Investor Services, Inc. or
Standard & Poors, a division of The McGraw Hill
Companies, or a combination thereof, as directed by and for the
benefit of the Surviving Corporation; provided,
however, that no gain or loss thereon shall affect the
amounts payable to the holders of Merger Shares and Company
Stock Options following completion of the Merger pursuant to
this Article III and Parent shall take all actions
necessary to ensure that the Surviving Corporation Fund includes
at all times cash sufficient to satisfy Parents obligation
under this Article III. Any and all interest and
other income earned on the Surviving Corporation Fund shall
promptly be paid to the Surviving Corporation.
(c) As promptly as practicable after the Merger Effective
Time, but in no event more than three (3) Business Days
following the Merger Effective Time, Parent and the Surviving
Corporation shall cause the Company Paying Agent to mail to each
person who was, as of immediately prior to the Merger Effective
Time, a holder of record of the Merger Shares or Company Stock
Options (i) a letter of transmittal (which shall be in
customary form approved by the Company and shall specify that
delivery shall be effected, and risk of loss and title to the
certificates representing the Merger Shares (the
Company Common Share Certificates) or
uncertificated Merger Shares represented by book entry (the
Uncertificated Shares) shall pass, only upon
proper delivery of the Company Common Share Certificates or
transfer of the Uncertificated Shares to the Company Paying
Agent) and
A-9
(ii) instructions for effecting the surrender of the
Company Common Share Certificates, the transfer of the
Uncertificated Shares or the surrender of Company Stock Options,
as applicable, in exchange for the Merger Consideration or the
Option Consideration, as applicable.
(d) Upon (i) surrender to the Company Paying Agent of
Company Common Share Certificates for cancellation, together
with such letter of transmittal, duly completed and validly
executed in accordance with the instructions thereto, and such
other documents as may be required pursuant to such instructions
or (ii) compliance with the reasonable procedures
established by the Company Paying Agent for delivery of
Uncertificated Shares or surrender of Company Stock Options, the
holder of such Company Common Share Certificates, Uncertificated
Shares or Company Stock Options, as applicable, shall be
entitled to receive in exchange therefor, in cash, the aggregate
Merger Consideration in respect thereof calculated in accordance
with Section 3.01(b), Section 3.01(c) or
Section 3.01(d), as applicable, in the form of a
check, to be mailed within three (3) Business Days of
receipt by the Company Paying Agent of such Company Common Share
Certificates, Uncertificated Shares or Company Stock Options, as
applicable, and the Company Common Share Certificates,
Uncertificated Shares or Company Stock Options, as applicable,
so surrendered shall forthwith be cancelled. Notwithstanding the
foregoing, if any stockholder of the Company who beneficially
owns in excess of thirty percent (30%) of the outstanding
Company Common Shares provides to the Company wire transfer
account information and otherwise complies with this
Section 3.03 at least three (3) Business Days
prior to the Company Stockholder Meeting, such stockholder shall
receive the Merger Consideration to which such stockholder is
entitled pursuant to Section 3.01(b) by wire
transfer from the Company Paying Agent immediately after the
Merger Effective Time.
(e) In the event of a transfer of ownership of Merger
Shares that is not registered in the transfer records of the
Company, payment of the Merger Consideration in respect of the
applicable Merger Shares may be made to a person other than the
person in whose name the Company Common Share Certificates so
surrendered or Uncertificated Shares so transferred are
registered if such Company Common Share Certificates shall be
properly endorsed or otherwise be in proper form for transfer or
such Uncertificated Shares shall be properly transferred and the
person requesting such payment shall pay any transfer or other
taxes required by reason of the payment of the Merger
Consideration in respect thereof or establish to the reasonable
satisfaction of the Surviving Corporation that such tax has been
paid or is not applicable. Until surrendered or transferred, as
the case may be, as contemplated by this
Section 3.03, each Company Common Share Certificate
or Uncertificated Share shall be deemed at all times after the
Merger Effective Time to represent only the right to receive
upon such surrender the Merger Consideration. No interest shall
be paid or shall accrue on any cash payable to holders of
Company Common Share Certificates, Uncertificated Shares or
Company Stock Options pursuant to the provisions of this
Article III.
(f) Any portion of the Surviving Corporation Fund that
remains undistributed to the holders of Merger Shares or Company
Stock Options for one (1) year after the Merger Effective
Time shall be delivered to the Surviving Corporation, upon
demand, and any holders of Merger Shares or Company Stock
Options who have not theretofore complied with this
Article III shall thereafter look only to the
Surviving Corporation for, and the Surviving Corporation shall
remain liable for, payment of their claims for the Merger
Consideration or Option Consideration, as applicable. Any
portion of the Surviving Corporation Fund remaining unclaimed by
holders of Merger Shares or Company Stock Options as of the date
which is immediately prior to such time as such amounts would
otherwise escheat to or become property of any Governmental
Authority shall, to the extent permitted by applicable Law,
become the property of the Surviving Corporation free and clear
of any claims or interest of any person previously entitled
thereto. None of Parent, the Company Paying Agent or the
Surviving Corporation shall be liable to any holder of Merger
Shares or Company Stock Options for cash delivered to a public
official pursuant to any abandoned property, escheat or similar
Law.
(g) If any Company Common Share Certificate shall have been
lost, stolen or destroyed, upon the making of an affidavit of
that fact by the person claiming such Company Common Share
Certificate to be lost, stolen or destroyed and, if required by
the Surviving Corporation, the posting by such person of a bond,
in such reasonable amount as the Surviving Corporation may
direct, as indemnity against any claim that may be made against
it with respect to such Company Common Share Certificate, the
Company Paying Agent shall pay in respect of Merger Shares to
which such lost, stolen or destroyed Company Common Share
Certificate relate the Merger Consideration to which the holder
thereof is entitled.
A-10
(h) At the Merger Effective Time, the stock transfer books
of the Company shall be closed and there shall be no further
registration of transfers of Merger Shares thereafter on the
records of the Company. From and after the Merger Effective
Time, the holders of Company Common Share Certificates,
Uncertificated Shares or Company Stock Options shall cease to
have any rights with respect thereto, except as otherwise
provided in this Agreement, the certificate of incorporation of
the Surviving Corporation, or by applicable Law.
Section 3.04 Company Dissenting
Shares. Notwithstanding anything in this
Agreement to the contrary, Company Common Shares or Company
Restricted Shares that are outstanding immediately prior to the
Merger Effective Time and that are held by any Person who is
entitled to demand, and who properly demands, appraisal of such
Company Common Shares or Company Restricted Shares pursuant to,
and who complies in all respects with, Section 262 of the
DGCL (such Section, Section 262, and,
such Company Common Shares, Company Dissenting
Shares) shall not be converted into the right to
receive the Merger Consideration, as provided in
Section 3.01(b) or Section 3.01(d), but
rather, the holders of Company Dissenting Shares shall be
entitled only to payment of the fair value of such Company
Dissenting Shares in accordance with Section 262 (and, at
the Merger Effective Time, such Company Dissenting Shares shall
no longer be outstanding and shall automatically be cancelled
and shall cease to exist, and such holders shall cease to have
any right with respect thereto, except the right to receive the
fair value of such Company Dissenting Shares in accordance with
Section 262); provided that if any such holder shall
fail to perfect or otherwise shall waive, withdraw or lose the
right to appraisal under Section 262, then the right of
such holder to be paid the fair value of such holders
Company Dissenting Shares shall cease and such Company
Dissenting Shares shall be deemed to have been converted as of
the Merger Effective Time into, and to have become exchangeable
solely for, the right to receive the Merger Consideration
(without interest thereon) as provided in
Section 3.01(b) or
Section 3.01(d). The Company shall notify
Parent as promptly as reasonably practicable of any demands
received by the Company for appraisal of any Company Common
Shares or Company Restricted Shares, and Parent shall have the
right to participate in all negotiations and proceedings with
respect to such demands. Prior to the Merger Effective Time, the
Company shall not, without the prior written consent of Parent
(which consent shall not be unreasonably withheld, delayed or
conditioned), voluntarily make any payment with respect to, or
settle or offer to settle, any such demands, or agree to do any
of the foregoing.
Section 3.05 Withholding Rights. The
Company, the Surviving Corporation or the Company Paying Agent,
as applicable, shall be entitled to deduct and withhold from the
consideration otherwise payable pursuant to this Agreement to
any holder of Company Common Shares, Company Stock Options and
Company Restricted Shares, such amounts as it is required to
deduct and withhold with respect to the making of such payment
under the Code or any provision of state, local or foreign Tax
law. To the extent that amounts are so withheld, or paid over to
or deposited with the relevant Governmental Authority (including
any taxing authority) by the Company, the Surviving Corporation
or the Company Paying Agent, as applicable, such amounts shall
be treated for all purposes of this Agreement as having been
paid to the holder of the Company Common Shares, Company Stock
Options and Company Restricted Shares, in respect of which such
deduction and withholding was made by the Company, the Surviving
Corporation or the Company Paying Agent, as applicable.
Section 3.06 Adjustments to Prevent
Dilution. In the event that the aggregate
Merger Consideration and Option Consideration to be paid at
Closing pursuant to Sections 3.01(b), 3.01(c)
and 3.01(d) is increased by more than One Million Dollars
($1,000,000) as a result of the Companys breach of its
representations and warranties set forth in
Sections 4.03(a) and 4.03(b) (the amount of
such increase above One Million Dollars ($1,000,000) being
referred to herein as the Excess Amount), the
Merger Consideration and the Option Consideration shall be
ratably and equitably reduced so that the aggregate Merger
Consideration and Option Consideration to be paid at Closing
pursuant to Sections 3.01(b), 3.01(c) and
3.01(d) is reduced by an amount equal to the Excess
Amount. In the event that, and only to the extent permitted by
Section 6.01(b), the Company changes (or establishes
a record date for changing) the number of Company Common Shares
or Company Restricted Shares, as applicable, issued and
outstanding prior to the Merger Effective Time as a result of a
stock split, stock dividend, recapitalization, subdivision,
reclassification, combination, exchange of shares or similar
transaction with respect to the outstanding Company Common
Shares or Company Restricted Shares, as applicable, at any time
during the period from the date hereof to the Merger Effective
Time, then the Merger Consideration and Option Consideration
shall be appropriately adjusted, taking into account the record
and payment or effective dates, as the case may be, for such
transaction.
A-11
ARTICLE IV
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
Except as set forth in the Company Disclosure Schedule or the
Company SEC Reports filed at least one (1) Business Day
prior to the date hereof (excluding disclosure contained in the
risk factors section or constituting
forward-looking statements, in each case solely to
the extent such disclosure is cautionary, predictive or
speculative in nature), the Company hereby represents and
warrants to the Buyer Parties as follows:
Section 4.01 Organization and Qualification;
Authority.
(a) The Company (i) is a corporation duly organized,
validly existing and in good standing under the laws of the
State of Delaware, (ii) is duly qualified or licensed to do
business as a foreign corporation and is, to the extent
applicable, in good standing under the laws of any other
jurisdiction in which the character of the properties owned,
leased or operated by it therein or in which the transaction of
its business makes such qualification or licensing necessary and
(iii) has all requisite corporate power and authority to
own, lease and operate its properties and carry on its business
as now conducted, except, in the case of clauses (ii) and
(iii), as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.
(b) The Company has previously provided or made available
to Parent copies of the Company Charter and Company Bylaws and
all such documents are in full force and effect and no
dissolution, revocation or forfeiture proceedings regarding the
Company have been commenced.
Section 4.02 Company Subsidiaries.
(a) Each of the Companys subsidiaries (the
Company Subsidiaries), together with the
jurisdiction of organization of each such Company Subsidiary and
the number and class of all capital stock or equity interests of
each such Company Subsidiary that are outstanding (and the
identity of the holders thereof), is set forth in
Section 4.02(a) of the Company Disclosure Schedule.
Each Company Subsidiary is a corporation, partnership, limited
liability company, trust or other organization duly incorporated
or organized, validly existing and, to the extent applicable, in
good standing under the laws of the jurisdiction of its
incorporation or organization. Each of the Company Subsidiaries
has the requisite corporate, limited partnership, limited
liability company or similar power and authority to own, lease
and operate its properties and carry on its business as now
conducted, except where the failure to have such power and
authority would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. Each
of the Company Subsidiaries is duly qualified or licensed to do
business and is, to the extent applicable, in good standing in
each jurisdiction where the character of the properties owned,
leased or operated by it or the conduct or nature of its
business makes such qualification or licensing necessary, except
for jurisdictions in which the failure to be so qualified,
licensed or in good standing would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect.
(b) The Company conducts its insurance operations through
the Company Subsidiaries set forth in
Section 4.02(b)(i) of the Company Disclosure
Schedule (collectively, the Company Insurance
Subsidiaries). Each of the Company Insurance
Subsidiaries is, where required, (i) duly licensed or
authorized as an insurance company in its jurisdiction of
incorporation, (ii) duly licensed or authorized as an
insurance company or is an eligible excess or surplus lines
insurer in each other jurisdiction where it is required to be so
licensed, authorized or eligible and (iii) duly authorized
or eligible in its jurisdiction of incorporation and each other
applicable jurisdiction to write each line of business reported
as being written in the Company SAP Statements (as hereinafter
defined), except where the failure to be so licensed, authorized
or eligible would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. Each
Company Subsidiary that acts as an insurance broker, agent,
managing general agent, producer or intermediary
(Company Insurance Intermediary) is duly
licensed in each jurisdiction in which it is required to be so
licensed, except where the failure to be so licensed would not,
individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect. The Company Insurance Intermediaries
are set forth in Section 4.02(b)(ii) of the Company
Disclosure Schedule.
(c) All of the outstanding shares of capital stock of, or
other equity interests in, each Company Subsidiary have been
duly authorized, validly issued and are fully paid and
nonassessable. The Company is, directly or indirectly, the
record and beneficial owner of all of the outstanding shares of
capital stock or other equity interests of each of
A-12
the Company Subsidiaries and the Company owns all such capital
stock and other equity interests free and clear of any Liens
(other than Permitted Liens) or limitations on voting rights,
and free of any preemptive rights and any other limitation or
restriction (including any limitation or restriction on the
right to vote, sell, transfer or otherwise dispose of the stock
or other ownership interests, other than such limitations or
restrictions under federal or state securities laws).
Section 4.03 Capitalization.
(a) The authorized capital stock of the Company consists of
Fifty Million (50,000,000) Company Common Shares and Ten Million
(10,000,000) shares of preferred stock, par value $0.10 per
share, of the Company (Company Preferred
Shares). As of May 31, 2008, (i) 17,018,738
Company Common Shares were issued and outstanding, all of which
are duly authorized, validly issued, fully paid and
nonassessable and (ii) 0 Company Common Shares were held in
the treasury of the Company. No Company Preferred Shares are
issued and outstanding. Since May 31, 2008, the Company has
not issued any Company Common Shares, Company Restricted Shares
or Company Stock Options (or any securities exchangeable or
exercisable for or convertible into any of the foregoing),
except for the issuance of Company Common Shares upon the
exercise of any Company Stock Options issued and outstanding as
of May 31, 2008 and set forth in
Section 4.03(b).
(b) As of May 31, 2008, 436,374 Company Common Shares
were reserved for future issuance pursuant to outstanding
Company Stock Options and other purchase rights and stock awards
granted pursuant to the Incentive Plans (collectively, the
Company Stock Awards).
Section 4.03(b) of the Company Disclosure Schedule
sets forth all of the Company Stock Awards (including Company
Stock Options and Company Restricted Shares), and the exercise
prices of the Company Stock Options, issued and outstanding as
of the date of this Agreement.
(c) Except as set forth in Section 4.03(b) or
Section 4.03(c) of the Company Disclosure Schedule
or as described in Section 4.03(a) above:
(i) there are no shares of capital stock or options,
warrants or other rights, agreements, arrangements or
commitments of any character relating to the issued or unissued
capital stock of the Company or any Company Subsidiary or
obligating the Company or any Company Subsidiary to issue or
sell any shares of capital stock of, or other equity interests
in, the Company or any Company Subsidiary;
(ii) there are no outstanding contractual obligations of
the Company to repurchase, redeem or otherwise acquire any
shares of capital stock or other equity rights of the Company;
(iii) the Company is under no obligation, contingent or
otherwise, by reason of any agreement to register the offer and
sale or resale of any of its securities under the Securities Act
of 1933 (the Securities Act);
(iv) except as set forth in the Voting Agreement, there are
no agreements or understandings to which the Company or any
Company Subsidiary is a party with respect to the voting of any
shares of capital stock or other equity interests of the Company
or any Company Subsidiary or which restrict, or grant any
rights, preference or privilege with respect to, the transfer of
any such shares or other equity interests, nor does the Company
have knowledge of any third party agreements or understandings
with respect to the voting of any such shares or other equity
interests or which restrict the transfer of any such shares or
other equity interests;
(v) there are no accrued or unpaid dividends or other
distributions with respect to any Company Common Shares or
Company Restricted Shares or any shares of capital stock or
other equity interests of any Company Subsidiary; and
(vi) there is no outstanding Voting Debt of the Company or
any Company Subsidiary.
Section 4.04 Authority Relative to this Agreement;
Validity and Effect of Agreements.
(a) The Company has all necessary corporate power and
authority to execute and deliver this Agreement, to perform its
obligations hereunder and to consummate the transactions
contemplated by this Agreement. Except for the approvals
described in the following sentence, the execution, delivery and
performance by the Company of this Agreement and the
consummation of the transactions contemplated by this Agreement
have been duly and validly authorized by all necessary corporate
action on behalf of the Company. No other corporate proceedings
on the part of the Company or any Company Subsidiary are
necessary to authorize this Agreement or to consummate the
A-13
transactions contemplated hereby, including the Merger, other
than the adoption of this Agreement by the holders of at least a
majority of the outstanding Company Common Shares entitled to
vote in accordance with the DGCL (the Company
Stockholder Approval) and the filing of the
Certificate of Merger pursuant to the DGCL. This Agreement has
been duly and validly executed and delivered by the Company and,
assuming the due authorization, execution and delivery by each
of Parent and MergerCo, constitutes a legal, valid and binding
obligation of the Company, enforceable against the Company in
accordance with its terms, except as may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent transfer and similar laws of general applicability
relating to or affecting creditors rights or by general
equity principles.
(b) The Special Committee has (i) determined that this
Agreement and the transactions contemplated hereby, including
the Merger, are advisable and fair to, and in the best interests
of, the Company and its stockholders and (ii) resolved to
recommend to the Company Board that it approve and declare
advisable this Agreement and the transactions contemplated
hereby, including the Merger.
(c) The Company Board, acting upon the recommendation of
the Special Committee, has (i) determined that this
Agreement and the transactions contemplated hereby, including
the Merger, are advisable and fair to, and in the best interests
of, the Company and its stockholders, (ii) approved this
Agreement and the transactions contemplated hereby, including
the Merger and (iii) recommended that the Companys
stockholders adopt this Agreement.
Section 4.05 No Conflict; Required Filings and
Consents.
(a) The execution and delivery by the Company of this
Agreement do not, and the performance of its obligations
hereunder will not, (i) conflict with or violate the
Company Charter or Company Bylaws, (ii) assuming that all
consents, approvals, authorizations and other actions described
in subsection (b) of this Section 4.05 have
been obtained and all filings and other obligations described in
subsection (b) of this Section 4.05 have been
made, conflict with or violate any Law applicable to the Company
or any Company Subsidiary or by which any property or asset of
the Company or any Company Subsidiary is bound,
(iii) require any consent or notice, or result in any
violation or breach of, or conflict with, or constitute (with or
without notice or lapse of time or both) a default (or give rise
to any right of purchase, termination, amendment, acceleration
or cancellation) under, result in the loss of any benefit under,
or result in the triggering of any payments pursuant to, any of
the terms, conditions or provisions of any Company Material
Contract to which the Company or any Company Subsidiary is a
party or by which it or any of its respective properties or
assets may be bound or (iv) result in the creation of a
Lien (except for Permitted Liens) on any property or asset of
the Company or any Company Subsidiary except, with respect to
clauses (ii), (iii) and (iv), for such triggering of
payments, Liens, encumbrances, filings, notices, permits,
authorizations, consents, approvals, violations, terminations,
amendments, accelerations, cancellations, conflicts, breaches,
defaults, losses of benefits or rights which would not,
individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.
(b) The execution and delivery by the Company of this
Agreement do not, and the performance of its obligations
hereunder will not, require any consent, approval, authorization
of, or filing with or notification to, any Governmental
Authority, except (i) for (A) applicable requirements
of the Securities Exchange Act of 1934 (the Exchange
Act), (B) the pre-merger notification
requirements of the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976 (the HSR
Act), (C) any filings required under the rules
and regulations of the NYSE, (D) the filing of the
Certificate of Merger pursuant to the DGCL, (E) any
registration, filing or notification required pursuant to state
securities or blue sky laws and (F) filings with, and
approval of, the insurance regulatory authorities in the
jurisdictions listed in Section 4.05(b) of the
Company Disclosure Schedule (the Company Insurance
Approvals) and (ii) where the failure to obtain
such consents, approvals, authorizations or permits, or to make
such filings or notifications would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect.
Section 4.06 Compliance with Laws; Permits; Insurance
Matters.
(a) The business and operations of the Company and the
Company Subsidiaries are being conducted in compliance with all
applicable Laws, except for such non-compliance as would not,
individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect. Without limitation of the foregoing,
each of the Company Insurance Subsidiaries is marketing or
selling insurance products in compliance with insurance laws
applicable to the business of such Company Insurance Subsidiary
in the respective jurisdictions in which such
A-14
products are being marketed or sold, except for such
non-compliance that would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.
(b) Insurance Contracts.
(i) Except as set forth in Section 4.06(b)(i)
of the Company Disclosure Schedule:
(A) to the extent required by Law, all policies, binders,
slips, certificates and other agreements or contracts of
insurance (Insurance Contracts) issued by a
Company Insurance Subsidiary, since January 1, 2007, are on
forms approved by applicable insurance Governmental Authorities
or have been filed and not objected to by such authorities
within the period provided for objection, except as would not
reasonably be expected to be material to the Company Insurance
Subsidiaries taken as a whole; and
(B) any rates of a Company Insurance Subsidiary which are
required to be filed with or approved by any Governmental
Authority have been so filed or approved, except as would not
reasonably be expected to be material to the Company Insurance
Subsidiaries taken as a whole.
(ii) Except as set forth in Section 4.06(b)(ii)
of the Company Disclosure Schedule or except as would not,
individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect:
(A) to the knowledge of the Company, the Company Insurance
Subsidiaries and the Company Insurance Intermediaries are not
subject to any pending market conduct claim or complaint by a
Governmental Authority;
(B) neither the Company nor any Company Insurance
Subsidiary or Company Insurance Intermediary has received
written notice of any action, or, to the knowledge of the
Company, is aware of any threatened action, which would
reasonably be expected to give rise to a market conduct claim by
a Governmental Authority; and
(C) since January 1, 2007, the Company Insurance
Subsidiaries have (1) to the knowledge of the Company,
timely paid all guaranty fund assessments that are due, or
claimed or asserted by any state guaranty fund or association or
by any insurance Governmental Authority to be due and
(2) provided for all such assessments in the Company SAP
Statements to the extent necessary to be in conformity with SAP
in all material respects as then in effect.
(iii) Except as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect or except as set forth in
Section 4.06(b)(iii) of the Company Disclosure
Schedule, since January 1, 2007, all Insurance Contract
claims due and payable by or on behalf of the Company Insurance
Subsidiaries have been paid in accordance with the terms of the
Insurance Contracts under which they arose, except for such
exceptions for which the Company Insurance Subsidiary has a
reasonable basis to believe that there is a reasonable basis to
contest payment.
(c) Regulatory Filings. (i) Since
January 1, 2007, the Company, each Company Insurance
Subsidiary and each Company Insurance Intermediary has filed all
material reports, statements, documents, registrations, filings
and submissions required to be filed with any insurance
Governmental Authority and (ii) to the knowledge of the
Company, any material deficiencies or violations noted in all
such material reports, statements, documents, registrations,
filings and submissions have been resolved to the satisfaction
of the Governmental Authority that noted such deficiencies or
violations.
(d) Except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect,
(i) the Company and the Company Subsidiaries have all
Permits required to legally conduct their respective businesses
as now conducted and to own their respective assets,
(ii) the Company and the Company Subsidiaries are in
compliance with all such Permits, (iii) all such Permits
are valid and in full force and effect and (iv) no such
Permit is the subject of any suit or pending proceeding seeking
the revocation, suspension, non-renewal or material impairment
of such Permit.
(e) Prior to the date of this Agreement, the Company has
made available to Parent a true and complete copy of all
material actuarial reports prepared by actuaries, independent or
otherwise, on or after January 1, 2007, with
A-15
respect to the Company or any Company Insurance Subsidiary, and
all material attachments, addenda, supplements and modifications
thereto (the Actuarial Analyses). The
information and data furnished by each Company Insurance
Subsidiary to its independent actuaries in connection with the
preparation of the Actuarial Analyses were accurate in all
material respects. Furthermore, each Actuarial Analysis prepared
internally by the Company or a Company Subsidiary was based upon
data and information that were accurate in all material respects
at the relevant time of preparation.
(f) All material reinsurance treaties or agreements to
which any Company Insurance Subsidiary is a party or under which
any Company Insurance Subsidiary has any material existing
rights, obligations or liabilities (the Company
Reinsurance Agreements) are set forth in
Section 4.06(f)(i) of the Company Disclosure
Schedule. Except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, to the
knowledge of the Company, as of the date of this Agreement,
(i) no party to a Company Reinsurance Agreement is in
default as to any provision thereof, (ii) since
January 1, 2007, no notice of intended cancellation has
been received by a Company Insurance Subsidiary from any
reinsurer with respect to any such Company Reinsurance
Agreement, (iii) with respect to ceded Company Reinsurance
Agreements, none of the Company Insurance Subsidiaries
reinsurers has denied coverage with respect to any material
claim pending and (iv) except as set forth in
Section 4.06(f)(ii) of the Company Disclosure
Schedule, each Company Insurance Subsidiary is entitled under
applicable Law to take full credit in its Company SAP Statements
for all amounts recoverable by it pursuant to a Company
Reinsurance Agreement, and all such amounts have been properly
recorded in its books and records and are properly reflected in
its financial statements.
(g) Producers.
(i) Except as set forth in Section 4.06(g)(i)
of the Company Disclosure Schedule, to the knowledge of the
Company, since January 1, 2007, each Person, including
salaried employees of the Company, the Company Insurance
Subsidiaries and the Company Insurance Intermediaries,
performing the duties of insurance producer, reinsurance
intermediary, agent, managing general agent, wholesaler, broker,
solicitor, adjuster or customer representative for the Company
or any Company Insurance Subsidiary (collectively,
Producers), at the time such Producer wrote,
sold, produced, solicited or serviced business, or performed
such other act for or on behalf of the Company or Company
Insurance Subsidiary that may require a Permit, was duly
licensed and appointed as required by applicable Law, in the
particular jurisdiction in which such Producer wrote, sold,
produced, solicited or serviced such business, except as would
not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect.
(ii) Except as set forth in Section 4.06(g)(ii)
of the Company Disclosure Schedule, since January 1, 2007,
the Company, the Company Insurance Subsidiaries and the Company
Insurance Intermediaries have not made a filing with any
Governmental Authority seeking an exemption under 18 USC
§ 1033(e)(2) with respect to any Producer.
(iii) Except as set forth in
Section 4.06(g)(iii) of the Company Disclosure
Schedule, as of the date hereof, to the knowledge of the
Company, no Producer has indicated to the Company, a Company
Insurance Subsidiary or a Company Insurance Intermediary that
any Producer will be unable or unwilling to continue its
relationship as a Producer with the Company, any Company
Subsidiary or any Company Insurance Intermediary within twelve
(12) months after the Closing, except as would not,
individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.
(h) Managing General Agency
Agreements. Except as set forth in
Section 4.06(h) of the Company Disclosure Schedule
or except with respect to policies issued under the Company
Insurance Subsidiaries I-Bind system, neither the Company
nor any Company Insurance Subsidiary has any managing general
agency contracts or similar arrangements under which an
independent party has authority to perform underwriting analysis
and issue insurance policies or reinsurance contracts on behalf
of the Company or any Company Insurance Subsidiary or otherwise
to bind the Company or any Company Insurance Subsidiary to such
policies or contracts without the prior approval of the Company
or such Company Insurance Subsidiary.
(i) Since January 1, 2007, none of the Company, the
Company Insurance Subsidiaries or the Company Insurance
Intermediaries nor, to the knowledge of the Company, any of
their respective directors, officers, agents, or
A-16
employees has directly or indirectly made any contribution,
gift, bribe, rebate, payoff, influence payment, kickback or
other payment to any Person, private or public, regardless of
form, whether in money, property or services (i) to obtain
favorable treatment in securing business, (ii) to pay for
favorable treatment for business secured, (iii) to obtain
special concessions or for special concessions already obtained,
for or in respect of the Company or such Company Insurance
Subsidiary or (iv) in violation of any Law.
(j) Except as expressly provided in any of the agreements
set forth in Section 4.06(j) of the Company
Disclosure Schedule, none of the Company, the Company Insurance
Subsidiaries or the Company Insurance Intermediaries is a party
to any market services agreement, placement services agreement
or similar agreement providing for the payment of contingent
commissions other than commissions based upon the profitability
of business written. All material fee or commission payments due
from the Company Insurance Subsidiaries with respect to
Insurance Contracts or due to the Company Insurance
Intermediaries are described in written contracts, binders of
insurance or other forms of written confirmation.
Section 4.07 SEC Filings; Financial Statements.
(a) The Company has timely filed all forms, reports and
documents (including all exhibits) required to be filed by it
with the United States Securities and Exchange Commission (the
SEC) since May 19, 2006 (the
Company SEC Reports). The Company SEC
Reports, each as amended, if applicable, (i) complied in
all material respects with, the requirements of the Securities
Act or the Exchange Act, as the case may be, each as in effect
as of the date of filing of such Company SEC Reports, and
(ii) as of their respective dates (or, if amended, as of
the date of such amendment) did not contain any untrue statement
of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements
made therein, in light of the circumstances under which they
were made, not misleading. None of the Company Subsidiaries is
subject to the periodic reporting requirements of the Exchange
Act or required to file any form, report or other document with
the SEC or the NYSE. To the knowledge of the Company, there are
no material unresolved comments received from the SEC staff with
respect to the Company SEC Reports on or prior to the date
hereof. To the knowledge of the Company, none of the Company SEC
Reports filed on or prior to the date hereof is subject to
ongoing SEC review or investigation.
(b) Each of the consolidated financial statements
(including, in each case, any notes thereto) contained in the
Company SEC Reports, each as amended prior to the date of this
Agreement, was prepared, in all material respects, in accordance
with and complied, in all material respects, with GAAP applied
on a consistent basis throughout the periods indicated (except
as may be indicated in the notes thereto) and each fairly
presented, in all material respects, the consolidated financial
position, results of operations and cash flows of the Company
and its consolidated Company Subsidiaries as of the respective
dates thereof and for the respective periods indicated therein
except as otherwise noted therein (subject, in the case of
unaudited statements, to normal and recurring year-end
adjustments).
(c) As used herein, the term Company SAP
Statements means the statutory statements of each of
the Company Insurance Subsidiaries as filed with the applicable
insurance regulatory authorities in their respective
jurisdictions of domicile, and any state where it is licensed or
from which it has received a Permit, for the year ended
December 31, 2007, the quarterly period ended
March 31, 2008 and any subsequent quarterly period ended
prior to the Closing. Each Company Insurance Subsidiary has
filed or submitted all Company SAP Statements required to be
filed with or submitted to the appropriate insurance regulatory
authorities of the jurisdiction in which it is domiciled, and
any state where it is licensed or from which it has received a
Permit, on forms prescribed or permitted by such authority,
except for such failures to file that would not, individually or
in the aggregate, reasonably be expected to have a Material
Adverse Effect. The Company SAP Statements were prepared in all
material respects in conformity with SAP consistently applied
for the periods covered thereby (except as may be indicated in
the notes thereto), and the Company SAP Statements fairly
presented, in all material respects, the statutory financial
position of such Company Insurance Subsidiaries as of the
respective dates thereof and the results of operations of such
Company Insurance Subsidiaries for the respective periods then
ended. No material weakness has been asserted with respect to
any Company SAP Statements filed prior to the date of this
Agreement by the applicable Company Insurance Subsidiarys
domiciliary state regulator or the insurance regulator of a
state where it is licensed or from which it has received a
Permit, which has not been cured, waived or otherwise resolved
A-17
to the satisfaction of such state regulator except for those
weaknesses that would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.
(d) Neither the Company nor any Company Subsidiary is a
party to, or has any commitment to become a party to, any joint
venture, off-balance sheet partnership or any similar contract
(including any contract or arrangement relating to any
transaction or relationship between or among the Company and any
Company Subsidiary, on the one hand, and any unconsolidated
Affiliate, including any structured finance, special purpose or
limited purpose entity or Person, on the other hand, or any
off-balance sheet arrangements (as defined in
Item 303(a) of
Regulation S-K
of the Securities Act), where the result, purpose or intended
effect of such contract is to avoid disclosure of any material
transaction involving, or material liabilities of, the Company
or any Company Subsidiary in the Companys or the Company
Subsidiaries published financial statements or any Company
SEC Reports.
(e) The Company maintains a system of internal accounting
controls sufficient to provide reasonable assurances regarding
the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
GAAP. The Company (i) has designed disclosure controls and
procedures (within the meaning of
Rules 13a-15(e)
and
15d-15(e) of
the Exchange Act) to ensure that material information is made
known to management of the Company by others within the Company
to allow timely decisions regarding required disclosure and to
make the certifications required by the Exchange Act with
respect to the Company SEC Reports and (ii) has disclosed,
based on its most recent evaluation prior to the date of this
Agreement, to its auditors and the audit committee of its Board
of Directors (A) any significant deficiencies and material
weaknesses in the design or operation of internal controls over
financial reporting which are reasonably likely to adversely
affect in any material respect its ability to record, process,
summarize and report financial data and (B) any fraud,
whether or not material, that involves management or other
employees who have a significant role in its internal controls
and the Company has provided to Parent copies of documentation
related to such disclosure contemplated in clauses (A) and
(B) above.
Section 4.08 Absence of Certain Changes or
Events. Except as disclosed in the Company
SEC Reports filed prior to the date hereof, or as contemplated
by this Agreement, since March 31, 2008, (a) the
Company has conducted its business in all material respects in
the ordinary course of business consistent with past practice
and (b) there has not been an event, occurrence, effect or
circumstance which, individually or in the aggregate, has had or
would reasonably be expected to have a Material Adverse Effect.
Section 4.09 Absence of Undisclosed
Liabilities. The Company and the Company
Subsidiaries do not have any material liabilities required by
GAAP to be reflected on a consolidated balance sheet of the
Company, except for liabilities (a) reflected on or
reserved against in the Companys consolidated balance
sheet, as of March 31, 2008, included in the Companys
consolidated financial statements, (b) incurred in the
ordinary course of business consistent with past practice since
March 31, 2008, (c) incurred in connection with the
Merger or any transaction contemplated by this Agreement,
(d) which have been discharged or paid in full in the
ordinary course of business consistent with past practice, or
(e) set forth in Section 4.09 of the Company
Disclosure Schedule.
Section 4.10 Absence of
Litigation. As of the date of this Agreement,
(a) there is no material Action pending or, to the
knowledge of the Company, threatened in writing against the
Company or any of the Company Subsidiaries or any of its or
their respective properties or assets and (b) neither the
Company nor any of the Company Subsidiaries is subject to any
order, judgment, writ, injunction or decree (other than those
applicable generally to insurers in one or more of the
Companys and the Company Subsidiaries lines of
business).
Section 4.11 Employee Benefit Plans.
(a) Section 4.11(a) of the Company Disclosure
Schedule lists all material employee benefit plans (as defined
in Section 3(3) of the Employee Retirement Income Security
Act of 1974 (ERISA)) and all material bonus,
stock option, stock purchase, restricted stock, incentive,
deferred compensation, retiree medical or life insurance,
supplemental retirement, severance or other benefit plans,
programs or arrangements, and all material employment,
termination, severance or other contracts or agreements (other
than individual option agreements) to which the Company or any
Company Subsidiary is a party, with respect to which the Company
or any Company Subsidiary has any obligation or which are
maintained, contributed to or sponsored by the Company or any
Company Subsidiary for the benefit of any current or former
employee, officer, director or consultant of the Company or any
A-18
Company Subsidiary (collectively, the
Plans). The Company has made available
to Parent copies, which are correct and complete in all material
respects, of the following: (i) the Plans, (ii) the
annual report (Form 5500) filed with the Internal
Revenue Service (IRS) for the last year,
(iii) the most recently received IRS determination letter,
if any, relating to the Plans and (iv) the most recent
summary plan description for such Plans (or other descriptions
of such Plans provided to employees) and all material
modifications thereto.
(b) Each Plan has been operated in all material respects in
accordance with its terms and the requirements of all applicable
Laws, including ERISA and the Code. Each Plan that is intended
to be qualified under Section 401(a) of the Code or
Section 401(k) of the Code has received a favorable
determination letter from the IRS, or is entitled to rely on a
favorable opinion issued by the IRS, and, to the knowledge of
the Company, no fact or event has occurred since the date of
such determination letter or letters from the IRS to adversely
affect, in any material respect, the qualified status of any
such Plan or the exempt status of any such trust.
(c) Except as set forth in Section 4.11(c) of
the Company Disclosure Schedule, neither the Company nor any
Company Subsidiary sponsors or has sponsored any Plan that
provides for any post-employment or post-retirement health or
medical or life insurance benefits for retired, former or
current employees of the Company or any Company Subsidiary,
except as required by Section 4980B of the Code.
(d) Full payment has been made, or otherwise properly
accrued on the books and records of the Company and any Company
Subsidiary, of all amounts that the Company and any Company
Subsidiary are required under the terms of the Plans to have
paid as contributions to such Plans on or prior to the date of
this Agreement (excluding any amounts not yet due).
(e) Except as set forth in Section 4.11(e) of
the Company Disclosure Schedule, no Plan, either individually or
collectively, provides for any payment by the Company or any
Company Subsidiary that would constitute a parachute
payment within the meaning of Section 280G of the
Code after giving effect to the transactions contemplated by
this Agreement.
(f) Neither the Company nor any ERISA Affiliate sponsors or
has sponsored in the past six years any Plan (or United States
based pension plan in the case of an ERISA Affiliate) that is
subject to Title IV or Section 302 of ERISA or
Section 412 or 4971 of the Code. Neither the Company nor
any ERISA Affiliate contributes to or has ever contributed to,
or otherwise incurred any withdrawal liability under, any
multiemployer plan (within the meaning of Section 3(37) of
ERISA). For purposes of this Section 4.11(f), an
entity is an ERISA Affiliate of the Company
if it would have ever been considered a single employer with the
Company under 4001(b) of ERISA or part of the same controlled
group as the Company for purposes of Section 302(d)(8)(C)
of ERISA.
(g) Except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect,
(i) there is no unfair labor practice charge or complaint
pending against the Company or any Company Subsidiary,
(ii) there is no labor strike, slowdown, work stoppage,
lockout or labor dispute pending or, to the knowledge of the
Company, threatened against or affecting the Company or any
Company Subsidiary, and neither the Company nor any Company
Subsidiary has experienced any strike, slowdown, work stoppage,
lockout or other labor dispute by or with respect to its
employees within the last three (3) years, (iii) there
are no charges with respect to or relating to the Company or any
Company Subsidiary pending before any Governmental Authority
responsible for the prevention of unlawful employment practices
and (iv) the Company and each Company Subsidiary are, and
at all times have been in compliance with, all applicable Laws
relating to employment of labor, including all applicable Laws
relating to wages, hours, collective bargaining, employment
discrimination, civil rights, safety and health, workers
compensation, pay equity, classification of employees and the
collection and payment of withholding
and/or
social security Taxes.
Section 4.12 Information
Supplied. None of the information supplied or
to be supplied by the Company for inclusion or incorporation by
reference in the proxy statement relating to the Company
Stockholders Meeting (as amended, supplemented or modified
from time to time, the Proxy Statement)
will, at the time the Proxy Statement is first mailed to the
Company stockholders or at the time of the Company
Stockholders Meeting, contain any untrue statement of a
material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are
made, not misleading, except that no representation or warranty
is made by the Company with respect to statements made or
A-19
incorporated by reference therein based on information supplied
by Parent or MergerCo for inclusion or incorporation by
reference therein.
Section 4.13 Intellectual
Property. Except as would not, individually
or in the aggregate, reasonably be expected to have a Material
Adverse Effect:
(a) either the Company or a Company Subsidiary owns, or is
licensed or otherwise possesses legally enforceable rights to
use, subject to any existing licenses or other grants of rights
to third parties, all Intellectual Property used in their
respective businesses as currently conducted (collectively, the
Company Intellectual Property); and
(b) as of the date of this Agreement, (i) there are no
pending or, to the knowledge of the Company, threatened Actions
by any person alleging infringement of any material Intellectual
Property rights of any person by the Company or any Company
Subsidiary for their use of the Company Intellectual Property,
(ii) to the knowledge of the Company, the conduct of the
business of the Company and the Company Subsidiaries does not
infringe any Intellectual Property rights of any person,
(iii) neither the Company nor any Company Subsidiary has
made any claim of a violation or infringement by others of its
rights to, or in connection with, the Company Intellectual
Property and (iv) to the knowledge of the Company, no
person is infringing any Company Intellectual Property.
Section 4.14 Taxes. Except as set
forth in Section 4.14 of the Company Disclosure
Schedule or as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect:
(a) all Tax Returns required to be filed by or with respect
to the Company or any of the Company Subsidiaries have been
timely filed (except those under valid extension) and such Tax
Returns are true, complete and correct;
(b) all Taxes due and payable by the Company or any of the
Company Subsidiaries have been timely paid, withheld or
adequately provided for in accordance with GAAP on the
Companys most recent consolidated financial statements;
(c) neither the Company nor any of the Company Subsidiaries
has received written notice of any proceeding or audit against,
or with respect to any Taxes of, the Company or any of the
Company Subsidiaries that has not been finally resolved;
(d) neither the Company nor any of the Company Subsidiaries
has granted any extension or waiver of the limitation period
applicable to any income Tax Returns;
(e) there are no Liens for Taxes (other than Permitted
Liens) upon any of the assets of the Company or any of the
Company Subsidiaries;
(f) neither the Company nor any of the Company Subsidiaries
is a party to or is bound by any Tax sharing, allocation, or
indemnification agreement (other than such an agreement
exclusively between or among the Company and the Company
Subsidiaries);
(g) neither the Company nor any of the Company Subsidiaries
(i) has been a member of a group filing a consolidated,
combined or unitary Tax Return (other than a group the common
parent of which was the Company) or (ii) has any liability
for the Taxes of any Person (other than the Company or any of
the Company Subsidiaries) under Treasury
Regulation Section 1.1502-6
(or any similar provision of state, local or foreign Law);
(h) neither the Company nor any of the Company Subsidiaries
has constituted either a distributing corporation or
a controlled corporation in a distribution of stock
intended to qualify for tax-free treatment under
Section 355 of the Code in the two (2) years prior to
the date of this Agreement;
(i) neither the Company nor any of the Company Subsidiaries
has participated in a transaction described in Treasury
Regulations
Section 1.6011-4(b)(2),
(3) or (4); and
(j) to the knowledge of the Company, no claim has been made
during the past three (3) years by any appropriate
Governmental Authority in a jurisdiction where neither the
Company nor any of the Company Subsidiaries has filed Tax
Returns indicating that the Company or any of the Company
Subsidiaries is or may be subject to any material taxation by
such jurisdiction.
A-20
Section 4.15 Environmental
Matters. Except as would not, individually or
in the aggregate, reasonably be expected to have a Material
Adverse Effect, to the knowledge of the Company, there has been
no Release or threatened Release of any Hazardous Substance at,
on, under or from any real property owned or leased by the
Company or the Company Subsidiaries.
Section 4.16 Material Contracts.
(a) Except as set forth in Section 4.16 of the
Company Disclosure Schedule or as filed with the SEC prior to
the date hereof, as of the date of this Agreement, neither the
Company nor any Company Subsidiary is a party to, and none of
their respective properties or assets are bound by, any contract
which is a material contract (as such term is
defined in Item 601(b)(10) of
Regulation S-K
promulgated by the SEC). Each of the contracts of the type
described in this Section 4.16 is referred to in
this Agreement as a Company Material Contract.
(b) (i) Neither the Company nor any Company Subsidiary
is and, to the knowledge of the Company, no other party is, in
material breach or violation of, or in material default under,
any Company Material Contract, and, to the knowledge of the
Company, no event has occurred which would result in any such
breach or violation of, or such default (in each case, with or
without notice or lapse of time or both) and (ii) none of
the Company or any of the Company Subsidiaries has received any
claim of such breach or violation of, or default under, any
Company Material Contract. Each Company Material Contract is
valid, binding and enforceable against the Company or the
Company Subsidiaries, as applicable, and, to the knowledge of
the Company, the other parties thereto in accordance with its
terms, except as may be limited by applicable bankruptcy,
insolvency, rehabilitation, conservatorship, reorganization,
moratorium, fraudulent transfer and similar laws of general
applicability relating to or affecting creditors rights
generally, or creditors rights with respect to insurance
companies, or by general equity principles, and is in full force
and effect with respect to the Company or the Company
Subsidiaries, as applicable, and, to the knowledge of the
Company, with respect to the other parties thereto.
Section 4.17 Interested Party
Transactions. Except as set forth in the
Company SEC Reports prior to the date hereof, since
January 1, 2008, (i) neither the Company nor any of
the Company Subsidiaries is a party to any agreement or
arrangement, and no event has occurred as of the date of this
Agreement that would be required to be reported by the Company
pursuant to Item 404 of
Regulation S-K
promulgated by the SEC and (ii) neither the Company nor any
of the Company Subsidiaries is a party to any agreement or
arrangement with Alleghany Corporation or its Affiliates.
Section 4.18 Insurance. Section
4.18 of the Company Disclosure Schedule contains a
complete and accurate list of all material insurance policies
maintained by the Company as of the date of this Agreement.
Except as set forth in Section 4.18 of the Company
Disclosure Schedule or for exceptions that individually or in
the aggregate, would not reasonably be expected to have a
Material Adverse Effect, all material insurance policies
maintained by the Company are in full force and effect, all
premiums due and payable thereon have been paid, and no written
notice of cancellation or termination has been received with
respect thereto.
Section 4.19 Brokers. No Person other
than UBS Securities LLC is entitled to any brokerage,
finders or other fee or commission in connection with the
transactions contemplated by this Agreement based upon
arrangements made by or on behalf of the Company or any Company
Subsidiary.
Section 4.20 Opinion of Financial
Advisor. Prior to the execution of this
Agreement, the Company Board and the Special Committee have
received the opinion of UBS Securities LLC, as of June 27,
2008, to the effect that, as of such date, and based upon and
subject to various assumptions made, procedures followed,
matters considered and limitations described in the opinion, the
Merger Consideration to be received by the holders of Company
Common Shares (other than Alleghany Corporation, its subsidiary
Alleghany Insurance Holdings LLC or any of their respective
affiliates) is fair, from a financial point of view, to such
holders.
Section 4.21 No Other Representations or
Warranties. Except for the representations
and warranties contained in this Agreement, neither the Company
nor any other Person on behalf of the Company or any Company
Subsidiary makes any other express or implied representation or
warranty with respect to the Company or any Company Subsidiary
or with respect to any other information provided by or on
behalf of the Company or any Company Subsidiary.
A-21
ARTICLE V
REPRESENTATIONS
AND WARRANTIES OF THE BUYER PARTIES
Except as set forth in the Parent Disclosure Schedule or the
Parent SEC Reports filed at least one (1) Business Day
prior to the date hereof (excluding disclosure contained in the
risk factors section or constituting
forward-looking statements, in each case, to the
extent such disclosure is cautionary, predictive or speculative
in nature), Parent and MergerCo hereby jointly and severally
represent and warrant to the Company as follows:
Section 5.01 Organization and Qualification;
Authority.
(a) Each of the Buyer Parties (i) is a corporation
duly organized, validly existing and in good standing (or
similar concept under applicable Law) under the laws of the
jurisdiction of its incorporation, (ii) is duly qualified
or licensed to do business as a foreign corporation and is, to
the extent applicable, in good standing under the laws of any
other jurisdiction in which the character of the properties
owned, leased or operated by it therein or in which the
transaction of its business makes such qualification or
licensing necessary and (iii) has all requisite corporate
power and authority to own, lease and operate its properties and
carry on its business as now conducted, except, in the case of
clauses (ii) and (iii), as would not, individually or in
the aggregate, reasonably be expected to have a Parent Material
Adverse Effect.
(b) Each of the Buyer Parties has previously provided or
made available to the Company copies of its certificate of
incorporation, bylaws or similar organizational documents, and
all such documents are in full force and effect and no
dissolution, revocation or forfeiture proceedings regarding the
Buyer Parties have been commenced.
Section 5.02 Ownership of MergerCo; No Prior
Activities. MergerCo was formed solely for
the purpose of engaging in the transactions contemplated by this
Agreement and has not engaged in any business activities or
conducted any operations other than in connection with the
transactions contemplated by this Agreement. All the issued and
outstanding shares of capital stock of MergerCo are, and as of
the Closing Date will be, owned beneficially by Parent as the
ultimate controlling person of MergerCo.
Section 5.03 Authority Relative to this Agreement;
Validity and Effect of Agreements. Each of
the Buyer Parties has all necessary corporate power and
authority to execute and deliver this Agreement, to perform its
obligations hereunder and to consummate the transactions
contemplated by this Agreement. The execution, delivery and
performance by each of the Buyer Parties of this Agreement and
the consummation of the transactions contemplated by this
Agreement have been duly and validly authorized by all necessary
corporate action on behalf of the Buyer Parties, and no other
corporate proceedings on the part of either of the Buyer Parties
are necessary to authorize this Agreement or to consummate the
transactions contemplated by this Agreement, including the
Merger, except for the approval of this Agreement by the sole
stockholder of MergerCo, which will be effected by written
consent immediately following the execution of this Agreement.
This Agreement has been duly and validly executed and delivered
by the Buyer Parties and, assuming the due authorization,
execution and delivery by the Company, constitutes a legal,
valid and binding obligation of each of the Buyer Parties,
enforceable against each of the Buyer Parties in accordance with
its terms, except as may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium, fraudulent transfer and
similar laws of general applicability relating to or affecting
creditors rights or by general equity principles.
Section 5.04 No Conflict; Required Filings and
Consents.
(a) The execution and delivery by each of the Buyer Parties
of this Agreement do not, and the performance of each of the
Buyer Parties obligations hereunder will not,
(i) conflict with or violate the certificate of
incorporation, bylaws or similar organizational documents of
either of the Buyer Parties, (ii) assuming that all
consents, approvals, authorizations and other actions described
in subsection (b) of this Section 5.04 have
been obtained and all filings and obligations described in
subsection (b) of this Section 5.04 have been
made, conflict with or violate any Law applicable to any of the
Buyer Parties or any of their subsidiaries, or by which any of
their properties or assets are bound, (iii) require any
consent or notice, or result in any violation or breach of, or
conflict with, or constitute (with or without notice or lapse of
time or both) a default (or give rise to any right of purchase,
termination, amendment, acceleration or cancellation) under,
result in the loss of any benefit under, or result in the
triggering of any payments
A-22
pursuant to, any of the terms, conditions or provisions of any
note, bond, mortgage, indenture, contract, agreement, lease,
license, permit, franchise or other instrument or obligations to
which any Buyer Party or any of their respective subsidiaries is
a party or by which it or any of their respective properties or
assets may be bound or (iv) result in the creation of a
Lien (except for Permitted Liens) on any property or asset of
the Buyer Parties or any of their subsidiaries except, with
respect to clauses (ii), (iii) and (iv), such triggering of
payments, Liens, encumbrances, filings, notices, permits,
authorizations, consents, approvals, violations, terminations,
amendments, accelerations, cancellations, conflicts, breaches,
defaults, losses of benefit or rights which would not,
individually or in the aggregate, reasonably be expected to have
a Parent Material Adverse Effect.
(b) The execution and delivery of this Agreement by each of
the Buyer Parties do not, and the performance of each of the
Buyer Parties obligations hereunder will not, require any
consent, approval, authorization of, or filing with or
notification to, any Governmental Authority, except (i) for
(A) applicable requirements of the Exchange Act,
(B) the pre-merger notification requirements of the HSR
Act, (C) any filings required under the rules and
regulations of the NYSE, (D) the filing of the Certificate
of Merger pursuant to the DGCL, (E) any registration,
filing or notification required pursuant to state securities or
blue sky laws and (F) filings with, and approval of, the
insurance regulatory authorities in the jurisdictions listed in
Section 5.04(b) of the Parent Disclosure Schedule
(the Parent Insurance Approvals and, together
with the Company Insurance Approvals, the Transaction
Insurance Approvals) and (ii) where the failure
to obtain such consents, approvals, or authorizations or
permits, or to make such filings or notifications would not,
individually or in the aggregate, reasonably be expected to have
a Parent Material Adverse Effect.
Section 5.05 Information
Supplied. None of the information supplied or
to be supplied by either of the Buyer Parties for inclusion or
incorporation by reference in the Proxy Statement will, at the
time the Proxy Statement is first mailed to the Companys
stockholders or at the time of the Company Stockholders
Meeting, contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of
the circumstances under which they are made, not misleading,
except that no representation or warranty is made by the Buyer
Parties with respect to statements made or incorporated by
reference therein based on information supplied by the Company
for inclusion or incorporation by reference therein.
Section 5.06 Absence of
Litigation. As of the date of this Agreement,
except as would not, individually or in the aggregate,
reasonably be expected to have a Parent Material Adverse Effect,
(a) there is no Action pending or, to the knowledge of
Parent, threatened in writing against Parent or any of its
subsidiaries or any of its or their respective properties or
assets and (b) neither Parent nor any of its subsidiaries
is subject to any order, judgment, writ, injunction or decree.
Section 5.07 Availability of
Funds. Parent has the financial capacity to
perform its obligations under this Agreement and to cause
MergerCo to perform its obligations under this Agreement. Parent
has or will have, and will cause MergerCo to have, prior to the
Merger Effective Time, sufficient funds to pay the aggregate
Merger Consideration and the Option Consideration contemplated
by this Agreement and to perform the other obligations of Parent
and MergerCo contemplated by this Agreement.
Section 5.08 No Ownership of Company Capital
Stock. Neither Parent nor any of its
subsidiaries own any Company Common Shares or any option,
warrant or other right to acquire any Company Common Shares.
Section 5.09 Other Agreements or
Understandings. Except for the Voting
Agreement, neither Parent nor any of its subsidiaries is a party
to any written contract, arrangement or understanding with any
member of the Company Board or any officer at or above the level
of senior vice president of the Company or any person that
beneficially owns 5% or more of the shares of the outstanding
capital stock of the Company, in each case, that relates to the
voting or disposition of the Company Common Shares in respect of
the Merger.
Section 5.10 Brokers. No Person other
than Goldman, Sachs & Co. is entitled to any
brokerage, finders or other fee or commission in
connection with the transactions contemplated by this Agreement
based upon arrangements made by or on behalf of the Buyer
Parties or any of their Affiliates.
Section 5.11 Interest in
Competitors. Neither Parent nor MergerCo owns
any interest (nor do any of their respective Affiliates insofar
as such Affiliate-owned interest would be attributed to Parent
or MergerCo under the
A-23
HSR Act) in any entity or Person that derives a substantial part
of its revenues from a line of business within the
Companys principal line of business.
Section 5.12 No Additional Representations or
Warranties.
(a) Each of the Buyer Parties acknowledges that it and its
representatives have received access to such books and records,
facilities, equipment, contracts and other assets of the Company
and the Company Subsidiaries which it and its representatives
have desired or requested to review, and that it and its
representatives have had full opportunity to meet with the
management of the Company and the Company Subsidiaries and to
discuss the business and assets of the Company and the Company
Subsidiaries.
(b) Each of the Buyer Parties acknowledges that
(i) neither the Company nor any person has made any
representation or warranty, express or implied, as to the
accuracy or completeness of any information regarding the
Company furnished or made available to the Buyer Parties and
each of their respective representatives except as expressly set
forth in Article IV (which includes the Company
Disclosure Schedule and the Company SEC Reports) and
(ii) except as contemplated by this Agreement, neither the
Company, its Affiliates, or their respective subsidiaries,
stockholders, controlling persons, including Alleghany
Corporation or its Affiliates, or representatives nor any other
person, shall be subject to any liability or responsibility
whatsoever to the Buyer Parties or their respective Affiliates
or any of their respective subsidiaries, stockholders,
controlling persons, or representatives on any basis (including
in contract or tort, under federal or state securities Laws or
otherwise) resulting from or based upon the Companys
making available to the Buyer Parties any information or
Parents use of any such information. The term
information as used in this
Section 5.12(b) includes any information, documents
or material in the due diligence materials provided to the Buyer
Parties and their respective representatives, including in the
data room, management presentations (formal or
informal), any statement, document or agreement delivered
pursuant to this Agreement, any financial statements and any
projections, forecasts, estimates or other forward-looking
information (including in any management presentations,
information or descriptive memorandum, supplemental information
or other materials or information with respect to any of the
foregoing) provided or otherwise made available to the Buyer
Parties or any of their Affiliates, stockholders, controlling
persons or representatives or in any other form in connection
with the transactions contemplated by this Agreement.
ARTICLE VI
CONDUCT OF
BUSINESS PENDING THE MERGER
Section 6.01 Conduct of Business by the Company Pending
the Merger. From the date of this Agreement
until the Merger Effective Time, except as required by this
Agreement, as may be required by applicable Law or as set forth
in Section 6.01 of the Company Disclosure Schedule
or except with the prior written consent of Parent, which
consent shall not be unreasonably withheld, delayed or
conditioned (provided that consent of Parent shall be
deemed to have been given if Parent does not object within three
(3) Business Days after request for such consent is
actually received by Parent), the Company shall, and shall cause
each of the Company Subsidiaries to, conduct its business in the
ordinary course consistent with past practice and shall use its
commercially reasonable efforts to preserve substantially intact
the business, assets and organization of the Company and the
Company Subsidiaries and to preserve the current beneficial
relationships of the Company and the Company Subsidiaries with
any Person with which the Company or any Company Subsidiary has
material business relations (including customers, suppliers,
directors, officers and key employees). Except as required by
this Agreement, as may be required by applicable Law or as set
forth in Section 6.01 of the Company Disclosure
Schedule, neither the Company nor any Company Subsidiary shall,
between the date of this Agreement and the Merger Effective
Time, do any of the following without the prior written consent
of Parent, which consent shall not be unreasonably withheld,
delayed or conditioned; provided, however, that
consent of Parent shall be deemed to have been given if Parent
does not object within three (3) Business Days after
request for such consent is actually received by Parent.
(a) amend or otherwise change any provision of the Company
Charter or Company Bylaws, or similar organizational or
governance documents;
(b) (i) authorize for issuance, issue, sell, pledge,
dispose of, grant or transfer or agree or commit to issue, sell,
dispose of, grant or transfer any shares of any class of capital
stock of the Company or any Company Subsidiary or
A-24
any options, warrants, convertible securities or other rights of
any kind to acquire any shares of such capital stock, or any
other ownership interest, of the Company or any Company
Subsidiary, other than the issuance of Company Common Shares
issuable pursuant to Company Stock Awards outstanding on the
date hereof, (ii) repurchase, redeem or otherwise acquire
any securities or equity equivalents except in connection with
the exercise of Company Stock Options or the vesting of Company
Stock Awards, (iii) declare, set aside or pay any dividends
on, or make any other actual, constructive or deemed
distributions (whether in cash, shares, property or otherwise)
in respect of, any shares of the Companys capital stock or
the shares of stock or other equity interests in any Company
Subsidiary that is not directly or indirectly wholly owned by
the Company, other than (A) dividends by any direct or
indirect wholly owned Company Subsidiary to the Company or any
other Company Subsidiary and (B) dividend equivalents
already accrued as of the date hereof and paid with respect to
Company Stock Awards outstanding on the date hereof and set
forth in Section 6.01(b) of the Company Disclosure
Schedule or (iv) split, combine or reclassify any shares,
stock or other equity interests of the Company or any Company
Subsidiary or issue or authorize the issuance of any securities
in respect of, in lieu of or in substitution for shares of such
shares, stock or other equity interests;
(c) merge or consolidate with any other Person or adopt a
plan of complete or partial liquidation, dissolution, merger,
consolidation, restructuring, recapitalization or other
reorganization of the Company or any Company Subsidiary (other
than the Merger), except (i) that a Company Subsidiary may
merge with another Company Subsidiary or (ii) for
acquisitions (including by way of merger, consolidation,
acquisition of equity interests or assets or any other business
combination) by the Company or any Company Subsidiary of any
Person providing for purchase price consideration (including any
related amounts or promissory notes) of an amount less than Five
Million Dollars ($5,000,000) individually or Ten Million Dollars
($10,000,000) in the aggregate;
(d) sell, lease, license, subject to a Lien (other than a
Permitted Lien) or otherwise surrender, relinquish or dispose of
any assets or property of the Company or any Company Subsidiary
other than in the ordinary course of business, except for
(i) sales of investment assets by the Company or any of the
Company Subsidiaries in the ordinary course of business
consistent with past practice, (ii) transfers and pledges
of assets in connection with the conduct of the insurance
business, including pursuant to reinsurance, coinsurance, ceding
of insurance, assumption of insurance or indemnification with
respect to insurance and similar arrangements, in the ordinary
course of business consistent with past practice,
(iii) sales or transfers of assets between wholly owned
Company Subsidiaries, (iv) pursuant to existing written
contracts or commitments as set forth in
Section 6.01(d) of the Company Disclosure Schedule
or (v) in an amount not in excess of Five Million Dollars
($5,000,000) in the aggregate;
(e) incur any indebtedness for borrowed money or issue any
debt securities or assume, guarantee or endorse, or otherwise as
an accommodation become responsible for, the obligations of any
person (other than a Company Subsidiary) for borrowed money,
other than indebtedness for borrowed money incurred in the
ordinary course of business and pursuant to any credit agreement
to which the Company or any Company Subsidiary is a party as of
the date of this Agreement (which shall be deemed to include
draws or standby letters of credit under the Companys line
of credit facility or other similar lines of credit);
(f) except as required by the terms of the Plans or awards
made thereunder prior to the date of this Agreement,
(i) increase the compensation or benefits payable to its
directors, officers or employees (other than increases for
employees or officers below the level of senior vice president
made in the ordinary course of business consistent with past
practice), (ii) amend, change, terminate or waive any
rights under any Employment Agreement or (iii) establish,
adopt, enter into or amend to materially increase benefits under
any collective bargaining, bonus, profit sharing, thrift,
compensation, stock option, restricted stock, pension,
retirement, deferred compensation, employment, loan, retention,
consulting, indemnification, termination, severance or other
similar plan, agreement, trust, fund, policy or arrangement with
any director, officer or employee (other than with respect to
(A) agreements for new hires of non-executive officers in
the ordinary course of business consistent with past practice
that do not provide any change in control benefits and
(B) each award under the Companys Performance
Incentive Plan and the Companys Long Term Incentive Plan;
(g) pre-pay any long-term debt (which shall be deemed to
include pre-payments or repayments of lines of credit facilities
or other similar lines of credit or payments made in respect of
any termination or settlement of any interest rate swap or other
similar hedging instrument relating thereto) in an amount
exceeding Five Million Dollars
A-25
($5,000,000) in the aggregate for the Company and the Company
Subsidiaries taken as a whole, except in the ordinary course of
business consistent with past practice and in accordance with
the terms of such debt;
(h) except as required by Law or changes in GAAP or SAP
which become effective after the date of this Agreement,
materially change any of its accounting policies (whether for
financial accounting or Tax purposes);
(i) authorize, or enter into any commitment for, any new
material capital expenditures (such authorized or committed new
material capital expenditures being referred to hereinafter as
the Capital Expenditures) in an amount
in excess of Two Million Dollars ($2,000,000) in the aggregate;
(j) pay, discharge, settle or satisfy any material
litigation, arbitrations, proceedings, claims, liabilities or
obligations other than any payment, discharge, settlement or
satisfaction in the ordinary course of business consistent with
past practice (which includes payment of policyholders
claims) where the amounts paid or to be paid, except in the case
of policyholder claims, (i) are covered by insurance
coverage maintained by the Company or (ii) are in an amount
less than Five Million Dollars ($5,000,000) in the aggregate;
(k) take any action that would cause any of the
representations or warranties of the Company contained herein to
become inaccurate in any material respect or any of the
covenants of the Company to be breached in any material respect
or result in the failure to be satisfied of any of the
conditions set forth in Section 8.02;
(l) create or have any subsidiary of the Company other than
the Company Subsidiaries as of the date of this Agreement;
(m) (A) amend, change, cancel, terminate or waive or
release, in any material respect, any rights under any Company
Material Contract that was required to be filed as an exhibit to
the Company SEC Reports pursuant to
Regulation S-K
of the Securities Act or (B) enter into any new contract,
agreement or arrangement that would be required to be filed as
an exhibit to the Company SEC Reports pursuant to
Regulation S-K
of the Securities Act;
(n) (i) settle or compromise any material Tax audit,
(ii) make or change any material Tax election or file any
material amendment to a material Tax Return, except, in each
case, as required by applicable Law, or (iii) surrender any
right to claim a material refund of Taxes;
(o) enter into (i) any agreement or arrangement that
would be required to be reported by the Company pursuant to
Item 404 of
Regulation S-K
promulgated by the SEC or (ii) any agreement or arrangement
with Alleghany Corporation or its Affiliates; or
(p) enter into any agreement or otherwise make a commitment
to do any of the foregoing.
Section 6.02 Conduct of Business by Buyer Parties
Pending the Merger. The Buyer Parties agree
that, between the date of this Agreement and the Merger
Effective Time, except as required by this Agreement, they shall
not, directly or indirectly, without the prior written consent
of the Company, take or cause to be taken any action that
(a) could be expected to materially delay or impair the
consummation of the transactions contemplated by this Agreement,
or propose, announce an intention, enter into any agreement or
otherwise make a commitment to take any such action or
(b) would cause any of the representations or warranties of
the Buyer Parties contained herein to become inaccurate in any
material respect or any of the covenants of the Buyer Parties to
be breached in any material respect or result in the failure to
be satisfied of any of the conditions set forth in
Section 8.03.
Section 6.03 MergerCo. Parent will
take all actions necessary to cause MergerCo to perform its
obligations under this Agreement and to consummate the Merger on
the terms and conditions set forth in this Agreement.
Section 6.04 Incentive Plans. Prior
to the Closing, the Company Board shall take all actions
reasonably required to terminate all equity based Incentive
Plans effective as of the Merger Effective Time, such that,
except for the Option Consideration and the Restricted Stock
Consideration, the Company shall have no further obligations
with respect thereto.
A-26
ARTICLE VII
ADDITIONAL
AGREEMENTS
Section 7.01 Company Proxy Statement; Other Filings;
Stockholders Meeting.
(a) As promptly as reasonably practicable following the
date of this Agreement, the Company shall prepare and, after
consultation with Parent in accordance with the second sentence
of Section 7.01(b), file with the SEC the Proxy
Statement and each of the Company and Parent shall, or shall
cause their respective affiliates to, prepare and, after
consultation with each other, file with the SEC all Other
Filings that are required to be filed by such party in
connection with the transactions contemplated hereby. Parent and
the Company shall cooperate with one another in connection with
the preparation of the Proxy Statement and shall furnish all
information concerning such party as the other party may
reasonably request in connection with the preparation of the
Proxy Statement. Parent and the Company shall each use its
commercially reasonable efforts to have the Proxy Statement
cleared by the SEC as promptly as reasonably practicable after
such filing. The Company will use commercially reasonable
efforts to cause the Proxy Statement to be mailed to the
Companys stockholders as promptly as reasonably
practicable after the Proxy Statement is cleared by the SEC.
(b) As promptly as reasonably practicable, each of Parent
and the Company shall notify the other of (i) the receipt
of any comments from the SEC and all other written
correspondence and oral communications with the SEC relating to
the Proxy Statement and (ii) any request by the SEC for any
amendment or supplement to the Proxy Statement or for additional
information with respect thereto. All filings by the Company
with the SEC in connection with the transactions contemplated
hereby, including the Proxy Statement and any amendment or
supplement thereto and all mailings to the Companys
stockholders in connection with the Merger and transactions
contemplated by this Agreement shall be subject to the
reasonable prior review and comment of Parent. All filings by
Parent with the SEC in connection with the transactions
contemplated hereby shall be subject to the reasonable prior
review and comment of the Company.
(c) If, at any time prior to the Merger Effective Time, any
information relating to the Company, Parent or MergerCo or any
of their respective Affiliates, directors or officers is
discovered by the Company, Parent or MergerCo which should be
set forth in an amendment or supplement to the Proxy Statement
or Other Filings, so that the Proxy Statement or Other Filings
would not contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading,
the party that discovers such information shall promptly notify
the other parties and an appropriate amendment or supplement
describing such information shall be filed promptly with the SEC
and, to the extent required by law, disseminated to the
stockholders of the Company.
(d) Notwithstanding any Adverse Recommendation Change, the
Company shall, in accordance with the Company Charter and
Company Bylaws, promptly and duly call, give notice of, convene
and hold, as soon as reasonably practicable following the date
upon which the Proxy Statement is cleared by the SEC, a meeting
of the holders of Company Common Shares and Company Restricted
Shares (the Company Stockholders
Meeting) for the purpose of seeking the Company
Stockholder Approval. The Company Board shall (i) except as
otherwise provided in Section 7.03, recommend
adoption of this Agreement and include in the Proxy Statement
such recommendation and (ii) use its commercially
reasonable efforts to solicit such adoption.
Section 7.02 Access to Information;
Confidentiality.
(a) Upon reasonable prior notice and subject to applicable
Law, from the date hereof until the Merger Effective Time, the
Company shall, and shall cause the Company Subsidiaries and the
officers, directors, employees, auditors, counsel and agents of
the Company and the Company Subsidiaries to, afford Parent and
its officers, directors, employees, auditors, counsel and
agents, following notice from Parent to the Company in
accordance with this Section 7.02, reasonable access
during normal business hours to the officers, employees, agents,
properties, offices and other facilities, books and records of
the Company and the Company Subsidiaries, and all other
financial, operating and other data and information as Parent
may reasonably request. Notwithstanding the foregoing, the
Company and the Company Subsidiaries shall not be obligated to
disclose (i) any competitively sensitive information,
(ii) any information that, in the reasonable judgment of
the Company, would result in the loss of attorney-client
privilege with respect to such information or which would
constitute a waiver of any other
A-27
privilege or trade secret protection held by the Company or any
Company Subsidiary or (iii) any information that would
result in a breach of an agreement to which the Company or any
of the Company Subsidiaries is a party. Parent shall schedule
and coordinate all inspections with the Company and shall give
the Company at least two (2) Business Days prior written
notice thereof, setting forth the inspection or materials that
Parent or its representatives intend to conduct or review, as
applicable. The Company shall be entitled to have
representatives present at all times during any such inspection,
and no such inspection shall unreasonably disrupt or interfere
with the operations of the Company or any Company Subsidiary. No
investigation pursuant to this Section 7.02 or
information provided, made available or delivered to Parent
pursuant to this Section 7.02 or otherwise shall
affect any representations or warranties of the Company or
conditions or rights of Parent contained in this Agreement.
(b) Prior to the Merger Effective Time, all information
obtained by Parent pursuant to this Section 7.02
shall be kept confidential in accordance with the
confidentiality agreement dated April 28, 2008 between
Parent and the Company (the Confidentiality
Agreement).
Section 7.03 No Solicitation of Transactions by the
Company.
(a) During the term of this Agreement, none of the Company
or any Company Subsidiary shall, nor shall it authorize or
permit, directly or indirectly, any officer, trustee, director,
employee, investment banker, financial advisor, attorney,
broker, finder or other agent or representative of the Company
or any Company Subsidiary to, (i) initiate, solicit,
knowingly encourage or knowingly facilitate (including by way of
furnishing nonpublic information or assistance) any inquiries or
the making of any proposal or other action that constitutes, or
may reasonably be expected to lead to, any Company Acquisition
Proposal, (ii) enter into discussions or negotiate with any
Person in furtherance of such inquiries or to obtain a Company
Acquisition Proposal, or (iii) enter into an agreement
(other than a confidentiality agreement entered into in
accordance with the provisions of this Agreement) with respect
to a Company Acquisition Proposal. Notwithstanding the foregoing
or any other provision of this Agreement to the contrary, if at
any time prior to the receipt of the Company Stockholder
Approval, the Company or any Company Subsidiary receives a
Company Acquisition Proposal that was not received in breach or
violation of this Section 7.03(a), the Special
Committee or the Company Board may (directly or through advisors
or representatives) (x) contact such Person and its
advisors for the purpose of clarifying the proposal and any
material terms thereof and the conditions to and likelihood of
consummation, so as to determine whether such proposal is, or is
reasonably likely to lead to, a Company Superior Proposal and
(y) if the Company Board or the Special Committee
determines in good faith after consultation with its legal and
financial advisors that such Company Acquisition Proposal is, or
is reasonably likely to lead to, a Company Superior Proposal,
the Company Board may (1) furnish non-public information
with respect to the Company and the Company Subsidiaries to the
Person who made such Company Acquisition Proposal pursuant to a
confidentiality agreement executed by the Company and such
Person on terms with respect to confidentiality that are at
least as restrictive as the terms of the Confidentiality
Agreement (provided that the Company provides Parent with
notice within thirty six (36) hours of any such furnishing
and that the Company has previously or concurrently furnished
such information to Parent), (2) participate in
negotiations regarding such Company Acquisition Proposal and
(3) following receipt of a Company Acquisition Proposal
that constitutes a Company Superior Proposal, terminate this
Agreement pursuant to, and subject to and only after compliance
with, Section 9.01(f).
(b) The Company Board shall not, directly or indirectly,
(i) (A) withdraw (or amend or modify in a manner adverse to
Parent) or publicly propose to withdraw (or amend or modify in a
manner adverse to Parent), its approval, recommendation or
declaration of advisability of this Agreement, the Merger or the
other transactions contemplated by this Agreement or
(B) recommend, adopt or approve, or propose publicly to
recommend, adopt or approve, any Company Acquisition Proposal
(any action described in this clause (i) being referred to
as an Adverse Recommendation Change) (it
being understood that a stop, look and listen
communication by the Company Board to the Company stockholders
pursuant to
Rule 14d-9(f)
promulgated under the Exchange Act or the taking of a neutral or
no position with respect to any Company Acquisition Proposal
shall not constitute an Adverse Recommendation Change) or
(ii) approve or recommend, or publicly propose to approve
or recommend, or allow the Company or any Company Subsidiary to
execute or enter into, any letter of intent, memorandum of
understanding, agreement in principle, merger agreement,
acquisition agreement, option agreement, joint venture
agreement, partnership agreement or other similar agreement,
arrangement or understanding (other than a confidentiality
agreement referred to in Section 7.03(a))
(A) constituting or that could reasonably be expected to
lead to any Company
A-28
Acquisition Proposal or (B) requiring the Company to
abandon, terminate or fail to consummate the Merger or any other
transaction contemplated by this Agreement; provided that
in the case of
sub-clauses (A)
and (B) of this clause (ii), the Company shall not be
prohibited from entering into an agreement pursuant to, and
subject to and only after compliance with,
Section 9.01(f). Notwithstanding the foregoing or
any other provision of this Agreement to the contrary, at any
time prior to obtaining the Company Stockholder Approval, and
subject to the Companys compliance in all material
respects with the other provisions of this
Section 7.03, as applicable, the Company Board may
make an Adverse Recommendation Change if the Company Board
determines in good faith after consultation with its legal and
financial advisors that failure to take such action would be
inconsistent with its fiduciary duties to the stockholders of
the Company under applicable Law.
(c) The Company shall promptly advise Parent in writing of
any Company Acquisition Proposal (and in no event less than
thirty six (36) hours following the Companys initial
receipt of any Company Acquisition Proposal), the material terms
and conditions of any such Company Acquisition Proposal
(including any changes thereto) and the identity of the Person
making any such Company Acquisition Proposal. The Company shall
keep Parent reasonably informed of the status (including any
change to the material terms and conditions thereof) of any such
Company Acquisition Proposal.
(d) Nothing in this Section 7.03 or elsewhere
in this Agreement shall prevent the Company Board or the Special
Committee from taking and disclosing any position or disclosing
any information required to be disclosed under applicable Law or
from complying with
Rule 14d-9
or
Rule 14e-2(a)
promulgated under the Exchange Act, and to the extent referred
to therein, Item 1012(a) of
Regulation M-A
with respect to a Company Acquisition Proposal. In addition,
nothing in this Section 7.03 or elsewhere in this
Agreement shall prohibit the Company from taking any action that
any court of competent jurisdiction orders the Company to take.
Section 7.04 Employee Benefits Matters.
(a) From and after the Merger Effective Time, Parent shall
honor and shall cause the Surviving Corporation to honor all
Plans, compensation arrangements and agreements and employment,
severance and termination plans and agreements in accordance
with their terms as in effect immediately before the Merger
Effective Time. For a period of one (1) year following the
Merger Effective Time, Parent shall provide, or shall cause to
be provided, to each current employee of the Company and the
Company Subsidiaries while such employee remains employed by the
Company or the Company Subsidiaries (Company
Employees) (i) compensation (including incentive
compensation) no less favorable in the aggregate than the
compensation (including incentive compensation) provided to
Company Employees immediately before the Merger Effective Time
and (ii) employee benefits that are no less favorable, in
the aggregate, than the benefits provided to similarly situated
employees of Parent.
(b) For all purposes (including purposes of vesting,
eligibility to participate and level of benefits) under the
employee benefit plans of Parent and its subsidiaries providing
benefits to any Company Employees after the Merger Effective
Time (the New Plans), each Company Employee
shall, subject to applicable Law and applicable tax
qualification requirements, be credited with his or her years of
service with the Company and the Company Subsidiaries and their
respective predecessors before the Merger Effective Time, to the
same extent as such Company Employee was entitled, before the
Merger Effective Time, to credit for such service under any
similar Company employee benefit plan in which such Company
Employee participated or was eligible to participate immediately
prior to the Merger Effective Time; provided that the
foregoing shall not apply to the extent that its application
would result in a duplication of benefits. In addition, and
without limiting the generality of the foregoing, (i) each
Company Employee shall be immediately eligible to participate,
without any waiting time, in any and all New Plans to the extent
coverage under such New Plan is comparable to coverage under any
Plan in which such Company Employee participated immediately
before the consummation of the Merger (such plans, collectively,
the Old Plans) and (ii) (A) for
purposes of each New Plan providing medical, dental,
pharmaceutical or vision benefits to any Company Employee,
Parent shall cause all pre-existing condition exclusions and
actively-at-work requirements of such New Plan to be waived for
such Company Employee and his or her covered dependents, unless
such conditions would not have been waived under an Old Plan in
which such Company Employee participated immediately prior to
the Merger Effective Time and (B) Parent shall cause any
eligible expenses incurred by such employee and his or her
covered dependents during the portion of the plan year of the
Old Plan ending on the date such employees participation
in the corresponding New Plan begins to be taken into
A-29
account under such New Plan for purposes of satisfying all
deductible, coinsurance and maximum
out-of-pocket
requirements applicable to such employee and his or her covered
dependents for the applicable plan year as if such amounts had
been paid in accordance with such New Plan.
(c) Parent shall, and shall cause the Surviving Corporation
to, honor and abide by Section 7.04(c) of the
Company Disclosure Schedule.
(d) If requested by Parent at least five (5) Business
Days prior to the Closing Date, the Company shall take (or cause
to be taken) all actions, pursuant to resolutions of the Company
Board, necessary or appropriate to terminate, immediately prior
to the Merger Effective Time, any Company Benefit Plan that
contains a cash or deferred arrangement intended to qualify
under Section 401(k) of the Code (a Company 401(k)
Plan). If the Company is required to terminate any
Company 401(k) Plan, then the Company shall provide to Parent
prior to the Closing Date written evidence of the adoption by
the Company Board of resolutions authorizing the termination of
such Company 401(k) Plan (the form and substance of which
resolutions shall be subject to the prior review and approval of
Parent, which approval shall not be unreasonably withheld or
delayed).
(e) This Section 7.04 shall be binding upon and
inure solely to the benefit of each of the parties to this
Agreement, and nothing in this Section 7.04,
expressed or implied, is intended to confer upon any other
person any rights or remedies of any nature whatsoever under or
by reason of this Section 7.04. Without
limiting the foregoing, no provision of this
Section 7.04 will create any third party beneficiary
rights in any current or former employee, director or consultant
of the Company or any Company Subsidiaries in respect of
continued employment (or resumed employment) or any other
matter. Nothing in this Section 7.04 is intended to
amend any Plan or any employee benefit plan, agreement or
arrangement of Parent, or interfere with Parents, the
Companys or any Company Subsidiarys right, as
applicable, from and after the Closing to amend or terminate any
Plan, or any employee benefit plan, agreement or arrangement of
Parent or the employment of, or provision of services by, any
director, employee, independent contractor or consultant.
Section 7.05 Section 16
Matters. Prior to the Merger Effective Time,
the Company Board, or an appropriate committee of non-employee
directors thereof, shall adopt a resolution consistent with the
interpretive guidance of the SEC so that the disposition by any
officer or director of the Company who is a covered person of
the Company for purposes of Section 16 of the Exchange Act
and the rules and regulations thereunder
(Section 16) of Company Common Shares,
Company Stock Options to acquire Company Common Shares (or
Company Common Shares acquired upon the vesting of any Company
Stock Awards) or Company Restricted Shares pursuant to this
Agreement and the Merger shall be an exempt transaction for
purposes of Section 16.
Section 7.06 Directors and Officers
Indemnification and Insurance of the Surviving Corporation.
(a) Without limiting any additional rights that any
director, officer, trustee, employee or agent may have under any
employment or indemnification agreement or under the Company
Charter, Company Bylaws or this Agreement or, if applicable,
similar organizational documents or agreements of any of the
Company Subsidiaries, from and after the Merger Effective Time,
Parent and the Surviving Corporation shall: (i) indemnify
and hold harmless each person who was, is at the date of this
Agreement or becomes during the period from the date of this
Agreement through the Closing Date, (A) a director or
officer of the Company or the Company Subsidiaries, (B) a
director, officer or trustee of another entity (but only to the
extent that such person is or was serving in such capacity at
the request of the Company) or (C) an employee or agent of
the Company or the Company Subsidiaries (but only to the extent
that the Company shall have determined at any time prior to the
date of this Agreement to indemnify
and/or hold
harmless such employees or agents set forth in
Section 7.06(a) of the Company Disclosure Schedule)
(collectively, the Indemnified Parties) to
the fullest extent authorized or permitted by applicable Law
without regard to whether indemnification may be available to
such Indemnified Party from another Person, as now or hereafter
in effect, in connection with any Claim and any judgments,
fines, penalties and amounts paid in settlement (including all
interest, assessments and other charges paid or payable in
connection with or in respect of such judgments, fines,
penalties or amounts paid in settlement) resulting therefrom and
(ii) promptly pay on behalf of or, within thirty
(30) days after any request for advancement, advance to
each of the Indemnified Parties, to the fullest extent
authorized or permitted by applicable Law, as now or hereafter
in effect, any Expenses incurred in defending, serving as a
witness with respect to or otherwise participating in any Claim
in advance of the final disposition of such Claim, including
payment on behalf of or advancement to the Indemnified Party of
any Expenses incurred by
A-30
such Indemnified Party in connection with enforcing any rights
with respect to such indemnification or advancement, in each
case, without the requirement of any bond or other security;
provided that the Person to whom expenses are advanced provides
an undertaking to repay such advances if it is ultimately
determined that such Person is not entitled to indemnification.
The indemnification and advancement obligations of Parent and
the Surviving Corporation pursuant to this
Section 7.06(a) shall extend to acts or omissions
occurring at or before the Merger Effective Time and any Claim
relating thereto (including with respect to any acts or
omissions occurring in connection with the approval of this
Agreement and the consummation of the transactions contemplated
hereby, including the consideration and approval thereof and the
process undertaken in connection therewith and any Claim
relating thereto), and all rights to indemnification and
advancement conferred hereunder shall continue as to a person
who continues to be or who has ceased to be (A) a director
or officer of the Company or the Company Subsidiaries,
(B) a director, officer or trustee of another entity (but
only to the extent that such person is or was serving in such
capacity at the request of the Company) or (C) an employee
or agent of the Company or the Company Subsidiaries (but only to
the extent that the Company shall have determined at any time
prior to the date of this Agreement to indemnify
and/or hold
harmless such employees or agents set forth in
Section 7.06(a) of the Company Disclosure Schedule)
after the date of this Agreement and shall inure to the benefit
of such persons heirs, executors and personal and legal
representatives. Neither Parent nor the Surviving Corporation
shall settle, compromise or consent to the entry of any judgment
in any actual or threatened Action in respect of which
indemnification has been or could be sought by such Indemnified
Party hereunder unless such settlement, compromise or judgment
includes an unconditional release of such Indemnified Party from
all liability arising out of such Action or such Indemnified
Party otherwise consents thereto.
(b) Without limiting the foregoing, Parent and MergerCo
agree that all rights to indemnification, advancement and
exculpation from liabilities for acts or omissions occurring at
or prior to the Merger Effective Time now existing in favor of
any current or former (i) director or officer of the
Company or the Company Subsidiaries, (ii) director, officer
or trustee of another entity (but only to the extent that such
person is or was serving in such capacity at the request of the
Company) or (iii) an employee or agent of the Company or
the Company Subsidiaries (but only to the extent that the
Company shall have determined at any time prior to the date of
this Agreement to indemnify
and/or hold
harmless such employees or agents set forth in
Section 7.06(a) of the Company Disclosure Schedule)
as provided in the Company Charter and Company Bylaws (or, as
applicable, the charter, bylaws, partnership agreement, limited
liability company agreement or other organizational documents of
any of the Company Subsidiaries) and indemnification agreements
of the Company or any of the Company Subsidiaries set forth in
Section 7.06(b) of the Company Disclosure Schedule
shall be assumed by the Surviving Corporation in the Merger,
without further action, at the Merger Effective Time and shall
survive the Merger and shall continue in full force and effect
in accordance with their terms.
(c) For a period of six (6) years from the Merger
Effective Time, the organizational documents of the Surviving
Corporation shall contain provisions no less favorable with
respect to indemnification and advancement than are set forth in
the Company Charter and Company Bylaws, which provisions shall
not be amended, repealed or otherwise modified for a period of
six (6) years from the Merger Effective Time in any manner
that would affect adversely the rights thereunder of the
Indemnified Parties, unless such modification shall be required
by Law and then only to the minimum extent required by Law.
(d) Immediately prior to the Closing, (i) the Company
shall purchase, from an insurer chosen by the Company, a single
payment, run-off policy of directors and officers
liability insurance covering current and former officers and
directors of the Company and the Company Subsidiaries, with
limits of Twenty Million Dollars ($20,000,000) for each claim
and in the aggregate, for a premium not to exceed Four Hundred
Thousand Dollars ($400,000), such policy to become effective at
the Closing and remain in effect for a period of six years after
the Closing and (ii) Parent shall provide for the current
officers and directors of the Company and the Company
Subsidiaries who continue in such capacity after the Closing to
be covered under Parents directors and
officers liability program with the same terms as those
applicable to the officers and directors of Parent and its
subsidiaries.
(e) If the Surviving Corporation or any of its respective
successors or assigns (i) consolidates with or merges with
or into any other person and shall not be the continuing or
surviving corporation, limited liability company, partnership or
other entity of such consolidation or merger or
(ii) transfers or conveys all or substantially all of its
A-31
properties and assets to any person then, and in each such case,
proper provision shall be made so that the successors and
assigns of the Surviving Corporation assume the obligations set
forth in this Section 7.06.
(f) Parent shall cause the Surviving Corporation to perform
all of the obligations of the Surviving Corporation under this
Section 7.06 and the parties acknowledge and agree
that Parent guarantees the payment and performance of the
Surviving Corporations obligations pursuant to this
Section 7.06.
(g) This Section 7.06 is intended for the
irrevocable benefit of, and to grant third party rights to, the
Indemnified Parties and shall be binding on all successors and
assigns of the Company, Parent and the Surviving Corporation.
Each of the Indemnified Parties shall be entitled to enforce the
covenants contained in this Section 7.06.
Section 7.07 Further Action; Best Efforts.
(a) Subject to the terms and conditions herein provided, as
promptly as practicable, the Company, Parent and MergerCo shall
(i) make all filings and submissions under the HSR Act,
(ii) use reasonable best efforts to obtain as promptly as
practicable the termination of any waiting period under the HSR
Act, (iii) use reasonable best efforts to cooperate with
each other in (A) determining which filings are required to
be made prior to the Merger Effective Time with, and which
material consents, approvals, permits, notices or authorizations
are required to be obtained prior to the Merger Effective Time
from, Governmental Authorities in connection with the execution
and delivery of this Agreement and related agreements and
consummation of the transactions contemplated hereby and thereby
and (B) timely making all such filings and timely seeking
all such consents, approvals, permits, notices or
authorizations, and (iv) use reasonable best efforts to
take, or cause to be taken, all other actions and do, or cause
to be done, all other things necessary or appropriate to
consummate the transactions contemplated hereby as soon as
practicable. In connection with the foregoing, the Company, on
the one hand, will provide Parent, and Parent, on the other
hand, will provide the Company, with copies of material
correspondence, filings or communications (or oral summaries or
memoranda setting forth the substance thereof) between such
party or any of its representatives, on the one hand, and any
Governmental Authority or members of their respective staffs, on
the other hand, with respect to this Agreement and the
transactions contemplated hereby. Without limiting any of the
Companys obligations contained in this
Section 7.07(a), Parent and MergerCo shall
coordinate, and assume primary responsibility for managing, any
required continuance of membership or other application, notice
filing or other required submission with the NYSE or any other
self-regulatory agency.
(b) In furtherance and not in limitation of
Section 7.07(a), (i) as soon as reasonably
practicable following the date of this Agreement, the Company
and Parent shall cooperate in all respects with each other and
use (and shall cause their respective subsidiaries to use) their
respective reasonable best efforts to prepare and file with the
relevant insurance regulators requests for approval of the
transactions contemplated by this Agreement and shall use all
reasonable efforts to have such insurance regulators approve the
transactions contemplated by this Agreement, (ii) each
party shall give the other party prompt written notice if it
receives any material notice or other communication from any
insurance regulator in connection with the transactions
contemplated by this Agreement, and, in the case of any such
written notice or communication, shall promptly furnish the
other party with a copy thereof, (iii) all applications and
substantive correspondence with the insurance regulators shall
be approved in advance by the Company (such approval not to be
unreasonably withheld, conditioned or delayed) and
(iv) each party shall have the right to participate in and
shall, to the extent reasonably practicable, receive reasonable
prior notice of, all meetings (telephonic or otherwise) of the
other party with any insurance regulators in respect of the
transactions contemplated by this Agreement.
(c) For purposes of this Section 7.07,
reasonable best efforts shall include
(i) executing settlements, undertakings, consent decrees,
stipulations or other agreements, (ii) selling, divesting,
holding separate or otherwise conveying any particular assets or
categories of assets or businesses of Parent,
(iii) agreeing to sell, divest, hold separate or otherwise
convey any particular assets or categories of assets or
businesses of the Company contemporaneously with or subsequent
to the Closing, (iv) permitting the Company to sell,
divest, hold separate or otherwise convey any particular assets
or categories of assets or businesses of the Company prior to
the Closing, and (v) otherwise taking or committing to take
actions that after the Closing Date would limit the freedom of
action of Parent or its Subsidiaries (including the Surviving
Corporation) with respect to, or its or their ability to retain,
one or more of its or their businesses, product lines or assets,
in each case as may be required in order to avoid the entry of,
A-32
or to effect the dissolution of, any injunction, temporary
restraining order or other order in any suit or proceeding which
would otherwise have the effect of preventing or materially
delaying the Closing.
Section 7.08 Public
Announcements. The parties hereto agree that
no public release or announcement concerning the Merger or the
transactions contemplated by this Agreement shall be issued by a
party without the prior written consent of the other parties
(which consent shall not be unreasonably withheld, delayed or
conditioned), except as such release or announcement may be
required by Law or the rules or regulations of any securities
exchange, in which case the party required to make the release
or announcement shall use its commercially reasonable efforts to
allow the other parties reasonable time to comment on such
release or announcement in advance of such issuance. The parties
have agreed upon the form of a joint press release announcing
the Merger and the execution of this Agreement. Notwithstanding
the foregoing, the Company shall not be required to obtain the
consent of Parent or MergerCo in connection with, or provide
Parent or MergerCo the opportunity to comment on, any public
announcement regarding a Company Acquisition Proposal.
Section 7.09 State Takeover Laws. If
any fair price, business combination or
control share acquisition statute or other similar
statute or regulation is or may become applicable to any
transaction contemplated by this Agreement, the parties shall
use commercially reasonable efforts to (a) take such
actions as are reasonably necessary so that the transactions
contemplated hereunder may be consummated as promptly as
practicable on the terms contemplated hereby and
(b) otherwise take all such actions as are reasonably
necessary to eliminate or minimize the effects of any such
statute or regulation on such transaction.
ARTICLE VIII
CONDITIONS
TO THE MERGER
Section 8.01 Conditions to the Obligations of Each
Party. The obligations of the Company, Parent
and MergerCo to consummate the Merger are subject to the
satisfaction or waiver in writing at or prior to the Merger
Effective Time of the following conditions:
(a) The Company Stockholder Approval shall have been
obtained by the Company;
(b) Any waiting period (and any extension thereof)
applicable to the consummation of the Merger under the HSR Act
shall have expired or been terminated, and any approvals
required thereunder shall have been obtained;
(c) No Governmental Authority shall have enacted, issued,
promulgated, enforced or entered any injunction, order, decree
or ruling (whether temporary, preliminary or permanent) which is
then in effect and has the effect of making consummation of the
Merger illegal or prohibiting consummation of the
Merger; and
(d) The Transaction Insurance Approvals shall have been
obtained and the waiting periods applicable thereto shall have
terminated or expired.
Section 8.02 Conditions to the Obligations of Parent and
MergerCo. The obligations of Parent and
MergerCo to consummate the Merger are subject to the
satisfaction or waiver by Parent in writing at or prior to the
Merger Effective Time of the following additional conditions:
(a) The representations and warranties of the Company
contained in this Agreement that (i) are not made as of a
specific date shall be true and correct as of the date of this
Agreement and as of the Closing, as though made on and as of the
Closing, and (ii) are made as of a specific date shall be
true and correct as of such date, in each case, except where the
failure of such representations or warranties to be true and
correct (without giving effect to any limitation as to
materiality or Material Adverse Effect
set forth in such representations and warranties (other than the
representation in Section 4.08(b)) has not had and
would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect; provided,
however, that notwithstanding the foregoing, the
representations and warranties of the Company contained in
Section 4.01(a), Section 4.04 and
Section 4.08(b) shall be true and correct in all
respects, in each case, as of the date of this Agreement and as
of the Closing, as though made on and as of the Closing (except
to the extent expressly made as of an earlier date, in which
case as of such earlier date);
A-33
(b) The Company shall have performed, in all material
respects, all obligations and complied with, in all material
respects, its agreements and covenants to be performed or
complied with by it under this Agreement on or prior to the
Merger Effective Time; and
(c) The Company shall have delivered to Parent a
certificate, dated as of the Closing Date, signed by an
executive officer of the Company, and certifying as to the
satisfaction by the Company, of the applicable conditions
specified in Section 8.02(a) and
Section 8.02(b).
Section 8.03 Conditions to the Obligations of the
Company. The obligation of the Company to
consummate the Merger is subject to the satisfaction or waiver
by the Company in writing at or prior to the Merger Effective
Time of the following additional conditions:
(a) The representations and warranties of Parent and
MergerCo contained in this Agreement that (i) are not made
as of a specific date shall be true and correct as of the date
of this Agreement and as of the Closing, as though made on and
as of the Closing, and (ii) are made as of a specific date
shall be true and correct as of such date, in each case, except
where the failure of such representations or warranties to be
true and correct (without giving effect to any limitation as to
materiality or Parent Material Adverse
Effect set forth in such representations and warranties)
has not had and would not reasonably be expected to have,
individually or in the aggregate, a Parent Material Adverse
Effect;
(b) Each of Parent and MergerCo shall have performed, in
all material respects, all obligations and complied with, in all
material respects, its agreements and covenants to be performed
or complied with by it under this Agreement on or prior to the
Merger Effective Time; and
(c) Parent shall have delivered to the Company a
certificate, dated as of the Closing Date, signed by an officer
of Parent and certifying as to the satisfaction of the
conditions specified in Section 8.03(a) and
Section 8.03(b).
Section 8.04 Frustration of
Conditions. None of the Company, Parent or
MergerCo may rely on the failure of any condition set forth in
Section 8.01, Section 8.02 or
Section 8.03, as the case may be, to be satisfied if
such failure was caused by such partys failure to act in
good faith or to use its reasonable best efforts to consummate
the Merger and the other transactions contemplated by this
Agreement, as required by and subject to
Section 7.07.
ARTICLE IX
TERMINATION,
AMENDMENT AND WAIVER
Section 9.01 Termination. This
Agreement may be terminated and the Merger may be abandoned at
any time prior to the Merger Effective Time whether before or
after the stockholders of the Company have approved the Merger
at the Company Stockholders Meeting, as follows (the date
of any such termination, the Termination
Date):
(a) by mutual written consent of Parent and the Company;
(b) by either Parent or the Company if the Closing shall
not have occurred on or before March 27, 2009 (as such date
may be extended pursuant to the immediate following provision,
the Outside Date); provided,
that if, as of the Outside Date, all conditions set forth in
Section 8.01, Section 8.02 and
Section 8.03 shall have been satisfied or waived
(other than conditions which by their terms are required to be
satisfied or waived at the Closing) other than the conditions
set forth in Section 8.01(b) or
Section 8.01(d), then either the Company or Parent
may extend the Outside Date until the date that is 3 months
from the initial Outside Date by providing written notice to the
other party; provided, however, that the right to
terminate this Agreement under this Section 9.01(b)
shall not be available to a party whose failure to fulfill any
obligation under this Agreement materially contributed to the
failure of the Merger Effective Time to occur on or before such
date;
(c) by either Parent or the Company if any Governmental
Authority shall have enacted, issued, promulgated, enforced or
entered any injunction, order, decree or ruling or taken any
other action (including the failure to have taken an action)
which, in either such case, has the effect of making
consummation of the Merger illegal or otherwise preventing or
prohibiting consummation of the Merger (Governmental
Order), which Governmental Order shall have become
final and non-appealable; provided, however, that
the terms of this Section 9.01(c) shall
A-34
not be available to any party unless such party shall have used
its reasonable best efforts to oppose any such Governmental
Order or to have such Governmental Order vacated or made
inapplicable to the Merger;
(d) by either Parent or the Company if the Company
Stockholder Approval shall not have been obtained at the Company
Stockholders Meeting; provided, however,
that the right to terminate this Agreement under this
Section 9.01(d) shall not be available to the
Company where the failure to obtain the Company Stockholder
Approval is caused by any action or failure to act of the
Company that constitutes a material breach of this Agreement;
(e) by Parent if an Adverse Recommendation Change shall
have occurred and Parent shall have exercised its right to
terminate this Agreement pursuant to this
Section 9.01(e) within ten (10) Business Days
of obtaining actual knowledge of such occurrence; or
(f) by action of the Company Board, if at any time prior to
receipt of the Company Stockholder Approval, (i) the
Company Board or the Special Committee has received a Company
Superior Proposal, (ii) the Company is in compliance in all
material respects with Section 7.03, (iii) the
Company shall have first given Parent at least three
(3) Business Days prior written notice of its intent to
terminate this Agreement pursuant to this subsection and to
enter into a definitive agreement with respect to such Company
Superior Proposal (indicating in such notice the most recent
material terms and conditions of such Company Superior Proposal)
(a Superior Proposal Notice), and during
the three (3) Business Day period immediately following the
delivery of such Superior Proposal Notice, the Company
negotiates, or offers to negotiate, with Parent to make such
adjustments to the terms and conditions of this Agreement as
would enable the Company, Parent and MergerCo to proceed with
the transactions contemplated herein on such adjusted terms,
(iv) after taking into account any such adjustments, the
Company Board determines in good faith that the Company Superior
Proposal described in the Superior Proposal Notice
continues to constitute a Company Superior Proposal
(provided that any amendment, supplement or modification
to the financial terms or other material terms of any Company
Superior Proposal shall be deemed a new Company Superior
Proposal and the Company may not terminate this Agreement
pursuant to this Section 9.01(f) unless the Company
has complied with the requirements of this
Section 9.01(f) with respect to such new Company
Superior Proposal, including sending a Superior
Proposal Notice with respect to such new Company Superior
Proposal and offering to negotiate for a three (3) Business
Day period from the delivery of such new Superior
Proposal Notice), (v) the Company pays to Parent the
Termination Fee in accordance with
Section 9.03(b)(i) concurrently with or prior to
such termination and (vi) the Company Board concurrently
approves, and the Company concurrently enters into, a definitive
agreement providing for the implementation of such Company
Superior Proposal.
Section 9.02 Effect of
Termination. In the event of the termination
of this Agreement pursuant to Section 9.01, this
Agreement shall forthwith become void, and there shall be no
liability under this Agreement on the part of any party hereto
except that the provisions of Section 7.02(b), this
Section 9.02, Section 9.03 and
Article X shall survive any such termination;
provided, however, that, subject to
Section 9.03(e), nothing herein shall relieve any
party hereto from any liabilities or damages (which the parties
acknowledge and agree shall not be limited to reimbursement of
expenses or
out-of-pocket
costs, and may include the benefit of the bargain lost by a
partys stockholders (taking into consideration relevant
matters, including the total amount payable to such stockholders
under this Agreement, lost combination opportunities and the
time value of money), which shall be deemed in such event to be
damages of such party) arising out of its willful and material
breach of any provision of this Agreement or fraud.
Section 9.03 Fees and Expenses.
(a) Except as otherwise set forth in this
Section 9.03, all expenses incurred in connection
with this Agreement shall be paid by the party incurring such
expenses, whether or not the Merger is consummated.
(b) In the event this Agreement shall be terminated:
(i) by the Company pursuant to Section 9.01(f),
the Company shall pay to Parent the Termination Fee; or
(ii) by Parent or the Company pursuant to
Section 9.01(d) and Alleghany Insurance Holdings,
LLC shall have voted the Company Common Shares subject to the
Voting Agreement in favor of the Merger in
A-35
compliance with Section 1.01(A) of the Voting Agreement,
the Company shall pay to Parent the Termination Fee; or
(iii) by Parent pursuant to Section 9.01(e),
the Company shall pay to Parent the Termination Fee.
(c) Except as set forth in Section 9.01(f), the
Termination Fee shall be paid by the Company as directed by
Parent in writing in immediately available funds within three
(3) Business Days after the date of the event giving rise
to the obligation to make such payment.
(d) For purposes of this Agreement, Termination
Fee means Sixteen Million Five Hundred Thousand
Dollars ($16,500,000).
(e) Each of the Company and Parent acknowledges and agrees
that in the event that Parent is entitled to receive and
actually receives the Termination Fee pursuant to this
Agreement, Parents receipt of the Termination Fee shall
constitute each of the Buyer Parties sole and exclusive
remedy for, and such amount shall constitute liquidated damages
in respect of, any termination of this Agreement regardless of
the circumstances giving rise to such termination.
(f) Each of Parent, MergerCo and the Company shall bear its
own expenses in connection with this Agreement and the
transactions contemplated hereby, except that Parent and the
Company shall each bear and pay one-half of the costs and
expenses incurred in connection with filings and submissions
under the HSR Act and the filing, printing and mailing of the
Proxy Statement.
Section 9.04 Waiver. At any time
prior to the Merger Effective Time, the Company, on the one
hand, and Parent and MergerCo, on the other hand, may
(a) extend the time for the performance of any obligation
or other act of the other party, (b) waive any inaccuracy
in the representations and warranties of the other party
contained herein or in any document delivered pursuant hereto,
and (c) waive compliance with any agreement of the other
party or any condition to its own obligations contained herein.
Any such extension or waiver shall be valid if set forth in an
instrument in writing signed by the Company or Parent (on behalf
of Parent and MergerCo). The failure of any party to assert any
of its rights under this Agreement or otherwise shall not
constitute a waiver of those rights.
ARTICLE X
GENERAL
PROVISIONS
Section 10.01 Non-Survival of Representations and
Warranties. The representations, warranties,
covenants and agreements in this Agreement and in any
certificate delivered pursuant hereto shall terminate at the
Merger Effective Time, except for (a) those covenants and
agreements contained herein that by their terms apply or are to
be performed in whole or in part after the Merger Effective Time
and (b) this Article X.
Section 10.02 Notices. All notices,
requests, claims, demands and other communications hereunder
shall be in writing and shall be given (and shall be deemed to
have been duly given upon receipt) by delivery in person, by
prepaid overnight courier (providing proof of delivery), by
facsimile or by registered or certified mail (postage prepaid,
return receipt requested) to the respective parties at the
following addresses or facsimile numbers (or at such other
address for a party as shall be specified in a notice given in
accordance with this Section 10.02):
if to Parent or MergerCo:
Allied World Assurance Company Holdings, Ltd
27 Richmond Road
Pembroke HM 08, Bermuda
Facsimile No:
441-295-5117
Attention: Wesley D. Dupont, General Counsel
A-36
with a copy to:
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019
Facsimile No:
(212) 728-9763
Attention: Steven A. Seidman, Esq.
if to the Company:
Darwin Professional Underwriters, Inc.
9 Farm Springs Road
Farmington, CT 06032
Facsimile No:
860-284-1301
Attention: Mark I. Rosen, General Counsel
with copies to:
Dewey & LeBoeuf LLP
1301 Avenue of the Americas
New York, NY 10019
Facsimile No:
(212) 259-6333
|
|
|
|
Attention:
|
Morton A. Pierce, Esq.
|
James A. FitzPatrick, Jr., Esq.
Cleary Gottlieb Steen & Hamilton LLP
One Liberty Plaza
New York, NY 10006
Facsimile No:
(212) 225-3999
Attention: Christopher E. Austin, Esq.
Section 10.03 Severability. If any
term or other provision of this Agreement is invalid, illegal or
incapable of being enforced by any rule of law or public policy
or the application of this Agreement to any person or
circumstance is invalid or incapable of being enforced by any
rule of law or public policy, all other conditions and
provisions of this Agreement shall nevertheless remain in full
force and effect so long as the economic or legal substance of
the transactions contemplated by this Agreement is not affected
in any manner materially adverse to any party. To such end, the
provisions of this Agreement are agreed to be severable. Upon
such determination that any term or other provision is invalid,
illegal or incapable of being enforced, the parties hereto shall
negotiate in good faith to modify this Agreement so as to effect
the original intent of the parties as closely as possible in a
mutually acceptable manner in order that the transactions
contemplated by this Agreement be consummated as originally
contemplated to the fullest extent possible.
Section 10.04 Amendment. This
Agreement may be amended by the parties hereto by action taken
by their respective boards of directors (or similar governing
bodies or entities) at any time prior to the Merger Effective
Time; provided, however, that, after approval of
the Merger by the stockholders of the Company, no amendment may
be made without further stockholder approval which, by Law or in
accordance with the rules of the NYSE, requires further approval
by such stockholders. This Agreement may not be amended except
by an instrument in writing signed by the parties hereto.
Section 10.05 Entire Agreement;
Assignment. This Agreement, together with the
Confidentiality Agreement, the Disclosure Schedules and the
Exhibits hereto, constitute the entire agreement among the
parties with respect to the subject matter hereof, and supersede
all prior agreements and undertakings, both written and oral,
among the parties, or any of them, with respect to the subject
matter hereof. This Agreement shall not be assigned (whether
pursuant to a merger, by operation of law or otherwise).
Section 10.06 Performance
Guaranty. Parent hereby guarantees the due,
prompt and faithful performance and discharge by, and compliance
with, all of the obligations covenants, terms, conditions and
undertakings of each of the Buyer Parties under this agreement
in accordance with the terms of this Agreement including any
such
A-37
obligations, covenants, terms, conditions and undertakings that
are required to be performed, discharged or complied with
following the Merger Effective Time.
Section 10.07 Specific
Performance. Subject to
Section 9.03(e), the parties hereto agree that
irreparable damage would occur in the event any provision of
this Agreement were not performed in accordance with the terms
of this Agreement and that money damages would not be a
sufficient remedy for any breach of this Agreement, and
accordingly, the parties hereto shall be entitled to specific
performance of the terms of this Agreement, in addition to any
other remedy at law or equity.
Section 10.08 Parties in
Interest. This Agreement shall be binding
upon and inure solely to the benefit of each party hereto, and
nothing in this Agreement, express or implied, is intended to or
shall confer upon any other person any right, benefit or remedy
of any nature whatsoever under or by reason of this Agreement,
other than (a) the provisions of Section 7.06
(which are intended to be for the benefit of the persons covered
thereby or the persons entitled to payment thereunder and may be
enforced by such persons), (b) following the Merger
Effective Time, the provisions of Article III (which
are intended to be for the benefit of the persons covered
thereby or the persons entitled to payment thereunder and may be
enforced by such persons) and (c) the right of the Company,
on behalf of its stockholders, to pursue damages in the event of
Parents or MergerCos breach of this Agreement or
fraud, which right is hereby acknowledged and agreed by Parent
and MergerCo.
Section 10.09 Governing Law; Forum.
(a) All disputes, claims or controversies arising out of or
relating to this Agreement, or the negotiation, validity or
performance of this Agreement, or the transactions contemplated
hereby shall be governed by and construed in accordance with the
laws of the State of Delaware without regard to its rules of
conflict of laws.
(b) Except as set out below, each of the Company, Parent
and MergerCo hereby irrevocably and unconditionally consents to
submit to the sole and exclusive jurisdiction of the courts of
the State of Delaware or any court of the United States located
in the State of Delaware (the Delaware
Courts) for any litigation arising out of or relating
to this Agreement, or the negotiation, validity or performance
of this Agreement, or the transactions contemplated hereby (and
agrees not to commence any litigation relating thereto except in
such courts), waives any objection to the laying of venue of any
such litigation in the Delaware Courts and agrees not to plead
or claim in any Delaware Court that such litigation brought
therein has been brought in any inconvenient forum. Each of the
parties hereto agrees, (i) to the extent such party is not
otherwise subject to service of process in the State of
Delaware, to appoint and maintain an agent in the State of
Delaware as such partys agent for acceptance of legal
process, and (ii) that service of process may also be made
on such party by prepaid certified mail with a proof of mailing
receipt validated by the United States Postal Service
constituting evidence of valid service. Service made pursuant to
(i) or (ii) above shall have the same legal force and
effect as if served upon such party personally within the State
of Delaware. For purposes of implementing the parties
agreement to appoint and maintain an agent for service of
process in the State of Delaware, each of Parent and MergerCo
does hereby appoint CT Corporation as such agent and the Company
does hereby appoint Corporation Service Corporation as such
agent.
Section 10.10 Waiver of Jury
Trial. Each of the parties hereto hereby
waives to the fullest extent permitted by applicable Law any
right it may have to a trial by jury with respect to any
litigation directly or indirectly arising out of, under or in
connection with this Agreement or the transactions contemplated
by this Agreement. Each of the parties hereto (a) certifies
that no representative, agent or attorney of any other party has
represented, expressly or otherwise, that such other party would
not, in the event of litigation, seek to enforce that foregoing
waiver and (b) acknowledges that it and the other party
hereto have been induced to enter into this Agreement and the
transactions contemplated by this Agreement, as applicable, by,
among other things, the mutual waivers and certifications in
this Section 10.10.
Section 10.11 Headings. The descriptive
headings contained in this Agreement are included for
convenience of reference only and shall not affect in any way
the meaning or interpretation of this Agreement.
Section 10.12 Counterparts. This
Agreement may be executed and delivered (including by facsimile
transmission) in two or more counterparts, and by the different
parties hereto in separate counterparts, each of which when
executed shall be deemed to be an original but all of which
taken together shall constitute one and the same agreement.
A-38
Section 10.13 Waiver. Except as
provided in this Agreement, no action taken pursuant to this
Agreement, including, without limitation, any investigation by
or on behalf of any party, shall be deemed to constitute a
waiver by the party taking such action of compliance with any
representations, warranties, covenants or agreements contained
in this Agreement. The waiver by any party hereto of a breach of
any provision hereunder shall not operate or be construed as a
waiver of any prior or subsequent breach of the same or any
other provision hereunder.
IN WITNESS WHEREOF, Parent, MergerCo, and the Company have
caused this Agreement to be executed as of the date first
written above by their respective officers thereunto duly
authorized.
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, LTD
|
|
|
|
By
|
/s/ Scott
A. Carmilani
|
Name: Scott A. Carmilani
|
|
|
|
Title:
|
President and Chief Executive Officer
|
Name: Wesley D. Dupont
|
|
|
|
Title:
|
Senior Vice President, General Counsel & Secretary
|
ALLIED WORLD MERGER COMPANY
|
|
|
|
By
|
/s/ Scott
A. Carmilani
|
Name: Scott A. Carmilani
Name: Wesley D. Dupont
DARWIN PROFESSIONAL UNDERWRITERS, INC.
Name: Stephen J. Sills
|
|
|
|
Title:
|
President, Chairman & CEO
|
A-39
Annex B
June 27, 2008
The Special Committee of the Board of Directors and the Board of
Directors
Darwin Professional Underwriters, Inc.
9 Farm Spring Road
Farmington, Connecticut 06032
Dear Members of the Special Committee and Members of the Board
of Directors:
We understand that Darwin Professional Underwriters, Inc., a
Delaware corporation (the Company), is considering a
transaction whereby Allied World Assurance Company Holdings
Ltd., a Bermuda limited company (Parent), will
acquire the Company. Pursuant to the terms of an Agreement and
Plan of Merger, draft dated June 26, 2008 (the
Agreement), among the Company, Parent and Allied
World Merger Company, a Delaware corporation and wholly owned
subsidiary of Parent (MergerCo), MergerCo will merge
with and into the Company, and the Company will become a wholly
owned subsidiary of Parent (the Transaction).
Pursuant to the terms of the Agreement, each of the issued and
outstanding shares of the common stock, par value of $0.01 per
share, of the Company (Company Common Stock), will
be converted into the right to receive $32.00 (the
Consideration). The terms and conditions of the
Transaction are more fully set forth in the Agreement.
You have requested our opinion as to the fairness, from a
financial point of view, to the holders of Company Common Stock
(other than Alleghany Corporation, its subsidiary Alleghany
Insurance Holdings LLC or any of their respective affiliates
(collectively, Alleghany)) of the Consideration to
be received by such holders in the Transaction.
UBS Securities LLC (UBS) has acted as financial
advisor to the Special Committee of the Board of Directors of
the Company (the Special Committee) in connection
with the Transaction and will receive a fee for its services, a
portion of which is payable in connection with this opinion and
a significant portion of which is contingent upon consummation
of the Transaction. In the ordinary course of business, UBS and
its affiliates may hold or trade, for their own accounts and the
accounts of their customers, securities of the Company, Parent
and Alleghany Corporation and, accordingly, may at any time hold
a long or short position in such securities. The issuance of
this opinion was approved by an authorized committee of UBS.
Our opinion does not address the relative merits of the
Transaction as compared to other business strategies or
transactions that might be available with respect to the Company
or the Companys underlying business decision to effect the
Transaction. Our opinion does not constitute a recommendation to
any shareholder as to how such shareholder should vote or act
with respect to the Transaction. At your direction, we have not
been asked to, nor do we, offer any opinion as to the terms,
other than the Consideration to the extent expressly specified
herein, of the Agreement or any related documents or the form of
the Transaction. In addition, we express no opinion as to the
fairness of the amount or nature of any compensation to be
received by any officers, directors or employees of any parties
to the Transaction, or any class of such persons, relative to
the Consideration. In rendering this opinion, we have assumed,
with your consent, that (i) the final executed form of the
Agreement will not differ in any material respect from the draft
that we have reviewed, (ii) Parent and the Company will
comply with all material terms of the Agreement, and
(iii) the Transaction will be consummated in accordance
with the terms of the Agreement without any adverse waiver or
amendment of any material term or condition thereof.
In arriving at our opinion, we have, among other things:
(i) reviewed certain publicly available business and
financial information relating to the Company;
(ii) reviewed certain internal financial information and
other data relating to the business and financial prospects of
the Company that were provided to us by the management of the
Company and not publicly available, including financial
forecasts and estimates prepared by the management of the
B-1
Company that you have directed us to utilize for purposes of our
analysis; (iii) conducted discussions with members of the
senior management of the Company concerning the business and
financial prospects of the Company; (iv) reviewed publicly
available financial and stock market data with respect to
certain other companies we believe to be generally relevant;
(v) compared the financial terms of the Transaction with
the publicly available financial terms of certain other
transactions we believe to be generally relevant;
(vi) reviewed current and historical market prices of
Company Common Stock; (vii) reviewed the Agreement; and
(viii) conducted such other financial studies, analyses and
investigations, and considered such other information, as we
deemed necessary or appropriate. At your request, we have
contacted third parties to solicit indications of interest in a
possible transaction with the Company and held discussions with
certain of these parties prior to the date hereof.
In connection with our review, with your consent, we have
assumed and relied upon, without independent verification, the
accuracy and completeness in all material respects of the
information provided to or reviewed by us for the purpose of
this opinion. In addition, with your consent, we have not made
any independent evaluation or appraisal of any of the assets or
liabilities (contingent or otherwise) of the Company, nor have
we been furnished with any such evaluation or appraisal. With
respect to the financial forecasts and estimates referred to
above, we have assumed, at your direction, that they have been
reasonably prepared on a basis reflecting the best currently
available estimates and judgments of the management of the
Company as to the future financial performance of the Company.
Our opinion is necessarily based on economic, monetary, market
and other conditions as in effect on, and the information
available to us as of, the date hereof.
Based upon and subject to the foregoing, it is our opinion that,
as of the date hereof, the Consideration to be received by the
holders of Company Common Stock (other than Alleghany) in the
Transaction is fair, from a financial point of view, to such
holders.
This opinion is provided for the benefit of the Special
Committee and the Board of Directors in connection with, and for
the purpose of, their evaluation of the Transaction.
Very truly yours,
UBS SECURITIES LLC
B-2
Annex C
Delaware
General Corporation Law
§
262. Appraisal rights.
(a) Any stockholder of a corporation of this State who
holds shares of stock on the date of the making of a demand
pursuant to subsection (d) of this section with respect to
such shares, who continuously holds such shares through the
effective date of the merger or consolidation, who has otherwise
complied with subsection (d) of this section and who has
neither voted in favor of the merger or consolidation nor
consented thereto in writing pursuant to § 228 of this
title shall be entitled to an appraisal by the Court of Chancery
of the fair value of the stockholders shares of stock
under the circumstances described in subsections (b) and
(c) of this section. As used in this section, the word
stockholder means a holder of record of stock in a
stock corporation and also a member of record of a nonstock
corporation; the words stock and share
mean and include what is ordinarily meant by those words and
also membership or membership interest of a member of a nonstock
corporation; and the words depository receipt mean a
receipt or other instrument issued by a depository representing
an interest in one or more shares, or fractions thereof, solely
of stock of a corporation, which stock is deposited with the
depository.
(b) Appraisal rights shall be available for the shares of
any class or series of stock of a constituent corporation in a
merger or consolidation to be effected pursuant to § 251
(other than a merger effected pursuant to § 251(g) of this
title), § 252, § 254, § 257, § 258, §
263 or § 264 of this title:
(1) Provided, however, that no appraisal rights under this
section shall be available for the shares of any class or series
of stock, which stock, or depository receipts in respect
thereof, at the record date fixed to determine the stockholders
entitled to receive notice of and to vote at the meeting of
stockholders to act upon the agreement of merger or
consolidation, were either (i) listed on a national
securities exchange or (ii) held of record by more than
2,000 holders; and further provided that no appraisal rights
shall be available for any shares of stock of the constituent
corporation surviving a merger if the merger did not require for
its approval the vote of the stockholders of the surviving
corporation as provided in subsection (f) of § 251 of
this title.
(2) Notwithstanding paragraph (1) of this subsection,
appraisal rights under this section shall be available for the
shares of any class or series of stock of a constituent
corporation if the holders thereof are required by the terms of
an agreement of merger or consolidation pursuant to §§
251, 252, 254, 257, 258, 263 and 264 of this title to accept for
such stock anything except:
a. Shares of stock of the corporation surviving or
resulting from such merger or consolidation, or depository
receipts in respect thereof;
b. Shares of stock of any other corporation, or depository
receipts in respect thereof, which shares of stock (or
depository receipts in respect thereof) or depository receipts
at the effective date of the merger or consolidation will be
either listed on a national securities exchange or held of
record by more than 2,000 holders;
c. Cash in lieu of fractional shares or fractional
depository receipts described in the foregoing subparagraphs a.
and b. of this paragraph; or
d. Any combination of the shares of stock, depository
receipts and cash in lieu of fractional shares or fractional
depository receipts described in the foregoing subparagraphs a.,
b. and c. of this paragraph.
(3) In the event all of the stock of a subsidiary Delaware
corporation party to a merger effected under § 253 of
this title is not owned by the parent corporation immediately
prior to the merger, appraisal rights shall be available for the
shares of the subsidiary Delaware corporation.
(c) Any corporation may provide in its certificate of
incorporation that appraisal rights under this section shall be
available for the shares of any class or series of its stock as
a result of an amendment to its certificate of incorporation,
any merger or consolidation in which the corporation is a
constituent corporation or the sale of all or substantially all
of the assets of the corporation. If the certificate of
incorporation contains such a provision, the procedures of this
section, including those set forth in subsections (d) and
(e) of this section, shall apply as nearly as is
practicable.
C-1
(d) Appraisal rights shall be perfected as follows:
(1) If a proposed merger or consolidation for which
appraisal rights are provided under this section is to be
submitted for approval at a meeting of stockholders, the
corporation, not less than 20 days prior to the meeting,
shall notify each of its stockholders who was such on the record
date for such meeting with respect to shares for which appraisal
rights are available pursuant to subsection (b) or
(c) hereof that appraisal rights are available for any or
all of the shares of the constituent corporations, and shall
include in such notice a copy of this section. Each stockholder
electing to demand the appraisal of such stockholders
shares shall deliver to the corporation, before the taking of
the vote on the merger or consolidation, a written demand for
appraisal of such stockholders shares. Such demand will be
sufficient if it reasonably informs the corporation of the
identity of the stockholder and that the stockholder intends
thereby to demand the appraisal of such stockholders
shares. A proxy or vote against the merger or consolidation
shall not constitute such a demand. A stockholder electing to
take such action must do so by a separate written demand as
herein provided. Within 10 days after the effective date of
such merger or consolidation, the surviving or resulting
corporation shall notify each stockholder of each constituent
corporation who has complied with this subsection and has not
voted in favor of or consented to the merger or consolidation of
the date that the merger or consolidation has become effective;
or
(2) If the merger or consolidation was approved pursuant to
§ 228 or § 253 of this title, then either a
constituent corporation before the effective date of the merger
or consolidation or the surviving or resulting corporation
within 10 days thereafter shall notify each of the holders
of any class or series of stock of such constituent corporation
who are entitled to appraisal rights of the approval of the
merger or consolidation and that appraisal rights are available
for any or all shares of such class or series of stock of such
constituent corporation, and shall include in such notice a copy
of this section. Such notice may, and, if given on or after the
effective date of the merger or consolidation, shall, also
notify such stockholders of the effective date of the merger or
consolidation. Any stockholder entitled to appraisal rights may,
within 20 days after the date of mailing of such notice,
demand in writing from the surviving or resulting corporation
the appraisal of such holders shares. Such demand will be
sufficient if it reasonably informs the corporation of the
identity of the stockholder and that the stockholder intends
thereby to demand the appraisal of such holders shares. If
such notice did not notify stockholders of the effective date of
the merger or consolidation, either (i) each such
constituent corporation shall send a second notice before the
effective date of the merger or consolidation notifying each of
the holders of any class or series of stock of such constituent
corporation that are entitled to appraisal rights of the
effective date of the merger or consolidation or (ii) the
surviving or resulting corporation shall send such a second
notice to all such holders on or within 10 days after such
effective date; provided, however, that if such second notice is
sent more than 20 days following the sending of the first
notice, such second notice need only be sent to each stockholder
who is entitled to appraisal rights and who has demanded
appraisal of such holders shares in accordance with this
subsection. An affidavit of the secretary or assistant secretary
or of the transfer agent of the corporation that is required to
give either notice that such notice has been given shall, in the
absence of fraud, be prima facie evidence of the facts stated
therein. For purposes of determining the stockholders entitled
to receive either notice, each constituent corporation may fix,
in advance, a record date that shall be not more than
10 days prior to the date the notice is given, provided,
that if the notice is given on or after the effective date of
the merger or consolidation, the record date shall be such
effective date. If no record date is fixed and the notice is
given prior to the effective date, the record date shall be the
close of business on the day next preceding the day on which the
notice is given.
(e) Within 120 days after the effective date of the
merger or consolidation, the surviving or resulting corporation
or any stockholder who has complied with subsections
(a) and (d) of this section hereof and who is
otherwise entitled to appraisal rights, may commence an
appraisal proceeding by filing a petition in the Court of
Chancery demanding a determination of the value of the stock of
all such stockholders. Notwithstanding the foregoing, at any
time within 60 days after the effective date of the merger
or consolidation, any stockholder who has not commenced an
appraisal proceeding or joined that proceeding as a named party
shall have the right to withdraw such stockholders demand
for appraisal and to accept the terms offered upon the merger or
consolidation. Within 120 days after the effective date of
the merger or consolidation, any stockholder who has complied
with the requirements of subsections (a) and (d) of
this section hereof, upon written request, shall be entitled to
receive from
C-2
the corporation surviving the merger or resulting from the
consolidation a statement setting forth the aggregate number of
shares not voted in favor of the merger or consolidation and
with respect to which demands for appraisal have been received
and the aggregate number of holders of such shares. Such written
statement shall be mailed to the stockholder within 10 days
after such stockholders written request for such a
statement is received by the surviving or resulting corporation
or within 10 days after expiration of the period for
delivery of demands for appraisal under subsection (d) of
this section hereof, whichever is later. Notwithstanding
subsection (a) of this section, a person who is the
beneficial owner of shares of such stock held either in a voting
trust or by a nominee on behalf of such person may, in such
persons own name, file a petition or request from the
corporation the statement described in this subsection.
(f) Upon the filing of any such petition by a stockholder,
service of a copy thereof shall be made upon the surviving or
resulting corporation, which shall within 20 days after
such service file in the office of the Register in Chancery in
which the petition was filed a duly verified list containing the
names and addresses of all stockholders who have demanded
payment for their shares and with whom agreements as to the
value of their shares have not been reached by the surviving or
resulting corporation. If the petition shall be filed by the
surviving or resulting corporation, the petition shall be
accompanied by such a duly verified list. The Register in
Chancery, if so ordered by the Court, shall give notice of the
time and place fixed for the hearing of such petition by
registered or certified mail to the surviving or resulting
corporation and to the stockholders shown on the list at the
addresses therein stated. Such notice shall also be given by 1
or more publications at least 1 week before the day of the
hearing, in a newspaper of general circulation published in the
City of Wilmington, Delaware or such publication as the Court
deems advisable. The forms of the notices by mail and by
publication shall be approved by the Court, and the costs
thereof shall be borne by the surviving or resulting corporation.
(g) At the hearing on such petition, the Court shall
determine the stockholders who have complied with this section
and who have become entitled to appraisal rights. The Court may
require the stockholders who have demanded an appraisal for
their shares and who hold stock represented by certificates to
submit their certificates of stock to the Register in Chancery
for notation thereon of the pendency of the appraisal
proceedings; and if any stockholder fails to comply with such
direction, the Court may dismiss the proceedings as to such
stockholder.
(h) After the Court determines the stockholders entitled to
an appraisal, the appraisal proceeding shall be conducted in
accordance with the rules of the Court of Chancery, including
any rules specifically governing appraisal proceedings. Through
such proceeding the Court shall determine the fair value of the
shares exclusive of any element of value arising from the
accomplishment or expectation of the merger or consolidation,
together with interest, if any, to be paid upon the amount
determined to be the fair value. In determining such fair value,
the Court shall take into account all relevant factors. Unless
the Court in its discretion determines otherwise for good cause
shown, interest from the effective date of the merger through
the date of payment of the judgment shall be compounded
quarterly and shall accrue at 5% over the Federal Reserve
discount rate (including any surcharge) as established from time
to time during the period between the effective date of the
merger and the date of payment of the judgment. Upon application
by the surviving or resulting corporation or by any stockholder
entitled to participate in the appraisal proceeding, the Court
may, in its discretion, proceed to trial upon the appraisal
prior to the final determination of the stockholders entitled to
an appraisal. Any stockholder whose name appears on the list
filed by the surviving or resulting corporation pursuant to
subsection (f) of this section and who has submitted such
stockholders certificates of stock to the Register in
Chancery, if such is required, may participate fully in all
proceedings until it is finally determined that such stockholder
is not entitled to appraisal rights under this section.
(i) The Court shall direct the payment of the fair value of
the shares, together with interest, if any, by the surviving or
resulting corporation to the stockholders entitled thereto.
Payment shall be so made to each such stockholder, in the case
of holders of uncertificated stock forthwith, and the case of
holders of shares represented by certificates upon the surrender
to the corporation of the certificates representing such stock.
The Courts decree may be enforced as other decrees in the
Court of Chancery may be enforced, whether such surviving or
resulting corporation be a corporation of this State or of any
state.
(j) The costs of the proceeding may be determined by the
Court and taxed upon the parties as the Court deems equitable in
the circumstances. Upon application of a stockholder, the Court
may order all or a portion of the expenses incurred by any
stockholder in connection with the appraisal proceeding,
including, without limitation,
C-3
reasonable attorneys fees and the fees and expenses of
experts, to be charged pro rata against the value of all the
shares entitled to an appraisal.
(k) From and after the effective date of the merger or
consolidation, no stockholder who has demanded appraisal rights
as provided in subsection (d) of this section shall be
entitled to vote such stock for any purpose or to receive
payment of dividends or other distributions on the stock (except
dividends or other distributions payable to stockholders of
record at a date which is prior to the effective date of the
merger or consolidation); provided, however, that if no petition
for an appraisal shall be filed within the time provided in
subsection (e) of this section, or if such stockholder
shall deliver to the surviving or resulting corporation a
written withdrawal of such stockholders demand for an
appraisal and an acceptance of the merger or consolidation,
either within 60 days after the effective date of the
merger or consolidation as provided in subsection (e) of
this section or thereafter with the written approval of the
corporation, then the right of such stockholder to an appraisal
shall cease. Notwithstanding the foregoing, no appraisal
proceeding in the Court of Chancery shall be dismissed as to any
stockholder without the approval of the Court, and such approval
may be conditioned upon such terms as the Court deems just;
provided, however that this provision shall not affect the right
of any stockholder who has not commenced an appraisal proceeding
or joined that proceeding as a named party to withdraw such
stockholders demand for appraisal and to accept the terms
offered upon the merger or consolidation within 60 days
after the effective date of the merger or consolidation, as set
forth in subsection (e) of this section.
(l) The shares of the surviving or resulting corporation to
which the shares of such objecting stockholders would have been
converted had they assented to the merger or consolidation shall
have the status of authorized and unissued shares of the
surviving or resulting corporation. (8 Del. C. 1953, § 262;
56 Del. Laws, c. 50; 56 Del. Laws, c. 186, § 24; 57 Del.
Laws, c. 148, §§
27-29; 59
Del. Laws, c. 106, § 12; 60 Del. Laws, c. 371, §§
3-12; 63 Del. Laws, c. 25, § 14; 63 Del. Laws, c. 152,
§§ 1, 2; 64 Del. Laws, c. 112, §§
46-54; 66
Del. Laws, c. 136, §§
30-32; 66
Del. Laws, c. 352, § 9; 67 Del. Laws, c. 376, §§
19, 20; 68 Del. Laws, c. 337, §§ 3, 4; 69 Del. Laws,
c. 61, § 10; 69 Del. Laws, c. 262, §§ 1-9; 70
Del. Laws, c. 79, § 16; 70 Del. Laws, c. 186, § 1; 70
Del. Laws, c. 299, §§ 2, 3; 70 Del. Laws, c. 349,
§ 22; 71 Del. Laws, c. 120, § 15; 71 Del. Laws, c.
339, §§
49-52; 73
Del. Laws, c. 82, § 21; 76 Del. Laws, c. 145,
§§
11-16.)
C-4
Annex D
VOTING
AGREEMENT
THIS VOTING AGREEMENT (this Agreement) made and
entered into as of June 27, 2008, by and among Allied World
Assurance Company Holdings, Ltd, a Bermuda company
(Parent), Allied World Merger Company, a Delaware
corporation and a wholly owned subsidiary of Parent
(MergerCo), and Alleghany Insurance Holdings, LLC
(Stockholder), a Delaware limited liability company
and wholly owned subsidiary of Alleghany Corporation, a Delaware
corporation (Stockholder Parent).
WHEREAS, Darwin Professional Underwriters, Inc., a Delaware
corporation (the Company), Parent and MergerCo are
entering into an Agreement and Plan of Merger dated the date
hereof (the Merger Agreement), providing for the
merger of MergerCo with and into the Company, with the Company
continuing as the surviving corporation (the
Merger); and
WHEREAS, Stockholder owns approximately 9,371,096 shares
(the Shares) of Common Stock, par value $0.01 per
share of the Company (Company Common Stock).
NOW, THEREFORE, in consideration of the execution and delivery
by Parent of the Merger Agreement and the mutual covenants,
conditions and agreements contained herein and therein, the
parties agree as follows:
ARTICLE 1
AGREEMENTS
1.01 Voting Agreements.
(A) During the Term (as defined below) at any meeting of
stockholders of the Company or at any adjournment or
postponement thereof at which a vote in favor of the Merger
Agreement is sought, Stockholder shall vote (or cause to be
voted) a number of shares of Company Common Stock equal to forty
percent (40%) of the shares of Company Common Stock outstanding
and entitled to vote as of the relevant meeting of stockholders
in favor of the adoption of the Merger Agreement. On the date
that is three (3) Business Days prior to the date of the
applicable meeting of stockholders of the Company (or the
applicable adjournment or postponement thereof), Stockholder
shall deliver and grant a revocable proxy to the proxyholders
named in the Companys proxy card (the
Proxyholders) granting the Proxyholders the power
and authority to vote the number of Stockholders shares of
Company Common Stock that is equal to forty percent (40%) of the
shares of Company Common Stock outstanding and entitled to vote
as of the relevant meeting of stockholders in favor of the
adoption of the Merger Agreement as contemplated by this
Section 1.01(A) and Stockholder shall not, during the Term,
amend, withdraw, revoke, alter, modify or change such proxy at
any time prior to the date of such meeting of stockholders of
the Company (or such adjournment or postponement thereof);
provided, however, that Stockholder may amend, withdraw,
revoke, alter, modify or change such proxy if such meeting (or
the applicable adjournment or postponement thereof) is postponed
or adjourned for a date more than three (3) Business Days
after such amendment, withdrawal, revocation, alteration,
modification, or change; provided, further,
however, that notwithstanding any such amendment,
withdrawal, revocation, alteration, modification, or change,
Stockholders obligations pursuant to this
Section 1.01(A) (and the exceptions to those obligations)
shall apply, during the Term, with respect to any meeting
convened following such a postponement, or reconvened following
such an adjournment, at which a vote in favor the Merger
Agreement is sought.
(B) During the Term at any meeting of stockholders of the
Company or at any adjournment or postponement thereof, in any
action by written consent of the stockholders of the Company, or
in any other circumstances upon which the vote, consent or other
approval of the Stockholder is sought, Stockholder shall vote
(or cause to be voted) the Shares (i) notwithstanding
Section 1.03 of this Agreement, against any Company
Acquisition Proposal; and (ii) against any other proposal
or action that could reasonably be expected to impede, interfere
with, delay or postpone the Merger or change in any manner the
voting rights of any class of shares of the Company (including
any amendments to the Company Charter or Company Bylaws).
1.02 Transfers. During the Term, Stockholder shall
not (i) sell, transfer, pledge, assign, or otherwise
dispose of (including by gift) (collectively,
Transfer), or consent to any Transfer of, any Shares
or any interest therein, except
D-1
pursuant to the Merger, or (ii) except as does not prohibit
compliance with this Agreement, grant any proxy,
power-of-attorney
or other voting authorization in or with respect to the Shares
or deposit the Shares into a voting trust or enter into a voting
agreement or voting arrangement with respect to the Shares.
1.03 No Solicitation. During the Term, Stockholder
shall not take any action prohibited by Section 7.03(a) of
the Merger Agreement that would be prohibited if it were a
representative of the Company other than at a time that the
Company has informed Stockholder that the Company or its
representative or the Company Board is permitted to take such
actions under Section 7.03(a). Notwithstanding any other
provisions of this Agreement (including Section 1.02 and
this Section 1.03), Stockholder may enter into any
agreement with respect to a Company Acquisition Proposal
concurrently with the Company entering into an agreement with
respect to such Company Acquisition Proposal; provided, however,
that the Company has deemed such Company Acquisition Proposal to
be a Company Superior Proposal.
1.04 Ownership. Neither Parent, MergerCo, nor any of
their respective subsidiaries was, prior to the execution
hereof, or will become, nor will Parent or MergerCo, or any of
their respective subsidiaries cause any of such entities
respective Affiliates to become, prior to the Merger
Effective Time, a 10% Stockholder (as those terms
are defined in Article EIGHTH of the Restated Certificate
of Incorporation of Stockholder Parent
(Article EIGHTH)). Neither Parent, MergerCo,
nor any of their respective subsidiaries was, prior to the
execution hereof, or will become, nor will Parent or MergerCo,
or any of their respective subsidiaries cause any of such
entities respective affiliates or
associates to become, prior to the Merger Effective
Time, an interested stockholder of Stockholder
Parent (as those terms are defined in Section 203 of the
DGCL (Section 203)). Parent and MergerCo
acknowledge that if (i) Parent, MergerCo, any of their
respective subsidiaries, or any of such entities
Affiliates were, prior to the date hereof, or become a 10%
Stockholder or (ii) Parent, MergerCo, any of their
respective subsidiaries, or any of such entities
affiliates or associates were, prior to the date hereof, or
become an interested stockholder of Stockholder Parent, in each
case prior to the Merger Effective Time, the restrictions
contained in Article EIGHTH or Section 203,
respectively, could come into effect such that the Stockholder
Parent could not cause the Stockholder to take the actions
contemplated by Section 1.01(A) without approval by the
stockholders of Stockholder Parent, in which case it shall not
be a breach of this Agreement if Stockholder does not take the
actions contemplated by Section 1.01(A).
ARTICLE 2
REPRESENTATIONS AND WARRANTIES OF STOCKHOLDER
2.01 Authority Relative to this Agreement.
Stockholder has all necessary limited liability company power
and authority to execute and deliver this Agreement and to
perform its obligations hereunder. The execution, delivery and
performance of this Agreement by Stockholder have been duly and
validly authorized by all necessary limited liability company
action on the part of Stockholder, and no other limited
liability company proceedings on the part of Stockholder are
necessary to authorize this Agreement or to perform the
obligations hereunder. This Agreement has been duly executed and
delivered by, and (assuming the due authorization, execution and
delivery by Parent and MergerCo) constitutes a legal, valid and
binding Agreement of, Stockholder, enforceable against
Stockholder in accordance with these terms, except as such
enforcement may be subject to or limited by (i) bankruptcy,
insolvency, reorganization, moratorium, fraudulent transfer or
other Laws, now or hereafter in effect, relating to or affecting
creditors rights generally and (ii) the effect of
general principles of equity (regardless of whether
enforceability is considered in a proceeding at law or in
equity) (collectively, the Enforceability
Exceptions).
2.02 No Conflict. Assuming compliance with
Section 1.04, neither the execution and delivery of this
Agreement nor the performance by Stockholder of its obligations
hereunder will result in a violation of, or a default under, or
conflict with, (A) any provision of its certificate of
incorporation, bylaws or limited liability company agreement or
(B) any contract, trust, commitment, agreement,
understanding, arrangement or restriction of any kind to which
such Stockholder is a party or bound or to which the Shares are
subject, except, in the case of clause (B), as would not
prevent, delay or otherwise materially impair such
Stockholders ability to perform its obligations hereunder.
Assuming compliance with Section 1.04, execution, delivery
and performance of this Agreement by Stockholder will not
violate, or require any consent, approval or notice under, any
provision of any judgment, order, decree, statute, law, rule or
regulation applicable to Stockholder or the Shares, except
(x) for any reports under Sections 13(d) and 16 of the
Exchange Act as may be required in connection with this
Agreement and
D-2
the transactions contemplated hereby or (y) as would not
reasonably be expected to prevent, delay or otherwise materially
impair Stockholders ability to perform its obligations
hereunder.
2.03 Title to Shares. Stockholder is the beneficial
owner and record owner of the Shares. Stockholder does not
beneficially own any securities convertible into or exercisable
for any shares of Company Common Stock or any other securities
of the Company having voting rights other than the Shares.
Stockholder has the sole right and power to vote such shares,
and no other Person has the right and power to vote such shares
on all matters submitted to holders of shares of Company Common
Stock. The Shares are held by Stockholder, or by a nominee or
custodian for the benefit of Stockholder, free and clear of all
liens, claims, security interests, proxies, voting trusts or
agreements, understandings or arrangements or any other
encumbrances or limitations of voting rights whatsoever, except
for any such encumbrances arising hereunder or as would not
reasonably be expected to prevent, delay or otherwise materially
impair Stockholders ability to perform its obligations
hereunder.
ARTICLE 3
REPRESENTATIONS AND WARRANTIES OF PARENT AND
MERGERCO
3.01 Authority Relevant to this Agreement. Each of
Parent and MergerCo has all necessary corporate power and
authority to execute and deliver this Agreement and to perform
its obligations hereunder. The execution, delivery and
performance of this Agreement by Parent and MergerCo have been
duly and validly authorized by all necessary corporate action on
the part of Parent and MergerCo, and no other corporate
proceedings on the part of either of Parent or MergerCo are
necessary to authorize this Agreement or to perform the
obligations hereunder. This Agreement has been duly executed and
delivered by, and (assuming the due authorization, execution and
delivery by Stockholder) constitutes a legal, valid and binding
Agreement of, Parent and MergerCo, enforceable against Parent
and MergerCo in accordance with these terms, except as such
enforcement may be subject to or limited by the Enforceability
Exceptions.
3.02 No Conflict. Neither the execution and delivery
of this Agreement nor the performance by Parent and MergerCo of
their obligations hereunder will result in a violation of, or
default under, or conflict with (A) any provision of either
such parties memorandum of association, certificate of
incorporation, bylaws or byelaws or (B) any contract,
trust, commitment, agreement, understanding, arrangement or
restriction of any kind to which Parent or MergerCo is a party
or bound except, in the case of clause (B), as would not
prevent, delay or otherwise materially impair the ability of
Parent or MergerCo to perform its obligations hereunder.
Execution, delivery and performance of this Agreement by Parent
and MergerCo will not violate, or require any consent, approval
or notice under, any provision of any judgment, order, decree,
statute, law, rule or regulation applicable to Parent or
MergerCo except (x) for any reports under
Sections 13(d) and 16 of the Exchange Act as may be
required in connection with this Agreement and the transactions
contemplated hereby or (y) as would not reasonably be
expected to prevent, delay or otherwise materially impair such
partys ability to perform its obligations hereunder.
ARTICLE 4
MISCELLANEOUS
4.01 Capacity. Stockholder is entering into this
Agreement solely in its capacity as the record holder or
beneficial owner of the Shares and nothing herein shall limit or
affect any actions taken by Stockholder or any of its Affiliates
or associates in the capacity of director or officer of the
Company, and no such person who is or becomes during the term
hereof a director or officer of the Company shall be deemed to
make any agreement or understanding in this Agreement in such
persons capacity as a director or officer.
4.02 Termination. This Agreement, and all rights and
obligations of the parties hereunder, shall terminate upon (and
shall only be effective from the date hereof until) the first to
occur of (a) the Merger Effective Time, (b) the date
upon which the Merger Agreement is terminated in accordance with
its terms, (c) the date of an Adverse Recommendation
Change, (d) unless consented to by Stockholder, the date of
any amendment to the Merger Agreement that is materially adverse
to the Company, its stockholders or Stockholder (including,
without limitation, any decrease in or change in the form of the
consideration to be paid to stockholders or the addition of any
material obligation or liability on the part of the Company or
its stockholders) (such period from the date hereof until such
termination is referred to herein as the Term);
provided, however, that notwithstanding the foregoing, this
Article IV shall survive any termination of this Agreement.
D-3
4.03 Notices. All notices, requests, claims, demands
and other communications under this Agreement shall be in
writing and shall be given (and shall be deemed to have been
duly given upon receipt) by delivery in person, by prepaid
overnight courier (providing proof of delivery), by facsimile or
by registered or certified mail (postage prepaid, return receipt
requested) to the respective parties at the following addresses
or facsimile numbers (or at such other address for a party as
shall be specified by like notice):
if to Parent or MergerCo:
Allied World Assurance Company Holdings, Ltd
27 Richmond Road
Pembroke HM 08, Bermuda
Facsimile No.:
441-295-5117
Attention: Wesley D. Dupont, General Counsel
with a copy to:
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019
Facsimile No:
212-728-9763
Attention: Steven A. Seidman, Esq.
if to Stockholder:
Alleghany Insurance Holdings, LLC
7 Times Square Tower
New York, NY 10036
Facsimile No:
212-759-8149
Attention: Robert M. Hart, Senior Vice President,
Secretary & General Counsel
with a copy to:
Morris, Nichols, Arsht & Tunnell LLP
1201 N. Market Street
P.O. Box 1347
Wilmington, DE
19899-1347
Facsimile No.:
(302) 658-3989
Attention: Frederick H. Alexander, Esq.
4.04 Forum. Except as set out below, each of the
Parent, MergerCo and Stockholder hereby irrevocably and
unconditionally consents to submit to the sole and exclusive
jurisdiction of the courts of the State of Delaware or any court
of the United States located in the State of Delaware (the
Delaware Courts) for any litigation arising
out of or relating to this Agreement, or the negotiation,
validity or performance of this Agreement (and agrees not to
commence any litigation relating thereto except in such courts),
waives any objection to the laying of venue of any such
litigation in the Delaware Courts and agrees not to plead or
claim in any Delaware Court that such litigation brought therein
has been brought in any inconvenient forum. Each of the parties
hereto agrees, (i) to the extent such party is not
otherwise subject to service of process in the State of
Delaware, to appoint and maintain an agent in the State of
Delaware as such partys agent for acceptance of legal
process, and (ii) that service of process may also be made
on such party by prepaid certified mail with a proof of mailing
receipt validated by the United States Postal Service
constituting evidence of valid service. Service made pursuant to
(i) or (ii) above shall have the same legal force and
effect as if served upon such party personally within the State
of Delaware.
4.05 Interpretation. The descriptive headings
contained in this Agreement are included for convenience of
reference only and shall not affect in any way the meaning or
interpretation of this Agreement. Capitalized terms used but not
defined herein shall have the meaning set forth in the Merger
Agreement.
4.06 Counterparts. This Agreement may be executed
and delivered (including by facsimile transmission) in two or
more counterparts, and by the different parties hereto in
separate counterparts, each of which when executed shall be
deemed to be an original but all of which taken together shall
constitute one and the same agreement.
D-4
4.07 Entire Agreement. This Agreement (including the
documents and instruments referred to herein) constitutes the
entire agreement among the parties with respect to the subject
matter hereof, and supersedes all prior agreements and
undertakings, both written and oral, among the parties, or any
of them, with respect to the subject matter hereof.
4.08 Governing Law. All disputes, claims or
controversies arising out of or relating to this Agreement, or
the negotiation, validity or performance of this Agreement,
shall be governed by and construed in accordance with the laws
of the State of Delaware without regard to its rules of conflict
of laws.
4.09 Amendment. No amendment, modification or waiver
in respect of this Agreement shall be effective against any
party unless it shall be in writing and signed by such party.
4.10 Parties in Interest. This Agreement shall be
binding upon and inure solely to the benefit of each party
hereto, and nothing in this Agreement, express or implied, is
intended to or shall confer upon any other person any right,
benefit or remedy of any nature whatsoever under or by reason of
this Agreement.
4.11 Assignment. Neither this Agreement nor any of
the rights, interests or obligations under this Agreement shall
be assigned, in whole or in part, by operation of law or
otherwise, by any of the parties without the prior written
consent of the other parties. Any assignment in violation of the
foregoing shall be void.
4.12 Further Assurances. Stockholder shall, without
further consideration, and at its own expense, from time to
time, perform such further acts and execute and deliver, or
cause to be executed and delivered, such additional or further
consents, documents and other instruments as Parent may request
for the purpose of effectuating the matters covered by this
Agreement or that are necessary to vest in Parent the power to
carry out and give effect to the provisions of this Agreement;
provided, however, that in no event shall the Stockholder be
required to incur expenses in excess of $50,000 pursuant to this
Section 4.12.
4.13 Certain Events. In the event of any stock
split, stock dividend, merger, reorganization, recapitalization
or other change in the capital structure of the Company
affecting the Company Common Stock or other voting securities of
the Company, the number of Shares shall be deemed adjusted
appropriately and this Agreement and the obligations hereunder
shall attach to any additional shares of Company Common Stock or
other securities of the Company issued to or acquired by
Stockholder.
4.14 Expenses. All costs and expenses incurred in
connection with the transactions contemplated by this Agreement
shall be paid by the party incurring such costs and expenses.
4.15 Specific Performance. The parties hereto agree
that, in the event any provision of this Agreement is not
performed in accordance with the terms hereof, (a) the
non-breaching party will sustain irreparable damages for which
there is not an adequate remedy at law for money damages and
(b) the parties shall be entitled to specific performance
of the terms hereof, in addition to any other remedy at law or
in equity, including an injunction restraining such breach or
threatened breach.
4.16 Severability. If any term or other provision of
this Agreement is invalid, illegal or incapable of being
enforced by any rule of law, or public policy, all other
conditions and provisions of this Agreement shall nevertheless
remain in full force and effect so long as the economic or legal
substance of this Agreement is not affected in any manner
materially adverse to any party. Upon such determination that
any term or other provision is invalid, illegal or incapable of
being enforced, the parties hereto shall negotiate in good faith
to modify this Agreement so as to effect the original intent of
the parties as closely as possible in a mutually acceptable
manner in order that the terms of this Agreement remain as
originally contemplated to the fullest extent possible.
D-5
IN WITNESS WHEREOF, Parent, MergerCo and Stockholder have caused
this Agreement to be duly executed and delivered as of the date
first written above.
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, LTD
|
|
|
|
By:
|
/s/ Scott
A. Carmilani
|
Name: Scott A. Carmilani
Title: President and Chief Executive Officer
Name: Wesley D. Dupont
Title: Senior Vice President, General Counsel &
Secretary
ALLIED WORLD MERGER COMPANY
|
|
|
|
By:
|
/s/ Scott
A. Carmilani
|
Name: Scott A. Carmilani
Title: President
Name: Wesley D. Dupont
Title: Secretary
ALLEGHANY INSURANCE HOLDINGS, LLC
Name: Weston Hicks
Title: Chief Executive Officer
D-6
Proxy DARWIN
PROFESSIONAL UNDERWRITERS, INC.
PROXY FOR SPECIAL MEETING OF
STOCKHOLDERS ON OCTOBER 15, 2008
THIS PROXY IS SOLICITED ON
BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints
Stephen J. Sills, John L. Sennott, Jr. and Mark I. Rosen as
proxies, each with the power to appoint his substitute and with
authority in each to act in the absence of the other, to
represent and to vote all shares of stock of Darwin Professional
Underwriters, Inc. which the undersigned is entitled to vote at
the special meeting of stockholders of Darwin Professional
Underwriters, Inc. to be held at the Companys principal
corporate offices at 9 Farm Springs Road in Farmington,
Connecticut, on October 15, 2008 at 10:00 a.m., local time,
and any adjournment or postponement thereof, with all powers
that the undersigned would have if personally present thereat:
This proxy when properly executed
will be voted in the manner directed herein by the undersigned
stockholder. UNLESS A CONTRARY DIRECTION IS INDICATED, THIS
PROXY WILL BE VOTED FOR ADOPTION OF THE MERGER AGREEMENT AND FOR
THE ADJOURNMENT PROPOSAL, IF NECESSARY OR APPROPRIATE. IF
SPECIFIC INSTRUCTIONS ARE INDICATED, THIS PROXY WILL BE
VOTED IN ACCORDANCE THEREWITH.
(Continued and to be marked,
dated and signed on other side)
Address Change/Comments (Mark
the corresponding box on the reverse side)
FOLD AND DETACH HERE
|
|
|
|
|
|
|
Please Mark Here for
Address Change or
Comments
|
|
o
|
|
|
SEE REVERSE SIDE
|
|
|
|
|
|
|
|
|
|
Please mark your vote
|
|
x
|
|
|
as indicated in this
example
|
|
|
THE BOARD OF DIRECTORS, WHICH
IS SOLICITING THIS PROXY, RECOMMENDS A VOTE FOR
PROPOSALS 1 AND 2.
|
|
|
|
1. Adoption of the Agreement and Plan of Merger,
dated as of June 27, 2008, by and among Darwin Professional
Underwriters, Inc., Allied World Assurance Company Holdings, Ltd
and Allied World Merger Company.
|
|
|
2. Approval of the adjournment of the special
meeting, if necessary or appropriate, to solicit additional
proxies if there are insufficient votes at the time of the
special meeting to adopt the Merger Agreement.
|
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
o
|
|
o
|
|
o
|
|
o
|
|
o
|
|
o
|
The proxies named above, Stephen
J. Sills, John L. Sennott, Jr. and Mark I. Rosen, are authorized
to vote in their discretion upon such other matters as may
properly come before the special meeting and any adjournment or
postponement of the special meeting.
|
|
|
|
|
Signature
|
|
Signature
|
|
Date
|
NOTE: Please sign as name
appears hereon. Joint owners should each sign. When signing as
attorney, executor, administrator, trustee or guardian, please
give full title as such. If signing on behalf of a corporation,
please sign in full corporate name by the president or other
authorized officer(s). If signing on behalf of a partnership,
please sign in full partnership name by authorized
person(s).
FOLD AND DETACH HERE
Vote by Internet or Telephone
or Mail
24 Hours a Day, 7 Days a
Week
Internet and telephone voting is available through 11:59 PM
Eastern Time the day prior to the special meeting day.
Your Internet or telephone vote authorizes the named proxies
to vote your shares in the same manner as if you marked, signed
and returned your proxy card.
|
|
|
|
|
|
|
|
|
Internet
|
|
|
|
Telephone
|
|
|
|
Mail
|
www.investorvote.com
|
|
|
|
1-800-652-8683
|
|
|
|
|
Use the Internet to vote your proxy.
Have your proxy card in hand when you access the web site.
|
|
OR
|
|
Use any touch-tone telephone to vote your proxy. Have your
proxy card in hand when you call.
|
|
OR
|
|
Mark, sign and date your proxy card and return it in the
enclosed postage-paid envelope.
|
|
|
|
|
|
|
|
|
|
If you
vote your proxy by Internet or by telephone,
you do NOT need to mail back your proxy card.